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Ever since Chinese medicine encountered modern science in the late nineteenth 
century, the relationship between the two traditions has been extremely one-sided. At 
best, scientists perceived Chinese medicine as an archive of primitive knowledge from 
which potentially useful drugs could be extracted. Chinese medicine practitioners 
themselves, meanwhile, began a long struggle throughout the twentieth century to 
modernise their medicine with the help of Western theories and technology. At the 
turn of the twenty-first century, the involvement of systems biologists in Chinese 
medicine research created a new encounter, however, that, at least in the rhetoric of its 
actors, promised a very different kind of relationship: a match of two systems brought 
together by a shared interest in understanding life, health, illness and medicine as 
intrinsically complex and not amenable to the reductionist approaches of mainstream 
science. This research empirically investigates the nature of this relationship and how 
it emerged. It aims to contribute to the contemporary history of Chinese medicine by 
exploring the relationship between Chinese medicine and systems biology. This thesis 
argues that a heterogeneous network evolved, which is composed of human and 
nonhuman actors and their interactions created globally distributed research projects 
on Chinese medicine and systems biology.  
For the purpose of this research, a multi-sited ethnography was conducted over a 
period of eleven months and a literature survey was employed to trace the start and the 
development of this heterogeneous network. Ethnographic data reveals in four 
chapters on the rhetoric and perceptions of the actors, their involvement in Chinese 
medicine research, their laboratory practice, and the networks and political ties, which 
developed into a heterogeneous network of Chinese medicine and systems biology 
research. This research concludes that in the 2000s, a heterogeneous network emerged 
through the shared ideologies of systems thinking and holism. The shared ideologies 
set the groundwork for systems biologists to engage with Chinese medicine on its own 
terms, and created scientific practices, co-operation and funding opportunities between 
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Since the moment Chinese medicine encountered modern science in the late nineteenth 
century, the relationship between the two traditions has been rather one-sided. At best, 
pharmaceutical scientists perceive Chinese medicine as an archive of primitive 
knowledge from which potentially useful drugs can be extracted (Hsu, 2009; Jia, 2005). 
At worst, they dismiss Chinese medicine as a non-biomedical treatment, quack 
medicine1, or a pseudoscience (Colquhoun, 2012; Van Hollen, 2005; Hsu, 2008; Xu, 
1999; Scheid, 2014). In the twentieth century, Chinese medicine practitioners began a 
long struggle to modernise their medicine with the help of modern science (see for 
example, Lei, 2014; Scheid, 2002a; Taylor, 2005; Zhan, 2009; Andrews, 2014). At the 
turn of the twenty-first century, the phenomenon of an “interface” between systems 
biology, which is a multidisciplinary field that aims for a system-level understanding 
of a living organism2, and Chinese medicine emerged (see Scheid, 2014). The term 
“interface” was first coined by Scheid (2014) to describe the translation between 
Chinese medicine and Western medicine through the Chinese medicine concept of 
zheng 证 . Zheng describes patterns or symptoms in Chinese medicine diagnosis 
(Farquhar, 1994; Scheid, 2002a). In contrast, systems biologists and Chinese medicine 
researchers involved in this “interface”, speak of a match of two systems brought 
together by a shared interest in understanding life, health, illness and medicine, as 
intrinsically complex and not as something that is amenable to the reductionist 
approach of mainstream science (see, for example, van der Greef, 2005; van der Greef 
                                               
 
1 The Cambridge Dictionary defines quack as “a person who dishonestly pretends to have medical skills 
or knowledge” (see Cambridge Dictionary, no date). Thus, quack medicine is not a (bio-)medical 
practice. Colquhoun (2012, p. 2) refers to complementary medicine and describes this as a “non-
evidence based medicine”. 
2 The definition of systems biology varies in the literature due to the multi-disciplinary background of 
systems biologists from biology, chemistry, biochemistry, engineering, bioinformatics and physics (see 
Nersessian, 2017). Most systems biologists define systems biology as a system-level understanding, 
which includes the networks of gene interactions, biochemical pathways, the underlying mechanisms 
and the behaviour of the system (Kitano, 2002; Ideker, Galitski and Hood, 2001). Others add to this 
definition that systems biology studies protein, metabolic and cellular pathways, which interact and are 




et al., 2010; Wang et al., 2005; van Wietmarschen et al., 2009, 2011; Zhang et al., 
2012). According to their description, the new “interface” or match transforms the 
interpretation of encounters as a confrontation between the two opposites of modern 
science and Chinese medicine to a relationship between them, which is based on shared 
perspectives, and is not always guided by the same aims.  
Since the 2000s, scientists have published articles about how systems biology has been 
used to examine Chinese medicine. These publications have taken the form of review 
articles and reports on Chinese medicine and systems biology research (see for 
example Wang et al., 2005; van der Greef, Hankemeier and Mcburney, 2006; van der 
Greef et al., 2010; Barlow et al., 2012; Uzuner et al., 2012; Buriani et al., 2012; Flower 
et al., 2012; Li, Yang and Gong, 2009), clinical studies (see, for example, Lu et al., 
2006; van Wietmarschen et al., 2012; Huang et al., 2011; Litscher 2012), and research 
articles (see Scheid, 2014). These publications have primarily focused on the scientific 
evaluation of good practices in Chinese medicine research, the efficacy of Chinese 
medicine practice and therapies, and the historical investigation of the use of the 
Chinese medicine concept of zheng. The numerous studies on systems biology and 
Chinese medicine indicate that a scientific relationship is present between the two 
fields, and that other concepts and materials, such as omics technology or Chinese 
medicine drugs and practices are vital for their investigations. However, the existence 
of an “interface” or relationship and the nature of this relationship between Chinese 
medicine and systems biology, as well as, the development and defining features have 
yet to be unravelled.  
Recent work by historians and STS scholars has investigated how modern science is 
integrated into Chinese medicine and has had a direct impact on it (see Lei, 2014; 
Scheid and Lei, 2014). Whilst ethnographers have provided empirical studies with STS 
approaches on the influence of science in traditional medicines (see, for example, 
Adams, Dhondup and Phuoc, 2010; Pordié and Gaudilliere, 2014; Kloos, 2017), little 
if any empirical work has been done to investigate the perspective of Western scientists 
on the integration of modern science in traditional medicine. It is still not known how 
systems biologists and technology participate and perform in current interaction 
processes between science, technology and Chinese medicine. It is also not known 




technology. This thesis aims to investigate the involvement of systems biologists in 
Chinese medicine studies and Chinese medicine researchers in systems biology to 
understand how this latest relationship between Chinese medicine and systems biology 
emerged, what it was influenced by and how it changed from its emergence to the mid 
2010s.  
The aim of this study to investigate the emergence, interpretation and nature of this 
suspected “interface” between Chinese medicine and Western medicine in relationship 
to encounters that happened in the twentieth century. In this thesis, Rogaski’s (2004, 
p.8) definition of encounters will be used. She claims that encounters are “moments of 
co-operation as well as coercion” between Chinese medicine and modern science or 
Western medicine that occurred before the twenty-first century. The term “interface” 
or relationship will be used to describe the contact or interactions between Chinese 
medicine and systems biology in the last two decades. This study will provide a 
historical and ethnographic account of various types of involvement of scientists and 
materials in this “interface” and multiple factors that have contributed to its emergence 





1.1 RESEARCH HYPOTHESIS AND QUESTIONS 
 
The relationship between Chinese medicine and systems biology is defined in the 
secondary and scientific literature as an “interface” or a match. Thus, my research 
hypothesises that there is an “interface” or a relationship between Chinese medicine 
and systems biology. The actors involved might share perspectives and intentions 
which generated and shaped this interface from the beginning.  
Based on this hypothesis this study investigates the following questions: 
1. Is there an “interface” and if so, can this latest contact between Chinese 
medicine and systems biology be referred to as an “interface” and what is its 
nature? 
2. How does this “interface” differ from previous encounters between Chinese 
medicine and modern science and Western medicine? 
3. How did the actors become involved in Chinese medicine and systems biology 
research?  
4. How did the participation of the human and nonhuman actors in Chinese 
medicine and systems biology research influence the development of the 
relationship between Chinese medicine and systems biology? 
The objectives of this thesis are, first, to investigate the perceptions of this “interface” 
and how the “interface” arose and what its nature is. Secondly, to find out what makes 
it stable, detectable or describable and distinguished from past encounters between 
Chinese medicine and modern science. Thirdly, to discover how it emerged and 
developed over the past thirty years. To date, these issues are not addressed in the 
literature. While an extensive analysis of the existing literature is paramount, the scope 
of this study reaches beyond scientific literature about this phenomenon. The thesis 
not only aims to identify various academic and scientific components that underpin the 
emergence of the “interface”, but it also aims to provide an ethnographic account on 
the way this “interface” emerged and developed in multiple sites. I am going to focus 




In order to answer my research questions, I will employ methodological triangulation 
(Flick, 2014). With a triangulation approach, different data will be collected to expose 
the different interpretations and the development of this “interface” between Chinese 
medicine and systems biology. My methods will include: a literature survey, multi-
sited ethnography and episodic interviews. 
A literature survey of the secondary scientific literature published in Chinese medicine 
research and systems biology will be analysed to confirm scientific interest in Chinese 
medicine and systems biology. This analysis will enable me to identify the principal 
authors/actors and themes in this “interface” which will help me determine field 
research sites and topics of concern for both fields. 
To investigate the emergence of this “interface” as an ongoing process, ethnographic 
methods will be used to document the process as it is happening. The ethnographic 
method used to investigate this “interface” aims to capture details about its emergence, 
involvements of actors, influences, perceptions, experiences and development while it 
is still emerging. Thus, multi-sited ethnography will be used to investigate how the 
“interface” occurred in globally distributed fields. This will be achieved through 
participant observations which yield rich primary data on this “interface” beyond the 
scientific publications. 
Episodic interviews will be incorporated to collect episodes of biographic-narratives 
of the leading human actors. This method will help me obtain in-depth descriptions of 
their perspectives and experiences about their involvement and work in this “interface”.  
The meeting of two fields creates a multidisciplinary interaction between Chinese 
medicine and systems biology. Both fields themselves are multidisciplinary. For 
example, systems biology is a mix of biology, physics, chemistry, engineering and 
bioinformatics. Chinese medicine is a mongrel of traditional practices and theories 
mixed with biomedical disease categories and technology (see for example Lei, 2014; 
Taylor, 2005; Scheid, 2002a). In order to explore the scientific relationship between 
these two fields and to distinguish implemented structures from modern science into 
Chinese medicine, knowledge of Chinese medicine and the lenses of Science and 




ethnography, history and STS research can grasp the nature of this scientific 
relationship.  
My research is the first to investigate the “interface” between Chinese medicine and 
systems biology with multi-sited ethnography. Multi-sited ethnographic descriptions 
and interview data will be provided through field research for eleven months from 
2015 and 2016 in England (UK), in Graz (Austria), in Leiden and Zeist (the 
Netherlands), in Harbin, Dalian and Hangzhou (China) and Tokyo (Japan) (see Table 
1 for the dates and observation details of my fieldwork). Data will be analysed to gain 
a “thick description”, which are detailed accounts and explanations of social actions 
to produce conceptual structures for conveying the findings of the study to an audience 
or an outsider of the study (see Geertz, 1988). My study aims to present a thick 
description of the relationships between human and nonhuman actors which constitute 
to this “interface”. The actors include students, professors, Chinese medicine 
practitioners, researchers, politicians, technology, and laboratory materials. The 
themes acquired from thematic coding will be refined into codes to provide rounded, 
detailed chapters of the emergent “interface” and its development. The themes and 
codes will uncover various aspects of this “interface” and inform the analysis of 
“modes of ordering” this “interface” as a heterogeneous network, vision and vocation, 
which will be presented in Chapter 8.  
The first research question: “Is there an ‘interface’ and if so, can this latest contact 
between Chinese medicine and systems biology be referred to as an ‘interface’ and 
what is its nature?” will examine the term and the nature of this “interface”. To answer 
the first question, results from a literature survey will be compared with interview data 
on the perception and interpretation of “interface” by actors in the field of Chinese 
medicine and systems biology studies. The second question: “How does this   
“interface” differ from previous encounters between Chinese medicine and modern 
science and Western medicine?” will be explored with the use of a literature survey on 
the development of concepts such as holism and systems thinking in systems biology 
and Chinese medicine. This analysis will provide an answer to why actors in this 
“interface” believe in a shared ground between Chinese medicine and systems biology.  
The third research question: “How did the actors become involved in Chinese medicine 




data will show the motivations and aims of the actors that influenced their decision to 
undertake Chinese medicine and systems biology research. The answer to this question 
will demonstrate the interest of the actors in Chinese medicine and demonstrate how 
this changed their approaches to medicine and their way of practising science 
following their involvement with Chinese medicine. Therefore, the involvement of the 
actors will show a conscious decision that was influenced by their vision, interest, 
needs and values.  
The last research question will reflect on: “How did the participation of the human and 
nonhuman actors in Chinese medicine and systems biology research influence the 
development of the relationship between Chinese medicine and systems biology?” To 
answer this question, I will analyse ethnographic data and secondary and scientific 
literature to reveal how the actors were employed in various global research 
collaborations on Chinese medicine and systems biology between 2005 and 2012.  
This thesis will demonstrate that the “interface” has emerged through different 
involvements of scientists in Chinese medicine and systems biology research. Thus, it 
makes an important contribution to the investigation of scientific and technological 
studies on how scientists approached and engaged with Chinese medicine. It aims to 
contribute to contemporary history of Chinese medicine and the concept of “modes of 
ordering” (Law, 1994) through the combined analysis of ethnographic data and 
scientific literature, which places this most recent “interface” in the historical context 





1.2 THESIS ORGANISATION 
 
This thesis is divided into nine chapters. Following the Introduction (Chapter 1), 
Chapter 2 will review the existing literature on the historical encounters between 
Chinese medicine and modern science. It will look at the works of Scheid (2002a, 
2007), Taylor (2005), Zhan (2009), Lei (2014), Andrews (2014), to name a few. First, 
the literature will inform the approach of this thesis on the emergent “interface” 
between Chinese medicine and systems biology with perspectives from historical and 
ethnographic studies. The emergence of a relationship of scientific interactions 
between Chinese medicine and systems biology will be investigated and analysed. 
Secondly, previous encounters that occurred in the twentieth century will inform this 
study about changes that happened in Chinese medicine following the contact with 
modern science. This chapter will consider a variety of methodological and theoretical 
approaches taken by Chinese medicine historians, anthropologists and STS scholars 
(Scheid, 2002a, 2014; Lei, 2014; Andrews, 2014; Law, 1994; Latour, 1987, 2013). 
Chapter 2 thus sets the disciplinary framework for this thesis in Chinese medicine 
history, ethnography and STS study and aims to fill the gap in the recent history of 
Chinese medicine and scientific studies with the focus on involvement.  
Chapter 3 will discuss the research methods used for this study. The methodological 
triangulation emanates from anthropology and STS studies and will combine a 
literature survey, participant observation and episodic interviews. The triangulation 
will provide critical methods to investigate the emergence of the current “interface” 
during the past three decades. A thematic coding of ethnographic and literature survey 
data will establish the main themes and codes which will be presented in four Chapters 
(4, 5, 6, and 7), and which are accounts of the relationships between Chinese medicine 
researchers and systems biologists.  
In Chapter 4, I will analyse the findings of interviews and a literature survey on the 
three codes: rhetoric and coining the term “interface”, perceptions and definition of 
this “interface” and Chinese medicine and systems biology are the same. A literature 
survey will present the historical traces of their sameness. The thematic coding from 




medicine and systems biology and how systems biologists and Chinese medicine 
researchers (referred to as the actors in this thesis) described their relationship in 
research papers. The second section will examine interview data on the perceptions 
and descriptions of this “interface” and the work of the actors. The interview material 
will reveal the insights of this relationship in four codes: co-operation, molecules as a 
bridge, technology as a bridge, the sameness of Chinese medicine and systems biology. 
The last section will explore historical accounts of the belief that Chinese medicine 
and systems biology are the same. This chapter will analyse how systems thinking and 
holism became central concepts in Chinese medicine and systems biology studies. 
Hence, Chapter 4 will build the groundwork for the definitions and perceptions of the 
term “interface” and the ideological connections between systems biology and Chinese 
medicine.  
Chapter 5 will identify the involvement of the actors with Chinese medicine or systems 
biology research. The analysis of interview material will disclose early involvement 
of the actors in Chinese medicine in the 1990s, which later developed into initial 
studies on Chinese medicine and systems biology. Thus, I will call those involved, the 
inner circle of the relationship between Chinese medicine and systems biology. The 
main theme of the inner circle will be “involvement” which can be divided into four 
different types: (a) technology and health, (b) complexity, (c) family and exploitation, 
and (d) the discontentment with reductionist representation of medicine and research 
practice.  
Chapter 6 will examine ethnographic data that will elaborate on the theme “Laboratory 
practice and industrial ties”. The codes in this chapter will be (a) co-operation projects, 
(b) laboratory practice and technology, and (c) funding and industrial ties. These codes 
will demonstrate academic and industrial structures, which facilitate this “interface” 
by employing students, researchers and omics technology in projects that examine 
systems biology concepts and various aspects of Chinese medicine. This chapter will 






In Chapter 7, the last theme of “Networks and political ties” will be explained having 
analysed data from interviews and the literature survey. This analysis will present three 
codes: (a) political networking, (b) joining Chinese medicine studies, and (c) funding 
and regulations. These codes detect that actors were invited or employed in network 
organisations and an international consortium to participate in discussions on Chinese 
medicine research and regulations in a European healthcare setting.  
Chapter 8 will analyse the various themes and codes of Chapters 4, 5, 6 and 7 with the 
adaption of “modes of ordering” (Law, 1994; Moser, 2005). Law’s (1994) “modes of 
ordering” define in STS an approach to study how interactions between human and 
nonhuman actors co-evolve in society and science. Moser’s (2005) application of 
“modes of ordering” is important for this study as Moser includes multi-sited 
ethnography and he patterns the life stories of interview materials. Moser (2005) uses 
this concept to understand the “ordering” of normality which disabled people regain 
through technology. With the concept of ordering, I aim to analyse how technology, 
as an actor, generates in co-operation with humans a new understanding of a 
phenomenon (i.e., this “interface”).  
My thesis will analyse three “modes of ordering”, which are heterogeneous networks, 
vision and vocation. The first ordering of heterogenous networks, is a definition gained 
from my data of life stories. This mode will answer the research question of the 
existence and nature of the “interface”. The ordering of heterogeneous networks will 
reveal that projects and collaborations were built to challenge existing research 
paradigms and expensive healthcare systems. The second and third orderings are 
adopted from Law’s “modes of ordering vision and vocation”. I will analyse with the 
“ordering of vision” the emergence of this “interface” through the involvement of 
systems biologists in the study of and the learning from Chinese medicine. This mode 
will analyse how technology and concepts of systems thinking and holism facilitated 
systems biologists to engage with Chinese medicine. While the mode of vocation will 
investigate the employment of the actors and the development of their studies on 
Chinese medicine and systems biology from understanding Chinese medicine to 
examining the safety and regulation of this medicine. With these “modes of ordering”, 




generating and transforming the “interface” between systems biology and Chinese 
medicine. 
The concluding chapter summarises the main findings of the thesis. It restates the 
research aim to contribute to the contemporary history of Chinese medicine by being 
the first ethnographic and historical exploration of this ongoing phenomenon. It also 
aims to contribute to STS studies with the theoretical analysis of different modes of a 
heterogeneous networks, vision and vocation of scientists and technology in the 
research of Chinese medicine and how various involvements transform the research 
approach to investigate Chinese medicine. Finally, it evaluates the limitations of the 





2. HISTORICAL AND METHODOLOGICAL ORIENTATIONS  
 
The term “interface” was coined to describe the translation process between Chinese 
medicine and systems biology (Scheid, 2014). To understand how researchers have 
interpreted past meetings or confrontations between Chinese medicine and modern 
science, this chapter reviews significant works in the area of Chinese medicine history 
and medical anthropology regarding past encounters between Chinese medicine and 
modern science and the emergent relationship between Chinese medicine and systems 
biology. It aims to identify how Chinese medicine researchers refer to and describe 
meetings between Chinese medicine and modern science and to notice differences or 
similarities to the present encounter. The next section in this chapter will review 
medical anthropology as a feasible methodology for this thesis. This methodology will 
be considered in combination with concepts of STS to explore the nature and the 
emergence of the relationship between Chinese medicine and systems biology.  
In recent literature, Scheid (2014) describes the relationship between Chinese 
medicine and systems biology as an “interface”. He employs the concept of “boundary 
objects” by Star and Griesemer (1989), which analyses a concrete or an abstract object 
that mediates between two distinct fields to facilitate collaborative work. Scheid claims 
that the Chinese medicine concept zheng, translated by Farquhar (1994) as a pattern or 
a symptom in Chinese medicine disease description, serves as a boundary object 
between Chinese medicine and systems biology and creates and “interface” between 
them. Scheid (2014) presents two genealogies that argues first that zheng is a central 
aspect that joins systems biology and Chinese medicine together. In the second 
genealogy, Scheid (2014) elaborates on zheng and its role as a pivotal point in Chinese 
medicine that has changed its meaning several times since the eleventh century. He 
shows in both genealogies that zheng connects institutional, political and economic 
settings and that zheng historically co-created the systems biology and Chinese 
medicine “interface”.  
Scheid’s use of zheng as a boundary object offers a new tool to study the relationship 
between Chinese medicine and systems biology. In order to analyse the relationship 




two distinct sides, such as Chinese medicine and systems biology. However, as soon 
as one field is integrated into the other, the use of this concept is not reasonable as one 
actor understands both fields without a translation tool (Star and Griesemer, 1989).  
In 2005, Wang, Lamers, Korthout, Van Nesselrooij, Witkamp, Van Der Heijden, 
Voshol, Havekes, Verpoorte and Van Der Greef first published their interest in zheng 
as a bridge between systems biology and Traditional Chinese Medicine. Their idea is 
to transcribe zhengs with metabolomics into a biomedical and scientific context. 
Metabolomics is the study of a metabolite complement in biological samples through 
experiments and chemical analysis (Jenkins et al., 2004). Omics technology facilitates 
the production of large datasets such as mass spectrometry or gas chromatography and 
identify the metabolites in reference databases (ibid). Wang et al. (2005) defined what 
Scheid (2014) calls an “interface” as a bridge between Chinese medicine and 
molecular pharmacology as they recognised a shared system understanding between 
systems biology and Chinese medicine. This understanding assists systems biology to 
function as a translator or a bridge between bioscience and Chinese medicine. In later 
publications, Jan van der Greef, van Wietmarschen, Schroën, Wang, Hankemeier and 
Xu (2010) wrote about Systems biology-based diagnostic principles as pillars of the 
bridge between Chinese and Western medicine, which contributes to their original idea 
to new personalised medicine by gaining insights into pattern differentiation methods 
of Chinese medicine diagnosis. Van der Greef and his colleagues assume Chinese 
medicine as one of the most acknowledged and well documented personalised 
traditional medical systems in the world.  
The idea of bridging Chinese medicine and systems biology soon after occurred in 
2012 in a “Special Issue” on Traditional Chinese medicine research in the post-
genomic era. The editors and authors of the special issue were members of a 
consortium of Chinese medicine researchers, pharmaceutical scientists, bioscientists 
and biotechnology scientists for the integration of Chinese medicine in the European 
healthcare system, which was funded by the European Research Council (ERC, see 
more about the funding in Chapter 7 on Networks and political ties). The authors 
mentioned van der Greef’s et al. (2010) and Wang’s et al. (2005) article as the 
groundwork for the relationship between Chinese medicine and systems biology 




et al., 2009). The special issue included review articles on Chinese materia medica 
(Chan et al., 2012; Zhao, Guo and Brand, 2012), application of omics techniques in 
systems biology to Chinese medicine practice and pharmacovigilance in herbal 
medicine research on drug safety and study designs.3 They concluded that systems 
biology and omics technologies are instruments to modernise Chinese medicine 
regarding drug standardisation and preparation through metabolic fingerprinting. 
Fingerprinting is the systemic identification of drugs through measurements of global 
and dynamic metabolic responses of an organism to a biological stimulus, for example, 
medication, or genetic manipulation.  
For instance, one of the aims in metabolomics is to use magnetic resonance fields, such 
as the nuclear magnetic resonance spectroscopy (NMR) technique. The NMR 
measures atomic nuclei to characterise and quantify all small molecules in a complex 
biological sample, for example, a Chinese medicine multiple herb prescriptions or 
formula (fufang 复方) (Wang and Chan, 2010). The authors of the special issue 
conclude that omics technology and systems biology enable an understanding of 
complex biological perturbations, the therapeutic intervention and disease prevention 
with Chinese medicine. However, with the demand that studies be standardised and 
conducted according to the required level of scientific quality, design and reporting, 
other authors worry about the personalised aspect of Chinese medicine (Scheid and 
MacPherson, 2012). Hence, the articles of the special issue manifest that a research 
interest between Chinese medicine and systems biology emerged with the demand for 
standards to validate and authenticate Chinese medicine.  
The questions that surface from the publications on Chinese medicine and systems 
biology are two: how did the relationship between systems biology and Chinese 
medicine emerge? Second, what is behind the rhetoric of modernising and 
standardising Chinese medicine? These questions lead to the question of whether or 
not encounters between Chinese medicine and modern science which happened in the 
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past were similar to or different from the present relationship between Chinese 
medicine and systems biology. In the following section, I am going to discuss the 
literature of Chinese medicine with the focus on encounters between modern science 




2.1 ENCOUNTERS IN THE LITERATURE 
 
In this section, I will elaborate on three separate encounters between Chinese medicine 
and Western medicine or modern science: (1) the modernisation of Chinese medicine 
at the turn of the twentieth century, (2) the standardisation of Chinese medicine in the 
1960s and (3) the globalisation of Chinese medicine in the 1970s and 1980s. The 
literature shows historical accounts of past encounters, but not of the new relationship 
established in the 2000s, which is the most recent meeting between Chinese medicine 
and science.  
 
2.1.1 THE MODERNISATION OF CHINESE MEDICINE 
 
In this section, I will reflect on the phase which came after the defeat of Western and 
Japanese powers in the late nineteenth century and the proposal for the abolition of 
Chinese medicine in 1929. At this time, researchers such as Andrews (2014), Rogaski, 
(2004) and Lei (2014) noticed an increased interest of Chinese medicine practitioners 
in Western science. Andrews (2014, p. 12) claims that a “whole generation of Chinese” 
blamed traditional values such as Confucianism, Chinese medicine and the lack of 
science for the weakness of China to defend the country against the West and Japan in 
the nineteenth century. As a result, Chinese intellectuals looked towards the West to 
learn from and to integrate modern science. Science and Western medicine became 
crucial instruments for the modernisation and the regaining the power in the country 
(see, Rogaski, 2004; Lei, 2014; Unschuld, 1985; Scheid, 2002a; Croizier, 1968).  
Historians have argued that Chinese intellectuals considered Western medicine and 
science as a kind of reification of modernity (see Croizier, 1968; Rogaski, 2004). 
While the Chinese associated science with modernisation, the Americans viewed it as 
an advancement of democracy and popular wisdom, and Europeans connected science 
with technology and radicalism (Barnes, 2005). Rogaski (2004) interprets the 
modernisation of Chinese medicine as the enforcement of political powers. The 




along with Western medicine. Rogaski (ibid) employs Foucault’s concept of 
“biopower” by linking the actions of a state to administrate and govern life to the 
modernisation of China and Chinese medicine. In this regard, she believes that 
individuals were organically aligned with the goals of the state by “internalising 
disciplinary regimes” (ibid, p. 16) such as accepting vaccinations, hygienic baths or 
soaps. Therefore, hygiene as part of the modernisation process in China connected 
Chinese nationalism with sanitary science in the nineteenth century. Both, hygiene and 
nationalism, connected elements to modernity regarding the reconstruction of cities, 
the ordering of society and the transformation of human beings into healthier and 
stronger people. With this strategy, reformers aimed to sanitise as the West had the 
image of “the sick man of Asia” which arose after Western powers defeated China in 
the nineteenth century (ibid, p. 302). Hence, Rogaski concludes that sanitary science 
served as a stable political tool to resolve social and physical deficiencies by 
combining Western medicine with the Chinese body as a nation and as the individual 
body of Chinese people.  
In the past two decades, there has been literature on the notion of the purity of 
modernity, which asserts that neither Chinese nor Western medicine are “pure” 
cultures as they are influenced by the other or other cultures (Andrews, 2014; Lei, 
2014). Andrews (2014, p. 7) analysed the notion of science and Western medicine and 
stated that the Western medicine and science are “markers of modernity” in China. 
She supported this by highlighting the science and technology study that the scholar 
Latour published in 1993, which examined the concept of “modern constitution”. 
Andrews (2014) follows Latour’s idea of modernity as an illusion and a messy 
construct of relationships or networks between humans and nonhumans. Andrews 
believed that the problem with modernity emerges unavoidably as the network cannot 
be continuously monitored to ensure that non-modern elements cause an impurity of 
the network. She continues by stating that if the actors of the network carry modern 
and traditional features, then the network of modernity will be mixed. Thus, Andrews 
claims that in whatever direction the movement goes when modern values mix with 





In her study, Andrews (2014) found that since the defeats of Western and Japanese 
powers at the turn of the twentieth century, China imported modern science, which 
influenced the transformation of Chinese medicine in various ways. Supporters of the 
“Self-Strengthening Movement” (ziqiang yundong 自强运动) from 1860 to 1895 tried 
to overcome the weakness of China. Thus, they started to import modern technologies 
and modern science and integrated them, amongst other fields, into Chinese medicine. 
Andrews asserts that with this occurrence, the pressure for modernisation increased 
and resulted in a wide-range adaption that “redefined” and “shaped” Chinese culture 
and Chinese medicine to an “instrument of cultural and political self-fashioning” (ibid, 
p. 13). Three examples in her work present the tension between Chinese medicine and 
modern science: theories, reforms and overseas training in modern science. For the 
first example, Andrews presents the reformer Liang Qichao 梁啟超 (1873-1929) who 
proposed to abolish Chinese medicine theories, which were incommensurable with 
Western medicine. For instance, Liang Qichao considered the theory of Five Phases 
(wuxing 五行) as unstable and confusing (ibid, p. 178). Thus, he hoped to reinvigorate 
the strength of China by eliminating those theories and by combining the best of 
Chinese and Western medicine (ibid). The second example includes reforms of the 
adaption of bacteria theory, the medication against syphilis with mercury, as well as 
Western anatomy and physiology into Chinese medicine practices exemplified Qiu 
Jisheng 裘吉生 (legal name Qiu Qingyuan 裘慶元, 1872-1947). Qiu attempted to 
ensure the existence of Chinese medicine in modern Chinese culture by reforming and 
modernising it (ibid). Finally, Chinese students studied overseas, in particular, in Japan 
to learn Japan’s “model of East Asian modernity” and Asian thinking about Western 
science (ibid, p. 70). Andrews (2014) claims that students returning from Japan blamed 
the “inward-looking” attitude of China for the defeats by Western and Japanese powers 
and the loss of the former German colonies in China on Japan after the World War I 
and the treaty of Versailles. Those students reacted to the treaty with the “May Fourth 
Movement” in 1919 and demanded a radical modernisation of China by abolishing 
traditional values including Confucianism and Chinese medicine. Andrews (ibid) work 
shows that modernity of Chinese medicine was a constant redefinition by Chinese 




In the same vein, Lei (2014) applies STS concepts of Latour’s (1993) “modern 
constitution” and the concept of “translation” from actor-network theory by Latour 
(1987), Callon (1986) and Law (1994) in his study. Lei (2014) speaks against dual 
historiography between traditional and modern Chinese and Western medicine and 
applies the concept of translation to investigate how socio-technical networks between 
Chinese medicine and Western medicine were formed in 1920. Based on this concept, 
Lei (2014) claims that the modernisation of Chinese medicine with modern science 
caused Chinese medicine to become a hybrid medicine with aspects of traditional 
Chinese medicine and modern Western medicine. For instance, his results conform to 
Andrews (2014) findings that Chinese medicine scholars went to Japan or overseas to 
study Western medicine. He adds that Chinese students engaged with Western 
medicine and science by either studying the literature of Western science, or by being 
confronted with Western medicine by returning Chinese students who were trained in 
Western medicine overseas. Accordingly, assimilation and convergences to Western 
medicine happened in an unstructured, sporadic and individual manner, e.g., by the 
Chinese medicine practitioners Li Hongzhang 李鸿章 (1823-1901), Tang Zonghai 唐
宗海 (1851-1908), Zhang Xichun 张锡纯 (1860-1933), Zhu Peiwen 朱沛文 (fl. 1850). 
They added Western drugs to Chinese medicine prescriptions or learned Western 
pathology to incorporate them in new prescriptions for mastering unsolved issues in 
Chinese medicine doctrines. Another example of convergence is the Western and 
Chinese medicine practitioner Tang Zonghai. His idea was to converge the Chinese 
medicine doctrine of qi transformation with Western anatomy and physiology and he 
was inspired by the steam engine (Lei, 2014).4 Lei (2014) argues with the concept of 
modernity that Chinese medicine gradually converted into a hybrid medicine.  
Other researchers view the “Self-Strengthening Movement” as an index for shaping 
the encounter between Chinese medicine and Western science (Scheid, 2002a). Scheid 
(ibid) investigates plurality and synthesis in Chinese medicine with the lenses of 
Andrew Pickering’s “the mangle of practice” (or the “mangle” as it can be known), 
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which is a process that transforms and creates culture, practices, subjectivity and 
history. Pickering (1995) defines the transformations and creations as the “dance of 
agency” between humans and nonhumans. By drawing on the mangle and network 
constructions which were inspired by actor-network theory, Scheid (ibid) identifies 
doctors, patients and tenets of thought within Chinese medicine tradition as agents and 
as constructors in structuring a medical system. Plurality and synthesis, thus, reveal 
the continuity of transformations within Chinese medicine but also influence from the 
outside, for example, the synthesis with Western medicine and science. Scheid (ibid) 
claims that Chinese medicine has always been plural in its practice and thoughts. 
Consequently, the reoccurring but varying engagement of Chinese medicine 
practitioners with Western medicine and science during the twentieth century created 
many ways to practice Chinese medicine.  
In his later work, Scheid (2007) discloses that the modernisation process of Chinese 
medicine rearranged the various schools of thought in Chinese medicine into three 
groups. The groups either demanded (i) the abolition of Chinese medicine, (ii) its 
reformation to a social utility by introducing changes along with the Japanese system 
or (iii) preserving Chinese medicine but admitting some modernisations. The first 
group of advocates of Western medicine proposed to abolish Chinese medicine, which 
directly impacted the second and the third group united in the fight against the abolition 
of their medicine (Scheid, 2007). The first group initially attempted to synthesise 
Chinese medicine and Western medicine but, later they required the abolition of 
Chinese medicine in the May Fourth movement as a “wholesale westernisation” 
(quanpan xihua 全盘西化). This modernisation entailed the replacement of traditional 
values, such as Confucianism and Chinese medicine, with modern science, which was 
personified as “Mr Science” (sai xiansheng 赛先生) (Scheid, 2007, p. 176). This group 
differentiated the practice of Chinese medicine from older theories and employed 
Western scientific methods to evaluate Chinese medicine.  
In contrast to the first group, the reformers of Chinese medicine were willing to accept 
the Western empiricism as they were familiar with it due to their training in Japan. 
They suggested integrating useful Chinese medicine aspects into a strong Western 
medical practice. This group of reformers acted according to the political tendencies 




2007). By reshaping both systems, the conservatives generated flexible networks of 
practitioners which became the fulcrum for both the transformation and the 
maintenance of the Chinese medicine (ibid).  
The third group, the cultural radicals, safeguarded Chinese medicine as a “national 
essence” (guocui 国粹) of China. For example, Zhang Taiyan 张太炎 (1869-1936), 
the teacher of Yu Yunxiu 余云岫  (also Yu Yan, 1879-1954), and his followers 
transformed the notion of preserving the “spirit of the nation” into a vital part of 
China’s civilisation (Scheid, 2007, p. 177). They wanted to prove that Chinese 
medicine was more advanced than Western medicine by showing, for instance, that 
practitioners performed surgeries in the Han dynasty (202BC-220AD). Preservers 
used the past achievements of pioneers in Chinese medicine and its value as an 
indigenous medical art reinforced with its long history to protect Chinese medicine 
against the influence of Western culture (Croizier, 1968). This discourse of 
modernisation shows that Chinese medicine practitioners engaged with Western 
medicine and science to define or synthesise their medicine.  
Lei (2014) demonstrates with the concept of translation, that Chinese medicine 
practitioners formed alliances with politicians and Western medicine doctors in the 
early twentieth century. He analysed that the confrontation headed into a networking 
process between Chinese medicine practitioners and scholars and the politicians of the 
Guomindang (Nationalist Party, GMD or also Kuomintang - KMT, 1912-1949). 
Chinese medicine practitioners allied to fight against the abolition proposal by Yu 
Yunxiu. Yu Yunxiu was very well read in Chinese medicine due to the fact that he was 
a Western-trained practitioner and one of the cultural radicals he worked for the newly 
established Ministry of Health (MOH). Yu Yunxiu’s abolition plan stated that Chinese 
medicine was an individualistic medicine, which was ineffective to prevent epidemics 
(Lei, 1999). Yu’s proposal mobilised Chinese medicine practitioners and joined all 
fragmented schools of thought in Chinese medicine into one group for demonstrating 
unity against Yu and his followers. The unification happened with the help of Chinese 
medicine advocates such as Chen Cunren 陈存仁 (1908-1990) and Zhang Zanchen 張
赞臣 (1904-93) who initiated a petition against the abolition in March 1929. Lei (1999) 
argues that this day marks the encounter of Chinese medicine with the first modern 




a network of alliances with the Chinese politicians against Western-style doctors. 
However, the government only supported Chinese medicine practitioners in exchange 
for the modernisation of their practice and organisation. Thus, Lei (1999, 2014) argues 
that the consequence for the support of the GMD, was first modernisations of Chinese 
medicine into a national medicine and the establishment of the Institute of National 
Medicine (guoyi guan 国医官).  
Lei (1999) argues that it was no surprise that Chinese medicine advocates tried to find 
scientific evidence for the efficacy of Chinese medicine drugs. By doing so, they 
demonstrated the wisdom of Chinese medicine and its ability to resolve public health 
problems, which became a serious issue after the failing of Chinese medicine to deal 
with the Manchurian plague in 1911 and 1912. According to Lei (1999), historians in 
Chinese medicine have overlooked the significance of Chinese medicine drugs in the 
National Medicine Movement (guoyi yundong 国医运动) from 1929 to 1931 and the 
translation of changshan 常山 (Dichroa febrifuga) from a Chinese medicine context 
into a modern scientific context. The translation elevated Chinese medicine from an 
individualistic medicine to become a public medicine. With the help of Chen Guofu 
陳果夫 (1892–1951), a Chinese medicine advocate and GMD ideologist, changshan 
became scientifically validated as an effective antimalaria drug in the 1940s. Lei (1999) 
argues that although changshan was recommended as a successful treatment of malaria 
and was acknowledged in English studies of Chinese materia medica, as well as 
Chinese paper and documents, it was not trusted until scientific evidence showed its 
effects. Once this had happened, it was translated into the Western medicine socio-
technical network. Hence, the successful translation happened through the political 
power of Chen Guofu, which enabled him to bridge the barriers between Western-style 
doctors and Chinese medicine drugs. However, his clinical experiments with 
changshan on human subjects violated the ethical code and the Western scientific 
protocol. Instead of first extracting the active compounds, in the drug, which were the 
essential substances that have a direct effect on human health (Biesalski et al., 2009), 
and, then, testing them on animals, Chen Guofu started with his experiment on humans. 
Even though Chen Guofu shortened the translation process by starting with the clinical 
tests, he provided a reason for new allegations against Chinese doctors as unethical. 




this research, defended this procedure with the explanation that the formula was not a 
new drug; it was in use for a long time and thus empirically safe (Lei, 2014). Chen’s 
example demonstrated that although the content of changshan was for Chinese 
medicine and Western medicine the same, the context differed and required a 
translation with the means of Western science to reach a consensus of its efficacy. The 
evidence of the efficacy of its drug granted the position of Chinese medicine in the 
modernisation process of China as a useful source of drugs.  
The literature, which I have discussed here, demonstrates that political discussions 
about China’s weaknesses introduced the idea of the modernisation of China’s 
healthcare system with what modernisers and reformers such as Yu Yunxiu and the 
Nationalist party in China considered as modern, namely Western medicine and 
science. The modernisation process of Chinese medicine in the late Qing dynasty and 
early Republican period demonstrated Chinese medicine advocates as fragmented 
groups with different interests. They unified after some advocates shifted to Western 
medicine and proposed to abolish Chinese medicine. Chinese medicine was confronted 
with mainly Chinese modernisers and doctors of Western medicine, such as Yu 
Yunxiu who demanded the implementation of Western science and methods as 
markers of modernity as a tool to reinvigorate China and its powers (Andrews, 2014; 
Lei, 2014). The transformation of alliances and interest changed this encounter and 
engaged Chinese medicine practitioners and scholars in the translation and 
transformation process of Chinese medicine with Western medicine. The reshaping of 
Chinese medicine happened through the scientific evaluation of Chinese materia 
medica and the institutionalisation of Chinese medicine with the example of Western 
medicine. Historians show different perspectives of this encounter as either driven by 
politics (Andrews, 2014; Hanson, 2011; Rogaski, 2004; Croizier, 1968) or that 






2.1.2 THE STANDARDISATION OF CHINESE MEDICINE 
 
In this section, I will reflect on the small body of literature before and after the 
foundation of the People’s Republic of China (PRC) in 1949. This period refers to the 
Chinese Communist Party’s (CCP) policies from 1949 to 1976 and their wide-ranging 
standardisation (guifanhua 规范化) and systematisation (xitonghua 系统化) processes 
that formed Chinese medicine into what is widely known today as “Traditional 
Chinese Medicine” (TCM). 5  Scheid (2002a) and Taylor (2005) distinguish three 
political phases during the standardisation of Chinese medicine: (1) the “co-operation 
between Chinese and Western Medicine” (zhongxiyi hezuo 中西医合作) from 1945 
to 1949, (2) the “unifying Chinese and Western Medicine” (zhongxiyi tuanjie 中西医
团结 ) 1950 to 1958, and, (3) the “integrating Chinese and Western Medicine” 
(zhongxiyi jiehe 中西医结合) from 1958 to now. These phases will now be discussed.  
The historian Taylor (2005) analysed the period from 1945 to 1960 as most of the work 
on the Maoist era (1949-1976) discusses the historical events of the CCP with the focus 
after the 1950s (for example, Croizier, 1968; Unschuld, 1985; Scheid, 2002a, 2007; 
Farquhar, 1994; Hsu, 1999, 2008). Taylor’s (2005) detailed account explores political 
discourses in which workers and cadres of the party participated in converting Chinese 
medicine into a revolutionary medicine during the early years of the CCP (Michaels, 
2006). As Taylor (2005, p. 8) argues: “the role that Chinese medicine played in the 
Communist Revolution was passive. It was a suppressed element of society, and its 
representatives could by no means dictate the fate of the medicine”. She claims that 
political and medical leaders were instigators behind Chinese medicine becoming a 
revolutionary medicine. As was the aim in the Nationalist era (1928-1949), the 
preservation of Chinese medicine as a body of knowledge, was not part of the 
revolutionary plan. Taylor found the CCP provided a more stable infrastructure and 
national support to standardise Chinese medicine. However, the standardisation of 
Chinese medicine increased the control of the CCP, its interpreters and implementers 
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of policies over Chinese medicine and its fate. According to Taylor (2005, p. 1) after 
the foundation of the PRC, Chinese medicine representatives became “submissive” 
and “devoted” to the promotion of science and the advancements of Chinese medicine. 
Unlike Taylor (2005), Lei (2014) and Scheid (2002a) indicate that Chinese medicine 
advocates were actively involved in the standardisation process. As Scheid (2002a, p. 
66) argues: “the role of the state in shaping contemporary Chinese medicine is that of 
a powerful, but not an all-powerful, agent”.6 They dispute that the transformation of 
Chinese medicine was a continuous process. 
Taylor (2005) argues that Chinese medicine advocates played a passive role during the 
“co-operating Chinese and Western Medicine” phase. The CCP aimed to combine 
Western and Chinese medicine and promote the political line to people in remote areas, 
in order to gain their support during the Civil War (1946-1949) with the Nationalist 
party. Another reason was the shortage of Western medical supplies, which Chinese 
medicine was expected to fill. As CCP cadres and workers interpreted Mao’s co-
operation plan as “scientisation of Chinese medicine and promoting Western medicine” 
(ibid), they replaced superstitious and feudal elements in Chinese medicine with 
politically aligned Soviet theories. For example, Zhu Lian 珠链  (1909-1978), a 
Western-trained practitioner and wartime medical servant, scientised acupuncture with 
the Soviet theories of neuro-pathology theory (shenjing bingli xue 神经病理学). This 
change is seen in the military and political vocabulary used to divide the body into 
regions and sections (qu 区) (Taylor, 2005, p. 19-24). This description is still used 
today.  
During the unification period (1950-1958) the CCP set the groundwork for the creation 
of a new medicine by combining Chinese and Western medicine. Scheid (2002a) 
claims that the CCP aimed to upgrade Chinese medicine to scientific medicine, 
whereas Taylor (2005) asserts that the purpose for Mao in keeping Chinese medicine 
was to fuse it with Western medicine once Chinese medicine had achieved a 
sophisticated scientific level. Taylor (2005) shows that a series of policies denoted a 
piecemeal process which aided the standardisation of Chinese medicine. For example, 
                                               
 




Chinese medicine practitioners had to take an exam that strongly focussed on Western 
medicine.  
The following political strategy of the CCP was called “Chinese medicine practitioners 
study Western medicine” (1950-1953). This strategy introduced the first Chinese 
medicine practitioners in Western medicine and forced these practitioners to develop 
skills in Western science and medicine (Andrews, 2014; Taylor, 2005). Taylor (2005) 
found that CCP cadres and workers interpreted the unification policy according to their 
needs and professional orientation. Therefore, they formulated the strategy to 
“scientification of Chinese medicine and popularisation of Western medicine” by 
replacing superstitious elements with scientifically evaluated Western medicine (ibid, 
p. 32). Soon after the introduction of this policy, in 1954, the Chinese government 
reversed the policy of Chinese medicine study Western medicine to compel “Western 
medicine doctors to study Chinese medicine” (1954-1959). Other researchers stress 
the intention of the CCP as a modernisation of Chinese medicine under the leadership 
of a new cohort of Chinese medicine trained Western medicine doctors (Scheid, 
2002a). At the same time, Andrews (2014, p. 209) interpreted it as a way for the CCP 
to “rectify the undesirable ideological [bourgeois] tendencies of Western-trained 
doctors”. Croizier (1968) stresses the positive side of this policy as he views it as a 
way to increase the national pride of Chinese medicine practitioners when Western 
doctors study their medicine.  
As noted by Taylor (2005, p. 73) a further step in the standardisation process of 
Chinese medicine occurred with the publication of the English-language article “Why 
our Western-trained doctors should learn Traditional Chinese Medicine” (italics as in 
the original) in 1955 by the Deputy Minister of Health Fu Lianzhang’s 傅连章 (1894-
1968). In this article, Fu Lianzhang first attributed “traditional” to Chinese medicine. 
Thanks to this article and the modernisation methods of CCP, Taylor remarks that the 
change from Chinese medicine to TCM was “a medical construct (which is) distinct 
to Communist China” (2005, p 84). Thus, TCM is a product of the CCP which 
integrated the best of both Chinese and Western medicines and theories. Hsu (2009), 
an anthropologist, interprets TCM as a Janus-faced instrument of the CCP which 




“traditional” while the party also endeavoured to assimilate both medicines (Hsu, 
2009).  
The last phase, the integration phase, shifted the aim from one new medicine to the 
incorporation of standards of Western medicine into Chinese medicine (Taylor, 2005). 
The party manifested the integration of both medicines with the establishment of the 
Academies of Chinese medicine in Beijing, Shanghai, Chengdu. The establishment 
happened concurrently with the political change of China into a socialist state the CCP. 
Unlike, Scheid (2002a) believes the new academies had two main priorities: first, to 
bind Chinese medicine closer to the political centre and, second, to recover Mao’s 
decline. The priority related to the fact that academies were a way to tie influential 
Chinese medicine practitioners more closely to educational institutions in Beijing 
where the political centre of China was. For example, the MOH employed famous 
Chinese medicine practitioners like Qin Bowei 秦伯未  (1901-1970) and Zhang 
Cigong 章次公 (1903-1959) to advise the MOH and teachers at the Beijing College 
of TCM under the supervision of mostly Western medicine trained physicians in the 
Ministry. Consequently, Scheid (2002a) claims that Qin Bowei shaped Chinese 
medicine through his social networks and contacts with politicians and strengthened 
his network by exploring various ways to modernise Chinese medicine.7 Secondly, the 
party mobilised the cadres and Chinese medicine practitioners to establish a modern 
and scientific Chinese medicine in China. The scientification included strategies used 
to recover Mao’s decline after the Great Leap Forward disaster in 1959-1961 and the 
split of the Soviet Union in 1963. During this period, China suffered from famine and 
was short of medical stuff; thus, Chinese medicine was an inexpensive and mobile 
resource during the Cultural Revolution and this compensated for the lack of medical 
care resources. As a result, Chinese medicine underwent a systematisation aligned with 
biomedical disease categories and institutionalisation of the practice and education of 
Chinese medicine in hospitals and universities. 
 
                                               
 




Hsu (1999) demonstrates a view on the transformation of Chinese medicine education 
by analysing three ways of transmitting Chinese medicine knowledge. She employed 
in her ethnography the concept “styles of knowing” which were brought about by the 
philosopher of science Ian Hacking (1992), who emphasises the fluidity and 
individualistic aim that every style exhibit in its microsocial field which is influenced 
by interactions and negotiations. Hsu (1999) identified in Chinese medicine education 
and practice in China, three modes of transmission: personal, standard and secret 
transmission. These three modes encompass verbal and written transmission and first-
hand stories from practitioners who describe the integration of Chinese medicine and 
Western medicine as the standardisation of Chinese medicine practice and education 
in alignment with Western medicine and science. Hsu (1999) claims that the CCP’s 
implemented the biomedical institutionalised, pedagogical and clinical standards in 
Chinese medicine. For example, by disregarding the Five Phases (wuxing, wood, fire, 
earth, metal, and water) and focusing on the Five Organs (liver, heart, spleen, lungs, 
and kidneys) or teaching Western biomedical education thinking of Chinese medicine 
(e.g., TCM Instructions, Organ Clusters, TCM Aetiology and Pathogenesis, Outline of 
the TCM Preventive Health Care) instead of classical texts like the Inner Classics of 
the Yellow Emperor (Huangdi Neijing 黄帝内经) or the Classics of Difficult Issues 
(Nanjing 难经). Hsu claims that the standardisation of transmissions of Chinese 
medicine happened through “accidents of history” that shifted the focus to the physical 
body (Hsu, 1999, p. 223). She stresses that the standardised transmission of knowledge 
produced tension between classroom learning and strict control to unstructured and 
confusing practice in the clinic (ibid, p. 223). Hence, Hsu (1999) agrees with Taylor 
(2005) that the standardisation process was a reinterpretation of the integral elements 
of Chinese medicine aligned with the CCP’s expectations of a scientific practice, 
which was grounded in an effort of being systematic. 
In the analysis of Chinese medicine practice, Scheid (2002a) found that the CCP 
standardised and institutionalised Chinese medicine knowledge and practice with 
systematising its theories in 1958 in an article entitled the Outline of Traditional 
Chinese Medicine (zhongyixue gailun 中医学概论 ). The Outline revolutionised 
Chinese medicine leaning from apprentice-based learning and classical texts such as 
the Inner Classics on the Yellow Lord, the Devine Husbandman’s Materia Medica 




Disorders (Shanghan zabing lun 伤寒杂病论) until the early twentieth century. The 
core categories and structure of the Outline were biomedical diseases which guided 
the diagnosis of Chinese medicine. This guidance aimed to identify biomedical 
diseases which subsequently break down the disease into several different, but newly 
standardised Chinese medicine “patterns” (Scheid, 2002a). Farquhar (1994), an 
anthropologist, defines a pattern as a complex of symptoms and signs based on 
examinations like asking, pulse taking and tongue inspection. Patterns (in Chinese 
zheng 证) are categorised into the eight rubrics of yin/yang (阴阳), exterior/interior 
(biao 表/li 里), cold/hot (han 寒/re 热) and depletion/repletion (xu 虚/shi 实) (Scheid, 
2002a).  
Compared to Scheid (2002a), Hsu (1999) asserts that the new systematic structure of 
theories in the Outline generated difficulties for students. Teachers introduced the 
concepts one by one to the students and then expected them to bring the concepts 
together on their own. Chinese medicine was as a systematic TCM theory which the 
students learnt in the classroom before they could start with their medical practice. 
They were not disciples or followers anymore who could learn by observing the master 
in practice (Hsu, 1999). The Outline changed Chinese medicine to a new structured 
theory that created inconsistencies between Chinese medicine theory and its practice. 
Hsu (1999) observed that students struggled to apply the newly revised and biomedical 
influenced theories of Chinese medicine in clinical practice, as they could not relate 
their observations in the clinic to the newly learned biomedical thinking. However, the 
structure of the Outline convinced later reformers of Chinese medicine. Thus, it may 
be seen as a blueprint for later reforms in Chinese medicine, i.e., “pattern 
differentiation and treatment determination” (bianzheng lunzhi 辨证论治).  
Another example which examines integration is the “pattern differentiation and 
treatment determination”. Farquhar (1994, p. 212) explains in her seminal work on 
Chinese medicine practice that bianzheng lunzhi is a process of “the ‘four methods of 
examination’ (sizhen 四诊)” which “translates concrete signs and symptoms through 
complex analyses into ‘distinguishing patterns’ (bianzheng 辨证) for which there is a 
large repertoire of ‘formulae’ or prescriptions (fangji 方剂) that are modified for each 




bianzheng lunzhi is one example of systemised Chinese medicine knowledge as it 
adapted biomedical nosology with the priority to provide a correct diagnosis tool. Thus, 
bianzheng lunzhi discusses “processes as an ongoing synthesis of opposition” by 
employing diseases with Mao’s dialectical concept of “unity of opposites” (duili tongyi 
对立统一) with process emerging contradiction (Scheid 2002, p. 217-218). Apart from 
the reinterpretation of bianzheng lunzhi, the dialectical concept inspired Qin Bowei 
and other practitioners to redefine yin/yang and to include holism as a dialectical tool 
into Chinese medicine (Scheid, 2016). For example, Shi Jinmo 施今墨 (1881-1969) 
was one of its architects who westernised teaching materials in TCM universities by 
following Western medical doctors’ preferences for a biomedical aligned systematic 
representation of Chinese medicine practice and theory (Scheid, 2002b).  
Similarly, the anthropologist and STS scholar Karchmer (2010, p. 230) interprets 
bianzheng lunzhi as the “postcolonial transformation of Chinese medicine” of the 
1950s. He maintains that Chinese medicine representatives stressed bianzheng lunzhi 
as the essence of Chinese medicine, which made it unique compared to Western 
medicine. Simultaneously, it also served as a “mechanism for translating between 
Chinese medicine and Western medicine” (Karchmer, 2010, p. 23). It became a tool 
to bridge the two medicines in the practice of Chinese medicine practitioners. Thus, 
Scheid and Karchmer (2016) argue that the redefinition which emerged in the 1950s 
emphasised the difference of China’s political and medical system to Western 
countries biomedicine and politics. Nevertheless, he also indicates that Chinese 
medicine practitioners’ value bianzheng lunzhi as an essential diagnostic tool.  
According to Taylor (2005), in 1972, the consortium of revolutionary bodies (The 
Health Unit of the logistics department of the Guangzhou Army Guangzhou budui 
houqinbu weishengbu 广州部队后勤部卫生部) published a second edition of the 
Outline. She notes that the purpose of this edition switched from being an educational 
tool to a political one by stressing besides the integration of Chinese and Western 
medicine, the proposal to develop a “new national unified medicine and pharmaceutics” 
(Taylor, 2005, p. 110). In her article in 2004, Taylor argues that both versions, the 
Outline and its revision in 1972, served through their translations and interpretations, 
as a method to echo the reactions of the West on the production of standardised 




Manfred Porkert’s Theoretical Foundations of Chinese Medicine (1982) and Nathan 
Sivin’s Traditional Medicine in Contemporary China (1987). After the positive 
reaction to those works in the West, universities like the Nanjing Academy of TCM 
incorporated the Outline as standard teaching material, which Hsu (1999) confirmed. 
It influenced a new generation of Chinese medicine practitioners who apprehended the 
systematic influence of Western medicine and the Communist agenda as an intrinsic 
part of Chinese medicine. Thus, the integration between Chinese and Western 
medicine has covered an understanding gap between both medicines in China.  
As mentioned before, researchers agree that Chinese medicine pharmaceuticals 
received specific attention as a researchable field during the integration period (Hsu, 
2009; Unschuld, 1986; Nappi, 2009). Hsu (2009, p. 111) claims that the policies of the 
CCP transformed Chinese medicine into a medicine for chemical extraction of active 
compounds, the “TCM” or “Chinese propriety medicine” (CMP). Research in the 
1960s was based on the extraction of active compounds in Chinese medicine to 
produce standardised Chinese medicine drugs. Unschuld (1986) discovered that Liu 
Juiheng published the first modern and westernised Chinese medicine pharmacopoeia 
in 1956. The pharmacopoeia described 672 drugs in monographs according to the 
Western “drug code”, which included the place of origin, signature, function and 
chemical and physiological analysis of each drug. According to Nappi (2009), the 
Bencao gangmu 本草纲目, the Chinese materia medica, from 1598 was compared 
with the past version of materia medica substantial documentation in the Ming dynasty 
(1368-1644) by Li Shizhen’s 李時珍(1518-1593) and was continuously expanded. 
Croizier (1968) states that pharmaceuticals and the mobility of Chinese medicine 
techniques were valuable resources for the political course of the CCP.  
To sum up, in the standardisation period, the CCP party, party members, the MOH, 
Western medicine doctors and Chinese medicine advocates adapted medical education, 
practice methods and disease categories of Western medicine in Chinese medicine. 
From a political perspective, this supplied the population of China with Chinese 
medicine which was deemed an inexpensive and mobile medicine and with Chinese 
medicine practitioners trained in Western medicine. Consequently, most of the 
medical personnel were able to practice both Western medicine and the modernised 




level, the standardisation integrated Chinese medicine with Western medicine for a 
practice-based, pharmaceutical and institutional biomedical influenced medicine (see 
Scheid, 2002a; Taylor, 2005; Lei, 2014; Andrews, 2014). 
 
2.1.3 THE GLOBALISATION OF CHINESE MEDICINE 
 
In this section, I am going to discuss how Deng Xiaoping’s 邓小平 (1904-1997) 
reform and opening up policy in 1979 changed Chinese medicine’s position in China. 
The political change to open the country and the new economic course for exchange 
and foreign investment, loosened the control of the state over Chinese medicine 
practice. However, this new course forced Chinese medicine practitioners to orientate 
their practice towards the needs of a new economic system. Several lines of evidence 
describe these changes in six social and political characteristics. I will elaborate on the 
six characteristics that constituted to the globalisation phase and have led to the 
contemporary relationship between Chinese medicine and systems biology: (1) politics 
in China enacted Chinese medicine towards more scientific practice; (2) practitioners 
engaged in systems thinking; (3) education adapted biomedical organisation of 
knowledge; (4) globalisation of Chinese medicine happened through scientific interest 
in acupuncture; (5) standardisation processes facilitated commodification of Chinese 
medicine; (6) import of technoscience8 led to Chinese medicine pharmacotherapies.  
The globalisation phase of the 1980s started with the aim to rejuvenate the Chinese 
nation and China’s economic growth with science and technology in Deng’s four 
modernisations, i.e., agriculture, industry, national defence and science and technology 
(Scheid, 2002a).9 With the reform and opening up policy in 1979, Chinese medicine 
                                               
 
8 In STS, technoscience is an interdependent concept that avoids the distinction between humans and 
nonhumans as well as technology and science (see Latour, 1987). 
9  The four modernisations were originally proposed by Zhou Enlai. See Scheid, 2002a. See also 






researchers postulated a convergence between systems theory and Chinese medicine 
(Farquhar, 1994; Scheid, 2002a, 2007; Scheid and Lei, 2014; Luo et al., 2012a; Shao, 
2011; Qiu, 1982). According to Lou (2016), Deng aimed to integrate modern 
technology to enhance the scientific evaluation of Chinese medicine.10 Evans (1997) 
compared Deng’s strategy with Mao’s new medicine in the 1950s and found that Deng 
accepted a three-pillar system (san tiao daolu 三条道路 ) that included Chinese 
medicine, Western medicine and the integration of Chinese and Western medicine, 
namely TCM. Chinese medicine is mentioned as its own pillar here as Deng Xiaoping 
policies left Chinese medicine practitioners with more liberty in their practice and 
orientation, this is further discussed below.  
As found by Scheid (2002a), the Eleventh National Health Conference decided the 
plural healthcare system in 1979 with four reforms. The reforms stated that Chinese 
medicine had to be practised in hospitals rather than in primary or community 
healthcare systems, which had been the case since the Cultural Revolution. Secondly, 
medicine had to be administered by a professional with specialist knowledge rather 
than on knowledge from political cadres. Thirdly, the development of medicine was 
inseparable from technology. Finally, the establishment of a plural healthcare system 
resulted from the creativity and interpretation of practitioners and doctors to fulfil 
Deng’s reforms and to protect their existence as practitioners on the new market-driven 
rather than a social healthcare sector (Scheid, 2002a). Deng Xiaoping granted Chinese 
medicine a place in the public healthcare system, however, Chinese medicine 
practitioners had to pay the price with further institutionalisation of their medicine, as 
well as more biomedical education and the integration of modern technology into 
Chinese medicine. Evans (1997) argues that the technology and know-how reform was 
possible through international co-operation. The exchange of experts and students 
enabled Chinese intellectuals at home and abroad to absorb the knowledge needed to 
use imported technology and science.  
                                               
 
10 Deng called this modernisation plan to “rejuvenate the country through science and technology” 




Much of the available literature on the globalisation phase deals with Deng’s relaxed 
politics. These policies granted Chinese medicine representatives more autonomy in 
their practice and allowed them to regain their voice as Chinese medicine 
representatives in comparison with the Maoist era (Farquhar, 1994; Scheid, 2002a; 
Hsu, 1999; 2009). Farquhar (1994) noticed after the political turn, a change in the 
Chinese medicine publications, which split Chinese medicine scholarly work into two 
factions: the scholarly historical work and the laboratory and statistical research for 
clinical studies. Farquhar (1994) analyses the tension between practitioners who 
survived the Cultural Revolution, namely, senior doctors or laozhongyi 老中医, and 
the new generation, which she refers to as “scientizers” (ibid, p. 17).11 The scientizers 
were more interested in using biotechnology and exploring Chinese medicine through 
systems theory or immune system theories rather than examining the stories of the 
senior doctors or consulting classical texts (ibid). This new generation started to write 
about biomedical science and the technology employed in Chinese medicine which 
soon dominated the field (ibid). Therefore, some of the laozhongyi, e.g., Ma Boying 
马伯英, shifted in the 1990s to alternative areas like anthropology and history.12 
Farquhar (1994, p. 18) comments that with the scientisers “the field will quickly move 
far from the vision of the senior Chinese doctors”. This observation might be 
interesting to follow in the relationship that has ensued between Chinese medicine 
researchers and systems biology over the last two decades to see if there is tension 
between different “generations” or Chinese medicine researchers with a different 
academic background. It might be helpful to consider tensions in the domains of 
Chinese medicine and systems biology compared to those between the fields of 
Chinese medicine and systems biology.  
Others (see Scheid, 2002a; Karchmer, 2010) found that due to the three-pillar system, 
practitioners had to decide in the 1980s whether to include more Western medicine in 
their practice or explaining Chinese medicine concepts with new Western theories 
such as systems theory. In his article, Scheid (2014) categorises Chinese medicine 
                                               
 
11 After universities were reopened in China in 1978, the Ministry of Health selected leading Chinese 
medicine practitioners in urban regions and party members to teach in those universities (Farquhar, 
1994; Scheid, 2002a). 




practitioners into the “supporters of the integration of Chinese and Western medicine” 
and the “introducers of systems theory, cybernetics and quantum mechanics”. Scheid 
explains the interest in technological and ideological modernisation of Chinese 
medicine with the “permeability of medicine to outside influences” (2002a, p. 34). 
This view is supported by Karchmer (2010) who shows that the first group almost 
wholly integrated biomedicine into their practice of Chinese medicine. For example, 
doctors follow in their diagnosis the biomedical approach of first determining the 
disease and then the pattern (xian bian bing, zai bian zheng 先辨病，再辨证), rather 
than first diagnosing the pattern and then determining the treatment (ibid). The interest 
of Chinese medicine researchers in modern technology and theories, indicate that the 
interest in systems biology is not odd. It shows that Chinese medicine researchers are 
familiar with the application of Western theories in Chinese medicine. Thus, the 
employment of systems biology in the 2000s might be an organic process similar to 
the implication of systems thinking, hence, in Chapter 4, I will discuss in more detail 
the integration of systems thinking and systems biology. 
In the 1970s, the interest of international scientists in acupuncture supplied Chinese 
medicine with access to the global market (Zhan, 2009; Hsu; 1996). An increasing 
amount of literature reported the attempts of the Chinese government to globalise 
Chinese medicine (see, for example, Scheid, 1999; Zhan, 2009; Andrews, 2014; Hsu, 
2009; Ownby, 2013; Lou, 2016). A seminal study in this area can be found in Zhan’s 
(2009) work. Zhan uses the concept of “worlding” to demonstrate the “transnational” 
(Hannerz, 1998) commodification of Chinese medicine through “miracle acupuncture”, 
which was a political measure on the part of China to “get back on track with the   
world” (Zhan, 2009, see also Chapter 1). Zhan (2009) claims that in 1971 a front-page 
article in the New York Times on acupuncture analgesia interested biomedical doctors 
and scientists. The writer of the article was the American journalist James “Scottie” 
Reston who experienced first-hand acupuncture as an analgesic after his 
appendectomy in Beijing (ibid). Several months after his acupuncture experience, 
biomedical doctors and scientists visited China with President Richard Nixon to 
observe acupuncture analgesia. Zhan (2009) indicates that the “worlding” of Chinese 
medicine emerged from the interest of American biomedicine doctors in Chinese 
medicine. The Chinese government followed this interest and reduced Chinese 




European countries. However, Hsu (1996) discovered that Chinese hospitals had 
abandoned acupuncture analgesia in the 1980s while the Chinese state continued to 
propagate Chinese medicine to rural and poor areas, such as Africa, as preventive 
medicine.13 These accounts show that Chinese medicine was reduced to the practice 
of acupuncture. Acupuncture demonstrated an export value for the Chinese 
government, as it was not only an inexpensive and doable medical practice in Africa, 
but also raised medical and scientific interest in Western countries. Zhan’s 
investigation in “worlding” or the entanglement of Chinese medicine as a local 
phenomenon can help us understand the various applications of system biology in 
Europe and Asia, as well as to avoid a simplification of Chinese medicine and its 
transition on account of globalisation.  
In 1978, the growing interest in Chinese medicine and other traditional medicines 
caused a meeting of the World Health Organisation (WHO) in Geneva to discuss the 
education, research and the political strategies of integrating traditional medicine into 
healthcare systems. As a countermovement to the international interest in traditional 
medicine, Caudill (2000, p. xiii) reports that in the 1980s, the U.S. was ready to 
abandon and forbid the practice of acupuncture due to the lack of “scientific proof” for 
the claim acupuncturist made, for example, on acupuncture analgesia. However, it was 
unsuccessful, and investigations into the effect of acupuncture continued. Concerning 
scientific proof, Kaptchuk (2000) points out that in China acupuncture trials were 
always positive, which he thinks was due to a combination of biases and 
methodological shortcomings (Kaptchuk, 2000). The global attention that Chinese 
medicine received in 1982 lead the Chinese government to include Chinese medicine 
as a “nation’s traditional medicine” in the constitution of the PRC (Andrews, 2014, p. 
5-6). Thereby, Chinese medicine obtained a legitimate place in the healthcare system 
of China. 
                                               
 
13 See Stollberg (2009) for more accounts on the migration of Chinese medicine to Western countries, 
especially on Johannes Diedericus (Dick) van Buren who set up the first International College of 
Oriental Medicine in England and Holland in 1972 and taught Giovanni Maciocia, a practitioner who 






In the 1980s, Chinese medicine spread internationally, and the literature (see Hsu, 
1999, 2009; Scheid, 2002a; Barnes, 2009; Zhan, 2001, 2009) refers to various 
phenomena of “fevers”, i.e., “Chinese medicine fever” (see Scheid, 2002a, p. 92) and 
the effect of the interest in Chinese medicine in the West. Scheid (2002a) stresses that 
the “fevers” increased the number of international students studying Chinese medicine 
in China.14 This increased interest in Chinese medicine which according to Taylor 
(2005), was due to the CCP’s agenda to “open-heartedly and inseparably unite” 
Chinese medicine with Western medicine as a global medicine which began in the 
1950s. Taylor (2005) believes that without the CCP’s support, Chinese medicine 
would not have become an exportable product.  
In the 1990s, further standardisation and regulations of Chinese medicine supported 
the commodification of Chinese medicine in the international market (see Farquhar, 
1994, Hsu 2009, Zhan, 2009; Langwick, 2011). According to Scheid (2002b), the 
commodification of Chinese medicine was not only an avid step towards globalisation 
of Chinese medicine but also it secured the place of China as an influential role over 
the traditional medicine market with an export volume of USD 800 million by the year 
2000.15 Concurrently, China shielded the market against other East Asian medical 
traditions through the implementation of 305 international standards on Chinese 
medicine in 2010. A proposal to the International Organisation for Standardisation 
(ISO) to establish the Standardisation Administration of China (SAC) benefited 
research on Chinese medicine therapeutic effects. Subsequently, Chinese medicine 
developed into a commercial good that fitted into Deng’s market policies; thus, 
Chinese medicine advocates were reassured of the continuation of Chinese medicine 
                                               
 
14 In the 1970s, Chinese scientists studied various practices of Chinese medicine to prove its essence 
and its wonders (Zhan, 2009). For example, David Ownby (2013) describes that respected Chinese 
scientists examined Qigong and claimed to have found the material existence of qi. These studies were 
within the plan to modernise Chinese medicine and to legitimise various practices (Ownby, 2013, p. 
265). While the United States forbid its practice (Caudill, 2000) in post-colonial Macau (after 1999) the 
Chinese medicine practice upsurge occurred within the framework of a “cultural tradition rejuvenated 
with discourses of nationalism and modernity” (Lou, 2016). 
15 The export volume was also influenced by the “Chinese medicine fever”. The new flow of Chinese 
medicine training in China provided laozhongyi with a new legitimation towards the state and an escape 




as a medicine. However, the downside was Chinese medicine had a commercial value 
on the national and international market.  
A further step in the 1990s was towards technology and science (in short 
technoscience). Scheid and Lei (2014) note that as Deng demanded it in his reforms, 
technoscience created a high-tech hospitalisation of Chinese medicine in the 1990s and 
entangled Chinese medicine tradition into a cash-for-service system that turned away 
poor people (peasants), sold drugs over-the-counter in which doctors took 
commissions for drugs they prescribed. Additionally, the introduction of 
technoscience led to CMP as termed by Hsu (2009).  
Towards the end of the twentieth century, Chinese medicine had converted into a 
scientific researchable and commercialised traditional medicine (Scheid, 2013) that 
was determined by studies to develop CMP as alternative modernity, which means 
modern according to its labels and production, but traditional compared to biomedicine 
(Hsu, 2009). Scheid (2013) asserts that the Chinese government planned the 
production of traditional pharmaceutical products for the global market, which stressed 
the understanding of fufang composition and Chinese medicine efficacy through 
advanced technologies. The first achievement was in 2012 with the registration of 
Chinese medicinal capsules Diao Xin Xue Kang in the European Union (EU) market 
(Medicine Evaluation Board, 2012). Scheid and Lei (2014, p. 260) argue that overall 
the integration of technoscience was seen as the only way for “developing and carrying 
forward the heritage of Chinese medical tradition”.  
During the last ten years, research into Chinese medicine has moved towards 
evaluations of the practice and the investigation into certain Chinese medicine drugs. 
Different technoscientific methods have examined Chinese medicine to evaluate the 
best practice for Chinese medicine research and clinical practice. Leung and Xue (2005) 
suggest, for example to run clinical trials for evidence-based medicine (EBM) to 
transform the evidence of Chinese medicine, which was based before on empirical 
case histories, in the universal language of (Western) science. This transformation can 
be observed since the 2000s with the contribution to global drug development, which 
I will demonstrate in Chapter 6. Conversely, Scheid and MacPherson (2012) warn that 




and case studies ignore or are not capable of grasping the individual aspects or 
uniqueness of Chinese medicine.  
The research to date, which I have reviewed, has been concerned with the continuities 
and ruptures in the practice and education of Chinese medicine practitioners due to 
encounters between Chinese and Western medicine. In the literature, it is evident that 
science has been integrated into Chinese medicine, for example, in textbooks, theories 
such as bianzheng lunzhi, the new formation of TCM and the use of biomedical 
technology for diagnosis throughout history. Chinese medicine and modern science 
were presented as opponents in political agendas during the Nationalist era, and during 
the reformation processes of the Chinese state which made Chinese medicine a 
political tool (see Lei, 2014; Andrews, 2014). The standardisation of Chinese medicine 
during the 1950s and 1960s, showed that Chinese medicine was part of the political 
agenda and was transformed through the interpretation of cadres or Chinese medicine 
scholars who worked for the MOH (Taylor, 2005). In the 1980s, Chinese medicine 
practitioners participated in this reformation process in order to gain a voice and 
influence, as much as possible, the transformation of their medicine (Scheid, 2002a; 
2002b; 2013). The three encounters showed different political factions in power such 
as the Guomindang, the CCP under Mao and the CCP under Deng Xiaoping and their 
main agendas consisted of modernisation, standardisation and globalisation. Despite 
their different slogans, their aim was to modernise Chinese medicine. This was evident 
in the adaptions of institutional structure, disease classifications, their evaluation of 
Chinese medicine theories (e.g., with anatomy, physiology, neurology, systems theory 
or cybernetics), their labelling of Chinese medicine as a miracle medicine and 
alternative tradition for commercialisation in the global market. Chinese medicine was 
modernised and scientificised by others and by its practitioners. However, in the 
above-stated records, the Chinese government together with Chinese medicine 
practitioners trained in Western medicine and science and Chinese medicine 
practitioners and scholars participated in these changes. It can be said that for Chinese 
medicine to survive, it had to fight for a position in the Chinese healthcare sector, 
which was a fight that depended on the stance of government, party members or cadres. 
Typically, however, Western medicine was preferred as it was associated with 
modernity, and some Chinese medicine practitioners were active reformers and 




Chinese medicine practitioners arose out of a generation gap question. It is the 
laozhongyi against the young scientizers.  
In conclusion, most researchers refer to the encounters between Chinese medicine and 
modern science as something that happened to the medicine, and that Chinese 
medicine practitioners did not participate in the transformation (Taylor, 2005). 
Nevertheless, only some researchers view the modernisation and the influence of 
technoscience in Chinese medicine as a positive effect, which brings Chinese medicine 
forward (Scheid and Lei, 2014). Overall, Chinese medicine practitioners are familiar 
with encountering modern science and integrating aspects of it into their practice or 
theories. The question, thus, is how can the West and systems biology with the aim to 
establish a personalised medicine on the example of Chinese medicine cope with 
Chinese medicine?  
My research seeks, first, to combine stories from both sides of the involvement of 
Chinese practitioners and researchers, as well as to consider the involvement of 
Western scientists in the transformation process of Chinese medicine and science in 
the early 2000s. Secondly, I aim to observe this emergent phenomenon in multiple 
locations in China and the West. Therefore, the question of how this present 
relationship between Chinese medicine and systems biology has emerged and still is 
emerging requires an empirical approach of anthropology within STS. In the next 
section, I will discuss how medical anthropologists in the broader socio-historical 
discourse have investigated and presented encounters between different traditional 
knowledge, as well as therapeutics and scientific practices and how multi-sited 





2.2 MEDICAL ANTHROPOLOGY AND BIOTECHNOLOGY 
 
This section refers to medical anthropology as a methodology. Medical anthropology 
is a relatively young sub-discipline of social and cultural anthropology. It engages with 
humans in the context of health-related issues (Baer, Singer and Susse, 2003), social 
movements and debates in public health (Manderson, Harden and Cartwright, 2016). 
Medical anthropologists address new developments in medicine and life sciences 
(microbiology, biochemistry, genetics, parasitology, pathology, epidemiology and 
nutrition) to assess their influence and consequences on the lives of humans (Helman, 
2007). Based on these premises, medical anthropology adopts different theoretical 
frameworks and different foci. In the following sections, I will focus on two strands of 
medical anthropology: “medical anthropology of traditional medicine” and “medical 
anthropology at home” with the emphasis being on biotechnology and genetics.  
An exploration of how medical anthropologists have conceptualised encounters 
between Chinese medicine and Western medicine in the section of past encounters 
reveals trends in cross-disciplinary theories. Since the onset of anthropology in Asian 
medicines in the 1970s, anthropologists challenge the theoretical impasse of 
anthropology’s dichotomies, i.e., of East versus West, of traditional versus modern, of 
science versus culture, and nature versus culture (Nichter and Lock, 2002). The focus 
of this sub-discipline lies in comparative studies of “present-day human societies and 
their cultural systems” (Helman, 2007, p. 1) to reveal cultural, scientific and 
professional processes that have shaped Asian medicine in the long term (Leslie, 1976). 
In the early 1970s, anthropologists regarded traditional Asian medicines as “other” 
medicines (see Leslie, 1976, 1992; Kleinman, 1980; Scheper-Hughes and Lock, 1987; 
Unschuld, 1973). For example, Charles Leslie studied them on a small-scale level 
within villages and towns and the border of colonial empire studies (Nichter and Lock, 
2002, p. 2).  
In the 1990s, medical anthropology developed to a critical and sometimes activist 
approach which was sensitive to global situated political and economic issues (Nichter 
and Lock, 2002). Hess (1998) argues that anthropologists began to refer to STS 




modernist and post-colonialist context. Franklin (1995) notes that these 
anthropologists started the anthropology of biomedical research, science, ethical and 
legal questions. Another new trend that arose was critical medical anthropology (see, 
for example, Scheid, 2002a; Zhan, 2009; Sunder Rajan, 2002), which relates to Neo-
Marxian, critical and world systems theoretical perspectives (Baer, Singer and Susse, 
2003). Many of these studies compare traditional medicines with biomedicine, Nichter 
and Lock (2002, p. 2) and warn that neither traditional medicine is inherently 
conservative, and that biomedicine is not the only “scientific” medicine. Nichter and 
Lock (2002) argue that scientific and rational principles are immanent in traditional 
medicines, for example, Ayurvedic, Unami and Chinese medicine. Thus, it is essential 
to employ a critical stance to see transformations in medicines.  
Related to the historical and anthropological discussion of the development in Chinese 
medicine which was discussed in the previous section, medical anthropologists note 
similar globalisation and integration processes of Western medicine in several other 
traditional medicines. For example, Leslie (1976) demonstrates in his pioneering work 
on medical anthropology how Asian medicine changed. Researchers of ayurvedic 
medicine investigated the biomedicalisation and commercialisation of Ayurvedic 
medicine and formulae (Pordié and Gaudilliere, 2014; Pordié, 2012; 2014). Others 
investigated the transformation of Tibetan medicine into an efficacious transnational 
medicine (Schrempf, 2015), technoscientific medicine (Adams, 2001; Adams, 
Dhondup and Phuoc, 2010; van der Valk, 2017; Blaikie, 2013), an exile medicine that 
is globally accepted and standardised (Kloos, 2008, 2013) and the circulation of 
Tibetan and Chinese medicine by social actors (Springer, 2015). Other medical 
anthropologists studied the boundary communication between Arab medicine and 
biomedicine (Keshet and Popper-Giveon, 2013), investigated the hybridisation of 
medicine in Tanzania as a mix of biomedicine, traditional healing in Tanzania and 
Chinese medicine (Langwick, 2011), forms of enchantment in Western herbal 
medicine (Waddell, 2016) and identified Korean medicine as a heterogeneous and 
transnational reinvention of traditional knowledge (Kim, 2009). These examples 
represent only a small selection of anthropological studies in traditional medicine; 
however, these studies demonstrate the growing global interest in studying traditional 




Criticism arises with the cross-fertilisation of medical anthropology as an 
interdisciplinary field with the history of Chinese medicine. For instance, the idea of 
plural healing systems was adapted by historians as a socially constructed knowledge 
system that focuses on patients’ strategies rather than how historians viewed it before, 
such as an isolated medical system of patient choices (Hinrichs, 1998). Additionally, 
Helman (2007) expands on the concept of culture and warns of its misuse in its 
generalisation of cultures as static homogeneous systems. Cultures are in a constant 
process of historical, economic, social, political and geographical change, which 
manifests in people’s explanations of beliefs and behaviours (ibid).  
While medical anthropologists challenge the scientific evidence, which focuses on 
traditional medicine, Hampshire and Owusu (2013) argue that anthropologists present 
biomedicine as “colonising” and “co-opting” traditional medicine to use their 
“resources” in biomedical endeavours (2013, p. 248). Colonialism is a profound issue 
in medical anthropology and this instigated in the field a critical awareness of the study 
of “others” as “cultural” beings but overlooking the “cultural dimension and 
foundations of home” at the end of the colonial era (Van Dongen and Fainzang, 1998, 
p. 245). Due to discussions and the shortage of field research, the budget for abroad 
field trips abroad stimulated the emergence of the new sub-field “medical 
anthropology at home” (MAAH). MAAH aided medical anthropology to distance 
itself from colonialism and neo-colonial intellectual imperialism in Asian and African 
countries by studying “our” biomedicine (ibid). 
 
2.2.1 “MEDICAL ANTHROPOLOGY AT HOME” AND BIOTECHNOLOGY  
 
Van Dongen and Fainzang (1998) describe MAAH as the anthropological study of 
health issues at the home country of the researcher. It is a sub-discipline of medical 
anthropology that explores particular local practices that can inform the researcher, 
despite a lack of proper understanding in the field of study, for example, biology, 
epidemiology or psychology (Helman, 2007). Helman refers to this branch of medical 
anthropology as the “biocultural discipline” (ibid, p. 7), which he describes as a cross-




insights of anthropological and biological findings and provides in-depth data for the 
issue of investigation (Helman, 2007). In this field, since the 1990s, researchers have 
conducted ethnographies in biomedical sites such as hospital spaces (see Mol, 2002), 
health organisations (see Allen, 2014; Smith and Ward, 2015; Twycross, 2007) and 
health-related agencies (see Hare, 1993; Zhan, 2009; Jolibert, 2012; Clancey and Chen, 
2013; Sunder Rajan, 2002). The main issues investigated are health conditions in 
relationships with policies, biology and globalised political economies (Manderson, 
Harden and Cartwright, 2016).  
For example, Mol (2002) studies the disease atherosclerosis in a hospital in her 
hometown in Holland. She argues that multiple ontologies of a disease construct 
different realities in different localities. Her localities are in different departments of 
the hospital “Z”, e.g., the consultation room, laboratory, operation theatre, pathology 
and the patient (ibid). For her analysis, Mol (2002) applies the concept of “enactment” 
to differentiate the perception of a disease in different contexts. For instance, the doctor 
perceived an impaired leg as a medical indication for surgery. While for the patient it 
was merely seen as a handicap which prevented him/her from going up stairs. Harbers 
(2005) argues that Mol’s notion of ontologies is a different perspective of professional 
power struggles and should not be seen as an exclusion of factors but preferably as the 
inclusion of various elements of diagnosis resulting in a treatment. Her analysis, of 
“enactments”, has the potential to elaborate networks beyond power struggles by 
taking various perspectives within a specific setting (i.e., disease diagnosis and 
treatment) (Mol, 2002).  
MAAH, which interchangeably is used as “applied medical anthropology” and 
“clinical medical anthropology” (Helman, 2007), generated a vast body of knowledge 
in biomedical studies on biotechnology and genetics. Helman (ibid) says that in large 
parts, biotechnology culturally influences peoples’ attitude to health, illness and 
behaviour. He believes that this influence originates in the understanding of our body’s 
limits and what medicine in combination with technology can do or not to help us to 
overcome any physical restrains (ibid).  
Hadolt, Hörbst and Müller-Rockstroh (2012) study the transformations of medical 
techniques and medical artefacts in the context of human health. These transformations, 




system that trades human life as an economic value. Sunder Rajan (2002) calls this the 
biocapital, while Kilshaw (2018) views it more positively as the intersection between 
the modern Western world and Middle East countries. MAAH with its focus on 
biotechnology will be relevant for my study, as it can be used to view, from an 
anthropological perspective, how science and technology are applied to engage with 
and study Chinese medicine with the new approach of systems biology.  
Biotechnological studies show a wide range of influences of biotechnology on human 
lives, bodies and minds (e.g., Hadolt, Hörbst, and Müller-Rockstroh, 2012; Chen, 2003; 
Wiechers, Perin, and Cook-Deegan, 2013; Lock, 2015) and the monitoring of our 
lifestyle through smartphones (Manderson, Harden and Cartwright, 2016). The 
increasing use of biotechnology in the medical domain stimulated the demand for 
bioethical studies in medical anthropology. Sleeboom-Faulkner (2013, p.9), for 
example, developed in her study on bioethics the concept of “latent collaborations”. 
She describes the co-operation between Chinese stem cell researchers and foreign 
research institutions (e.g., U.S., UK, Japan and Korea) as a way for Chinese institutions 
to adapt international regulations and standards of safety, hygiene and bioethics. 
Additionally, Sleeboom-Faulkner (2013) identifies hidden networks as constructs of 
national funding, i.e., by the National Natural Science Foundation of China (NSFC) in 
cosmopolitan cities of China, i.e., Beijing, Shanghai, Guangzhou and international 
collaborators. Her work can be of relevance to identify how actors formed connections 
between China and Europe in the relationship between Chinese medicine and systems 
biology.  
The second track of biotechnology is genetics research, which investigates topics such 
as pharmacogenetics (Helman, 2007), genetic risk and cousin marriage (Kilshaw, 
2018), genetics as a form of biocapitalism (Sunder Rajan, 2002) and genome biobanks 
(Pálsson and Rabinow, 2015). Helman (2007), for example, investigates the 
manipulation of drugs and patients’ response to drugs. Pharmacologists need this 
information to create an individualised or personalised drug that is efficacious and safe 
for patients. Helman (ibid) discovered three major ethical and political issues for 
clinicians and social scientists in designing personalised drugs: (i) research 
prioritisation of certain health conditions, (ii) geneticisation, which is personal and 




patents on genomes of humans, animals and plants. The third is of particular interest 
for my study as this commercialisation, as mentioned by Hsu (2009) in the previous 
section, is an increasing problem in Chinese medicine. Helman (2007) claims that the 
genomes of indigenous medicinal plants are in danger as large foreign pharmaceutical 
companies patent or integrate the indigenous knowledge in Western databanks for 
biodiversity (i.e., biobanks). For example, turmeric is an herbaceous perennial plant of 
the ginger family (Finetti, 2011). It is used in India as a spice and as a remedy to treat 
wounds and rashes but through the US patent no. 5401504 the indigenous knowledge 
of turmeric was patented as a “new” invention for the commercialisation of a 
reformulated drug (ibid). The problem that arises is that foreign pharmaceutical 
companies “steal” the indigenous knowledge and do not share the benefits with 
indigenous people (ibid, p. 368). Two terms describe this development: biopiracy, 
which is the unauthorised use of indigenous plants by a large business corporation 
from developed countries, and biocolonialism, which happens when foreign 
companies patent new pharmaceutical drugs (ibid).  
Many traditional medicines are described as either “proprietary” medicine that are 
national and internationally recognised drugs (Pordié, 2014) or as “propriety” 
medicine that are medical drugs gained from traditional herbal fufangs and 
transformed into a biomedical propriety drug (Hsu, 2009). For example, Van der Valk 
(2017) investigates the industrial aspect of traditional medicines, patents and 
exploitation of indigenous products. Chinese medicine represents a source of 
traditional knowledge and herbal medicine that may become an issue with genetic 
studies. MAAH, in particular, is concerned with the issue of exploiting herbal 
medicine and the genetic identification and manipulation of drugs. Hsu (2009) and 
Efferth et al. (2018) investigate the issues of biopiracy or biocolonialism of patented 
Chinese medicine drugs in China and overseas. The increased use of biotechnology 
and omics technology in analysing Chinese medicine drugs for establishing a 
personalised medicine may, in the future, increase the concern of biopiracy.  
The issues of MAAH are diverse: distance from the field, length fieldwork and single-
sightedness. First, challenges of investigating health at home are to gain distance in 
the field because researchers might previously have been involved in the communities 




which complicates the analysis and reflection especially if the researcher is not aware 
of the way his own interests are culturally constructed (Helman, 2007). The study of a 
familiar setting suppresses the interconnectedness between “we” and the “others” thus, 
it reduces differences and similarities between our and the other culture (Hadolt, 1998). 
Hence, Hadolt (1998) suggests the concepts of “difference between” and “difference 
within” to study biomedicine at home. Secondly, the length of ethnographic research 
(of at least one year) may be inappropriate, e.g., in situations of health crises. Thirdly, 
phenomena are often in multiple sites, which challenge MAAH and its single-sited 
character. Hence, Fainzang (2010) proposes overcoming this issue by comparing 
studies from different research settings, e.g., a place abroad and one at home (ibid). 
Marcus (1995) advocates a “multi-sited ethnography” to overcome this problem by 
mapping relationships between local sites rather than producing a holistic 
representation of a world system. This method will be elaborated on in the following 
section. 
 
2.2.2 MULTI-SITED ETHNOGRAPHY 
 
To explore the “interface” between Chinese medicine and systems biology in multiple 
sites, an ethnography and, in particular, multi-sited ethnography can help to understand 
the complexities and the richness of the interactions between various actors working 
on scientific investigations arranged across European and Asian research 
institutions.  
Ethnography is synonymously described as the primary method in anthropology as 
well as a methodology for qualitative inquiry or case studies, which can include 
quantitative data and analysis (Hammersley, 2006). The core of ethnography is to 
study at first-hand people’s actions and statements in a particular context (ibid). 
Participant observation and open-ended interviews are the main instruments used to 
gather data and perspectives of people who are members of a certain social group or 
society in relevant settings (Helman, 2007). Hammersley and Atkinson (2007) state 
that ethnography includes both observations and interviews in the field to record 
people’s actions and accounts. These methods help collect unstructured data without a 




include meaning, functions and consequences of human actions and institutional 
practices. Through the interpretation of data, the researcher can reflect on the impact 
in the broader context or he or she can carry out an in-depth study of a few cases on a 
small-scale. From the data, verbal descriptions, explanations, theories, quantification 
and statistical data are produced. Data may include public or private documents and 
relatively informal conversations (Hammersley, 2006). It is important to produce a 
“thick description” of relevant and meaningful contents to describe and explain the 
contents of the study to an outsider (see Geertz, 2017).  
A vast body of complementary and alternative medicine (CAM) 16  research and 
Chinese medicine research demonstrate that ethnography yields richness of in-depth 
data of medical systems and practices (e.g., Farquhar, 1994; Hsu, 1999; Potrata, 2005; 
Scheid, 2002a; Ward, 2011; Kim, 2009; McMillen, 2004; Van der Valk, 2017). 
Ethnography is widely-applied to investigate and reflect on local and global issues 
such as the transmissions of Chinese medicine in China (see Hsu, 1999) and to 
countries outside China and non-Chinese (Barnes, 2009).  
Multi-sited ethnography moves away from single site fieldwork in conventional 
ethnography (e.g., used in laboratory studies and medical anthropology, see, for 
example, Mol, 2002; Latour, 1987; Knorr Cetina, 1983) to a mobile ethnography 
which takes place in multiple sites. Marcus (1995) established this method with the 
argument that social phenomena or economic relations became untraceable in a single 
site as they are shifted from studies on indigenous people (i.e., tribes) to exploration 
in the circulation of objects, cultural meanings, and identities that were dispersed in 
space and in time.  
In contrast, laboratory studies (see Knorr Cetina, 1983; Latour, 1987) are rich in 
material and details. Doing (2008) argues that this may lead to STS scientists failing 
to observe cases of contingencies for the production of scientific facts. Thus, STS 
scientists such as Lynch (1993), propose ethnomethodology. Ethnomethodology is a 
                                               
 
16 CAM describes a medical practice that is not mainstream or conventional medicine and is either used 
with conventional medicine (complementary) or in place of conventional medicine (alternative) 





detailed and rigorous descriptive study which involves recording the discussions and 
conversations of scientists in their everyday scientific practice (Keith and Rehg, 2008). 
Lynch (1993) argues that ethnomethodology considers emerging contingencies during 
the creation of scientific facts by focussing on the methods scientists use. 
Ethnomethodology, nonetheless, was not considered for this research as it focuses on 
the mundane details of social interactions and daily communication in local and lower 
level practices and neglects the broader structural level of multiple interactions 
between multiple sites. Thus, a multi-sited ethnography approach which examines the 
co-ordination between various sites and disciplines was used in this study.  
The relationships between sites arises from a shared object of study where contours, 
sides and relationships are unknown beforehand, but through juxtaposing or 
questioning aspects of the sites they become evident (Marcus, 1995). Falzon (2009) 
explains that even some advocates of multi-sited ethnography interpret the term “site” 
as either a location or a place or a perspective. Although multi-sited ethnography 
encompasses transformations and changes in space and systems, it still implicates the 
traditional methodological scaffold (i.e., observations and interviews). Multi-sited 
ethnography includes a commitment to language in a mechanical way and to practice 
a value-free social science with a touch of other forms of positivism (Marcus, 1995). 
This method emerged in the context of STS, thus, “following connections, associations 
and putative relationships” as a “circumstantial activist” are key to this method 
(Marcus, 1995, p. 97) and resonates with Latour’s (1987) “follow the actors” program, 
which I will discuss in the next section on STS lenses. Vinck (2010) argues that in 
medical anthropology of traditional medicine and biotechnology, multi-sited 
ethnography gives insights into transnational networks, which elucidates the 
transmission processes of scientific knowledge, expertise, data and technologies 
between varied biosociotechnical networks. Likewise, Kim (2009) argues for a multi-
sited ethnography to circumvent the limitation of single case studies in medical 
anthropology by tracing global assemblages of medical and traditional knowledge 
transformations. These examples are similar to the principal aim of my study which is 
to explore the emergence of relationships between the 1990s to 2010.  
By mapping the relationships between sites, multi-sited ethnography overcomes the 




mapping associations and relationships of a new object of study and sets this in the 
picture of earlier studies to illustrate a complex connected world. The comparative 
character of ethnography is maintained by questioning the contour and relationships 
of sites. As a result, findings of a multi-sited ethnography reveal fragments and 
discontinuities among sites (Marcus, 1995). Thus, Marcus and Fischer (2004) clarify 
that multi-sited research maps complex associations among various movements of 
actors, mobile objects or the transformation of objects and concepts in a transnational 
setting to avoid a Eurocentric or a dominant Western model, which resonates with the 
objective of this study.  
Relationships are not always visible in scientific publications. Strathern (1995) claims 
that connections are an act of crossing the boundaries of disciplines, power, and 
organisational levels. By doing so, collaborations generate noticeable and blurred 
networks of all sizes and scales, e.g., on an academic level or in the daily life of 
researchers and scientists. Occasionally, researchers may refer to their relationships 
with other scientists as “best friends” (Strathern 1995, p. 28). Although connections in 
this emergent “interface” between Chinese medicine and systems biology are not ties 
of kinship, their friendships may solidify their networks as extended forms of 
relationships. The focus on everyday practice helps to portray how actors established 
ties between systems biology and Chinese medicine. It also uncovers links between 
European and Asian institutions, which depicts reasons, intentions, gains, and losses 
throughout its process. 
A crucial aspect of adopting multi-sited ethnography is to understand the constructive 
nature of the empirical study and the field. Marcus (1995) posits that constructivism is 
the technique or method used in multi-sited ethnography to define the object of study. 
The ethnographer constructs a movement of a complex phenomenon among sites by 
tracing them with an initial concept that is contingent and malleable as the 
ethnographer traces it in the field. However, Gatt (2009) discusses various 
interpretations of constructivism in multi-sited ethnography, e.g., that people socially 
construct the field through ethnographic knowledge of the researcher and the 
information of the informant; or the ethnographer construct the field through the 
contextualisation of described and disentangled relationships. For this research, the 




to trace links in a socially constructed field that is only described in the scientific 
literature. 
Hammersley (2006) makes ethnographers aware of the critical tendency to carry out 
part-time observations. In multi-sited ethnography, the observation time in the field is 
shorter than in traditional anthropological studies where ethnographers live and study 
day and night the people of the relevant setting. In conventional ethnographic studies, 
fieldwork lasts at least one year (Helman, 2007) while in ethnographic work in 
institutions, universities or schools, the time is shorter. The shorter observations imply 
a danger of insufficient sampling, generalisation, an ahistorical viewpoint that can 
affect, for instance, a failure of recognising the cyclical process, which are work 
routines that change daily or weekly and show different tasks during the cycle as well 
as the change of patterns in the field. However, Hammersley (2006) asserts that this 
problem arises from the changing social conditions as most of the people observed do 
not live and work in the same place, which is the case for scientists and researchers. 
Thus, this restriction reflects on the nature of the observed societies, and with the 
transformation of society therefore, the methods have to adapt respectively.  
The data collected from audio- and video- recording devices produces a large amount 
of data in a short time and counterbalance the reduced contact with people and the lack 
of depth (Falzon, 2009). The lack of depth is also compensated by multi-sited 
ethnography with the role of the researcher as a “circumstantial activist” who reflects 
and tracks things and people and compares material among sites (Marcus, 1995, p. 95). 
Every site delivers different results through the variables of the setting but also through 
the time spent there. Thus, the data evolved in one single site exposes data for a 
comparison between local and global sites (Marcus, 1995). Falzon (2009, p. 8) argues 
that multi-sited research, which is conducted in short-term fieldworks covers the same 
data and depth by identifying the process on the example of anthropological studies at 
home. In-depth data is gained through a “time-space decompression”, meaning de-
centring the researcher is equal to the time he spends there, by adding more sites and 





In summary, medical anthropology and multi-sited ethnography are valuable for this 
research. Medical anthropology and MAAH facilitate insights into a merging field of 
traditional medicine, i.e., Chinese medicine, with biotechnology and genetics aspects 
in systems biology. Multi-sited ethnography in medical anthropology provides a 
methodology to map fragmented relationships, associations and connection between 
actors and sites which could describe the emergence of the relationship between 





2.3 STS LENSES 
 
This thesis is interested in discovering the nature and the involvement of the actors 
with their relationship between systems biology and Chinese medicine. The first 
problem that arises is if there is an “interface” and what the term “interface” means to 
the actors that work in field sites of systems biology and Chinese medicine research. 
This can be found out by observing actors in the field and their most recent publications. 
This question relates to the nature of this “interface” and to the difference between this 
emergent “interface” and past encounters between Chinese medicine and modern 
science. The question of the difference between encounters and this “interface” has 
arisen from questions of who established this “interface”; how scientists became 
involved in systems biology and Chinese medicine studies; and what was the role of 
technology in the involvement of actors and the shaping of this “interface”. In this 
section, I will critically discuss STS, laboratory studies and actor-network theory 
(ANT) as fundamental theories in the study of scientific practice. Subsequently, the 
“modes of ordering” will be considered for the analysis of the relationship between 
Chinese medicine and systems biology.  
Science, Technology and Society (also referred to as Science, Technology and Society 
- STS) offers interesting tools to study the scientific knowledge production and 
technological development in careful examination of interactions between scientists 
and with the artefacts to construct facts (Bijker et al., 1987; Knorr Cetina, 1981; Latour 
and Woolgar, 1986). STS is an interdisciplinary program associated with social 
sciences, history of science and technology, philosophy and anthropology (see Latour, 
2013; Law, 2004). Social constructivists within STS investigate scientific activities 
and technological developments as socially constructed through local social 
environments that shape science and technology through artefacts and networks (see, 
for example, Bijker et al., 2012). However, actor-network theorists consider that 
scientific knowledge is socially and technologically produced through interactions 
between human and nonhuman actors (see, for example, Latour, 1987; Law, 1994; 
Callon, 1986). To reveal the social context or the “seamless web” of interactions 
between actors (human and nonhumans) in the production of scientific knowledge, 




STS sets its importance in investigating emerging phenomena in science by identifying 
knowledge production processes (Bijker et al., 1987). This section will briefly 
introduce STS and identifies and discusses STS insights into investigating scientific 
work and developing technology which is relevant for this thesis, in particular, to the 
role of artefacts in the connection of distributed scientific fields.  
Forerunners of ANT were laboratory studies and their example of integrating 
observations in scientific knowledge production studies. Laboratory studies set the 
groundwork for studying scientific knowledge production in laboratories with 
ethnographic methods in day-to-day and first-hand observations (Knorr Cetina, 1981, 
1983; Latour and Woolgar, 1986; Lynch, 1993). For example, Latour and Woolgar 
(1986) and Knorr (1995) applied an ethnographic approach in the study of scientific 
practices to detach their research from depending on the scientists’ statement in their 
publications. In Latour and Woolgar’s influential book Laboratory Life (1986), the 
authors provide an ethnographic account of the activities of scientists in the Salt Lake 
laboratory. Latour and Woolgar (1986) meticulously analyse the actions and 
interactions between scientists and scientists and technology and materials. Collins 
(1995) and Amsterdamska (2008) argue that Latour and Woolgar (1986) established 
with this work the first social construction of scientific facts in the laboratory as a 
micro-analysis that supplanted the structural analysis of macro-sociological analysis. 
The careful study of actions in the laboratory provided insights into the experimental 
processes and the formulation of an accepted fact. Knorr Cetina (1981) states that it 
revealed the precise organisation of experiments and projects and their unpredictable 
progress and outcome which is influenced by local circumstances and social 
interaction of decision making and negotiations on project, rhetoric and scientific 
publications.  
Subsequent works in STS included the actor-network theory (short ANT; see, for 
example, Latour, 1987; Callon, 1986; Law, 1992) which focuses on technoscience as 
an interdependent concept that avoids a distinction between humans and nonhumans 
as well as technology and science. Instead ANT views humans and technology and 
science as joined in similar processes and only differentiated through their discipline 
of science and engineering (Latour, 1987). As opposed to past STS studies, ANT 




human and nonhuman properties (scientists, materials, organisations and partners) and 
declined the social tradition of human-focused studies by using the same vocabulary 
of translation for technology and society (Callon, 1986; Latour, 1987, 1993). STS 
scientists view ANT as the most influential concept in the field (Anderson and Adams, 
2008). Michel Callon’s (1986) work on “translation” between fishermen and scientists, 
Bruno Latour and Steve Woolgar’s (1986) experience in the Salk laboratories in 
California, U.S., and John Law’s (1992) work on “heterogeneous network” were the 
first ANT studies. Law (1992, p. 380) defines a heterogeneous network as a network 
that is generated through society and its consequences of power relations and materials 
that produce or affect knowledge, agents, social institutions, machines, and 
organisation. Society is the connection of various actors (i.e., humans, machines, 
materials) in networks who interact and generate knowledge. Others definition of 
actors in ANT studies included scallops (see Callon, 1986), inscription devices (Latour, 
1987), disability supporting technology (Moser, 2005), or organisations, governments 
and patient activist groups (Gottweis and Lauss, 2012) in addition to human actors 
who participate as actors in sociotechnical processes of knowledge building. Law 
(1994) argues that the agency of actors is an effect generated in a network of 
heterogeneous materials; thus, an agent (like a machine) is a network of different 
materials. To this end, STS theorists use a material-semiotic approach to map humans 
and materials (such as technology, lab equipment, research papers) and semiotics (such 
as concepts or written process of knowledge production) in laboratories of scientific 
knowledge production (Kim, 2009).  
The research questions of this thesis raise the methodological problems of how to 
analyse the involvement of the actors and their relationship between Chinese medicine 
and systems biology research and the emergence and development of their 
relationships. First, Woolgar (1981) and Barnes (1981) tried to analyse involvement 
as a social interest in the process of either being attracted to something and engaging 
voluntary with it, or participating in something. For this, Woolgar (1981, p. 367) refers 
to the use of the “interest model” as an explanatory “resource to explain the change in 
(or involvement with) the content of scientific knowledge, the relationship between 
social and knowledge products in terms of social and/or cognitive interests of 
participants”. Woolgar and Barnes study scientific practices as social processes, thus, 




scientific knowledge. In contrast, Callon and Law (1982) believe that knowledge 
production happens through social and technical interactions, which leads them to the 
conclusion that the interest model is a theoretical concept to understand why scientific 
culture grows in the way it does, and not how actors become involved in the process. 
Moreover, Woolgar (1981) states that the interest model was designed to study the 
demonstration or exposure of interests during scientific actions, which, does not aid 
the discovery of the involvement of scientists in a new field such as Chinese medicine 
and systems biology research.  
In the interest model perspective, STS studies depict that scientists participate in 
studies within their research area and research group; their projects are within their 
established area of knowledge (see, for example, Woolgar, 1981). Interest in a new 
topic but the same field is also the usual case study format in ANT (see, for example, 
Latour, 1987; Law, 1994; Callon, 1986; Timmermans and Berg, 1997). ANT studies 
try to understand emerging technoscientific cultures by following networks of human 
and nonhuman actors’ associations, statements and practices that show the continuous 
transformation of a social and technical (sociotechnical) network (Latour, 1987; 
Callon, 1986; Law, 2007). Thus, their points of departure are that scientists are already 
members of projects within their research fields, and, second, that cases are a single 
site, which is the centre of their study, see for example, Callon’s (1986) study on 
scallops in St Brieuc Bay, France.  
ANT scientists (Latour, 1987; Callon, 1986; Callon and Law, 1982) use the concept 
of “translations” to analyse the processes involved in enrolling human and nonhuman 
actors, the interest of the initiator of research and the so-called fact-builder (Latour, 
1987). They translate “inter-esse” as in between various actors. According to Callon 
(1986), interessement indicates that interests are not stable and change in a competitive 
enrolment of and between various actors through translations of the interest into a 
collaborative work. In order to enrol actors into a project, it is important to make them 
believe the claim or argument of the fact-builder (Latour, 1987). Callon and Law (1982) 
justified interessement as an escape from the problem of interests by Woolgar (1981) 
and Barnes (1981) and assess the measurement of interest through the correlation of 
nominal variables as problematic. Woolgar and Barnes investigate the interest of actors 




relate to Woolgar’s and Barnes’ interest approach as I aim to investigate the interests 
of the researchers. However, I am concerned about the researchers who find a specific 
problem within their field, and consequently initiate various processes to generate an 
experiment or research co-operation with all its implications such as funding, 
collaborators, suppliers, technology, materials, rhetoric, spokesmen and 
representatives. In other words, I am interested in the motivations that leads to a 
scientific project.  
ANT has been the object of a series of criticism. A major objection concerns the 
“generalised symmetry” with its resistance to differentiate between animate or 
inanimate actors or between individuals and organisations (Sayes, 2014; 
Amsterdamska 1990; Pickering, 1995). Amsterdamska (1990, p. 499) rejects the idea 
of a symmetry between humans and nonhumans as a “war whose only objective is 
domination” and a method used to find allies in and a way to strengthen a specific 
network. Even though Pickering (1995) relates his “mangle of practice” theory to ANT, 
he refuses the idea that machines, probes, microbes and quarks have intentions behind 
their action and perform (behaviour) intentionally. ANT proponents refuted this with 
the explanation that a rejection of a priori distinction between humans and nonhumans 
furnishes the researcher with a tool to investigate in a minute displacements translation, 
practices, processes, arguments and struggles (Sismondo, 2004).  
Another critique is that the ANT studies networks as a “seamless terrain” without 
hierarchies and structures of politics, industry and economics that interact in a global 
knowledge-making practice (Kim, 2009). Hence, social constructivists argue that ANT 
rejects the argument that humans construct science and that science is static and 
socially constructed (Bijker et al., 2012). However, ANT theorists as post-humanists 
follow the idea that humans and nonhumans construct scientific processes and that 
science is not imposing itself on society, but they are co-evolving (see, for example, 
Latour, 1999; Barad, 2007; Pickering, 1995; Law, 1994; Mol, 2002). Latour (1987) 
demonstrates that scientific facts and realities are produced through the effort of 
associations between various actors that transform an artefact into a fact by moving 





In this thesis, the diversity of scientific and technical aspects that emerged from the 
variety of actors and their different involvement in a new multi-disciplinary and multi-
sited study is essential and cannot be ignored. Biologists, biochemists, biomedical 
scientists, pharmacologists and artificial intelligence (AI) scientists would have all 
different ways of involving with Chinese medicine by engaging with another area of 
research. Those actors changed from biomedical studies on biomedical disease 
classifications and diagnoses, which they were familiar with or technological studies 
on intelligence in machines to Chinese medicine. Although translations provide a tool 
to understand how systems biology and Chinese medicine produced scientific 
knowledge, the crucial question of the actors’ involvement cannot be answered with 
translation. Consequently, translation was not selected for this investigation. Instead, 
additional concepts that originated in ANT and which focus on the motivators and 
drivers of scientists to engage in a multi-disciplinary study a non-scientific field like 
Chinese medicine are considered next – “mode of ordering”.  
“Modes of ordering” (Law, 1994) can be used as an analytical tool for sense-making 
of purposes or activities around scientific knowledge production. This concept stresses 
the reflection and the self-reflection of representations, demonstrations and enactments 
of ordering of “heterogeneous materials” in scientific practice. Law (1994, p. 23) 
defines heterogeneous materials as human and nonhumans that include people, 
technical devices, texts, “decisions”, relationships between organisations, and 
organisations. He claims “‘modes of ordering’ are about: they represent a way of 
imputing coherences or self-reflexive ‘logics’ that are not simply told, performed and 
embodied in agents, but rather speak through, act and recursively organize the full 
range of social materials” (ibid, p. 109). In this sense, “modes of ordering” are an 
analytical tool used to make sense of patterns that arise from the exploration. They 
offer an interpretation tool of how humans and materials interact and create complex 
effects, such as organisations through conditions of possibility, ways of ordering and 
webs of relations (Law, 2007).  
Law (1994) rejects the idea of a single “order” such as “social order”. He argues that 
social order is constructed of various materials - in which he includes, for example, 
talk, texts, machines, architecture - and of plural processes. Thus, every order consists 




order and investigation of the processes of “sociotechnical ordering”, the ordering of 
social intertwined processes with technology (Law, 1994, p. 2). Mol (2010) explains 
that “modes of ordering” is about work, precarious achievements in open-ended 
processes with a particular interest in the co-existence and co-operation of merits and 
drawbacks, for example, networks are achievements. According to Law (1994), 
networks emerge from interactions between associated actors and the changes that take 
place in their constant making and re-making. The active association of actors and the 
building of networks with other actors requires the translation of scientific facts and 
realities into new contexts and new locations. These translation processes generate and 
gather representations in a single place, which is the centre of representation or “centre 
of translation” in the translation concept of Latour (1987) and Callon’s (1986) theories.  
In “modes of ordering”, Law (1994) is interested in people, organisations and 
machines as agents and the kind of modes they perform. He argues that agency 
emerges through “modes of ordering”; it is an effect that is generated by decentring 
the subject and its bits and pieces; it emerges in between structures and non-structures 
rather than following one. For example, a vision of an invention does not follow 
existing structures of mundane organisation matters, it creates its way through them to 
generate something new. In summary, agency is not attached, embodied or acted by 
humans, but it is rather a matter of degree, which focuses on quantities and qualities, 
which cedes or can be lost through passiveness but regained through activity. Types 
of agency can be puzzle-solver like scientists, administration as a set of embodied 
skills, or vocation in the form of creativeness and consistency. Agency is nothing pre-
defined but rather it is unexpected and a new adaption to a situation, e.g., the 
consortium can be seen as an agency that emerges through the interaction between 
systems biology and omics.  
Moser (2005) remarked that the “modes of ordering” draw on material semiotics as a 
strategy to trace materials in local, situated practices and broader sets of relations and 
arrangements that conditions and limits practices. However, practices are limited to 
the range of their networks and material arrangements and cannot go further to reach 
actors outside of the network or reflect on the broader context (Hedgecoe and Martin, 
2008). Moser (2005) shows in her study that “modes of ordering” extend out of the 




the network. Moser (2005) uses the “mode of ordering” to investigate how people deal 
with their disability and to avoid a study design that highlighted the representation of 
differences between normal and not-normal and their distribution of power and agency 
which excluded alternative ways of living. Her “modes of ordering” do not 
demonstrate an ordering that relies on Law’s (1994) categorisation of administration, 
enterprise, vision or vocation but enactment through disability in the “ordering of 
normal, lack, fate and passion”. Moser (2005) identifies the ordering of perceptions 
and opposes categorising them as management arrangements.  
Additionally, Moser (2005) uses the “ordering of normal” as a category to the other 
modes and claims that actors move between different modes as they co-exist and are 
partially related. In her terms, modes are not only categorisation of organisations, but 
also ordering of ways of life that are classified by feelings and overlap with other 
modes; they are multiple and dynamic. Another example for the extension of ordering 
is given by Gottweis and Lauss (2012) where their use of ordering is as a strategy to 
pattern a network of interaction between biobanks and associated organisations for 
evaluation of failures and success. 
Critiques made claim that “modes of ordering” do not clearly define useful explanatory 
or interpretive categories and they do not reveal how Law (1994) moves from 
observation to abstraction and back (Gerson, 1995). Others warn of the reification of 
abstract metaphors from field concepts (see for example, Czarniawska-Joerges, 1996). 
However, Czarniawska-Joerges (1996) commends Law on the step beyond positivism 
and grounded theory. The idea that human and nonhuman actors are connected in a 
network that forms and creates a scientific practice that interests me. Mol (2010) 
defends “modes of ordering” and ANT by stating that it is a repository of terms and 
modes which describe what is going on. These modes are unpredictable and flexible 
in what deserves concern or care, strength in adaptability and sensitivity to underlying 
cases and stories. They draw contrasts, articulate silent layers and turn questions upside 
down.  
Moser’s approach of ordering based on conceptions describes involvement as a 
process of ordering in multiple and overlapping modes. However, a further issue is the 
multiplicity of field sites that generate this “interface”. The problem with an    




at least two partners to co-operate. Thus, if actors are Chinese medicine researchers 
and systems biologists, they incorporate the knowledge of both sides and do not need 
to co-operate with each other to gain the others expertise. Different ways of 
involvement suggest that various networks have been established in different sites 
worldwide. The idea of a “heterogeneous network” or multiple networks offers an 
understanding of multiple and various actors which are connected to one network. 
Latour (1987) describes networks as a collection of information, scientific results from 
other scientists, politicians, industries, collaborators, students, leaders, supporters, 
clinicians and scientists which are embedded in the structure, power and organisation. 
Law (1997) distinguishes three types of heterogeneity: materiality, alterity (being 
different) and fractionality (not singular, something different, which is more than one). 
Moreover, various parts of networks are juxtaposed into a patterned network to 
overcome resistance - of a material or an organising and ordering matter of materials 
– through complex engineering of fitting together social, technical, conceptual, textual 
and convert (translate) them into a set of equally diverse scientific practices (ibid).  
This study questions the emergence and nature of this “interface”, which includes a 
historical component, which observations cannot cover. Latour (2013) and Law (1994) 
agree that ANT and anthropology are deeply intertwined through the use of 
ethnography, which offer a method to look beyond dichotomies of us and them and 
nature and culture. In a later paper, Law (2012) confirms and adds that “modes of 
ordering” are a set of threads that are entangled in the ethnographic practice. However, 
the way we collect data in fieldwork and how we look at things and pose questions is 
more like a method rather a theory (ibid, p. 11). Kim’s (2009) successful combination 
of multi-sited ethnography with STS theory of global assemblages provides the 
necessary method to extends the range of networks as seamless terrain to multiple 
terrains and to multiple sites. Hence, multi-sited ethnography and “modes of ordering” 
might serve as a useful tool set to detect this “interface” through scientific publications 







In line with the research aim and objectives, this chapter has reviewed anthropology 
and STS scholarly efforts in the areas of traditional medicines, biotechnology and 
actor-network theory. The anthropological perspective on traditional medicines is 
valuable for this research, as anthropology’s toolset enables insights into traditional 
medicine, biotechnology and genetics. Medical anthropologists often employ STS 
concepts to acquire in-depth understanding beyond colonialism and dualism, and STS 
scientists apply ethnography to research scientific processes in real time (Hackett et 
al., 2008). Multi-sited ethnography and “modes of ordering” on the agency and 
interactions of humans and nonhumans and the move beyond the single-sitedness of 
laboratory studies, propose interesting conceptual and methodological instruments. 
This combination facilitates this research project with lenses to view multiple 
perspectives of the emergent “interface” by tracing human and nonhuman actors of 
various sites in a complex network of collaborators both from industry and public 
sector and state (i.e., government, funding agencies, academia, as mostly being partly 
supported by governments and federal money). Thus, the combination of multi-sited 
ethnography with “modes of ordering” will be the methodological framework of my 
study which concerns the emergent “interface” between systems biology and Chinese 
medicine in multiple sites worldwide. The methods of this thesis will be elaborated on 





3. RESEARCH METHODS 
 
This chapter will discuss the methods best suited to investigate the emergent 
“interface”, which was the arising phenomenon of a relationship between systems 
biology and Chinese medicine in the 2000s. In order to outline how human and 
nonhuman actors have generated this relationship between two different disciplines as 
well as to identify actors and their backgrounds, a methodological triangulation is 
proposed. In the following, I will provide an overview of the methodological 
triangulation followed by an outline of key methods applied in three main stages, 
namely: literature survey, participant observation, and episodic interviews. The last 
section will contain data analysis, data presentation and ethical issues concerning the 
research process. 
 
3.1 METHODOLOGICAL TRIANGULATION 
 
In order to address the research questions of is there an “interface”, what is the nature 
of it, how did actors become involved and how did it develop I have decided to employ 
the methodological triangulation by Flick (2014). A triangulation combines different 
research methods and information sources to gain saturated data of multiple fields and 
its dynamic from diverse stories. Flick (2014) defines three stages: taking a sample 
through a literature survey, analysing relationships and interactions between human 
and nonhuman actors and sites, mapping those actors and sites to case studies. I will 
adapt these steps to: (1) literature survey, (2) participant observation and (3) episodic 
interviews in the field sites and to relate them, and (4) data analysis and presentation. 
These methods will facilitate a systematic comparison to investigate relationships, 
partners and topics for co-operation, and will reflect on tensions within groups that 





3.1.1 LITERATURE SURVEY 
 
In order to identify the nature of the arising relationships between Chinese medicine 
and systems biology, I conducted a secondary scientific literature survey by following 
references. The first article I found was by Scheid (2014) on Convergent Lines of 
Descent: Symptoms, Patterns, Constellations, and the Emergent Interface of Systems 
Biology and Chinese Medicine. Scheid (2014) claimed that an “interface” between 
Chinese medicine and systems biology was emerging and calling for further 
ethnographic investigations on this “interface”. In this article, Scheid refers to the 
Chinese scientist Shen Ziyin 沈自尹(2005) who concurrently with a group of scientists 
in the Netherlands (Wang et al., 2005) discussed the possibility to bridge Chinese 
medicine and Western medicine with systems biology. Scheid’s article and the others 
will be discussed in more detail in Chapter 4. A further search on articles written and 
published since 2005 supported this claim of a contact between Chinese medicine and 
systems biology. The search contained the words “systems biology” and “Chinese 
medicine” in the title and was conducted in the databases Web of Science (see Figure 
1). The findings revealed that between 2005 and 2018 a total of 229 publications (141 
articles, 73 reviews, 8 proceedings papers, 5 editorial material, 1 letter, 1 meeting 
abstract) were published with a highpoint in 2012 of 41 publications (see Figure 1). 
An evaluation of the citations per year demonstrates that the attention on this topic 






FIGURE 1: PUBLICATION NUMBERS ON “SYSTEMS BIOLOGY” AND 




Figure 1: Web of Science statistic on publications from 2005 to 2018 on “Chinese 
medicine” and “systems biology”, which indicates the starting point in 2005 and the 
peak in 2012 with 41 publications (y=number of publications, x=year) (Source: Web 
of Science, updated 23 January 2019). 
 
Research on the publications in 2012 demonstrated that many of the articles referred 
to the “Special Issue” of the Journal of Ethnopharmacology in 2012. The Special Issue 
contained the results of a three-years funded (2009-2011) project by the European 
Research Commission (ERC) during the Framework Program 7 (FP7) to investigate 
scientific methods to study and regulate Chinese medicine (Web of Science, 2018). By 
tracing the ERC TCM consortium to the first scientific publication on systems biology 
and Chinese medicine, I discovered that Wang Mei, a molecular plant scientist in the 
Netherlands, and her colleagues, published an article on Metabolomics in 2005 on the 
context of systems biology bridging Traditional Chinese Medicine and molecular 
pharmacology (Wang et al., 2005). The article was printed in the Journal for 
Phytotherapy Research and up until 2017 it had received 148 citations. Jan van der 
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diagnostic principles as pillars of the bridge between Chinese and Western medicine 
in the Journal Planta Medica (van der Greef et al., 2010). Authors of the TCM 
consortium and in this field cited these two articles as the groundwork for this 
“interface” (Uzuner et al., 2012; Scheid, 2014; Luo et al., 2012b; Buriani et al., 2012; 
Verpoorte et al., 2009). The citations deliver another indicator for a relationship 
between systems biology and Chinese medicine. It also suggested that the first 
relationships emerged in the early 2000s and peaked out in 2011 and 2012.  
The literature survey provided an overview of the multi-dimensional context under 
investigation and set up a timeline of the relationships between systems biology and 
Chinese medicine. However, these articles did not reveal how the interest and the 
connection between the actors in those two fields were set up before 2005 and 
developed after the first publications. In order to uncover those stories behind the 
scientific papers about this what Scheid (2014) calls “interface”, I employed field 
research. The selected methods to investigate the “interface” were participant 
observations and episodic interviews. These methods supported me to collect data in 
the field about the human and nonhuman actors, the development of relationships 
between them, and to find meaningful relations, perspectives and intentions of actors 
that participated in generating and shaping this “interface” from the beginning.  
 
3.1.2 PARTICIPANT OBSERVATION 
 
In this section, the data collection through participant observation will be described.  
The literature survey provided a list of key persons for participant observation. They 
were selected because of their participation in establishing relationships and 
collaborations and due to their research studies and their research discipline. These 
key persons were contacted to gain access to their labs for observations. 
Participant observation served as one of the three data collection methods (besides 
literature survey and episodic interviews) for this research. First-hand observations are 
one of the main methods typically used in ethnographic studies as they facilitate a 
flexible approach to study human and nonhumans, i.e., technology and material in their 




responsive tool to investigate an uncertain phenomenon by shifting interest as the 
researcher encounters the unexpected (Boellstorff et al., 2012). Similarly, Fusch, 
Fusch and Ness (2017) have advocated that in participant observation the researcher 
becomes the data collection instrument due to the role as observer and interactor with 
members in the field. In order to perceive how the “interface” unfolded in the field by 
understanding their experiences in and perspectives on this “interface” participant 
observation is a feasible method.  
In my participant observations, I decided to use the regular and traditional method of 
paper and pencil, rather than using new gadgets such as a smartphone or a tablet. The 
traditional notebook was more useful as I was able to write in unexpected situations, 
which made using a notebook and pencil in the field more flexible. A laptop with all 
its extras such as cables would have been too heavy to carry around. Additionally, in 
settings outside of a laboratory, it would have attracted the unnecessary attention of 
the patients, for example, if I had used a laptop in the TCM hospital in China, the 
patients would have been more distracted by it and this would have inevitably 
disrupted my observations. Moreover, I found that paper was more reliable especially 
as it meant there were not any issues with battery life, and I was not faced with 
technical issues.  
I decided against what Tricia Wang (2012) calls “life fieldnoting”, which is a blog post 
on any social media that makes the research traceable and transparent. “Life 
fieldnoting” is similar to the social media Twitter in that you can post a photo and add 
one to five sentences, which presents at the end of the fieldwork a “thick description”. 
Wang also used “life fieldnoting” as a digital footprint that enabled people to locate 
her position in case of emergency. However, I found the approach with photos and 
note taking in the form of short sentences on the mobile phone feasible and employed 
it to take pictures, or I used this method in situations where I had no notebook.  
The study of Hein, O’Donohoe and Ryan (2011) confirm that mobile phones are 
popular in ethnographic work. However, I found that in the lab, the use of smartphones 
was tricky as the touchscreen did not react with the latex gloves; thus, it was to record 
my thoughts and observations in a notebook. Apart from that, laptops were not allowed 
in labs due to the chemicals and gears the students used. Consequently, I used eight 




Field sites (see Table 1) were located in the UK (Oxford), the Netherlands (Leiden, 
Zeist), Austria (Graz), China (Harbin, Dalian, Hangzhou) and Japan (Tokyo). Field 
research was conducted for four months in 2015 and seven months in 2016 (see 
fieldwork schedule in Table 1). The number of sites amounted to 11, including Chinese 
medicine pharmaceutical and pharmacokinetics17 laboratories, hospitals affiliated with 
Chinese medicine research institutions, systems biology and metabolomics research 
institutes, as well as one acupuncture research institute. I undertook “probes”, which 
are short field trips of 1-3 days to each site. They were this length due to lab restrictions 
but were long enough for me to get an overview of the research site. The probes 
followed the example of Sunder Rajan’s study in Silicon Valley and India (2002). For 
the probes, I went to Leiden, Zeist, Oxford, Tokyo and Graz. Following on from these, 
I conducted intensive short-term participant observations, which are common in multi-
sited ethnography as I discussed in Section 2.2.2. These were longer field research 
periods of 1-2 months at each site. For my research, I went to Harbin, Dalian and 
Hangzhou (see fieldwork schedule in Table 1). 
My observation schedule followed a two-stage process (see Table 1). First, I conducted 
fieldwork in Europe, then in China and Japan. The actors I observed were nine doctoral 
students (Year 1 to Year 3) in laboratories, five Chinese medicine practitioners in 
hospitals, and five scientists in their labs and offices. At the Chinese metabolomics 
and the Chinese herbal plant medicine research site in Harbin, I was able to gather in-
depth data in the lab. I observed twenty students and scientists who I selected due to 
their publications I always contacted them before my fieldwork. Only at the Harbin 
site, was I assigned by the head of the department to spend most of my observation 
time with one student. However, in other sites I was allowed to freely follow any 
student or scientist in the lab. During my observations, I had conversations with the 
scientists, I observed and followed them in their daily work in their labs and in their 
workplaces.  
                                               
 
17 Pharmacokinetics is a branch of pharmacology that studies the dynamics of drugs in the metabolism 




Table 1 summarises the time and duration of my visits to field sites as well as what I 
observed in the field. During my observations from all eleven field sites, I took 
extensive unstructured fieldnotes, photos, photocopies and collected pamphlets, 




TABLE 1: THE FIELDWORK SCHEDULE 
 
Where? Time & Duration What observed? 
1st stage of fieldwork 
TCM research in Graz, 
AT 
June 2015,  
1 day 
Chinese herbal medicine, acupuncture 
research unit 
International Conference 
on Health, Healthcare and 
Eco-civilisation at the 
London South Bank 
University, London, UK 
September 5-6, 2015 
2 days 
Latest research on Chinese medicine and 
systems biology,  
Gaining access to Chinese metabolomics, 
Harbin field site  
Research Council for 
Complementary Medicine 
- Demonstrating the value 
of Integrative Medicine, 
London, UK 
September 10, 2015 
1 day 
Discussion on research results and 
evidence base for integration of Chinese 
medicine, showcase new initiatives in 
provision and policy and funding issues, 
Gaining access to in vitro fertilisation field 
site 
Chinese medicine 
diagnosis project, Leiden, 
NL 
December 2015  
2 days 
Laboratory and technology observations 
Chinese medicine practitioner, workshop  
Cardiac project, 
University of Oxford, UK 
January 2016 
1 day 
Research leader of cardiac disease project 
2nd stage of fieldwork 
Chinese metabolomics 
research, Harbin, CN 
April-June 2016 
2 months 
Wet laboratory experiments on Chinese 
metabolomic research, 
Chinese medicine consultations, 






Wet laboratory experiments 
Medicinal plant garden 
August 2016 
1 month 
Observation in medicinal plant production 
In vitro fertilisation (IVF) 
project, Hangzhou, CN 
September 2016 
2 weeks 
Chinese medicine practitioner, 
consultations  




Wet lab experiments,  





Visit to systems biology institute,  
systems biology research only 
 
Table 1: The Fieldwork schedule describes places, time and duration as well as the 




During the fieldwork, I regularly consulted the literature to identify and contact further 
actors. More actors and sites were identified through “snowballing”, which Helfferich 
(2005) describes as recommendations of gatekeepers to further actors in the field. 
Further identification sources of actors were websites such as researchgate.com, 
academica.edu and linkedin.com. In addition, I attended conferences, i.e., the 
International Conference on Health, Healthcare and Eco-civilisation, London South 
Bank University from September 5-6, 2015 and the Research Council for 
Complementary Medicine - Demonstrating the value of Integrative Medicine, 
September 10, 2015 to approach further systems biologists and Chinese medicine 
researchers and to gain access to their laboratories. 
Table 2 provides an overview of projects, funding, timeframe and co-operation 
partners of their projects. Some actors denied fieldwork in their site as they either had 
insecure financial status for the research site or conducted high-confidential research 
projects. The names of all projects and informants (interchangeably used with actors) 
in this thesis were anonymised to preserve confidentiality and to capture the research 





TABLE 2: DESCRIPTIONS OF FIELD SITES 
 
Ethnographic sites  















China for best 
practice, 
safety and 
efficacy of CM  
09/2009 -  
05/2011 
 
€ 1.1 million 
200 members (13 
EU, 6 Non-EU 
states), 
120 institutions in 24 
countries; 
10 research groups 
in quality, efficacy, 

















2 partners in 2 
countries: 
  1 SB laboratory, 
  1 metabolomics 
institute, 
1 plant research co-
operator, 
1 CHM research 
university lab, 




1 spin-off company 
SB, new 
perspectives 













2 partners in 2 
countries,  
1 SB laboratory, 
1 metabolomics 
research institute,  
1 plant research 
department, 











study on CHM  















1 hospital  
technology producer 















1 university lab, 












SB study on 
biomedical 
diseases  




3 research institutes, 
2 university labs,  
industrial partners, 
































(IVF) with CHM  
IVF 
complimented 
with CHM to 
promote 
fertility 




public funding   
1 hospital, 





restore fertility  




interest in CM 
and Kampo 





2 research institutes 
on SB, 
1 disease modelling 
institute, 








Table 2: A description of the selected ethnographic sites and their projects themes, 




Abbreviations: Systems biology (SB), Chinese medicine (CM), artificial intelligence 
(AI), Ministry of Science and Technology (MOST), Royal Netherlands Academy of Arts 
and Sciences (KNAW), Chinese medicine (CM), systems biology (SB), artificial 
intelligence (AI), Chinese herbal medicine (CHM) and in vitro fertilisation (IVF).  
The field sites were selected according to the key persons that I identified during the 
literature survey. I contacted these key persons for an enquiry about their involvement 
and experiences in this “interface” between Chinese medicine and systems biology 
(see Table 3). Their leading roles have rendered access to essential information about 
their own projects and the historical process of this “interface”. They also provided 
information to other actors and sites working on Chinese medicine or systems biology. 
Actors were mostly related to the European Research Council Traditional Chinese 
medicine consortium (ERC TCM) as the ERC project aimed to identify scientists and 
researchers working on Chinese medicine and systems biology. Thus, the four key 
informants (see Table 3) were identified as “gatekeepers”, i.e., “actors with control 
over key sources and avenues of opportunity” (Hammersley and Atkinson, 2007, p. 
34). Hammersley and Atkinson (2007) describe gatekeepers as people connected with 
other actors who established themselves as contact or information points. Thus, a 
gatekeeper was the first person to contact for the coordination of the research and the 
communication between two or more sites as well as they decided with whom to co-
operate. Hence, I decided to identify and approach gatekeepers first as they were well 
grounded in the field – which was seen in their publications – and had information 
about the historical process and individual perspectives on relationships between 
Chinese medicine and systems biology.  
Table 3 lists the gatekeepers, their roles, involvement in projects and connections to 
further sites and actors. This table shows the four gatekeepers I identified through a 
literature survey and who I interviewed in my research. The table lists the role of the 
gatekeepers, the projects they were involved in and their Chinese medicine and 
systems biology research contacts, which are referred to or described in my thesis. 
Based on the information of these gatekeepers, I identified further actors and field sites 





TABLE 3: LIST OF GATEKEEPERS 
 
Gatekeeper Role Project Involvement 
Connection to other 
actors 
Gatekeeper 1 Head of institute 
CHM research 5 members of the ERC TCM consortium, 
TCM research 
association (2014-) 
6 research program 
leaders: 
1 head of a university co-
operation network,  
2 heads of acupuncture 
projects,  
2 heads of CHM 
phytotherapy projects,  
1 head of a Chinese 
medicine modernisation 
project 
Gatekeeper 2 Team leader 
SB for CM 
diagnosis project 







researchers in China 
scientists in China 
politicians in China 
Gatekeeper 3 Senior researcher 
SB for lipidomics 
project  
(CM lipidomics) 
2 heads of institution  
4 principal investigators 
1 collaborator of first 
CM/SB publication 
Gatekeeper 4 Post-doc student 
SB for CM 
diagnosis project 






Table 3: Gatekeepers, their role and connection to other actors in Chinese medicine 






Figure 2 shows the selected field sites. I narrowed the field sites to nine namely the 
ERC TCM project, Chinese diagnosis study, Lipidomics research, Chinese formula 
metabolomics, Acupuncture research, TCM research, in vitro fertilisation with 
Chinese medicine herbs, fast examination blood serum diagnostic kits and AI with 
Kampo.  
 




Figure 2: Field map of the observed research projects. Projects on the left were 
involved in the ERC TCM research while projects on the right focussed on systems 
biology and those only recently started to investigate Chinese medicine and Japanese 
medicine (Kampo).  
 
The selection of the field sites was done by tracing research funding and co-operation 
partners of the ERC TCM project. This included a flexible approach in the field for 
changing sites or identifying new sites according to the restriction of access or new 
information gathered in the field. Thus, I applied a theoretical sampling as a procedure 
of sampling data after collecting and analysing a certain number of field site data that 
























were relevant to the theory of the study (Flick, 2014). Coyne (1997) links analysis and 
decision processes together to make an impromptu decision for the next field site and 
for establishing a theory of the study. This theoretical sampling method assured both 
the comparability of the topics, the openness to other views as well as the organisation 
of field trips between the sites in Europe, China and Japan (see fieldwork schedule in 
Table 1).  
For this research project, actors from seven of the considered field sites (i.e., the ERC 
TCM project, Chinese diagnosis study, Lipidomics research, Chinese metabolomics, 
Acupuncture research, TCM research, in vitro fertilisation) were participants in the 
ERC TCM research for investigating Chinese medicine regulation and research in 
European healthcare services. The Chinese projects (i.e., Lipidomics research, Chinese 
metabolomics, in vitro fertilisation and the fast examination kits) received funding 
from the NSFC (see Table 2 for project funding and Appendix A for NSFC funding 
details). The NSFC financed projects to modernise Chinese medicine with the omics 
techniques. The European Research Commission (ERC), which I will describe in detail 
in Section 7.3.2, supported the ERC TCM consortium with EUR 1.1 million, which 
financed the management project team, including the principal investigator of the in 
vitro fertilisation project. All other co-operating projects, such as the Chinese 
diagnostic project, the Acupuncture research project, the Chinese medicine formulae 
metabolomics project and TCM research project did not benefit from the funding but 
became consortium members (see Table 2 for detailed description of projects). The 
field map (see Figure 2) shows that two systems biology projects were not affiliated 
with the ERC TCM research. The reason for my choice to include them into this 
research was to learn about the perspectives of systems biologists on Chinese medicine 
research who only recently started to scrutinise traditional medicines (Chinese and 























































































































































































































































































































































































































































Figure 3: The network map expands on the field map (see Figure 2) and shows the 
relationships between the sites connected to the ERC TCM consortium’s project, AI 
systems/systems biology and industrial partners. Orange fields with a red frame relate 
to the ERC TCM consortium, and the purple fields with a blue frame represent the 
separate network of AI and systems biology which observed systems biology and 
Chinese medicine research projects. Those without a frame stand for the partners, as 
indicated through the lines, who had no relationship to the ERC TCM. This network 
map informs the analysis on the relationship between Chinese medicine and systems 
biology which is shown in Chapters 6 and 7.  
Abbreviations: HLPC means High Liquid Performance Chromatography; UPLC 
stands for Ultra High-Performance Liquid Chromatography and Kampo is a 
traditional Japanese medicine.  
 
 




Figure 4: Key to the network map, the different colours depict the relationships 
between the identified sites in this research project.  
AI or systems biology research only
AI/systems biology co-operator
ERC TCM consortium  
ERC consortium members
Chinese medicine metabolomics cooperation
Technology 
producer Technology producer
Chinese medicine diagnosis research partner
Chinese herbal medicine
AI/systems biology co-operators




Figures 3 and 4 depict how I analysed the relationship between the different sites, 
which I introduced in Table 1, 2 and Figure 2, to the ERC TCM and the separate 
AI/systems biology projects. This figure only includes the sites I will include in my 
analysis in Chapters 4, 5, 6, 7 and 8.  
Compared to Figure 2, the network map illustrates the connections between the sites 
according to institutional affiliation, associations to research partners and industry. 
Figure 3 shows the connections between the countries involved in their research and 
how the actors and gatekeepers (see Table 3) were located for the projects undertaken. 
The network on the right side (in orange with a red frame) in Figure 3 represents the 
network of the ERC TCM, including the three projects that were involved in the project 
for the ERC TCM. These include the Chinese medicine metabolomics co-operation, 
the TCM research and the Chinese medicine diagnosis group. I will analyse the 
involvement of the actors in these projects and in the ERC TCM consortium, in more 
detail in Chapters 6 and 7. On the left side of Figure 3, the two AI/systems biology 
expert projects (the AI network and the fast examination kit network) can be observed. 
The AI/systems biologists involved in these projects did not participate in the ERC 
TCM consortium, but wanted to conduct Chinese medicine studies. Therefore, they 
are illustrated in a separate network. The next section will discuss the episodic 
interviews I conducted with the main actors in the field.  
 
3.1.3 EPISODIC INTERVIEWS 
 
Episodic interviews are biographic-narrative interviews that invite interviewees to tell 
their life story about a specific period in their life. The third research question focuses 
on the actors’ involvement and the development of the “interface” between Chinese 
medicine and systems biology. Sieder (2008) developed biographic-narrative 
interviews to investigate child abuse in boarding schools. The difference between 
episodic interviews and biographic-narrative interviews is that the episodic interviews 
focus on a specific period in the life of an interviewee and that does not follow the 
strict rule of first letting the interviewee tell his/her story, and then interviewer asks 




given in the narrative). Subsequently, the interviewer asks explicit questions (e.g., 
concerning any other interest that was not covered) (ibid). In the episodic interview, 
Flick (2014) propose the interviewer to ask open-end questions to further stimulate a 
narration from the interviewee.  
Flick (2000, 2014) claims that the significant advantage of using episodic interviews 
is its strength of gaining a rich and detailed narrative of actors in their personal and 
natural voice. The actors talk not only as scientists or professionals but also as 
participants in a free and more associative narrative on their experiences. This 
approach facilitates to discover what led to the decision to turn towards holistic 
research paradigms systems biology and Chinese medicine in co-operation with 
Chinese or European partners. First, the understanding of the involvement of scientists 
in this research granted insights into the development of their participation in Chinese 
medicine and systems biology research. I invited my interview partners to tell a story, 
e.g., “Can you tell how you became involved in systems biology/Chinese medicine 
research?” or “Can you tell me how you became an expert in systems biology?” This 
method enabled me to build a rapport and to give the interviewees enough space to 
expand on their stories. Building rapport is crucial for interviews to gain the trust and 
sympathy of students and researchers to tell their stories (see, for example, Berthin, 
2014). In the dynamic of the narration of selected periods in the life of the actors, 
unexpected things evolved. For example, some informants started to talk about key 
moments in their lives, which encouraged them to investigate Chinese medicine. 
Interviewees described changes in their lives. Those changes were what Sieder (2008) 
calls transitions as key happenings in the life. Thus, it became clear that the actors 
opened their mind to Chinese medicine following a transition. Secondly, to understand 
the present situation for the participants, I asked them for instance, “How do you 
position yourself in the field of systems biology and Chinese medicine research?” This 
question had the purpose of challenging the broadly defined field of systems biology 
and to understand why some actors in this “interface” have written differently about it. 
Therefore, by asking them to explain their position in the field, they could refine 
systems biology and Chinese medicine without any judgment from me as a researcher 
or any other scientist like collaborators or critics. Hence, the interview setting provided 




the frame of my questions. The last question in my interviews followed Flick’s (2014) 
suggestion of asking the informants if they wish to add any information.  
Personal interviews with actors on a one-to-one basis were considered favourable for 
the thesis compared to group interviews since the time to unfold personal views and 
interpretation of this the term and nature of this “interface” and the space for a certain 
level of confidentiality and trust were required and established (Flick, 2014). Moreover, 
the individual setting allowed me to interact with the interviewees and to acquire a 
substantial and profound material (ibid). The mix of an active and passive interviewer 
role to listen to the interviewee’s story and to ask questions throughout the interview 
process rather than at the end avoided a one-sidedness of a solely narrative interview. 
Consequently, it generated a conversation between the researcher and the interviewee, 
which makes Flick’ (2014) episodic interview different to Sieder’s (2008) biographic 
interview. 
In 2015, test interviews were conducted before entering the second fieldwork stage 
(see Table 1 for fieldwork schedule). During the test stage, the researcher is given the 
opportunity to trial the proposed questions and discover more about the research field 
(Flick, 2014). In this phase, I used semi-structured interviews with a topic guide that 
covered central questions (see Appendix B). After I had conducted four test interviews 
and undertaken a first analysis of the data to evaluate the method, data depth and 
further interview partners, as suggested by LeCompte and Goetz (1982) and Flick 
(2014), I recognised that those test interviews offered valuable traces to the historical 
process and were intertwined with life stories. The life stories could not be gathered 
through the short question-answer process of semi-structured interview as the intention 
was set differently at the beginning of the interview. As a result of this evaluation, 
interviews were adapted with a focus on scientists and their personal experience and 
involvement. Semi-structured interviews use open questions; however, they are 
limited in the space to develop a narrative about a significant period in the life of an 
interviewee (Flick, 2014). While in the episodic interview the interviewer opens with 
the question that addresses a specific period and let the interviewee tell the story until 
a further question emerges or fits into his narrative. With this approach, a broader 
spectrum and more in-depth information can be gathered. Thus, a change from semi-




Throughout the project, I carried out episodic interviews with fourteen actors. 
Interviewees included Chinese medicine pharmacognosists 18  (3), chemists (2), 
molecular biologists (2), systems biologists (3), Chinese medicine practitioners (2), 
and industrials (2). They were post-doctoral students, senior researchers, assistant 
professors and professors. Most of the scientists, I interviewed in the workplace and 
three interviews have been carried out via Skype. However, Hammersley (2006) has 
argued that the limitation of interviews is that interview data alone are not 
ethnographic. Thus, interviews served as a supplement to participant observation, 
which I described in the section above.  
The episodic interview method supplemented the literature survey with, what Kvale 
(2006) argue, subjective experiences and personal views and meanings of actors’ life 
situations. This perspective provided a look behind the publications of actors, which 
was crucial to understand the actors emerging interest in Chinese medicine or systems 
biology. The interview data revealed the development and change of relationships 
between the Chinese medicine and the systems biology side. The interview method 
was a flexible and powerful tool to investigate research questions with immediate 
relevance to the everyday work of actors (Britten, 1995).  
  
                                               
 
18 Pharmacognosists study natural products from organisms such as plants, microbes, and animals. Their 




3.2 DATA ANALYSIS AND PRESENTATION 
 
This section will talk about the data analysis methods used. Thematic coding as 
explained by Flick (2014), was selected in this thesis as an appropriate tool to analyse 
data gained through a triangulation of methods (participant observations, interviews 
and literature survey). It is a reasonable technique as it aims to present the data in 
specific themes, relationships and periods, which seemed significant for answering the 
research questions of this research.  
The thematic coding used in this thesis followed the procedure by Martini, Massa and 
Testa (2013). Martini, Massa and Testa (2013) describe the coding of data as a gradual 
refinement by investigating specific sets of data, i.e., interviews, observations, first to 
generate broad categories. These broad themes are then analysed again to refine them 
into more detailed codes. The data from the literature survey was analysed in broad 
categories. Subsequently, the categories were refined according to the rhetoric used to 
present the research of Chinese medicine with systems biology to the public and to 
attract the scientific community, as well as, political interests and instalments for 
funding.  
The results of the thematic coding will be presented in Chapters 4, 5, 6, and 7. The 
third step was to read the empirical data through the lenses of “modes of ordering” 
(Law 1994) which will be presented in Chapter 8. This analytical tool helped identify 
the emergence of this “interface” over time. It was used to categorise meanings of the 
different actors and their perceptions of the term “interface” from their work and their 
involvement in the research of Chinese medicine and systems biology or research 
projects.  
The interview and observation materials of this study were first analysed using the 
broad categories of (i) “interface” and the emergence of similarity between Chinese 
medicine and systems biology, (ii) involvement, (iii) laboratory practice, and (iv) 
networking and politics. In the refinement round of the coding, all data in the 
categories was split into coded segments, and the detailed codes were (a) definition of 
this “interface”, (b) Chinese medicine, and (c) systems biology (these will be 




through (a) technology and health, (b) complexity, (c) family and exploitation and (d) 
the discontentment with research practice. The codes in Chapter 6 will refer to (a) 
research projects, (b) technology, (c) industrial ties. Finally, Chapter 7 will present (a) 
political networking, (b) Chinese medicine studies, and (c) funding and regulations.  
Data on the emergence of an “interface” between Chinese medicine and systems 
biology and the similarities and difference to past encounters between Chinese 
medicine and modern science will be presented in four chapters according to the 
development of interest in Chinese medicine and systems biology studies. These 
chapters will demonstrate different perspectives and research sites in the world on this 
“interface”. Each chapter will initially introduce the setting and the actors with quotes 
and ethnographic descriptions to provide the reader with a global picture. The collected 
samples as represented in Chapters 4, 5, 6, and 7 are an extract of the global, diverse 
and vast networks. Some segments will offer a brief analysis of the data. An overall 
analysis will be presented in Chapter 8. This chapter will categorise the coded data of 
Chapters 4, 5, 6, and 7 and view it through the lenses of the concept “modes of 
ordering”. 
The interviews were either conducted in German, English or Chinese, depending on 
the wishes of the actors. The interviews and field notes for the analysis were 
transcribed verbatim (Hammersley and Atkinson, 2007). The specific segments that 
represented episodes relevant to the research questions were translated into English for 
common understanding. In order to transcribe, analyse, apply thematic coding and 
interpret the data, I used the computer assisted qualitative analysis software (CAQDAS) 
NVivo 10 and 11. It was expedient to organise different kinds of data and the enormous 
amount of materials I collected (e.g., publications, papers, articles, brochures, images, 





3.2.1 ETHICAL CONSIDERATIONS 
 
Following the ethical guidelines issued by the ethics committee at the University of 
Westminster, privacy and confidentiality were respected throughout the research 
process. Before every observation and interview, actors were informed about the aim 
of the research and the nature of the study was clearly explained to them. Requests 
were made for them to participate in the laboratory and workplace observations and 
interviews, as well as audio recordings and photographs on a voluntary basis. They 
were provided with copies of Participant Information Sheets (Appendix C) and 
Consent Forms (see Appendix D) on the day of the first observation or interview. For 
those who denied an audio recording, informed consent was given to use field notes 
without disclosing information about their identity. Signed or oral consent was 
obtained from all participants before the commencement of the study. Participants 
were provided with the right to withdraw until 1 January 2017, without giving a reason. 
Sieder (2008) warns that episodic interviews can cause a psychological effect for both 
the interviewer and the interviewee as they uncover a hidden narrative. Therefore, all 
participants were assigned pseudonyms that only share the academic title, i.e., Prof or 
Dr, in order to ensure the confidentiality of their identities (Flick, 2014). Project names 
were anonymised with fictional names following the example of Callon and Law (1982, 
p. 616) by using, for instance, the pseudonym of “Chinatown” for a British group of 
biochemists or “Stiftung” for a German team of polymer chemists.  
 
3.2.2 RELIABILITY AND VALIDITY  
 
In order to achieve valid and reliable results, methodological triangulation was used. 
As this thesis is an ethnographic study, it was difficult to detach myself from the study 
and be objective. LeCompte and Goetz (1982) indicate that perfect objectivity cannot 
be granted during ethnographic studies, as they record processes and actions, while 
they are happening in a natural setting as observed by the researcher. Ethnography is 
not a designed experiment that allows an exact replication of the situation. Thus, 




in ethnography. However, they agree that a triangulation of methods increases the 
validity and reliability of data. Likewise, Bauer and Gaskell (2007) argue that 
triangulation is an excellent method used to validate data by reflecting on an event 
from various perspectives (i.e., interviews, observations), which decentres one’s own 
person for reflexivity and thick description. Marcus (1995) claims that the description 
of ethnographic data delivers a certain amount of validity and offers the authenticity 
of the theoretical elaboration which often appears in the second part of the study, which 
in this thesis is presented in Chapter 8.  
A mixture of methods can also highlight inconsistencies. Flick (2014) warns that 
inconsistencies arise either from methodological limitations or the different angles the 
researcher takes to look at a phenomenon of interest. Inconsistencies will be attained 
in this thesis, which might appear between the data of the literature survey and 
interviews. For example, inconsistencies might be different descriptions of this 
relationship of an “interface” or match, incomplete historic background information 
from interviews, or between statements of actors in their texts and their narratives, or 
between the various publications of the actors. To this end, this thesis aims to recognise 
and complement inconsistencies with other methods. However, Burgess (2013) 
reminds us that sources of information are limited and that informants do not always 
get it right. In order to overcome these inconsistencies or having taken these 
inconsistencies into account, I opted to carry out a literature survey in order to add 
historical background information for the interviews. This was then followed up with 
interviews with the actors from the literature survey. The aim of the interviews was to 
gain personal narratives of the research that had been performed on Chinese medicine 
and systems biology as described in the literature. Once the interviews had been 
conducted, observations were performed to add first-hand data on the novel approach 
of systems biology to study Chinese medicine. The combination of the literature 
survey, observations and interviews was seen as the best methods to gain saturated and 







This chapter has outlined the research methods and described the research procedure 
in detail. A qualitative approach was adopted to fill a gap in the literature that called 
for an empirical investigation of the emergent “interface” between Chinese medicine 
and systems biology. Moreover, a triangulation approach of data collection methods 
will allow a comprehensive collection of data. The data from the literature survey will 
be supplemented with observations and episodic interviews. Observations are intended 
to capture interactions and technology in the field while interviews sought to record 
personal experiences, perspectives and historical processes. The data analysis will 
identify themes and the structure of themes and chapters to answer the research 
questions. The four Chapters 4, 5, 6, and 7 will give a fair representation of the various 
perspectives, experiences and processes in the “interface”. Data validity and reliability 
will be achieved through the adoption of methodological triangulation. Finally, efforts 
will be made to ensure the ethical integration in this research process.  
The next chapter will present the four finding chapters from the emergent “interface” 
between Chinese medicine and systems biology in the 1970s to the peak of Chinese 





4. RHETORIC AND PERCEPTIONS OF AN EMERGENT 
RELATIONSHIP BETWEEN CHINESE MEDICINE AND SYSTEMS 
BIOLOGY  
 
This chapter will answer the research question “Is there an ‘interface’? and if so, can 
this latest contact between Chinese medicine and systems biology be referred to as an 
‘interface’? and what is the nature of this ‘interface’?” The questions look to be 
answered with the use of a literature survey and episodic interviews which aim to 
identify the rhetoric in publications on this relationship and the perceptions of actors 
in the field.  
I will first explain (i) the coining of the term “interface” between Chinese medicine 
and systems biology by examining the literature. Then, I will present the codes 
identified through a thematic coding of the episodic interviews that I performed. The 
two codes of the interviews reveal (ii) a perception of this “interface” and (iii) the 
sameness of Chinese medicine and systems biology. The second code of perceptions 
shows the interpretations of actors in the field of this relationship between Chinese 
medicine and systems biology as co-operation, molecules as the “interface” and 
technology as a bridge. The third code of sameness includes the definitions for Chinese 
medicine and systems biology. The fourth and last code (vi) the historical trace of the 
sameness is gained from a literature survey. Results from the literature elaborate on 
the development of systems thinking and holism as constructing a “sameness” of 
Chinese medicine and systems biology. The results of this code contribute to 
answering the question “How does this ‘interface’ differ from previous encounters 
between Chinese medicine and modern science and Western medicine?”, which will 
be analysed in Chapter 8. The results of this chapter and Chapters 5, 6 and 7 will be 
drawn together and an in-depth analysis of themes and coded data will be given in 





4.1 RHETORIC AND COINING THE TERM “INTERFACE” 
 
As I pointed out in the literature review of this thesis (see Chapter 2), the term 
“interface” concerning the emergent relationship between Chinese medicine and 
systems biology in the early 2000s was first used in Scheid’s (2014) paper on 
Convergent Lines of Descent. In this section, I will elaborate on his investigation of 
this “interface” and how it emerged. 
Scheid (2014) argues that since the 2000s, having examined publications and 
interactions between Chinese medicine and systems biology, zheng seems to connect 
both sides and, thus, forms an “interface” between the two fields. Scheid argues that 
zheng is a boundary object that connects to distinct sides through patterns which both 
sides can understand and use for their communication without following the same aims 
for their co-operation, which I explained in Chapter 4. Scheid (2014) argues in his 
historical analysis that the “interface” was built on three pillars: shared ground, shared 
interest in personalised medicine and the dissemination of ideas through publications. 
First, he shows that systems biology and modern Chinese medicine have “structural 
commonalities and shared ideologies” of complexity and systems thinking (ibid, p. 
115). Second, they share an interest in a “new” personalised medicine with zheng. 
“New”, as far I understood, is opposed to the individual diagnosis and treatments 
Chinese medicine offered in the past 2000 years, which were in this “interface” newly 
deciphered with Chinese medicine and systems biology based on biotechnological 
tools.  
The final pillar is the dissemination of publications by Shen Ziyin (2005). Scheid (2014) 
discovered that Shen researched Chinese medicine in the 1950s and 1960s and 
undertook the first metabolite research on Chinese medicine zheng, however, he could 
not illustrate the whole zheng. In 2005, he published a paper on systems biology and 
Chinese medicine as a bridge. Scheid (2014) claims that Shen’s paper was taken up by 
a Chinese medicine researcher in Beijing, Lu Aiping (Lu et al., 2012), and by van der 
Greef and his colleagues (2010). He found that some of these papers claimed from a 
Chinese medicine perspective that zhengs were in Chinese medicine as a central 




systems biologists in van der Greef’s team interpreted zheng as a network or a system 
that was illustrated as a phenotype through metabolic fingerprinting. Scheid (2014, p. 
122) highlights that the connection between Lu and van der Greef was that they 
established a method to “objectify” Shen Ziyin’s unseen zheng, which he studied in 
the 1950s and 1960s. 
In summary, Scheid describes this “interface” as a bridge between the modern West 
and ancient China. This is due to various actors in this “interface” who still perceived 
a gap between the West and China probably due to their “historical ignorance and 
arrogance” as Scheid (2014, p. 108) argues. Zheng is seen as a bridge between Chinese 
medicine researchers and systems biologists as it connects both sides, but they 
understand it differently and use it to achieve different goals.  
Having established the origin of the label “interface” in the literature for the emerging 
relationship between Chinese medicine and systems biology, the interview performed 
on fourteen people will now be analysed. By analysing the data from the interviewees, 
I hope to reveal if there is an “interface”. If so, what the nature of this “interface” is. 
On the contrary, if no “interface” is revealed, I hope to find out how the actors perceive 





4.2 PERCEPTIONS AND DEFINITIONS OF THE “INTERFACE”  
 
By turning now to the empirical evidence from the systems biologists, Chinese 
medicine researchers and Chinese medicine systems biologists interviewed on the 
topic of an “interface” between Chinese medicine and systems biology, it is hoped to 
discover whether it in fact exists or not. In the following, I will present representative 
examples of interview data that will demonstrate in three codes the perception of the 
“interface” or relationship between systems biology and Chinese medicine. The codes 
were (i) co-operation, (ii) biochemistry as a bridge and (iii) technology as a bridge. 
This section will outline the interpretation of the nature of this “interface” from the 




Those interviewed who perceived the relationship between Chinese medicine and 
systems biology as an “interface”, described its nature as a co-operation. They claimed 
that the co-operation was established for data and knowledge exchange. Other systems 
biologists shared this opinion and added that the co-operation with Chinese medicine 
researchers was crucial to receive samples for their studies and to compensate for the 
lack of Chinese medicine knowledge. As one actor said:  
“For example, one does not have a background in Chinese medicine and does 
not know the fundamental things. Then, another one has a Chinese medicine 
background. In co-operation, we can compensate what we do not know about 
Chinese medicine with the knowledge of the other. For example, we do not have 
samples, so we have to co-operate to get samples.” (Lingma, 2016, Dalian)  
Co-operation was closely related to the worldwide rise of systems biology institutions 
and training programs. However, the research of Chinese medicine with systems 
biology had not made the expected progress due to the lack of technology and 
understanding of systems and the attitude of imposing a Western methodology on 




“I think they try to do things together, but I think they don’t have much progress. 
People keep trying but I don’t see any good outcome from Chinese labs yet. But 
I think people have this philosophy or idea and trying to do something. We are 
waiting for the results. I think there is definitely an interface and I think this 
systems biology thinking or systems biology, this word, is becoming more and 
more practice or the word for this kind of systems biology approach may be for 
the students or PhD students and professors.” (Prof Meng, 2016, Hangzhou)  
“Because they measured and could not get anything interesting, I mean, it is not 
that there isn’t anything interesting, but they haven’t got what they expected. 
Because after the omics [genomics era in 2000] they tried to identify the active 
compounds, and that is not how things work here. That is the modern systematic 
network like they actually try to bring Chinese medicine into the Western 
deduction idea and that failed. Because it doesn’t function that way. And then 
there is a lot of interesting things in Chinese medicine and how we can use the 
network approach from systems biology to study it. I think we will have more 
papers on that.” (Prof Musashi, 2016, Tokyo) 
The perception of an “interface” was defined as an attempt to establish co-operation 
between systems biology and Chinese medicine by interlinking them through expertise 
and materials. Besides the comments on the outcomes of this co-operation and the 
suggestions on a better approach for studies, they all agreed that there was an interface, 
and the nature of the interface was defined as co-operation between systems biology 
and Chinese medicine researchers. 
 
4.2.2 BIOCHEMISTRY AS A BRIDGE 
 
A common view amongst actors was the description that biochemical information was 
a bridge between Chinese medicine and systems biology. For them, biochemistry was 
the language both understood and used to communicate and describe the study results. 
With knowledge of Chinese medicine, researchers and systems biologists in molecular 
biology, could both explain in detail what was happening at the lowest level of the 
body and use the molecular data to describe processes in healthy and diseased bodies 





“There are a few publications where they try to understand the networks and the 
pathways. They are actually using molecular biology as a bridge. One side is like 
a pathway and a network, and the other side is TCM. They can identify which is 
the possible active compound and bring that active compound in combination 
with others into network-based biology or systems biology. So that’s how they 
interface at least of a molecule. I think that’s okay. That is a right approach, so 
at the end of the day what is working is the molecule right? So, it is good that 
we can attribute things to molecules and from molecules, we try to understand 
what is going on in our body. That is the right approach.” (Prof Musashi, 2016, 
Tokyo) 
Another interviewee understood biochemistry as a translation from biomedicine or 
biomedical drugs into hot and cold patterns of Chinese medicine diagnosis. The 
interviewee explained this with the example of aspirin, which demonstrated in Chinese 
studies that its use for cold diseases is better, due to the warm property the drug has in 
Chinese medicine. Apart from its biochemical bridge, this example is interesting as it 
reports a different interest in this “interface”, namely the translation from biomedicine 
into Chinese medicine and not from Chinese medicine into biomedicine. In contrast, 
most of the actors were interested in complex fufangs and not in investigations of 
biomedical drugs with Chinese medicine concepts of pattern differentiation.  
According to the definitions of interviewees, interface meant a place where systems 
biology and Chinese medicine met, which was the molecular level. The idea of 
molecules as an interface between systems biology and Chinese medicine or Chinese 
medicine and biomedicine was found in articles, such as by Wang et al. (2005), which 
proposed metabolomics as a bridge between molecular pharmacology and Chinese 
medicine. Those authors claimed that new technologies from the genomic era such as 
transcriptomics, proteomics, and metabolomics were used to analyse metabolites with 
a systems approach to phenotype the chemical characterisation of sample.  
Many interviewees claimed that molecules are the common ground between systems 
biology and Chinese medicine and that technology generated the information, which 
could be translated into both fields. This, of course, implies that since the 1950s, 
Chinese medicine practitioners have learned a standardised and modernised Chinese 
medicine which inevitably arose when the political agenda of the CCP put pressure on 
the introduction of Western medicine into Chinese medicine studies (see Taylor 2005). 
Therefore, the perception of an interface based on a shared molecular understanding 




Chinese medicine researchers over the past 60 years to translate parts of their medicine 
into molecular data and, thus, have made it accessible for systems biologists. 
Biochemical analysis has brought about the meeting between systems biology and 
Chinese medicine. Based on the molecular data they can apply concepts to link 
Chinese medicine with systems biology and Chinese medicine with biomedicine (van 
der Greef et al., 2010).  
 
4.2.3 TECHNOLOGY AS A BRIDGE  
 
A recurrent description of this “interface” between systems biology and Chinese 
medicine is that technology acts as a bridge between them. The majority of 
interviewees feel that technology is used as a translation tool between Chinese 
medicine and systems biology and that technology is utilized to understand 
fundamental biochemical processes and to investigate Chinese medicine. Nonetheless, 
systems biologists also recognise the need to understand processes before they 
translate them into metabolomics. One interviewee explained the translation as follows:  
“Chinese doctors, kind of group or cluster patterns together and give them certain 
kind of treatments, so we thought that is very important to know something about 
zhengs before we can translate them like in really herbal medicine.” (George, 
2015, Leiden) 
Technology functions as another bridge (e.g., biochemistry) between both systems. 
Technology is a crucial part of systems biology and its practice while omics are 
organically integrated into Chinese medicine research to advance the field. The 
integration in Chinese medicine happened as a result of the Chinese medicine 
modernisation that took place in the last century, which is outlined in Chapter 2. 
Modernisers employed technology and science into Chinese medicine and omics were 
seen as a further update of the technology Chinese medicine researchers already used 
for their studies. The frequent use of omics in systems biology and Chinese medicine 
emerges as a way to translate Chinese medicine into a scientific context as a “bridge” 





4.3 CHINESE MEDICINE AND SYSTEMS BIOLOGY ARE THE SAME 
 
In the code on “Chinese medicine and systems biology as the same”, interviewees 
denied calling the relationship between systems biology and Chinese medicine an 
“interface” because they argued that systems biology and Chinese medicine share 
commonalities such as holism and systems thinking. 
Three factors constructed the argument that the relationship between Chinese medicine 
and systems biology had was no “interface”. The interviewees referred to a sameness 
of Chinese medicine and systems biology as seen in the shared ideology of systems 
thinking and holism and the difference through the idea of Chinese medicine 
essentialism. First, I will present the data that shows systems thinking as being 
synonymous with holism. Then, I will elaborate on the difference between the two 
fields which led to the denial of an “interface”.  
The interviewees were of the opinion that Chinese medicine and systems biology 
appeared as an ontological similarity as they both used the concepts of systems 
thinking, which they correlated to holistic thinking in Chinese medicine and at 
systems-level understanding in systems biology. They saw connections between 
Chinese medicine and systems biology through the way both fields conveyed their 
ideas about the emergence and development of things. Systems biology was an 
ontological similarity or even the same as Chinese medicine. As two actors say:  
“I think there is no interface because between systems thinking and Chinese 
medicine there is no difference. Only people now use the term systems biology, 
which is basically the holistic thinking in Chinese medicine. I don’t think there 
is an interface at all. So, the way of thinking in systems biology and in Chinese 
medicine is always the same - there is no difference.” (Dr Huang, 2015, Leiden) 
“It is a concept to write a story. It is holistic, and Chinese medicine is holistic; 
therefore, they fit together to conduct research… because in the core of their 
ideas they are both a perfect match.” (Lingma, 2016, Dalian) 
Nonetheless, systems biologists highlighted that within their field they used the 
Western scientific terminology to avoid, for example, holism, as an inappropriate 
expression for the scientific community and journals. Systems biologists used terms to 




medicine. For example, systems biologists explained a phenomenon with biochemical 
mechanism, while Chinese medicine used an energetic understanding of qi, yin and 
yang. Systems biologists described the various functions and relationships between 
molecules differently. This demonstrates their belief that humans and all levels of an 
organism (i.e., genes, tissues, organs) are interrelated and interconnected with nature, 
as expressed by Kitano (2002). The relationship between the different levels facilitates 
communication between different levels in the organism and nature. For instance, Prof 
Musashi used the Taiji symbol (太极), which represents how systems biologists now 
view systems thinking. Schroën et al. (2014) state that Taiji translates to mean “great 
pole” which means two extremes or contradictions, such as, light and darkness, strong 
and weak, front and back. Prof Musashi uses the Taiji symbol to relate to Daoism and 
holism. This notion is supported by Prof Frank and Prof Musashi who assert:  
“I talk about systems biology as a bridge but actually I am looking at the systems 
as Chinese is and as Western should be. You know words are always creating 
polarities, so if you have a word like the light there is also dark, up there is also 
down. That is why we have polarities when we talk, and some people are more 
in one polarity and the others are in the other. That’s why you get some sort of 
unbalanced life but if you talk about what actually is there, then, names are just 
names and what you see. But it’s you who is talking about a holistic view on life 
and systems biology tends to be more biochemistry in daily life in Chinese 
medicine is explaining things more energetically and these are very close 
together. Actually, they are the same because if everything is connected and you 
cannot separate them out.” (Prof Frank, 2015, Leiden) 
“Holism, so the holistic view of the world and Fritjof Capra’s Daoism are a kind 
of the good old age of science. I like that. At the same time, holism is pretty much 
a systems way of thinking. In a way, it is how a system as a whole impact the 
function and behaviour of the system. If you look at the figure in my Science 
paper, you will see in the background the Taiji, the yin/yang symbol. So, I 
intentionally used this image. One is the dry [experiments], and one is the wet 
experiments. The dry side is the computational part, which has to be merged with 
the wet part. That is a mirror image, so actually in the figure one is the designer 
of the research, which comes up with the dry side, and the wet side is a kind of 
a background. I specifically use this sign. So, this is systems biology from the 
beginning, and in the first paper and the first figure I have imposed holism.” 
(Prof Musashi, 2016, Tokyo) 
The use of different terminology included the term holism, which systems biologists 
interpret as systems-level understanding. Holism is the shared idea of a living 
organism, which demarcates the fields of systems biology and Chinese medicine from 




Interviewees of both fields viewed the human organism in a bigger picture. One 
interviewee explained that both fields share the same understanding of the whole 
organism as interactions and relationships between the lower level, which is the 
molecular level, and the upper level, which is the whole organism, as well as its 
interactions with the environment. One interviewee referred to systems biology as 
being based on molecular biology, which was integrated to explain the lower structure 
to build relationships in the whole organism. In this understanding, systems biology 
and Chinese medicine met conceptually and philosophically. As the actor states: 
“When we see a whole organism in relation to his environment, this is much too 
complex so in the last 400 years we understood the lower layers now it is about 
time to understand the top layers, but we cannot skip the lower layers. What the 
Chinese did is describing the upper layers the human being in its relation to its 
universe and also the complexity of what happens in the processes in the body 
in these 15 conception ways…  but they never had and were not able to explain 
what they were seeing, so they don’t understand the lower levels. So now they 
are meeting [two levels through systems biology] and this can be so enriching I 
think.” (Kevin, 2015; Leiden) 
A further example of the existence of similarity between systems biology and Chinese 
medicine is that they both apply a multiple-to-multiple approach. One interviewee 
emphasised that Chinese medicine diagnoses multiple symptoms and treats them with 
many herbs - a formula or a prescription (fangji 方剂) (see Farquhar, 1994). While 
systems biologists use various techniques to detect numerous variables for a holistic 
analysis of biomarkers19 and relationships between proteins, genes and metabolites. 
This perception stresses another similar grounding of the two fields. 
The majority of interviewees claimed that systems biology and Chinese medicine share 
commonalities and, therefore, believe that there is no “interface”. Likewise, Chinese 
medicine researchers argued that there was no “interface” between Chinese medicine 
and systems biology but said that the reason is that systems biologists did not 
understand the Chinese medicine essentialism. They referred to Chinese medicine 
essentialism, as a quality of Chinese people and culture or experience that could not 
be translated by omics. Some interviewees mentioned the classification of diseases as 
                                               
 
19 A biomarker is a chemical or biological test result of an analysed biological material, which relates 




challenging to understand for non-Chinese, such as the eight rubrics (ba gang 八钢) 
analysis, which are yin and yang, exterior and interior, cold and hot, depletion and 
repletion (see Farquhar, 1994). They associate Chinese medicine as a central idea they 
learned as part of their upbringing. To understand this essentialism, systems biologists 
would have to learn the Chinese medicine theories and understand the Chinese 
language. For example, the following Chinese medicine researchers asserts:  
“This interface can only be established if systems biologists understand Chinese 
medicine theory and in order to understand the theory, they must learn Chinese.” 
(Prof Xiong, 2016; Harbin) 
“For Chinese, it is easier to understand Chinese medicine. Right? For example, 
if you have a balanced constitution, or a cold, hot, warm or cool constitution, 
that is easy to understand for us, but for you it could be difficult.” (Long, 2016; 
Dalian) 
This group of Chinese medicine researchers was reluctant to discuss omics as a way 
to translate Chinese medicine theories into the language of systems biology and to 
make Chinese medicine understandable to non-Chinese medicine researchers. 
However, the specific Chinese medicine characteristics could not be clearly defined 
by them. They did define Chinese medicine as a Chinese cultural heritage and 
emphasised the fact that a crucial part of Chinese medicine was reserved for the 
Chinese and their understanding of Chinese medicine. This distinction indicates a 
particular right of studying Chinese medicine for Chinese researchers and scientists. 
Evidence can be found here:  
“Omics are translation tools to make Chinese medicine understandable to 
Westerners because they cannot understand the ‘essence’ of Chinese medicine 
like Chinese do due to their cultural background.” (Ruili, 2016; Harbin) 
The emphasis on essence or essentialism links to the labelling of Chinese medicine as 
a “national essence” during the modernisation phase of Chinese medicine. As 
elaborated in Chapter 2, the formulation “national essence” categorised Chinese 
medicine as a “Made in China” product (Croizier, 1968, p. 344). However, the essence 
was also detached from Chinese medicine. Jingyan (经验) can be translated as an 
experience and has two different meanings. Lei (2014) discovered that in the late 
nineteenth century, jingyan referred to evaluated and effective drug prescriptions, and 
not the experience of the practitioner as Yu Yan, a moderniser of Chinese medicine, 




place at least since the early twentieth century. Therefore, socio-political struggles in 
the twentieth century tied the rhetoric of essentialism or “spirit” of Chinese medicine 
to the nation and the people and as being something unique.  
The Chinese government and Chinese medicine modernisation and globalisation 
associations maintained in their different globalisation plans for Chinese medicine, the 
continuation of the Chinese medicine essentialism. Such associations were founded in 
2003 and 2004 in mainland China, Hong Kong and Macao and were, for instance, the 
World Federation of Chinese Medicine Societies, the Consortium for Globalisation of 
Chinese Medicine and the International Society for Chinese Medicine. However, in 
the latest globalisation aspirations, Wu et al. (2015, p. 4) state that the successful 
globalisation of Chinese medicine requires the essence of Chinese medicine to 
“annotate” its theories into a scientific language to acquire a “universal acceptance by 
the modern scientific community”. Wu’s claim may change the mystic condition of 
Chinese medicine’s essence and which may dissociate it from the social feature. The 
discussion of a concept that disassociates Chinese medicine and systems biology 
coincides with the attention paid to omics and the help that omics provide to bridge 
the gap between Chinese medicine and systems biology actors in this “interface”.  
In this code we have seen that systems biologists and Chinese medicine research claim 
that both fields are ideologically the same. This now raises the question as to whether 
these actors define systems biology and Chinese medicine in the same way. If not, is 
it important to investigate what differences they believe appear between the two fields?  
The definition of sameness will be discussed in the next part of this sections. First, I 
will present the actors’ interpretation and descriptions of the two fields. This will lead 
to the question of how the idea of similarity between cutting-edge science and ancient 
medicine emerged, which I will answer with the use of a literature survey which will 





4.3.1 DEFINITIONS OF CHINESE MEDICINE  
 
In the previous section, most interviewees reported similarities between systems 
biology and Chinese medicine. At least six of those interviewed referred to there being 
a cultural difference between the two whilst others claimed that Chinese medicine is 
an ethnomedicine, a medicine based on observations and a vast resource of knowledge. 
The exciting part in the definition by those interviewed was that there was a clear 
differentiation for the definition of Chinese medicine between Chinese medicine 
researchers and Chinese systems biologists. Chinese medicine researchers in China 
defined Chinese medicine as an ethnomedicine or traditional medicine. The 
description followed the official description of Chinese medicine as a traditional 
medicine of China when Chinese medicine and the medicine of China’s non-Han 
minorities were included in the new constitution of the PRC (see Scheid and Karchmer, 
2016, p. 169). 
“Chinese medicine is an ethnomedicine or traditional.” (Prof Lou, 2016; Dalian) 
From a practical point of view, Chinese systems biologists stressed the different 
approach of Chinese medicine and biomedicine on the importance of the senses, such 
as the feeling of the pulse, or the experience of the Chinese medicine practitioner to 
establish a diagnosis and the energetic explanations. The Chinese systems biologists 
believe that the feeling of the pulse is an essential practice in Chinese medicine and a 
significant difference to biomedicine and science. As one interviewee stated: “Chinese 
medicine is not kexue [science] medicine, it is all about feelings of the doctor” (Long, 
2016, Dalian). Pulse diagnosis is not practiced for the same reasons and with the same 
detail in biomedicine. In Chinese medicine, the practitioners established the diagnosis 
through their observations and the experience (Farquhar, 1994; Kuriyama, 1999). 
Reading the pulse was part of the sizhen 四诊 with the four methods of diagnosis 
(observation (wang 望), auscultation and olfaction (wen 闻), interrogation (wen 问), 
touching pulse feeling and palpation (qie 切)) needed to make a diagnosis. There were 
distinct characteristics between Chinese medicine and biomedicine. Kuriyama (1999) 
described the pulse diagnosis as: feeling the pulse is knowing about the disease and a 




when comparing biomedicine with Chinese medicine, claimed that because of the 
Chinese medicine practitioners’ observations and their experience in practicing 
Chinese medicine, they are less likely to depend on technology when it comes to 
examining the body. Whilst, biomedicine experts, on the contrary, rely on technology 
to diagnose diseases. Karchmer (2010) contradicts this claim as he found that Chinese 
medicine practitioners more and more employ biotechnology to confirm or consult 
their diagnosis.  
Another Chinese biologist addressed in her definition that previous engagements with 
Chinese medicine resulted in exploitation of Chinese medicine. Helman (2007) calls 
this biopiracy or biocapitalism, which is a growing problem, not only for Chinese 
medicine but also other traditional medicine. I will discuss this in detail in Chapter 8. 
First, this is what the interviewee said: 
“Some of them they are quite good interactions and others just use Western 
technology and they hope to get the target and the component of Chinese 
medicine. So, they use the Chinese medicine as a sort of pool to fish out what 
they want. Then you have different people interacting with Chinese medicine. 
Some of them think that Chinese medicine is a concept that guides them to 
understand biology and others think Chinese medicine is just a rich pool and they 
can try to get out what they want. Both of them are quite interesting; and both of 
them can get the results they want.” (Dr Huang, 2015, Leiden) 
It is important to note that Chinese medicine researchers and systems biologists believe 
that there is an “interface” between Chinese medicine and systems biology. Chinese 
systems biologists and Chinese medicine researchers agree that Chinese medicine is 
different to biomedicine. Chinese medicine researchers maintain the official 
description of Chinese medicine while Chinese systems biologists stressed the 
observational skill of Chinese medicine practitioners that facilitated a diagnosis 
without technology. Another systems biologist mentioned the issue of exploitation of 
Chinese medicine. She claims that the beginning of its exploitation started in the 1990s 
when science and technology were the focus of Deng’s political agenda and the four 
modernisations (this was discussed in Chapter 2). The link with technology appears in 
the definitions of Chinese medicine essentialism that protects the crucial difference 
between Chinese medicine and biomedicine as well as technology is observed in 




reveal the aspects of systems biology which depends on technology and which 
correlates with Chinese medicine. 
 
4.3.2 DEFINITIONS OF SYSTEMS BIOLOGY 
 
Interviewees defined systems biology in three detailed codes: systems biology as a 
concept, systems biology as a set of technology and systems biology as a discipline. 
As a point of reference, in the literature (see Alon, 2007; Ideker, Galitski and Hood, 
2001; Scheid, 2014; Wolkenhauer et al., 2013), systems biology is described as an 
amalgam of disciplines (i.e., physics, chemistry, computer science, biology, 
engineering) that correlate with each other through the theoretical basis of systems 
thinking and the rejection of reductionism (Calvert and Fujimura, 2011). Systems 
biology has developed over the past two decades from a technology-driven enterprise 
to a new tool in life science with the aim to understand biological systems as complex 
networks (see, for example, van der Greef, Hankemeier and Mcburney, 2006; Calvert, 
2008, 2013).  
The first detailed code of “systems biology as a concept” tried to understand Chinese 
medicine holistically, namely systems-level understanding, and to discover new 
holistic approaches for bioscience and personalised medicine. However, the perception 
of holism in systems biology was somewhat counter-intuitive. Systems biologists used 
holism to distinct systems biology from molecular biology, while they integrated 
molecular data for holistic studies. Calvert and Fujimura (2011) confirm the contents 
of different epistemic virtues of reductionistic and holistic methods, which are 
necessary for generating computational models. As the following systems biologists 
stated: 
“This thing about using the binoculars both ways is indeed interesting and key 
to systems biology. In systems biology, we deal with both the details, all the 
individual molecules that are measured or symptoms that are registered with 
questionnaires. But then we try to fit the information into a wider picture.” 





“The only definition is this is the system-level understanding but how you 
understand the system-level or which part does not really matter. At least that is 
how I thought about. Systems biology is very vague, and a boundary is not 
created that is an intention, then we have a breath over the field and more people 
getting involved. That is by design. Systems biology is a systems-level 
understanding of biological system.” (Prof Musashi, 2016, Tokyo) 
“First, we are taking the human body and different organs on a molecular or 
cellular level. By analysing all the organs from a special level, we understand 
which gene is expressed the most in the liver compared to other organs. So, this 
is the way of a systems approach. It is not just talking about the liver or liver 
tissue, but you compare the liver with all the other organs, and then you come up 
with something maybe different or specific. Then, [in the sample of] the next 
patient you ask why is this different or specific if it must perform a different 
function, which is important for the liver.” (Prof Meng, 2016, Hangzhou) 
What emerges from these definitions here is that all interviewees agreed that systems 
biology followed a holistic paradigm used to distinguish molecular biology as a 
disciplinary difference while it also depended on molecular data to establish a holistic 
analysis. However, the difference between the two definitions is that the first group 
refer to the dependence on reductionistic data collection, whereas the second group 
referred to a combination with various high-throughput technology that produced 
reductionist data. Another Chinese biologist went further and claimed that systems 
biology is reductionist in the context of the Chinese notion huanyuan lun 还原论, 
which goes hand in hand with “the theory of return to the original condition” or 
“reconstruction theory”. The reconstruction theory is a guidance for research 
whereby systems biologists first understanding specific details and then using a 
holistic approach, they can understand the bigger picture. Chinese biologists 
believed that both approaches are important for the research of systems as through 
reductionism, a speculative study can be avoided while holism provides the 
overview of the general problem (Yang, 2016, pers. comm. 16 December).  
The actor also commented that a single study in systems biology referred to a study of 
one isolated pathway, which is the same principle as in reductionism. Her 
understanding of systems biology research was that systems biologists first 
deconstruct isolated paths in a system, then, they reconstruct them again by using 
different methods like a scientific study, statistic informatics and data interpretation. 
According to her, this combination of approaches makes systems biology holistic. The 




problem as every method has its limits. Accordingly, reductionism and holism are not 
mutually exclusive in systems biology.  
“For studying systems biology, we have to conduct several steps: sampling, 
sample preparation, analysing the samples and the use of bioinformatic tools to 
analyse the data. After that, we can compare the results of different groups to 
find the biomarker. After that, we focus on the data interpretation - this is the 
most important thing because we need to use the holistic knowledge to interpret 
the data, which is not a single biomarker, there are several biomarkers in the 
context of a disease and according to the increase and decrease we explain what 
the reason is.” (Lingma, 2016, Dalian) 
Another actor comments on the reconstruction theory as a different cultural 
background that equips Chinese scientists with a distinctive viewpoint on data. This 
viewpoint equips them with a different way of doing science and interpreting a 
relationship in a network that involves all molecules, which he would like to see in 
science and in healthcare.  
The second detailed code defined systems biology as a method or a set of technology 
to study in a mechanistic way Chinese medicine through pathways and active 
compounds. Similar to the first group, they refer to systems biology as a holistic study. 
However, they interpret holism as an approach that employs various cutting-edge 
technology sources and perspectives and establishes its analysis in a combination with 
reductionistic data to model pathways in the organism with molecular data. For drug 
discovery in Chinese medicine, some suggest applying computational models. Gu and 
Pei (2017) describe this as a common method, which uses chemical similarities from 
discovered molecules in herbal medicines for a computer simulation of the effect of 
the drug. To quote three interviewees:  
“My personal and easy definition of systems biology is to study a problem from 
various levels, e.g., metabolites, properties of genes and to use various omics 
technologies in order to understand the whole system. You can say that systems 
biology is a kind of hot technology.” (Ang, 2016, Harbin) 
“People have different definitions, and then you talk to some of the omics 
approaches and believe that is the way to do it. Systems biology is a large omics 
and a network analysis. Or if you go to someone else who does another detailed 
modelling and understand the control mechanism or pathway; or if you go to 
metabolomics systems biology about understanding the behaviour of network 
using, the large-scale, mass spectrometry, and pathways analysis and flux 
analysis, they all try to understand a particular aspect of a system using whatever 




“I think they combine the systems thinking in Chinese medicine or the 
philosophical systems thinking with the modern technology with the hope to get 
the whole set… if you have this data set [of various formulae tested on numerous 
people] up you can maybe try a different combination, or you can even do 
computational herbal medicine modelling to have data for some herbal medicine. 
Once they have some effect on the liver, then, with a special protein and a link 
you can model a sequence, which might have a different combination and then 
you have a different disease. You know diseases are like pathway networks, you 
can understand many things and like different models might be good for you. 
But this is a huge task, and I don’t think we can do that, there is no way I can see 
this happening.” (Prof Meng, 2016, Hangzhou) 
However, systems biologists stress that the most advanced technology was necessary 
to study pathways and the whole system. Another interviewee stressed that the 
combination of different experiment phases and analytical tools are necessary to 
conduct a systems biology study on different levels of a system or disease. He said:  
“Systems biology is to understand systems at different levels like proteins or 
dissect each component. You need to use the most advanced technology to 
understand each component; we call them pathways if you don’t have the 
technology the pathway is not complete, thus, you cannot do systems biology.” 
(Prof Meng, 2016, Tokyo) 
What is significant in any definition of systems biology regarding technology is that 
the study of all levels of a system is dependent on various technologies or omic 
techniques. Some actors stress that the technology used is not sufficient for this 
undertaking, which indicates that systems biology did not achieve its conceptual aim 
of systems-level understanding. Chapter 8 will examine the advancement of 
technology in more detail.  
The last detailed code was that systems biology is a discipline and is different from the 
discipline “biology”. Interviewees who worked in systems biology as part of a Chinese 
medicine project did not call themselves systems biologists because they did not 
consider systems biology as a discipline. The reasons were that it was a part of biology, 
that uses the same technologies as biology, or it does not fulfil the aspiration to 
understand biological processes in living organisms found in two interviews that spoke 






“Systems biology is part of the biology. I am a biologist, and systems biology is 
part of the biology. And only because now we use more omics technology and 
even other technologies to show the holistic behaviour in human beings or 
medicine is still basically biology. I am a biologist. I think that is fairer.” (Dr 
Huang, 2015, Leiden) 
“Systems biology is until now no discipline if it would be a discipline it would 
explain all the processes in biology, which it does not.” (Long, 2016, Dalian) 
However, some systems biologists observe that biologists practice systems biology by 
measuring systems performance, at the beginning and the end of an experiment, 
without paying attention to the development in-between. This approach contradicts the 
systems biology idea of understanding processes in living organisms: 
“Instead they have a complete rubbish understanding of systems biology. They 
also do experiments, before and after, like two points. They only look at the 
things that have changed but without intermediate measurements. Thus, we don’t 
know how things have changed.” (Prof Musashi, 2016, Tokyo) 
Some systems biologists claim that the name systems biology was imposed as a 
methodology that was practised in biology. Omics technologies such as genomics, 
proteomics, and transcriptomics were not a new invention. Evidence of this can be 
found in an article about metabolomics, which demonstrates the latest development of 
omics technology, in the use of biological research in the Netherlands (see van der 
Greef et al., 2013). Whilst one systems biologist has claimed that since the 2000s 
systems biology is considered a discipline, other systems biologists believe that it 
might become a discipline in the future. But in order for it to be considered a discipline, 
some limitations in the measurement and analysis need to be solved.  
“Actually, it is less, because it was more ego-driven from the desire to connect. 
So, people say, okay, there has been a long-time systems biology, it has not just 
appeared, it [systems biology] is just a name. The name appeared at a certain 
point in time, because people wanted to claim something.” (Frank, 2015, Leiden) 
“Definitely it is going to be a discipline, especially if it has an advanced 
measurement to practice systems biology better. Then, we [systems biologists] 
will become more discipline. But now, I think we are still in the formative years, 
there are so many things we don’t know yet, and we are still limited by how 






In contrast, other systems biologists refer to systems biology as an independent 
discipline. They argue that the establishment of various systems biology conferences, 
journals, departments worldwide is a clear sign that systems biology is a discipline. As 
one participant articulated:  
“We have a society, we have much public funding programs or the system 
biology program, and Harvard created a department for systems biology. There 
are a lot of systems biology research centres around the world, so if there is a 
social definition of being established. I think this is the one turning point in terms 
of stimulating people’s awareness and systems way of thinking in biology and 
let people recognise that this is a modern kind of field systems biology. I started 
doing systems biology in about 1995-96, and then we [the community] started 
using the term in 1996-97. It was about a decade when I started talking about it 
and people started recognising it and using the term in funding programs or for 
departments.” (Prof Musashi, 2016, Tokyo) 
“It is a kind of discipline which uses multiple technologies and not the single 
versus the multiple approach.” (Ang, 2016, Harbin) 
Overall, systems biology can be viewed as being in-between a discipline and a branch 
of biology. Some actors are convinced that it is an independent discipline due to the 
institutional and representational character it has established since the 2000s.  
 
4.3.3 DOES THE “INTERFACE” EXIST OR NOT?  
 
The results show that the overwhelming majority of those interviewed are against the 
term “interface”. They disagree with the description of the interaction between the 
various actors involved in the research of Chinese medicine and systems biology and 
the meeting of distinct fields. “Interface” would connotate that Chinese medicine and 
systems biology are different, which is not the case for those interviewed. They argue 
that Chinese medicine and systems biology share the same concept of holism, which 
they view as equal with systems thinking in systems biology. Most of the actors 
implicitly describe the relationship between the two fields as a connection through 
molecules, ideologies and technologies and not as a face-to-face relationship between 
humans. Thus, technology and molecular understanding are crucial to translate and 




Cultural differences surfaced in some interviews. Some of the participants mentioned 
characteristics of Chinese medicine that are not scientific and not prominent in 
biomedicine anymore. Other cultural differentiations referred to essentialism as a kind 
of preservation of the cultural values of Chinese medicine against the globalisation 
attempts of the Chinese government and various associations. However, their 
perception of difference may also express a reaction to the continuing attempt to 
globalise Chinese medicine since the 1980s, which we saw in Chapter 2.  
In conclusion, the data shows that many perceptions and descriptions of this “interface” 
are based on the similarity between Chinese medicine and systems biology. Despite 
the definition the actors use to define this “interface” between systems biology or 
Chinese medicine, they all agree that systems thinking or holism are integral parts in 
both. Thus, systems biology and Chinese medicine are defined either the same or can 
co-operate with this similarity. The question that arises is: how was systems thinking 
integrated into systems biology and Chinese medicine to connect both fields in the 
early 2000s? To answer this question, I will analyse the literature on the integration of 






4.4 HISTORICAL TRACE OF SAMENESS 
 
Results from interview material presented the idea that Chinese medicine and systems 
biology are the same, as they refer to systems thinking and holism synonymously. A 
look at the historical development of systems thinking in systems biology and Chinese 
medicine in this part will reveal that systems thinking in Chinese medicine and systems 
biology in the 2000s emerged from the integration of cybernetics in Chinese medicine 
and the development of systems biology from cybernetics. This will analyse the 
emergence of the perception that systems biology and Chinese medicine are the same.  
 
4.4.1 A SHARED INTEREST IN THE “PROBLEM” OF LIFE AMONG CHINESE MEDICINE 
PRACTITIONERS AND BIOLOGISTS 
 
The interest in life and its study existed for a long time not only for biologists but also 
for mathematicians, physicians and social scientists. In the early twentieth century, the 
American mathematician, child prodigy and one of the founders of cybernetics, 
Norbert Wiener (1894-1964), became interested in life as a form of control and 
regulation. Wiener wanted to formulate a theory of the control and regulation of 
communication between humans, machines and animals in 1948, which required an 
understanding of life and humans as systems. According to Ilgauds (1984), Wiener 
borrowed for his theory, the term “cybernetics”, which derives from the Greek 
kybernetes and means “the steersman”. Wiener’s (1994) theory Cybernetics or control 
and communication in the animal and the machine was first published in 1948 and 
became one of the key theories of cybernetics among John von Neumann and Oskar 
Morgenstern’s Theory of Games and Economic Behaviour (1944) as well as Shannon 
and Weaver’s (1949) The Mathematical Theory of Communication (see Umpleby, 
2008). Seising (2010) reports that cybernetics became a scientific theory for 
information control and regulation.  
Parallel to cybernetics, the Austrian biologists and philosopher Ludwig von 
Bertalanffy (1901-1972) observed butterflies to study systems. He published his 




the 1920s. General Systems Theory (GST) is the science to uncover universal 
principles that govern open, evolving systems (von Bertalanffy, 1968). To establish 
this theory, Bertalanffy and Bogdanov employed systems science, which was based on 
cybernetics but focussed more on social science models to overcome the problem of 
linearity in mathematics (ibid). Although von Bertalanffy’s GST stressed the 
principles in general systems and did not specifically target and control related systems, 
like systems scientists, Heylighen and Joslyn (2001) found that von Bertalanffy and 
second-order cyberneticians influenced each other’s work.  
Heinz von Foerster, another founder of cybernetics, founded the Biological Computer 
Laboratory (BCL) at the University of Illinois in 1958. He exchanged his ideas on self-
organising systems with systems scientists on a regular basis (Capra, 1996). According 
to Umpleby (2008), these systems scientists included the founders of the Autopoiesis 
theory: the Chilean biologists Humberto Maturana and Francisco Varela on a regular 
basis (see for Autopoiesis theory in Varela, Maturana and Uribe, 1974). Autopoiesis 
explains that systems are capable of reproducing and maintaining themselves. Hence, 
Autopoiesis, General System Theory and cybernetics underlined the beginning of a 
new era on the study of biology and life.  
In Chinese medicine, the interest in life was different. Qin Bowei (1955), a famous 
Chinese medicine practitioner (mentioned in Section 4.4.4), introduced holism as 
dialectic materialism into Chinese medicine. Along the same lines, Ren Yinqiu (1956) 
subsequently argued that since remote antiquity, Chinese medicine did not understand 
the material base for life, but it understood yin/yang as processes that constitute to life 
and to study life as being holistic. For example, the exterior of the body is yang, and 
the interior is yin. However, the organs are not all yin. Some of the organs are yin 
organs (zang 脏) as they store either qi, blood or fluids like the liver, and some are 
yang organs (fu 服) as they receive nutrition, such as the stomach. In this microcosmos, 
the human body is a small world that relates to its environment and is defined as heaven 
in Chinese. This model was known as the tianren heyi 天人合一. Qin (1955) compared 
the human yang qi with sunbeams because warm weather needs sun just as a healthy 
human body needs yang qi to warm the body. Thus, both heaven and human are two 
individual ecosystems that interrelate and depend on each other through similar 




Holism plays a vital role in the understanding of life. The word holism refers to the 
Greek word holos which means “whole”. In his seminal paper, Scheid (2016) found 
that despite the latest emphasis on holism as being intrinsic in the ancient tradition of 
Chinese medicine to distinguish Chinese medicine from complementary and 
alternative medicines (CAM), or biomedicine’s reductionist perspective, it is only a 
hundred years old. Zelko (2013) found that the former South African Prime Minister 
Jan Christiaan Smuts (1870-1950) coined this word holism first in his book Holism 
and Evolution (1926) as a translation of the German word Ganzheitlichkeit into 
English. According to Scheid (2016), Smuts added to Aristotle’s definition with the 
description that evolutionary processes form wholes through emerging properties, as 
opposed to the perception of a collection of parts. Although Smuts used holism to 
justify apartheid in South Africa, the recently invented term “holism” is still widely 
used in Chinese medicine and complementary and alternative medicine (CAM) fields.  
In the past century, holism was widely used. Holism appeared in connection with 
Gestalt psychology, Nazism, vitalism and later with Marxism in China (Scheid, 2016). 
Levine (2012, p. 30) demonstrated that in Weimar, Germany (1919-1933) and then 
under Nazism, holism was applied in cultural politics and science for example in 
eugenics and racial policies of the Germanic “Übermenschen” which was otherwise 
known as master/Aryan race. In Max Wertheimer’s (1880-1943) Gestalt psychology, 
living organisms are perceived as meaningful wholes, as a Gestalt, and not as isolated 
elements. Therefore, Capra (1982) argues that living organism exhibit qualities that 
are absent in the perception of isolated parts. The notion of holism used in Gestalt 
therapy became the utopian model for ethical frameworks of co-operation instead of 
conflicts, which were dominating the globe after the WWII and Vietnam war and 
during the Cold War.  
To sum up, the study of life is of interest for Western science and Chinese medicine. 
Cyberneticians were curious about the systems in machines and living organisms. 
They believed that living organisms are systems that control and regulate the 
transmission of information. In the same way, they hypothesised that machines are 
system that are either controlled by the technology or by the engineer. While in 
systems science, life was seen as a general system that governs and evolves through 




viewed as combinations and interrelations between yin and yang in the human body 
and its environment. What Western science and Chinese medicine still lack is the 
precise description or the evidence for their theories and holism. 
 
4.4.2 A “CRISIS” AMONGST BIOLOGISTS LEADING TO A RETURN TO 
HOLISM/VITALISM  
 
A crisis in biology arose from the increasing molecularization of biological and 
medical phenomena. During the 1920s and 1940s, the interest in biology and medicine 
diverged into molecular biology and the investigation of the smallest parts. In the 
1950s, the “Golden Age of Theoretical Biology” occurred through the shift in biology 
to mathematical descriptions of biological phenomena (Green and Wolkenhauer, 2013, 
p. 559). The Bertalanffy’s Society for General Systems Research (SGSR), which is 
now the International Society for the Systems Sciences (ISSS), initiated this shift to 
quantify transformations in biological systems. In the 1970s, the mathematical 
approach quickly advanced to interdisciplinary fields such as mathematic biology, 
biochemistry and biophysics and linked engineering in biology and biomedical science 
to the biotechnological industry, researchers and clinicians (Kaimal et al., 2011). The 
biotechnological methods followed a linear process of researching a phenomenon from 
the cause to the effect and became known as a “bottom-up research”, which used the 
reductionistic approach in molecular biology (Green and Wolkenhauer, 2013, p. 555). 
Thus, some biologists returned to the understanding of the wholes and holism. 
The reductionistic view in biology aroused a “crisis” amongst biologists and the idea 
of holism re-surfaced. Wood (2010) discovered that during the 1940s and the 1970s, 
various groups accentuated their opinion against reductionist thinking by stressing the 
value of humans as part of society and the global community. They wished to unite 
what was previously separated, for example, the body, mind, spirit, nature and 
technology. Likewise, Scheid (2016) found that in France, holists engaged with 
vitalism in opposition to mechanists. Weber and Esfeld (2003) explain that mechanists 
viewed everything as a system that consisted of interacting particles with a focus on a 
limited number of properties. In contrast, vitalists were interested in the whole body 




The holists idea emerged again to oppose, according to Lawrence and Weisz (1998), 
the idea of the dominating interest in biology in mechanism and reductionistic 
understanding of the body as a set of organs or physicochemical processes. Similarly, 
the holist advocate and physicist Capra (1996, p. 77) describes molecular biology as 
“originally a small branch of life sciences has now become a pervasive and exclusive 
way of thinking that has led to a severe distortion of biological research”. The result 
of the increased focus on molecular biology was the search for holistic ideas and 
approaches to studying biological phenomena. This influenced the development of 
linear and reductionistic, i.e., bottom-up research (i.e., detailed anatomical and 
mechanical models), to more holistic approaches.  
In this context, Noble (2010) proposed a middle-out approach in systems biology as a 
combination of the reductionist bottom-up and the holistic top-down approach (i.e., 
computer modelling of the cell). The middle-out approach deliberately starts at the 
biological level (i.e., tissue or cell) of the body and builds upwards until the researcher 
reaches enough knowledge and subsequently investigates the relationships between 
cells, tissues and organs of an organism. Thus, the researcher generates a 
comprehensive understanding of the system around his starting point and the 
relationship to lower or higher biological levels (Noble, 2010).  
As a reaction to molecularization in biology, in 1975, a group of scientists started to 
popularise Chinese Daoist philosophy. Pickering (2010) claims that Capra’s book on 
the interpretation of Daoism in physics provoked a rethinking of a holist approach in 
and outside of science. In the same vein, others refer to the last century as holistic due 
to the employment of holism into systems science, which generated a “Holos 
Consciousness” (Jaros, 2002, p. 14). This shift had an impact outside academia. Thus, 
the absorption of holism created the new fields of holistic medicine, holistic diet and 
holistic lifestyle which were invigorated by the Holos Consciousness (Jaros, 2002).  
A further shift to holism happened in the late 1990s. Scientists initiated a scientific 
turn by discussing the concept of holism in biology, physics, physiology, medicine and 
philosophy and by contrasting it with a reductionist approach of those disciplines 
(Capra, 1975, 1982; Zhang et al., 2010; van der Greef et al., 2007, 2010; Tong, 2009; 
Gatherer, 2010; Noble, 2010; Luo et al., 2012b). During my fieldwork, several of my 




motivation to establish and engage with systems biology (see Chapter 4.3). Actors in 
this new “interface” did not comment on these associations of holism with apartheid, 
Gestalt therapy, Nazism, vitalists and utopian ethical frameworks in their rhetoric on 
the systems biology and Chinese medicine “interface”. They referred to holism in 
China and Chinese medicine, where it became a way to catch up with the world and 
as a tool of resistance against Western imperialism. This will be expanded on below. 
 
4.4.3 CYBERNETICS AND SYSTEMS SCIENCE OPENING UP THE POSSIBILITY OF A 
RECOVERY OF HOLISM  
 
The interest of cyberneticians in the holism emerged from the keenness of British 
cyberneticians to Eastern philosophies and the establishment of a “nonmodern 
ontology” (Pickering, 2010). Pickering explains a nonmodern ontology as an ontology 
against the Western dualism of mind and matter, and rather influenced by Eastern 
philosophies. At the same time, American cyberneticians had to reorientate their field 
towards second-order cybernetics and social science by focusing on the role of the 
observer in modelling systems (see Heylighen and Joslyn, 2001). In this section, I 
will first reflect on Pickering’s (2009, 2010) exploration of British cyberneticians and 
ifs affinities to Eastern philosophy and then on the American shift to the second-order 
cybernetics.  
According to Pickering (2009, 2010), the first generation of British cyberneticians 
developed an interest in performances of Eastern philosophy and spirituality in the 
course of the counterculture movement. These cyberneticians used Eastern 
philosophies as a nonmodern ontology or as an alternative to conventional psychiatry 
in the 1960s to inform their studies on the brain. The leading figures were Grey Walter 
(1910-1977), William Ross Ashby (1903-1972) and Gregory Bateson (1904-1980). 
Bateson played a double role in cybernetics as he was one of the founders of 
cybernetics and a systems scientist together with Margaret Mead in the US as well as 
he was also a British cyberneticist. Pickering (2010) connects British cybernetics with 
Alan Watts, who was a British expatriate and a populariser of Eastern philosophy 
during the counterculture movement in the US. Watts consulted Bateson’s 




influenced Walter’s and Ashby’s (1968) studies on homeostasis and his illustration of 
the human brain as a performer, e.g., of hallucinations, of trance or the nirvana of 
Indian yogis and fakirs experience. Walter explored with cybernetics the altered stages 
of Indian yogis and their bodily experience for example, the suspension of their 
metabolism. He investigated those effects on healthy and diseased brains. The interest 
of the first generation of British cyberneticians in Eastern philosophy showed that 
cyberneticians in the 1960s looked beyond the reductive neurophysiology and aimed 
to study the brain as a holistic and “complex adaptive system” (Pickering, 2010, p. 8). 
Systems scientists adopted this holistic viewpoint and popularised it in their fields, e.g., 
Capra in physics (1975) and Laszlo in philosophy of science.  
The second generation of British cyberneticians, for example, Stafford Beer took a 
more radical approach and engaged with Indian philosophy through practising and 
teaching tantric yoga. Pickering (2010) states that Beer was an active promoter of 
holistic teaching and played an essential role in the integration of holism in cybernetics 
in various complex systems models he created for management or political cybernetics 
(see, for example, Beer, 1994). Both generations of British cyberneticians included 
Buddhist and Indian philosophy into their research, and opened first systems science 
and later other Western scientific fields in the holistic paradigm (Pickering, 2010).  
The shift to second-order cybernetics and the focus on systems science opened the 
field in the US to an observer centred and signified a further step in the integration 
process of cybernetics in other disciplines. Heylighen and Joslyn (2001, p. 3) argue 
that the new second-order cybernetics emphasised the “autonomy, self-organisation, 
cognition, and the role of the observer in modelling a system” as a distinction to first-
order cybernetics and other relating disciplines such as computer science. Umpleby 
(2008) stated that the development of the second-order cybernetics occurred as a 
rescue measurement of the field to pacify the student protests, as cybernetics was 
linked to missile and machine research. Consequently, the neurophysiologist and one 
of the founders Warren McCulloch created the second-order cybernetics in the 1970s 
to calm the situation. Besides this, through the integration of cybernetics into other 
fields such as control engineering, computer science and social science, as well as the 
death of the two founders and active promoters of cybernetics, Norbert Wiener and 




struggled to survive as a discipline but joined in the late 1980s with systems science 
to form “Cybernetics and Systems” (ibid, p. 6).  
Although, in the 1960s and 1970s, cybernetics was integrated into other disciplines, 
Pickering (2010) claims that the core idea of systems thinking continued in systems 
science and the emerging conferences, journals and new fields such as brain science, 
psychiatry, neurophysiology, management and organisation, robotics, engineering, 
science of general systems, biological computing, politics, entertainment, the arts, 
theatre and architecture, music and education. Systems thinking became a way of life 
that reached into and beyond the academic world. It was incorporated into family 
therapy, complexity theory, robotics, AI as well as cyborg studies by Haraway (1991) 
or the posthuman by Hayles (1999) and as a new kind of science (Pickering, 2009). 
Some claim systems biology was influenced by systems thinking through systems 
science cybernetics (namely Bateson), whilst others believe that it was influenced by 
physiology trajectories (Noble, 2010; Strange, 2005).  
Physiologists argue that physiology was the origin of systems biology (Noble, 2006, 
2010). This assumption stems from cybernetics and systems science as these groups 
of scientists consisted of physiologists like McCulloch (Umpleby, 2008). Additionally, 
Noble (2010) promotes systems biology as the reinvention and the logical successor 
of physiology. In his view, physiology has always dealt with the communication 
between distinct levels of the body (i.e., cells, tissues, organs) and its systems, which 
is not different to systems biology. In the face of this transition of physiology to 
systems biology, Strange (2005) fears that physiology could fade away due to the 
emergence of system biology and the trend of applying systems biology methods, such 
as functional genomics, genetics, non-mammalian model organisms, computational 
biology in physiology. Thus, Strange (2005) suggests a “renaissance of physiology” 
rather than moving systems biology into physiology departments and risk the “fading 
away of physiology” (2005, p. C986).  
The second trajectory of systems biology derives from molecular biology and 
genomics as opposed to cybernetics and physiology. Green (2014) claims that the 
connection to genomics arose from the development of systems biology after the age 
of molecular biology in the 1970s and the genomics boom in the 1990s. The substantial 




place between 1997 to 2007. Researchers agree that the HGP was the “‘holy grail’ of 
genetics and molecular biology” as it produced profound information on the 
organisation and structure of DNA, RNA, and proteins and a database of three billion 
nucleotides in the 24 chromosomal strings, however, it did not answer the cardinal 
question of “what is life?” (see for example Noble, 2010; Müller-Wille et al., 2007, p. 
16). This happened because the research paradigm of the HGP was reductionistic and 
it distorted the view on the human genome with molecular biology that had no idea of 
the syntax of genes (Capra, 1996). Consequently, Noble (2010) restated the question 
about what life is and stressed the importance of understanding the bigger picture and 
the relationships between cells rather than its smallest parts.  
The move to genomics research and the focus on genes with the HGP opened the 
floodgates in China for international research programmes, as well as for scientific 
research into diseases classified under Chinese medicine categories. Chee and Clancey 
(2013) disclose that the HGP included 80 laboratories in 15 countries worldwide. The 
HGP thrust China’s science into a new direction, for example, the Human Physiome 
Project or China’s Genomic Research Centres sequenced the last one per cent of the 
whole human genome of the HGP. On the whole, the HGP provided China with a new 
tool to make up leeway with science and the West. It developed a competitive and 
prestigious “big science” in China with “national” characteristics, which was 
comparable to genomics research in the United States (ibid, p. 313). In particular, 
Chinese scientists such as He Fuchu proposed to the committee of the HGP, a 
subsequent Human Liver Proteome Project (HLPP) and China hosted it to secure the 
participation of China in the HGP (see He, 2006, 2011).  
Liver research has been and still is a major research field in Chinese medicine. He 
(2006) proposed the HLPP due to the fact that hepatitis was a problem in China. After 
the HGP, China established four large-scale HLPP20 research institutions one being 
the Beijing Proteome Research Centre which joined the HLPP in 2004 (ibid). It 
became one of the most invested research centres among the “Giant 4” of quantum 
mechanics and nanotechnology in China (Chee and Clancey, 2013). Over the past two 
                                               
 





decades, systems biologists and Chinese medicine scientists have increased their 
investigations into liver diseases (see, for example, Jiang, 2005; Zhang et al., 2010; 
Yao, Li and Pei, 2013). These studies have applied genomics, proteomics and 
metabolomics in order to detect the effect of a fufang on a person’s metabolism 
(Angelova et al., 2008, p. 10). With genomics and subsequent omics technology, these 
studies have produced a wide range of genetic, protein and metabolic data from in vivo 
and in vitro studies that examined physiological effects after the intake of a fufang. 
Cybernetics developed and split into many disciplines. That said, systems theory 
remained a cardinal theory in systems science and the evolving field of systems 
biology. Whilst those interviewed claimed there is a similarity or sameness between 
systems theory and holism as demonstrated in the first part of this chapter, the 
development of cybernetics showed that cyberneticians and systems scientists 
employed holism in Zen Buddhism and Indian yogi practices and spirituality as an 
alternative to the reductionist and mechanists view in the 1970s. Bateson, Walter and 
Stafford integrated systems theories to exceeded the physical form of a brain or other 
substances and materials into interrelationships in the body, i.e., as a homeostasis 
system, or with nature or cosmos, i.e., as the mystery of God. During the counterculture 
movement, cyberneticians and promoters of Eastern philosophies influenced each 
other.  
Systems biology, in the cybernetic and genomics trajectory developed as an 
interdisciplinary field with different research and disciplinary foci. In the first part of 
this section, I presented the systems biology’s trajectory in cybernetics and physiology, 
which partly prepared the second trajectory of systems biology in genomics. These 
trajectories formed the multi-disciplinary character of systems biology. Alon (2007) 
argues that systems biologists recognise the value of interdisciplinary work, e.g., from 
mathematics, biology, chemistry, physics and computing to examine and calculate 
interactions on a molecular basis to answer the question what life is. The integration 
of various disciplines was displayed in the co-operative work between engineers, 
chemists and physicists to reveal and encode relationships between RNAs, 
transcriptomes, proteomes, metabolomes and interactomes from large datasets 
irreplaceable (Auffray et al., 2003). From the above, it is evident that systems biology 




biology. From those disciplines and through the engagement and integration systems 
thinking in cybernetics and systems science and of holistic approaches in Eastern 
philosophies the new field systems biology emerged. 
 
4.4.4 THE IMPORT OF THE OLD HOLISM INTO CHINESE MEDICINE AND CHINA  
 
The previous section showed the crisis in biology regarding molecular biology and the 
significant role that Eastern philosophies played in solving this crisis by importing 
holism into systems science and cybernetics. When systems biologists imported the 
Chinese medicine holism, they did not distinguish that, what they considered as “old” 
holism, was in fact the holism that was imported in the 1950s from Europe into Chinese 
medicine. In this section, I will give a brief history of holism and then discuss two 
groups which integrated holism and systems thinking into Chinese medicine. The first 
group integrated dialectic materialism and holism into Chinese medicine theory by 
following the political agenda of the CCP. The second group employed systems theory 
into Chinese medicine. 
To give a brief summary of the development of holism, Scheid (2016) shows in his 
paper Holism, Chinese medicine and Systems Ideologies that the common genealogy 
of holism in Chinese medicine and systems biology started before and during the 
interwar years (the 1930s), respectively. In the eighteenth century, holism emerged in 
Germany from the interaction of two different understandings: the cultural/structural 
and idealist, and the second was based on science, processes and materiality. The 
cultural/structural holism derived from idealist philosophers, such as Herder, 
Humboldt and Kantian, who viewed cultures as distinct parts that intimately connect 
and work together as a whole with its members contributing in unique ways. Scheid 
(2016) further claims that Hegel developed historical dialectics that underpinned 
history, emergence and process. Friedrich Engels criticised Hegel’s historical 
dialectics in 1972 and created his scientific holism (ibid). Engels claimed that Hegel’s 
historical dialectics lacked the interrelationships between all parts of the world and the 
temporary character that constitutes history. Scheid (2016, p. 68) argues that Engels 




dynamics that formulate scientific laws and organise principles to reveal the world as 
emergent relationships to humans. Hence, Scheid claims that holism is a concept that 
has its beginning in idealism, which Engels supplemented with the importance of 
emerging properties.  
Tonietti (2003) argues that in ancient Chinese science, the concept of holism is 
unknown. In his view, the dual role of yin/yang as holistic and opposites was not 
inherent in Chinese medicine and science before Chinese medicine scholars 
implemented them for political reasons in the 1950s (ibid). What Tonietti (2003) 
asserts about holism in Chinese medicine is not to be confused with Ren Yinqiu’s 
argument, stated above, that Chinese medicine did not understand the material 
substance of life. Chinese science has always been interested in the correlations 
between phenomena from the Daoist’s perspective. Daoism viewed natural 
phenomena as an infinite cycle of transformations, which were unstable movements 
and changes that generated beginnings and ends in the whole universe (ibid). Therefore, 
Chinese medicine received Daoism’s notion of transformation and change which 
penetrates and transforms into each other and, thus, eliminates any dualism. Hence, 
Tonietti (2003) claims that any distinction between the components is undefinable as 
they continuously transform and interpenetrate each other without becoming static. He 
concludes that the implementation of dialectic materialism and holism affects the 
dualistic or oppositional character in Chinese science and medical theories. 
Many scientists and researchers may disagree with Tonietti (2003), however, some 
studies agree that holism in Chinese medicine was integrated in the 1950s to assimilate 
and distinguished Chinese medicine from Western medicine (see, for example, Scheid, 
2016; Hsu, 1999). Scheid (2016) links the origin of the concept of holism to late 
eighteenth century Germany and which was further expanded on by Engels and which 
claims that everything in the world is interconnected through scientific laws and 
principles that form emergent relationships. In the following, we will see how Engels’ 
idea was implemented in Chinese medicine. 
In the early Communist era, Chinese medicine scholars followed Mao’s instructions 
and introduced dialectic materialism and holism into Chinese medicine to assimilate 
and differentiate their medicine to the epistemic level of biomedicine (Scheid and 




(Scheid, 2016). Besides the political aim to integrate Chinese and Western medicine 
(1958-1959) at that time, Scheid (2016) and Hsu (1999) claim that due to the new 
connotation of the classical Chinese medical conception of yin/yang, the discrepancy 
between the two medicines increased.  
Chinese medicine scholars embedded the translation of holism (zhengti guannian 整
体观念) into the yin/yang theory. As Scheid (2016) found, in Chinese, the term holism 
(zhengti) was a loanword borrowed partly from Mao Zedong and Ai Siqi (1910-1966), 
a Marxist philosopher and populariser of dialectic materialism, who worked on Engels’ 
dialectic materialism as well as on Buddhism and the translation of holism, which 
means “the conception of the wholes”. Zhengti stands for the “whole” coming from 
Mao’s On Practice and On Contradiction works (Scheid, 2016; Hsu, 1999). The 
Buddhist expression guannian is translated as the “direction of one’s attention” 
(Scheid, 2016, p. 69). For the assimilation of dialectic materialism, Mao and Ai used 
the notion of tongbian 通变, which means “interpenetration of opposites”, to grasp the 
dynamic of the relationships that constitute the world. By doing so, they changed 
Engels’ focus on the matter of things to processes of change and transformation 
(biantong 变通) (ibid).  
The first implementation of Engels’ dialectic materialism into Chinese medicine 
followed the instruction of Mao Zedong to accomplish the main political aim of 
modernising Chinese medicine (see Huang, 1962). Scheid (2007) views Qin Bowei, 
as the first Chinese medicine practitioner who applied dialectic materialism into the 
yin/yang theory of Chinese medicine. Qin (1955) explained in his article that yin/yang 
is a dialectic principle in which the two are conflicting but also interpenetrating each 
other. Therefore, they support Qin’s thesis that they are transforming opposites that 
create a unity between the body and its environment (ibid). To verify his theory, Qin 
used the characters of yin 阴 and yang 阳 as an objective reality and categorised the 
body into different sections which also vary according to the perspective of the 
observer. Eleven papers were published after Qin’s paper in 1955. Among them were 
Fang Yaozhong 方药中, Ren Yingqiu 任應秋, Ran Xiaofeng 冉小峰, Xiao Xi 萧熙, 




materialism through the transformation of yin/yang and its interrelationship between 
the body and the environment.  
In his article, Scheid (2016) claims that first Qin and his colleagues employed the 
theory of the “Unity of Opposites” (duili tongyi 对立统一) in Mao Zedong’s essay On 
Contradiction and generated a (proto-)science of Chinese medicine and textbooks for 
students. In Qin’s 1964 article, he demonstrated that holism in dialectic materialism 
offered a theoretical framework to refashion Chinese medicine. With yin and yang, he 
classified symptoms and patterns and systematised Chinese medicine by its functions, 
transformations and the differentiation between interior and exterior, depletion and 
repletion, hot and cold as well as ascend and descend (see also Qin, 1955). Scheid 
(2016) asserts that Qin’s systematisation became later known as the system of “pattern 
differentiation” (bianzheng lunzhi). He believes that bianzheng is the exchange 
between the understanding of a relational world by using the notion of 
“interpenetration of opposites” (tongbian 通变) and Engels theory on “dialectics” in 
Chinese medicine (ibid). Hsu (1999) argues that bianzheng affected a new way of 
explaining physiological and mental phenomena in Chinese medicine. 
The integration of holism in the form of Engels’ dialectics materialism in Chinese 
medicine is, to quote Scheid (2016, p. 71), “expunging all traces of the origins of this 
accommodation in the specific political context of the 1950s, Chinese medicine 
physicians today read European holism and dialectics back into ancient texts without 
experiencing any apparent sense of discontinuity”. He refers to the issue that dialectic 
materialism and holism were well integrated into the context of Chinese medicine 
theories and that they do not reveal any difference to Huangdi neijing and the Yijing 
(易经 Book of Changes). They became intrinsic concepts in Chinese medicine (ibid). 
The oppositional character of yin/yang differentiated Chinese medicine from European 
philosophies and medicine while Chinese medicine was assimilated with yin/yang and 
dialectical materialism to European theories. Other Chinese medicine scientists 






The second group of Chinese medicine practitioners integrated systems theory in 
Chinese medicine. Since the 1960s, they scientifically discussed Chinese medicine’s 
five elements theory (wuxing) and the congruence of yin/yang with the black box 
theory in cybernetics (Qiu, 1982). Qiu (1982, 1987) claims that, in 1960, Ren Shu first 
applied cybernetics in Chinese medicine acupuncture and reinterpreted it with 
information theory. For example, Ren explained meridians (jingluo 经络 ) as 
information channels, and acupuncture points (xuewei 穴位) served as generators of 
information. Secondly, Ren Shu related yin/yang and wuxing to feedback theory. He 
assigned yin, as the interior, to the number 1 and yang, as the exterior, to the number 
0. His hope was that a computer could use the translation of yin/yang and calculate a 
diagnosis one day (Qiu, 1982). These studies preliminary established the philosophical 
attempt to explain Chinese medicine theory that advanced until the proclamation of 
Deng Xiaoping’s three sciences (see Chapter 2).  
The integration of systems thinking resurfaced again in the 1980s when Deng Xiaoping 
proclaimed a new effort to evolve the domain of TCM with cybernetics, systems theory, 
and information theory started with the initiative of political leaders at Chinese TCM 
colleges (Fruehauf, 1999). Additionally, Chinese medicine practitioners were 
confronted with the abolition of yin/yang and wuxing theories by the supporters of an 
integrated Western and Chinese medicine. Thus, Chinese medicine practitioners aimed 
to accommodate systems thinking as a seamlessly integrated part in Chinese medicine. 
For example, Lü Bingkui (1981), a practitioner, called on Chinese medicine students 
to study medical systems theory for the further development of Chinese medicine, 
however, in this case to preserve the context of the old wisdom of Chinese medicine. 
He claimed that Chinese medicine was a system of relationships between nature, 
human and heaven and that pattern differentiation correlated with systems thinking by 
arguing that diseases are always connections of various processes in the human body 
(Lü, 1981). Subsequently, Scheid (2002a, p. 82) claims that Lü not only influenced a 
reinterpretation of Chinese medicine theory with his interventions, but he also sought 
“to preserve and promote the independent character of Chinese medicine”. Hence, Lü 





Chinese cyberneticians and systems thinkers supported the integration of systems 
theory in Chinese medicine. Qian Xuesen (also written as Tsien Hsue-shen) 钱学森 
(1911-2009) and Zhu Shina 祝世纳 strongly emphasise the importance of cybernetics 
in Chinese medicine as it demonstrates the scientific nature of Chinese medicine (see 
Scheid, 2014). According to Wang (2011), Qian Xuesen is one of the most important 
scientists in Modern China. Qian Xuesen is known as the father of China’s ballistic 
missile, rocket and space program (ibid). Since the 1980s, he engaged with the 
integration of cybernetics in Chinese medicine due to the increased attention Chinese 
medicine was gaining at that time from foreigners and other cyberneticians (see Jiang, 
2005; Xu, 1999; MacPhail, 2009). Qian delivered a method that was holistic and 
provided a solution to interlock ancient Chinese wisdom with modern Chinese science, 
but which also attracted foreigners to investigate other practices, such as Qigong 气功
(see Hsu, 1999; Xu, 1999). However, the inferior quality of Qigong studies led to the 
label of Chinese medicine as “pseudo-science” (Xu, 1999, p. 966-967). Scheid (2014) 
considers that, since then, Chinese medicine has become a scientific field trapped in 
the perception of being a pseudoscience.  
Researchers found that Qian Xuesen was interested in the application of a shared 
holistic perspective with cybernetics and systems theory in Chinese medicine (Jiang, 
2005). Qian proposed an “open complex giant system” as a new method to transcend 
reductionism by advancing holism. By building on “image thinking” (xingxiang siwei 
形象思维) of zheng as a whole body examination method, Qian and Dai (2007) 
established sub-models for diagnosis.  
To this end, Qian and Dai (2007) gathered information from the experiences of the 
practitioners with the four examinations (observation, interrogation, auscultation and 
olfaction, and touching the pulse and palpation) and collected classical texts. They 
compared the results from the diagnosis with the classical texts to find an “image” of 
the diagnosed zheng. This was similar to the translation of Chinese medicine diagnosis 
with pattern recognition, which van der Greef et al. (2010) described in his first trial 
as connecting mass spectrometry with computer software. According to Qiu (1982), 
image thinking led to computational diagnosis studies which aimed to verify Ren Shu’s 
hypothesis of the 1960s on the calculation of a Chinese medicine diagnosis with the 




medicine researchers lacked appropriate software, the experiment set a further step in 
the computational approach to Chinese medicine. Therefore, Qiu’s (1982) findings 
show that the idea of computational modelling existed already before the encounter 
with systems biology. 
From what has been discussed in this section, holism was integrated into Chinese 
medicine in the 1950s when Chinese medicine practitioners and researchers 
interpreted Mao’s policies of modernisation as dialectic materialism and systems 
theory in Chinese medicine. Although both groups used different methods, they 
reached the same conclusions that cybernetics, as well as holism, were compatible with 
Chinese medicine concepts. Hence, the relationship between Chinese medicine and 
systems biology derives from the long processes of integration which took place before 
the first studies on systems biology and Chinese medicine were published in 2005 by 
Wang et al. and Shen. 
 
4.4.5 THE MANY PERSONAL EAST/WEST CONNECTIONS 
 
An investigation into the shared ideology of systems thinking and holism between 
Chinese and Western scientists was based on the parallel evolvement of cybernetics in 
both the East and the West between 1930 and 1960. Links between the US and China, 
and medicine and Eastern philosophies, strongly influenced cybernetics and the 
juxtaposed field of systems science, which set the corner stone of systems biology. 
Thanks to the co-operation of the Chinese electronic student Li Yurong 李郁荣 (1904-
1989) and Wiener, a connection between Chinese and American cyberneticians 
facilitated the invention of one of the fundamental theories in cybernetics, the wave 
filter theory in 1934 (Wiener, 1994). Additionally, through their co-operation early 
cybernetics was introduced in China in the 1940s and in fact predated the “emergent 
interface”.  
The first contact between Chinese and American cyberneticians was in the 1930s 
before Wiener (1994), von Neumann and Morgenstern (1944) and Shannon and 
Weaver (1949) published the first books on cybernetics. Chinese exchange students, 




直 (1919-1982) and J.C. Yang (1919-2006) studied and worked closely with pioneers 
in this field from the early 1920s to 1960s. Li and Qian, for instance, worked with the 
mathematician Norbert Wiener. Song was a student of the famous control theorist 
Alexander Aronovich Feldbaum in Moscow and Guan worked with the mathematician 
Maurice Fréchet in France (Chen and Cheng, 2007; Greenhalgh, 2008). Secondly, 
through the co-operation of Wiener with Li, two fundamental theories in cybernetics 
were formed: the “wave filter” and the “prediction theory”. In 1934, during Wiener’s 
visiting professorship at the twenty-five years old Qinghua University in Beijing, the 
two scientists formulated the wave filter theory (see Wei, 1996; and Masani, 1990). Li, 
at that time was a young professor at Qinghua University and he assisted Wiener with 
an analogy-computing machine and electrical feedback understanding, to develop the 
wave filter theory based on harmonic analysis of probability calculation in 1934 (see 
Wiener, 1994). The theory was used to improve radar systems during WWII by 
filtering out disruptions in incoming messages and later for information technology, 
such as televisions (see Ilgauds, 1984). Li trained and established one of the first 
cyberneticians and institutions in China (see Peng, 2004).  
The second connection between cyberneticians in America and China was through 
Qian Xuesen. According to Wang (2011), Qian received his Master of Science degree 
at the M.I.T in 1936 and his PhD in 1939 at the California Institute of Technology 
(Caltech). His return to China was during the Korean War (1950-1953); thus, the 
Federal Bureau of Investigation of the U.S. accused him of spying during the Cold 
War for the Communist Party as an ally to the Soviet Union and Qian’s expertise in 
rocket science. After his detention, Qian returned to China in 1955 and served his 
country as a missile and rocket scientists and lead various nuclear-weapons and space 
(liangdan yixing 两弹一星) programs. He also played a significant role in the progress 
of technical science. His career was supported by the PRC’s twelve-year plan, which 
aimed to develop science and technology (Cao, Suttmeier and Simon, 2006; Peng, 
2004). In the 1930s, cybernetics was mostly transferred from America to China. 
However, in the 1960s, the political alliance between China and the Soviet Union 
changed the situation, and as a result, the student exchange programmes offered 
between China and the Soviet Union increased together with technological imports. 
The Soviet political connection led also to the import of the Soviets’ theories as they 




The dissemination of cybernetics happened at various levels in China. Chen and Cheng 
(2007) remark that Li and Qian set up cybernetics departments and societies in China 
to teach and instruct students and researchers in this new field. Peng (2004) argues that 
the excellent reception of cybernetics in China was influenced by the philosophical 
implications of cybernetics, e.g., the behavioural function with concepts of control, 
feedback and information. Chinese medicine researchers and modernisers found that 
the philosophical component resonated with the Chinese philosophy of harmony 
between human and nature and the tianren heyi, which the Chinese were keen to 
explore.  
In summary, the second part of this chapter described the relationship between Li 
Yurong and Qian Xuesen with US inventors of cybernetics and the dissemination of 
cybernetics in China in the 1950s and 1960s. It is important to note that not only 
scientific and technical interest played a crucial role in the dissemination of cybernetics 
in China, but also the philosophical commonalities with tianren heyi. In general, the 
implementations of feedback theory, wave filter theory and missiles shaped the 
Chinese research landscape and paved the way for an “interface” between Chinese 
medicine and systems biology. In particular, cybernetics permeated into Chinese 
medicine theories and became organically blended into Chinese medicine in the last 
decades of the twentieth century.  
The almost seamless integration of systems theory and holism in Chinese medicine 
seemed to have faded into oblivion in the twenty-first century. However, those 
processes of integration facilitated the correlation between systems biology and 
Chinese medicine. Thus, actors in the Chinese medicine and systems biology research 
assumed that the similarity originated from the ancient Chinese medicine and earlier 
forms of biology (see, for example, Li, Yang and Gong, 2009; van der Greef et al., 
2010; Wang, Zhang and Sun, 2012; Xu et al., 2013; Guo et al., 2014). Nevertheless, 
the rhetoric of holism in this relationship lacks specification. Actors often refer to 
ancient Greek philosophy and Aristotle (van der Greef et al., 2010) or Plato and 
Hippocrates (Wood, 2010; Weber and Esfeld, 2003). Despite the variation in the origin, 
they all use Aristotle’s definition of “the sum of the whole is bigger than its parts” 




The above-stated literature survey reveals that holism and systems thinking in Chinese 
medicine were adapted versions of holism. In the early twentieth century, Western 
scientists avoided this term after it was used by Nazis and in the apartheid movement. 
Nevertheless, by connecting it with old Chinese medicine theories, it became an “old” 
holism for Western systems scientists, while it was a “new” concept for Chinese 
medicine. Cybernetics and systems theory were melted into Chinese medicine in the 
same way as holism was integrated in Chinese medicine. They became an integral part 
of Chinese medicine concepts, beyond the recognition of systems scientists and later 
systems biologists. The historical integration indicates why most of the interviewees 
denied an “interface”, as both systems thinking developed into systems biology and 








5. INVOLVEMENT IN CHINESE MEDICINE AND SYSTEMS 
BIOLOGY RESEARCH 
 
As we have seen in the previous chapter, the emergent “interface” arose from a pre-
existing structure of systems thinking that was transmitted through cybernetics in 
Chinese medicine and systems biology during the twentieth century. This chapter will 
answer the research question of how the actors became involved in Chinese medicine 
and systems biology research. Episodic interviews together with thematic coding were 
the primary methods used to address this question. This chapter therefore focuses on 
interviews and descriptions of involvement, and has been divided into four codes 
according to the presentation of how actors became involved in Chinese medicine and 
systems biology research. The codes are (i) technological and health problem, (ii) 
search for complexity, (iii) family and exploitation of Chinese medicine and (iv) 
discontentment with a reductionist presentation of medicine and health.  
The question of involvement in systems biology and Chinese medicine is driven by 
the following two decisive issues in this research:  
• What motivated, inspired or fascinated scientists to risk their reputation by 
engaging with Chinese medicine and systems biology?  
• How did they deal with the bias of Chinese medicine as pseudoscience?21  
 
The question of why scientists with a reputation and rank in academia would risk their 
career was interesting in the context of the increasing pressure on scientists for 
professional achievements, which related to publications in high quality academic 
journals, such as Science or Nature. According to PubMed (2019), these journals have 
only recently started to publish articles on Chinese medicine.22 From this viewpoint, 
                                               
 
21 The connection of Chinese medicine with pseudoscience was discussed in Chapter 4, see also Xu 
1999; Scheid, 2014. 
22 In a research on the platform Web of Science with the search criteria journal “Science” and the term 
“Chinese medicine” resulted in eight articles of them were published two on the history of Chinese 
medicine and hospital care in Tianjin before 2003. The other six were published after 2003 on the 




the question about the involvement of the actors in the research on Chinese medicine 
and systems biology is of crucial interest in this study and will be elaborated on in this 
chapter.  
The label of pseudoscience has been attached to Chinese medicine since the 
introduction of science in China in the early nineteenth century and still exists to this 
day (Ward, 2011). Ward (2011) claims that the dualism of science/pseudoscience 
appeared when China started to associate biomedicine with science and the returning 
Chinese students from Japan introduced the Japanese word ke (meaning “making 
things orderly”). These students experienced public health movements in Japan, which 
initiated the implementation of Western medicine in the Japanese healthcare system. 
In China, the request for the implementation of Western medicine into the healthcare 
system peaked during the May Fourth Movement which occurred in 1919, and with 
the attempt of Yu Yunxiu and his proposal to abolish Chinese medicine in 1929 (this 
was discussed in Chapter 2; see also Ward, 2011; Lei, 2014; Andrews, 2014; Scheid, 
2002a). The struggle between Chinese and Western medicine continued in the twenty-
first century when opponents of Chinese medicine called in China for the abolition or 
exclusion of Chinese medicine from the medical system. The last attempt to abolish 
Chinese medicine was carried out by Professor Zhang Gongyao 张功耀 in 2006, he 
based his argument on the fact that Chinese medicine was a backward and farcical 
medicine (Ward, 2011). Overall, all the implementations and alignments with Western 
science by Chinese political agendas during the twentieth century, have not guaranteed 
the scientific status of Chinese medicine, neither in China nor overseas. This highlights 
the importance of the question of how scientists in Europe dealt with the label of 
Chinese medicine as a pseudoscience in their involvement in Chinese medicine 
research. In describing and analysing the themes gained from interview data, I will 
reflect on the effect the association of pseudoscience has had on those scientists and 
their Chinese medicine research.  
In this chapter, I will present the involvement of four actors who learned about Chinese 
medicine before they professionally conducted their first studies on systems biology 
and Chinese medicine in the early 2000s. The four actors are Prof Frank, Dr Huang, 
Kevin and George (see Table 2 for a detailed description of the Chinese diagnosis 




reasons: health problems, interest in complexity presented in Chinese medicine, the 
exploitation of Chinese medicine and discontentment with the reductionist 
representation of health and diseases. Their interest in Chinese medicine in the first 
place was not influenced by external factors such as research projects or funding. 
These actors hoped to find an alternative approach to study life and complexity and 
they wanted to regulate the pharmaceutical production of Chinese medicine. These 
scientists were interested in the complexity of Chinese medicine, which they related 
to Chaos Theory23 and they aimed to approach Chinese medicine with mathematical, 
statistical and computational methods coupled with omics technology. Due to their 
role as the initiators of Chinese medicine and systems biology research and the fact 
that they aimed to change approaches in medicine and healthcare, I call these actors 
the inner circle.  
When I introduce each actor, I will first give a brief description of the actor, I will then 
offer some data from the interviews on the involvement of actors in Chinese medicine 
and in systems biology and I will end by showing the involvement of actors in Chinese 
medicine and systems biology research. At the end of this chapter, I will conclude with 
the characteristics of their involvement. Due to ethical requirements, all names in these 
case studies are pseudonyms that correlate to the position of the actor, i.e., Professor.  
  
                                               
 
23 Chaos Theory is a “the qualitative study of unstable aperiodic behavior in deterministic nonlinear 




5.1 INVOLVEMENT THROUGH TECHNOLOGICAL AND A HEALTH 
PROBLEM  
 
Prof Frank is a systems biologist who works with biotechnology and omics technology 
in a pharmaceutical institute and his own systems biology company in the Netherlands. 
He demonstrates an involvement first in systems biology through his technological 
keenness and in Chinese medicine through a disease that could not be treated with 
biomedicine. His involvement in Chinese medicine is connected with his interest to 
bridge the gap between unrelated disciplines or technologies and to investigate human 
and nature as interconnected. For him, systems biology is not only a bridge, but also a 
tool to investigate systems, which are central to Chinese medicine, but which are 
missing in Western medicine.  
The first involvement of Prof Frank was in systems biology research, which started 
with his research on mass spectrometry and the measurements of molecules involved 
in biological pathways. His research contributed to the development of the main 
technique used to analyse biofluids in Chinese medicine studies. However, in the 
1980s, when he conducted experiments for his PhD, the problem with the available 
techniques, as defined by Prof Frank, was that he could only analyse a small number 
of unknown properties or chemical components to match them with a small number of 
samples. The process was slow and inappropriate for the identification of big data sets. 
His idea was to overcome this bottleneck with the new method of biofluid profiling 
and pattern recognition. For this, he used multiple technologies such as the PDP-8 
minicomputer as an electric control unit, specific software for the analysis, electronics 
for emission control and an ion formation for the mass spectrometry and 
chromatography. With the connection of these technologies, he measured atom masses 
through ionisation and analysed them with statistical, mathematical and computational 
methods. The combination of these technologies accelerated the analysis process from 
a few hundred to 1000 samples a day, and enabled lower weight molecular compounds 
to be measured in blood serum, urine, saliva and semen. Together with statistical tools 
for drug administration he corrected individual differences by profiling metabolomics. 




variables in his study to gain a pattern of the variables for further examination as 
needed for Chinese medicine drugs studies. 
Prof Frank’s change is owing to a conceptual shift in biology. Prof Frank demonstrates 
this shift by using computer software to analyse and illustrate the data and measuring 
technologies, and by debating his undertaking with his colleagues and supervisors who 
were against his technological experiment. Prof Frank defended his standpoint as a 
systems theorist by applying a complex and systems approach and multiple techniques 
and mathematical tools. Former systems theorists (e.g., van Bertalanffy) criticised as 
they believed they reduced its biological complexity (Green and Wolkenhauer, 2013). 
At the time of this experiment, systems biology was an unknown concept or discipline, 
however, according to the description of Green and Wolkenhauer (2013), the 
integration of mathematics and systems theory to describe biological phenomena was 
already the shift from biology to systems biology. This results from their interpretation 
that systems theory is the precursor of computational modelling of quantitative 
transformations. According to their definition, Prof Frank is a forerunner of today’s 
systems biology practice.  
Prof Frank does not view the development of omics as an invention. He argues that 
the technology and the methods he and other scientists used in the 1980s were the same 
as those used during the later renamed omics techniques or technologies in the 2000s. 
The use of several techniques, i.e., genomics, proteomics, transcriptomics, were 
holistic and built the new field of systems biology (see Chapter 4 for more information 
on systems biology) as he explains: 
“… the profiling of blood and looking at many things, looking at patterns, 
already started in 1980, but the names were not there, like metabolomics, became 
a word because everybody wanted to say a word with omics for something, so 
this is just trendy. So certainly, protein analysis became proteomics, and then 
people say okay metabolite analysis must become something, so they said now 
it is metabolomics or metanomics, or people start to invent new names, basically 
because people want to have new names so they can claim something, a new 
word.” (Prof Frank, 2015, Leiden) 
Despite Prof Frank’s opinion on the use of the name omics technology, his colleagues 
were against his first experiment which aimed to prove his hypothesis using a 
multivariant analysis, which utilised multiple technologies. His colleagues objected to 




he would deliver more unknown variables that could not be related to adequate objects. 
As a result, it would not be considered sound science. Nevertheless, the doubts of Prof 
Frank’s colleagues did not stop him from undertaking an unsupervised blind study of 
ten urine samples from female and male co-workers. In doing this experiment, he 
proved his hypothesis to his colleagues and gained their support and to publish his 
results. Without knowing which metabolite would express the gender, he discovered 
that in some samples the steroid levels were higher than in others. Thus, he concluded 
that those were male urine samples. With this method, he confirmed the obvious that 
more variables meant more information about the sample and allowed him to see a 
pattern that determines biomarkers for the prediction of diseases. Later, based on the 
evidence for his urine identification method, Prof Frank started his biofluid 
metabolomic analysis. His vision was to establish a personalised medicine with the 
insights gained from biofluid examination of Chinese medicine diagnosed and treated 
patients. 
The connection for Prof Frank between systems biology and Chinese medicine is that 
they both acknowledge the idea of holism. First, the dominating reductionist paradigm 
restricted Prof Frank to use holism in the context of systems biology and Western 
science. Due to the development to reductionism in science in the last century, holism 
has become negatively associated with Nazism, apartheid and with the counterculture 
movement. As shown in Chapter 4, most scientists relate holism to non-science or 
CAM. Consequently, Prof Frank could not use the term “holism” in biological and 
pharmaceutical studies. Western scientists and doctors were ignorant to inform 
themselves about Chinese medicine or the meridian theory because according to Prof 
Frank they did not fit into the box of Western science and medicine. As he says: 
“I think systems biology existed already for a long time because that’s a holistic 
view on life, but at this point in 2000... nobody wanted to use the word holistic 
although I think it is a better word, but it is not accepted in the scientific world. 
If you use it, then you are a complementary, alternative, or a crazy type. So, if 
you choose that word, you cannot use it. It still has a similar effect on Chinese 
medicine. Some Western doctors are interested in Chinese medicine and others 
think that it cannot be true. And if you ask them, why it cannot be true, they say, 
well because, in theory, it doesn’t fit to anything, it is just ridiculous. Then you 
ask: Have you ever read any manuscript? They reply never. So how do you place 
your opinion on that? Yeah, I am talking about strange meridians that don’t exist. 
They don’t understand the difference between concepts or physical items, or they 




One of the ways to translate Chinese medicine into Western science was facilitated by 
the Human Genome Project (HGP) project. From Prof Frank viewpoint, this project is 
an excellent example of the domination of reductionism. He argues against focusing 
on DNA sequencing in the hope to find out what is life what he calls the “mystery of 
life”. Biologists, cyberneticists and systems biologists widely discuss the question of 
what is life. For instance, Noble criticised the HGP as a failure in answering this 
question (see Chapter 4 and Noble, 2010). Instead of searching for the answer in genes, 
Prof Frank refers to nature, systems theory and an ecological viewpoint that increased 
his interest in other perspectives of life.  
“Then the Human Genome Project (HGP) came. The HGP people believed that 
if we know the sequence of DNA, we have solved the mysteries of life. That was 
how it started. For me, it was very strange. We used this in our presentation often, 
if you have a caterpillar it starts to eat and eat, and then it becomes a butterfly, 
but the gene sequences are still the same, so there is much more to this than just 
the gene sequence. You have to look at it from a more holistic perspective a more 
systems perspective. Then, I also started to become interested in other 
philosophies as to look at it from a systems perspective.” (Prof Frank, 2015, 
Leiden) 
Prof Frank refers to the “ecological” viewpoint of the physicist and populariser of 
systems science Fritjof Capra and his book The Tao of Physics (1975), whom I have 
introduced in Chapter 4 as one of the key actors in making holism interesting to a new 
generation of scientists. In his book, Capra argues that physics and the “unity of all 
things” (a Chinese Daoism concept) agree in the idea that all things in the universe are 
interconnected and there are no fundamental parts in it, which Capra calls the 
“ecological worldview” (Capra, 1975, p. 291). Prof Frank underlines this ecological 
worldview by saying that he looks for relationships in patterns of nature, which 
indicates that nature and life cannot be deducted from a DNA sequence. In his words: 
“I was doing analytical research and trying to understand systems since the 
1980... and I was very much into nature, I like to study nature. When I see nature 
from an ecological perspective, I look at connections and patterns of 
relationships. That is how I look at nature. That’s why I try to understand why 
nature is doing things as it does because after all everything is linked together. 
So, from that perspective, I stepped more and more out of reductionist 
framework.” (Prof Frank, 2015, Leiden) 
To overcome the reductionist limitations and the genomic hype of the 2000s, Prof 
Frank and some other researchers founded a systems biology company. They aimed to 




studies by focussing on systems theory and using a holistic approach. However, the 
mind of funders and researchers was not open to holistic studies or Chinese medicine 
research, as the focus was on biotechnological research and genomics, which I have 
shown in Chapter 4. In Prof Frank’s case, this was evidenced by showing the difference 
in the funding budget between his company which had five million dollars and Leroy 
Hood’s Systems biology Institute which was funded by Bill Gates with one hundred 
million dollars. In contrast to Prof Frank, Hood followed the genomics research trend 
focusing on functional genomics, which might have influenced the higher funding than 
Prof Frank obtained.  
Strong genomic and reductionistic interest also prevented Prof Frank from conducting 
holistic and Chinese medicine studies. Hence, he decided to divide his research 
interests into conducting profitable pharmaceutical research with his company, and 
Chinese medicine studies at his second research institution. Prof Frank argues that the 
research interests and funding for drugs and drugs modification studies increased. 
Wiechers, Perin, and Cook-Deegan (2013) confirm that this was an unintended side 
effect of the HGP, which was designed as an intergovernmental public funded project. 
They found that besides the public funding twice as much money was sponsored by 
private firms in genomics research and development (R&D). This also related to the 
expansion to DNA patent rights by 2000. Thus, biotechnology and genetic research 
developed to a business for private R&D and academic research market (ibid). 
Academics and governmental research institutions recognised this market and 
increased their research activities in pharmaceutical studies. As a result, Prof Frank 
supported financially his company with pharmaceutical studies and in his second 
workplace, in the food and nutrition department, he conducted holistic and Chinese 
medicine research. Prof Frank claims that:  
“When we started a company in 2000, nobody wanted to do anything else than 
to work for the Western pharmaceutical industry because that was where the 
money was. So, we had to make a contract with the other institution at a point in 
time. The investors and I said, well, because I was on both sides, the most logical 
was that only the pharmaceutical applications of our knowledge went into the 
company. That’s how we were rewarded, but everything else related to food and 





The above-mentioned paragraph talks about Prof Frank’s second involvement in 
Chinese medicine research. Before, this project he came into contract with Chinese 
medicine because of a health problem. 24  He underwent a treatment in Chinese 
medicine as biomedical doctors could not treat him. During his treatment, he learned 
about Chinese medicine, in particular, the idea of the interrelationship between humans 
and nature, which resonated with his ecological worldview. Moreover, Prof Frank 
experienced for the first time in his life, since he had suffered from the disease, that a 
doctor addressed his strengths and not his weaknesses. The optimism of the 
practitioner towards Prof Frank’s condition and his strength despite his disease was a 
unique whole body and mind experience. This experience confirmed Prof Frank’s 
perception of Chinese medicine as an integrated body and mind medicine. In addition, 
the positive attitude of the practitioner influenced Prof Frank’s thinking to accept his 
condition and to work on his whole body and not only on the diseased parts. Hence, 
against the prediction of biomedical doctors, Prof Frank did not die or become disabled 
because Chinese medicine aided his recovery. His experience with Chinese medicine 
demonstrated the capacity of Chinese medicine to him and sparked his interest to learn 
more about it. As a result, he scientifically studied the efficacy of Chinese medicine, 
which he had perceived as a higher-level understanding of systems view and holistic 
view, with technologies (mass spectrometry and gas chromatography), which he had 
been using since the 1980s.  
In the 2000s, Prof Frank started his research on Chinese medicine and confirmed his 
first observation that Chinese medicine thinking corresponded to his ecological 
worldview. In addition to his previous perception of the Chinese medicine human and 
nature relationship, Prof Frank interpreted the ecological worldview of Chinese 
medicine by stating that everything alive has a rhythm even diseases and ailments. He 
claims that Chinese medicine had used this perspective for a long time while in 
Western medicine it had not yet been addressed. 
  
                                               
 




“I was really interested in Chinese medicine because it has rhythm; it has 
symptom relationship; it has a holistic view of not only a person living within an 
environment and a certain climate. So, the person relates to the universe. That is 
what you see in Chinese medicine. That is why I was interested and it. So, if you 
look at your own diseases or ailments, you see there is always a rhythm in it 
because all life has rhythm. So, Western medicine has almost no clue about 
rhythm, so it always measures one-time-point.” (Prof Frank, 2015, Leiden) 
Prof Frank’s interest in Chinese medicine extended from a private interest to a 
professional reorientation. However, he found it difficult to cross the border between 
biomedicine and Chinese medicine, as it was a change between two professional 
worlds and from reductionism to holism. Although Prof Frank described himself as an 
audacious man with much experience in science and publications, he did not publish 
anything about Chinese medicine in a biomedical field until the 2000s. His first 
publication demanded much courage, as scientists in his field were depreciative 
towards Chinese medicine, in particular in a biomedical institution. This refers to the 
connotation that Chinese medicine is something alien or is a pseudoscience, in the 
sense that it is clearly not biomedicine, and not acknowledged as its equal to be studied 
at a biomedical institution. This is evinced by research on the integration of East Asian 
medicines in contemporary healthcare systems that document a power imbalance 
between biomedicine and other medicines in clinics and research (Cassidy, 2013). 
Consequently, Prof Frank decided to show the relationship between Western methods 
and concepts and Chinese medicine with the use of Western measurements:  
“We first had to collect the courage to publish. That is also something I need to 
explain because you cannot publish things in a Western world without much 
aggression against what you publish because Chinese medicine is not accepted 
in Holland as such and I am here also in a faculty with a lot of medical people. 
So, they are not in favour of this. The steps we took were that we do Western 
measurements and all time we show their Western and Chinese concepts, which 
are telling or guiding us to do new things.” (Prof Frank, 2015, Leiden) 
According to Prof Frank, a problem that frequently arises for those trying to understand 
Chinese medicine is that people cannot connect Chinese medicine to something they 
know, or they can benefit from it. Thus, he suggests the prediction of a disease can be 
made through the pattern recognition in Chinese medicine diagnosis and the 
technological support of metabolomic profiling and biomarkers, that signify certain 
conditions and biochemical processes. By using these techniques, Prof Frank believed 




scientists in their scientific language. The bridge between Chinese medicine and 
Western measurements, as he clearly states, is biochemistry that allows the prediction 
of a condition. Thus, it offers scientists a new interpretation technique of biomarkers 
and a biochemical translation of Chinese medicine, which could resolve the ignorance 
of scientists and their bias against Chinese medicine as an alien system. Prof Frank 
hoped that it would help them change their attitude to this medicine and become aware 
of the insights that can be gained through the different perspectives of this medicine. 
As Prof Frank argues:  
“People don’t want to read about the meridian theory because it is too far out. If 
they see that biochemistry fits with meridian theory, they say that’s strange and 
if you say but look, we can even predict what you don’t know and can test it... 
That’s how we did our research. Like, you have patients with the same disease, 
Chinese doctors say there are two groups, then we measure those two groups and 
we figure out what the biochemistry behind the disease is. Then we have the 
bridge... [and when they ask] why haven’t we found it? That’s very simple 
because you have never looked at it from this perspective.” (Prof Frank, 2015, 
Leiden) 
Prof Frank’s professional involvement in Chinese medicine was also influenced by Dr 
Huang, who is his partner and a Chinese medicine researcher and molecular biologist, 
whom I will introduce below. She played an essential role in Prof Frank’s involvement 
in Chinese medicine research as she proposed a co-operative research project to study 
Chinese medicine. Prof Frank’s description of Dr Huang’s role in this co-operation 
denotes the function of a gatekeeper, as someone who gained access to key people in 
China, such as the vice president of the Chinese Academy of Science (the function of 
a gatekeeper and a list of gatekeepers can be found in Table 3). According to him, 
the vice president shared her ideas of systems biology as a tool to measure Chinese 
medicine and to bridge Chinese medicine with biomedicine. Thus, the vice president 
supported Prof Frank and Dr Huang by connecting them to Chinese collaborators who 
in fact helped them realise their project on the investigation of Chinese medicine 
diagnosis with systems biology. 
Prof Frank’s involvement in Chinese medicine research was in his words something 
good that happened to him, to quote him: “That’s how the universe made it happened”. 
Several events happened in his life that led to his study of Chinese medicine. These 
events were connected with the development of technology to study systems and his 




(see Chapter 4) as well as his interest in Chinese medicine as the source of knowledge 
and the meeting with Dr Huang.  
 
5.1.1 REFLECTIONS ON THE TECHNOLOGICAL AND HEALTH PROBLEM 
INVOLVEMENT  
 
Prof Frank’s involvement takes more space in this chapter as it establishes the type of 
involvement for the actors in this chapter, the inner circle of the research on Chinese 
medicine and systems biology. Prof Frank’s involvement demonstrates his interest in 
bridging technology and medical systems, his personal therapeutic experience with 
Chinese medicine and his risk of losing his reputation as a scientist. Prof Frank used 
the notion bridge as a rhetorical device and as a technological tool. On a rhetoric level, 
Prof Frank uses the term “bridge” to define his function in connecting various 
technologies, as well as bridging systems biology and Chinese medicine with systems 
thinking and holism. He understands that life and nature are complex, and he 
discovered that Chinese medicine was a medical system that shared both his 
perceptions and his ecological worldview. The Chinese medicine worldview 
recognises life as rhythm, as holistic and complex. Prof Frank experienced this having 
undergone a Chinese medicine treatment after a fatal biomedical diagnosis. This 
experience urged Prof Frank to regain the control over his body after the recovery of 
this disease. Thus, Chinese medicine led him to realise the limitation of biomedicine 
and science and consequently, he reconsidered his scientific approach to health and 
diseases. Prof Frank’s notion of “bridge” also includes the interpretation that he 
bridged his experience with his professional life by engaging with Chinese medicine 
research.  
The second definition of the term “bridge”, which Prof Frank describes, is with regards 
to the use of technology in systems biology which translates Chinese medicine into 
Western science. His first involvement in systems biology equipped him with the 
technology and methods needed for the study of complex systems and for establishing 
connections between technologies, scientific fields (i.e., biology and chemistry, 
computation, mathematics) and Chinese medicine and its tenets. Through the use of 




and was able to translate Chinese medicine concepts with Western measurements into 
biochemistry. With this translation, he drew the attention of Western scientists to his 
research and gained their favour by applying this technique to the investigation of 
individual diagnosis in Chinese medicine to calculate and predict diseases with 
systems biology. Thus, Prof Frank’s endeavours and his capacity to act in this way 
were attached to and emerged from his previous interactions with omics techniques 
and systems theory.  
Prof Frank’s involvement in systems biology and Chinese medicine research contained 
risks of failures. These risks were apparent in his experiment on several technologies 
for the analysis of an unknown substance, i.e., the identification of the gender in urine 
samples. As well as the challenge he faced when engaging with a pseudoscientific 
medicine without losing his reputation as a scientist. In his involvement with systems 
biology, he controlled multiple variables in this experiment which depended on his 
ability to interpret the capacity of multiple technologies that he joined together with 
the data he collected. In later studies on big data set, theories and philosophy, he 
achieved with this method a successful study in Chinese medicine diagnosis with 
metabolomics. However, there was no guarantee that biomedical and Chinese 
medicine scientists would accept his approach. With systems biology and technology, 
he bypassed the debates surrounding Chinese medicine as scientific and holistic 
through his translation of Chinese medicine into big data and his analysis of multiple 
compounds in Chinese medicine. Consequently, Prof Frank performed an involvement 
that was not dominated by his need to publish or improve his scientific ranking, but 
because he felt the need to personalise medicine. Zhang and Wang (2017) found that 
Chinese researchers suffer from the pressure to publish, which impacts their research 
performance. This pressure was not seen in Prof Frank’s involvement. In contrast, he 
and Dr Huang had to collect their courage to publish the first research article on 
systems biology and Chinese medicine.  
In the early 2000s, funding and research interest was not open for holism and Chinese 
medicine studies, consequently, Prof Frank and Dr Huang had to consider their 
publication. The debates on holism and Chinese medicine research in his company and 
the lack of funding for genomics, demonstrated the narrow research support. Due to 




his scientific community was challenging. This also happened at a time when 
molecular biology was integrated as a fundamental method in biology (see Chapter 4). 
Likewise, Lei (2014) argues that in the early twentieth century, “practitioners of 
Western medicine were simply unable to trust Chinese medicine drugs unless they had 
successfully been ‘translated’ into the socio-technical network of biomedicine” (2014, 
p. 201). Thus, Lei indicates a similar tension to today’s situation between Chinese 
medicine, biomedicine and science as they do not receive a non-biomedicine system 
openly, but rather see it as a pseudoscientific medicine. From Lei’s example, it is 
evident that an attempt was made to align Chinese medicine research to Western 
science which was then pursued throughout the twentieth century. The main difference 
between the 1920s and the 2000s is that Western scientists are involved in producing 
evidence for the translation of Chinese medicine into a Western scientific context.  
The next code presents an involvement from Chinese medicine to Western science and 




5.2 INVOLVEMENT THROUGH COMPLEXITY 
 
Kevin’s involvement in Chinese medicine and systems biology was inspired by 
“complexity” (this is connected to the Chinese philosophy of Daoism). Kevin is a 
Chinese medicine practitioner, biochemist and AI scientist who is keen on Chaos 
Theory. Kevin’s involvement in Chinese medicine research and systems biology 
started with his interest to find a Western scientific field that embraces complexity 
similar to the Daoist representation. In doing so, his involvement presents a detour 
from Daoism, Western science, Daoist implementations in Chinese medicine to 
systems biology study that led him the connection between complexity represented as 
qi and systems biology through dynamic self-organising systems.  
Kevin’s first contact with Chinese medicine happened at the age of 11 through stories 
about Daoism and qi. These stories were told to him by his neighbour and a Chinese 
restaurant owner Mr La25. Informed by those stories and some knowledge of Chinese 
medicine, he became interested in Daoism and the consciousness as both have been, 
and still are, examples of complexity for him. Following this, Kevin then studied 
biochemistry, but he questioned the reductionist method and its capability to study the 
complexity neurons and neurotransmitter, but not the complexity of the consciousness. 
Interestingly, he did, however, think that Western science simplified and reduced 
complex matters, which in the end did not reflect reality as a complex phenomenon. It 
was evident that he distanced himself from the counterculture movement, i.e., the 
Hippies, on the West coast of the United States as complexity is often associated with 
holism and this movement. In Section 4.4.3, I elaborated on the connection between 
complexity as a holist approach and the counterculture movement. Kevin explicitly 
avoided a connection to this movement as he claims that Western science and scientific 
aspirations grasp complexity only with Chaos theory.  
 
                                               
 




Due to the reduction of complex issues in biochemistry, Kevin decided to study 
mathematics and Chaos Theory and he found out that they were the closest to the 
complexity of Daoism. Following on from this, he realised that to understand complex 
thinking, he needed to study Daoism and Chinese medicine. For this, he attended 
several acupuncture classes and moved to China to study Chinese medicine from 1985 
to 1990. He believed by studying Chinese medicine, he would experience the central 
aspect in Daoism, the qi and the dao 道 . Then, with a deeper practical-based 
understanding of qi and dao, he could bring together the two ways of thinking systems 
science and Chinese Daoism. He utters:  
“The dynamic self-organisation of nature is similar to the stories of Chinese 
Daoist philosophy, so I thought I have to do this course. So, I did a course in 
acupuncture then I went to China for a small course, three months on Chinese 
philosophy. And in Chinese philosophy, they said you have to do Daoist 
philosophy. I had to choose between martial arts or Chinese medicine to learn 
Daoist philosophy and to experience it and not to study it from the book. You 
cannot read Laozi, or Zhuangzi in the way you read Socrates, Plato, or Nietzsche, 
and you have to experience qi and the rhythm of dao. So, I thought Chinese 
medicine is maybe the thing which is closest to my biochemistry. So, this is why 
I choose Chinese medicine, and actually, I stayed there for four years to study 
Chinese medicine.” (Kevin, 2015, Zeist) 
At the end of his studies, Kevin wanted to continue with his research on complexity. 
He believed that Chinese medicine with its holistic approach was the ideal field to do 
so. However, the studies of Chinese medicine in China employed a Western medicine 
framework. Kevin found it distracting and misleading that Chinese medicine 
researchers at his university did not want to investigate Chinese medicine based on its 
own conceptual framework of qi and the interconnection with the human body. In 
contrast, he felt that they were only interested in modern science, and they radically 
evaluated the theories and practices of their medicine with Western scientific methods 
to make it appropriate for biomedicine. He claims their approach “violates” Chinese 
medicine, as they apply more and more Western science into the teaching and research 
practice of Chinese medicine. As an explanation for this radical approach, he believes 
that this approach was caused by the transition from Chinese medicine to TCM, which 
the CCP and Chinese medicine researchers created during the integration and 
standardisation phase. However, in Chapter 2, I showed that the transformations of 
Chinese medicine were not only caused by something they were effects of the political 




scholars. I demonstrated this with the example of acupuncture neuropathology and 
anatomy and in Chapter 4 and the explanation of qi, yin/yang or wuxing with dialectic 
materialism and cybernetics. Kevin explains this with the metaphor of a ball being 
squeezed into a cube:  
“Western research is like a cube, and everything I do as a researcher within the 
cube is science but at the moment I walk out of the cube it is not science anymore. 
So, now I have this rubber ball, which is Chinese medicine, and I have to prove 
to the world that this ball is a ball by showing it can roll and it can bounce, but I 
have a cube, so I take this rubber ball and press it, squeeze it into my cube. 
Because it is a rubber ball it fits in but by fitting it in it takes it out of shape now, 
it cannot bounce anymore, and it cannot roll, so I prove that this ball is not a ball, 
and this is continually happening when we start researching Chinese medicine 
with the Western methodology.” (Kevin, 2015, Zeist) 
When Kevin realised that the shift to modern medicine had taken place, he tried to find 
answers from practitioners in the countryside. This happened after he finished his 
Chinese medicine studies and he was confronted with the fact that Chinese medicine 
researchers were not interested in questions concerning the complexity of the qi and 
its pathway of meridians. In contrast, the practitioners in the countryside were not 
referring to Western science, physiology and pathology, which pleased him. The 
practitioners and their energetic pictures disclosed to Kevin that qi is the overall 
concept that explains the whole human body and the system of acupuncture. It shocked 
him that his teachers at the university taught him a concept of meridians that 
practitioners in the countryside told him did not exist. When he shared his discovery 
with his teacher at the university, the teacher was unimpressed and claimed to have 
known that. Kevin had to accept that the concept of meridians is unnecessary as qi is 
everywhere in the body and does not need a passageway to move in the body. This 
explanation of qi activated a reconsideration of the theory of meridians for Kevin: 
“And he said you have to see it as a concept and then I started to think that 
channels are the lines on which an organism organises itself around. An 
acupuncture point is an attractor on which tissues and functions are arranging 
themselves in relationship to other parts of the body, which have their own 
attractors, and so you get a very complicated picture. And then I saw that 
acupoints and channels are actually the connection between skin, muscle, bones, 
nerves and the physiological system, all the things we separated from each other, 
the meridians are the connections between them all. So, I was convinced that we 
can cut up as much as we want but we will never find channels. In that way, 
because everything is a channel, everything is qi, because it is all about 




Once Kevin understood that qi was complex, and it was not restricted to or followed 
channels in the body, he returned to Western science. Kevin realised that qi is 
everywhere and does not need channels. Following that he started to relate qi to 
Western science, even though he first criticised Chinese medicine researchers for their 
eagerness to practice Western science. Kevin related qi and the acupuncture point 
theory to systems thinking. This evoked his understanding of the human body and its 
cells as a dynamic self-organising system, which was grounded in systems thinking 
and directed him to systems biology. Hence, systems thinking was a bridge between 
complexity and systems biology.  
The idea of dynamic self-organising systems connected Kevin and Prof Frank. In the 
early 2000s, Prof Frank and Kevin met at a conference where they presented their ideas 
on living organisms as dynamic self-organising systems and systems biology. Their 
shared idea of systems facilitated a research co-operation between them. According to 
Kevin, the idea of dynamic self-organising systems derived from von Bertalanffy’s 
systems theory. Von Bertalanffy (1968) claims that cybernetics is the theory that 
controls and regulates, as it is based on information and feedback theory that show that 
systems are self-regulating. Originally Ashby (1958) formulated the theory of dynamic 
systems which von Bertalanffy employed. In Ashby view, “dynamic” describes the 
changes in correlation between the high and the low surroundings state of a system. 
Hence, a self-organising system is a system that evolves from a lower to a higher 
complexity by progressively differentiating between the states of the organisation. 
Based on this theory, Prof Frank stresses the relationship and interaction between 
different levels and the dualities within an object. While Kevin refers to the opposite 
inside an object, which are changing the states of their organisation. For example, the 
day is yang which changes at dusk into the night, which is yin. The number of 
relationships between the cells organised on a cell level, tissue level and organ level 
in the human body represents the complexity of the cell organisation in his comparison 
of dynamic self-organising systems. Kevin sums up his theoretical exploration by 
arguing that Chinese medicine research needs systems thinking approach:  
“So, we need to find another way of understanding this whole system of 
components to develop multi-target pharmacology, which can approach complex 
and chronic diseases as we are encountering it now in our time. So, this is why 




Systems thinking approach accomplishes his idea of complexity in Chinese medicine 
and in the methods used to investigate it, namely systems biology. Systems biology 
and dynamic self-organising systems theory are grounded in systems thinking and they 
embrace complexity. Hence, Kevin views research between Chinese medicine and 
systems biology as being technical, philosophically and culturally attractive and links 
it to Daoism as an integral part of Chinese medicine. 
 
5.2.1 REFLECTIONS ON THE INVOLVEMENT THROUGH COMPLEXITY 
 
In Prof Frank’s involvement, we saw an expected way of experiencing Chinese 
medicine and its effects first hand and, how he became curious and interested in 
studying it. Unlike Prof Frank, health issues or technology did not spark Kevin’s 
involvement, but the desire to learn about complex thinking, which he could not find 
in bioscience. Prof Frank focused on biochemistry and changed very late in his career 
to actively research Chinese medicine. Kevin, however, took a detour as he was 
involved in Western science and Chinese medicine but his interest in complexity, 
drove him to research systems biology and Chinese medicine. Another contrast with 
Prof Frank, is that Kevin does neither view himself as a bridge builder nor does he use 
the notion of “bridge” to describe his involvement in Chinese medicine or systems 
biology. The use of systems thinking in systems biology and the dynamic self-
organising system appears as a bridge which inevitably links Kevin’s approach to Prof 
Frank’s systems biology.  
Kevin’s interest in complexity not only triggered his involvement, but it also controlled 
his involvement in Chinese medicine and systems biology. Law and Mol (2002) 
describe complexity as a matter, multiple realities, an interest of researchers or a status. 
He presented an organic but cyclical progress from the question of complexity to his 
professional status as a Chinese medicine practitioner. During this process, he changed 
from Western science to Chinese medicine and then he explained the Chinese medicine 
concept of qi with a systems theory. Complexity is a crucial topic for him, and this 
guided him from Daoism to biochemistry and mathematics. What is more, his 
involvement represents a process from his understanding of complexity in Daoism and 




refined complexity in Daoism into the two concepts qi and dao. Only by gaining this 
experience, he was convinced that he would understand complexity. In Chapter 2, I 
mentioned that jingyan 经验 has two meanings of either the experience as in 
prescribing drugs or the experience in the practice of Chinese medicine (see Lei, 2014; 
Farquhar, 1994). Thus, jingyan can define both experience and practice. Following on 
from his experience with Chinese medicine, Kevin understood that the matter of qi 
was the representation of complexity and to study its movements he returned to 
Western science, in particular, to systems biology. Thus, qi, as well as complexity, are 
the centre of his involvement and which controlled his development from childhood 
until now. This interpretation directed him into another involvement, namely his 





5.3 FAMILY AND THE EXPLOITATION OF CHINESE MEDICINE 
INVOLVEMENT  
 
Dr Huang demonstrates her involvement through family and exploitation concerns. 
She is a molecular plant biologist who studied molecular biology for her undergraduate 
degree in Beijing at a TCM university and specialised in herbal plant biology. Dr 
Huang and Prof Frank were co-operation partners in their first Chinese medicine and 
systems biology study. For Dr Huang, the study of Chinese medicine appears as a 
realisation of the profession of her family and a way to protect Chinese medicine from 
exploitation.  
Dr Huang’s involvement in Chinese medicine started with her grandfather who was a 
Chinese medicine practitioner and introduced her to his profession. Her interest, 
however, was more in the scientific evidence production of Chinese medicine herbal 
drugs. This rhetoric is similar to the CCP’s policies of scientificising and the increasing 
production of Chinese medicine propriety medicines, which are Chinese herbal drugs 
that were transformed into biomedical drugs. A discussion on this can be found in 
Chapter 2 on the globalisation phase and Deng Xiaoping’s economic reforms during 
the 1980s and 1990s (see also Hsu, 2008, 2009). Concurrently, in China, a new 
infrastructure was introduced. This included Chinese medicine pharmaceutical 
research at Chinese universities and at Chinese medicine pharmaceutical industries 
together with new research on active compounds to produce Chinese propriety 
medicine and exchange program with other countries (see, for example, Hsu, 2009; 
Evans, 1997). In this context, her decision to study Chinese medicine pharmaceuticals 
rather than Chinese medicine might have been informed by these policies and 
emerging job opportunities for Chinese students at home and abroad. The new 
exchange agreements aided Dr Huang in particular to gain a scholarship from China 
for her cell biology and genetics doctoral study in the Netherlands. She describes the 
structure of the scholarship as an intergovernmental exchange agreement between 
China and the Netherlands. A report on fifteen years of co-operation between the 
Netherlands and China shows that an exchange agreement was signed in the early 




Dr Huang’s involvement in active Chinese medicine research started after she 
achieved a high-level position in her field. Her career took a conventional career route 
in academia as she started as an assistant professor at the University and as a research 
leader in a governmental research centre. In the research centre, she headed a division 
for plant biotechnology and with a small group she started to investigate the 
therapeutic effect of Chinese plant metabolites. She explains this change through her 
work in food, nutrition and plants that directed her to study Chinese medicine in the 
1990s. Once she had performed research on Chinese medicine plants, such as the 
harvesting time differences on a Chinese medicine plant ginkgo biloba she started co-
operation with pharmaceutical research centres.  
In her research centre and that of her collaborators, Dr Huang had the technological 
equipment for genetics, proteomics, and metabolomics studies. This technology is 
what she describes as the “newer technology”, and which became widely available 
after the international HGP and the growth of biotechnology (see Chapter 4; see also 
Wiechers, Perin, and Cook-Deegan, 2013; Chee and Clancey, 2013). This technology 
facilitated Dr Huang to conduct her research in Chinese herbal medicine, as well as 
her research team to study plant metabolites. When she discovered that her colleague, 
Prof Frank, used omics technology and was interested in Chinese medicine, she 
approached him to discuss a co-operation on Chinese medicine with systems biology 
research. Prof Frank agreed to the collaboration:  
“In 2000, I met Prof Frank, and I told him that I was interested in working on the 
traditional Chinese medicine. Moreover, at that time he was also interested in it 
and then we started within the research centre an internal project on the Chinese 
medicine and the biological effects with a successful result. It demonstrated that 
all animal models that worked for Western medicine have for sure the same 
therapeutic effect as Chinese herbal medicine and Chinese herbal medicine 
worked even better with fewer side effects.” (Dr Huang, 2015, Leiden) 
For Dr Huang, Chinese medicine and systems biology were a perfect match, as they 
both used systems thinking. Hence, she views systems biology as an equal partner for 
the holistic studies of Chinese medicine. However, in this combination, Dr Huang first 
expects that systems biology will prevent the repetition of past exploitation of Chinese 
medicine in the 1990s in the course of the commercialisation of Chinese medicine. 
Secondly, she mentions that Chinese medicine and its concepts are used to understand 




biologists in their research and to aid them understand what life is and to discover how 
to diagnose better and treat diseases. Dr Huang’s collaborative work with Prof Frank 
focussed on these issues. As more and more systems biologists adopt the viewpoint of 
Chinese medicine and she assumes that this change will stop the exploitation. Hence, 
she views the research interest in systems biology and Chinese medicine as a positive 
change.  
“Some of them have quite good interactions between Chinese medicine and 
systems biology, and others just use Western technology with the hope to get the 
target. Then you have different peoples who interact with Chinese medicine. 
Some of them think Chinese medicine concepts can guide some to understand 
the biology. Others are trying to get the component of Chinese medicine and use 
Chinese medicine as a sort of pool to fish out what they want. Both of them are 
quite interesting; both of them can get the results they want.” (Dr Huang, 2015, 
Leiden) 
In her view, it is important for researchers of Chinese medicine to deal with the 
complexity of multiple compounds in one fufang or individual prescriptions and other 
influences, e.g., differences in harvesting condition, preparations, storage and 
decoction of Chinese medicine drugs. Thus, systems biology with the use of omics 
technology equips her and other researchers, with a holistic approach to study 
changing life cycles (i.e., the effect of environmental conditions and cycles) of Chinese 
medicinal plants and the effect of the fufang in the human body. However, Chinese 
medicine should, in her view, not be used as a kind of pool where pharmacologists can 
fish out what they want. This problem was noted by many traditional medicine 
researchers over the past decades (see for example, Adams, Dhondup and Phuoc, 2010; 
van der Valk, 2017; Baer, Singer and Susse, 2003). This concern drove her to 
participate in further research projects on Chinese medicine drug safety, research 
practice and drug regulation and control, as we will see in more detail in Chapter 7. 
She hopes that a shared ground in complexity and systems thinking between systems 
biology and Chinese medicine will stop or prevent the further exploitation of Chinese 
propriety medicine commercialisation as was witnessed in the 1990s. As a result, she 
argues that a holistic investigation needs to respect Chinese medicine as a system, and 
not as a new drug development source. In this point, Dr Huang acknowledges that 





5.3.1 REFLECTIONS ON THE FAMILY AND THE EXPLOITATION OF CHINESE 
MEDICINE INVOLVEMENT  
 
Dr Huang’s involvement in systems biology appears as an organic development as she 
has already used omics technology in her plant research projects. Systems biology was 
neither a technological nor a conceptual bridge for Dr Huang as she thinks of both 
fields are the same. Her perception that both are the same derives from the integration 
of systems thinking in the Chinese medicine theoretical and educational system in the 
1980s and 1990s (see Hsu, 1999). When she studied at the Chinese medicine university, 
she learned those theories as an integral part of Chinese medicine, thus, her education 
in molecular biology, systems thinking, and Chinese medicine make it easy for her to 
draw connections between systems biology and Chinese medicine and to view them 
both as the same. Nonetheless, technology was a bridge between Chinese medicine 
and biology, which was intensively used in her research. As a molecular biologist and 
experienced with Chinese medicine, it suggests itself that biology had to learn from 
Chinese medicine to surpass the limitation of understanding life and to apply more 
systems thinking in biological approaches.  
Overall, Dr Huang’s involvement was not driven by her desire to understand 
complexity or what life is in biological terms, which was the case for Prof Frank or 
Kevin, instead it was the desire to prevent exploitation and regulate Chinese medicine 
drugs production and commercialisation. Similar to Kevin’s involvement, at a young 
age, Dr Huang was introduced to Chinese medicine and returned to it after she 





5.4 DISCONTENT IN THE REDUCTIONIST PRESENTATION OF MEDICINE 
AND HEALTH INVOLVEMENT 
 
The student George is another gatekeeper (Prof Carl, Dr Huang, Lingma) and he 
supported this thesis with crucial information on the networks in Chinese medicine 
and systems biology research (for more information on George, see Table 3, gatekeeper 
4). He was a medical biologist before he joined Prof Frank and Dr Huang’s PhD 
program. His involvement demonstrates a discontentment in the reductionist 
presentation of medicine and health in biomedical studies. He criticises the limited 
attention to the complex issues of life and social disparities that increase inadequate 
healthcare for poor people. His vision was a holistic approach to medicine and science; 
hence, he changed from biomedicine to alternative approaches:  
“I first realised the limitations of the reductionist view of biology and science as 
a whole when I was still at University around 1995… I studied medical biology, 
and at the time I had the idea that the way it was taught in university was too 
reductionist and too many details and didn’t have real connection what is going 
on your life.” (George, 2015, Leiden) 
George was frustrated with the issue that social and psychological problems were not 
reflected in the curriculum of life sciences and medical studies. His definition of health, 
however, is similar to the definition of health given by the World Health Organisation 
(WHO) from 1946, which states: “Health is a state of complete physical, mental and 
social well-being and not merely the absence of disease or infirmity” (WHO, 2016). 
The WHO’s defines health not as a status in the absence of any ailment, psychological 
or social influences. Consequently, the attention to psychological and social factors as 
influences on health, was lacking in education and was not considered general 
knowledge, while it was a stated issue in the WHO definition. Therefore, George 
criticises the disconnection between theoretical and educational understanding of 
medicine and health. In his view, medical education and practice do not teach or work 
with the complexity of life and health. Mainly he observes the effects of this problem 
in healthcare systems that are affected by policies that undoubtedly do not address a 
holistic approach. Thus, he suggests changing the political system, which, in his 




His frustration with the reduction of knowledge and information in medical studies 
caused him to leave academia and to find a job where he could contribute to healthcare. 
While he worked for different organisations on complementary and alternative 
treatments, he also learnt Taijiquan 太极拳, a physical practice of Chinese medicine 
that works on qi as energy in his body and is also a martial art. Through Taijiquan, he 
learned about Chinese medicine. The practice of Taijiquan helped him to understand 
health as being more than a medical intervention, but as an awareness of the body to 
cultivate and maintain a healthy condition. When George realised the effectiveness of 
Taijiquan, he wanted to share his findings to help the people and so he contacted Prof 
Frank. He asserts that:  
“So, I practised Taijiquan, and I noticed that I could use it actually to monitor 
my own body for things that are stiff or stuck. I can use it as a tool to help myself 
and also later all of us. So, that got me interested and then I met someone who 
worked at an organisation and is still working there. He founded a kind of 
collaboration between China and the Netherlands, and he wanted to study 
Chinese diagnosis and using systems biology techniques to do that. Yeah, I got 
in contact with him, and that got me kind of into this scientific field at that time.” 
(George, 2015, Leiden)  
The learning of Taijiquan and the insights he gained, resonate with Prof Frank’s idea 
of health. Prof Frank was familiar with George’s publication on CAM systems, and he 
was keen on his expertise and thinking and to have him on his team. Therefore, Prof 
Frank invited George to join his Chinese medicine diagnosis project as a PhD student. 
 
5.4.1 REFLECTIONS ON THE DISCONTENTMENT INVOLVEMENT 
 
George’s involvement with Chinese medicine research arose from his discontent with 
the reductionist approach in medical practices and education, the limited perspective 
of what is and the struggle with social disparities. Hence, he presented a similar path 
to Kevin’s search for complexity in medicine. He is also similar to Prof Frank in that 
he had the desire to change medicine and healthcare.  
George’s viewpoint on capitalism in medicine is comparable with Dr Huang’s 
argument on the commercialisation of medicine and herbal drugs. They recognised 




pharmaceutical companies stole from poor people through overharvesting natural 
resources, which are valuable supplies for indigenous people as they are used for 
medical treatments. This phenomenon is described as biocapitalism by Helman (2007) 
and discussed in more detail in Chapter 2. Thus, George strongly presents the problem 
of the impact of reductionistic view in medicine and on health. He views alternative 
medical systems and their holistic view on health, as well as their emphasis on the self-
maintenance and self-regulation of the organism, as essential knowledge that needs to 
be integrated into medical healthcare. This should happen together with the integration 
of social and psychological factors on health. Thus, his drive was to change the 
healthcare system by starting with the transmission of knowledge on alternative 







The identified actors Prof Frank, Kevin, Dr Huang and George revealed both personal 
and active involvement in Chinese medicine and systems biology. Their involvement 
is characterised by personal contact with Chinese medicine before they professionally 
engaged with Chinese medicine and systems biology research. They experienced 
through many different ways such as Taijiquan, family members or a disease the first 
contact with this medicine. Consequently, this personal experience informed their 
decision to change their professional research area to Chinese medicine research. In 
general, their involvement was inspired by the desire for a change in the dominating 
reductionist paradigm found in science and medicine to a more holistic approach. As 
a result, they found that Chinese medicine and its acknowledgement of complexity and 
holistic thinking, could establish new approaches to research diseases and also to cease 
the exploitation of Chinese medicine. They also believed that by understanding 
Chinese medicine, a new approach to medicine and life could be gained and this, in 
turn, could aid the reduction of costs in healthcare. 
The actors were fascinated by the understanding of life in Chinese medicine and its 
practice which accepted complexity within its concepts. Chinese medicine concepts 
appeared as worthwhile, to be implemented into modern scientific practice and to 
change healthcare systems. The question they asked over ten years later was how they 
could gain more information from experiments and then interpret them in relation to 
the whole system of the organism. The idea to learn from Chinese medicine and 
philosophy inspired systems scientists in the 1970s when they started to integrate 
Eastern philosophies in the early brain research as I elaborated on in Chapter 4.  
In the early 2000s, the inner circle hesitated to publish a Chinese medicine article in 
bioscientific journals and through a biomedical research institution. The main reason 
for their hesitation was because Chinese medicine was not a topical field for 
bioscientists to research, nor was it widely recognised as a research or publication area 
in the West. For example, a high-quality journal Science had only published six articles 
on Chinese medicine since 2003. Thus, it was evident that the motivation for the inner 




argued by Zhang and Wang (2017). Zhang and Wang affirm that professional success 
is often assessed through research performance, citation indexes, industrial co-
operation, together with research and economic performance in competitions for 
funding and positions. Subsequently, a person’s personality and interests can play a 
secondary role in the struggle of “selling” his or her research through publications and 
patents. Zhang and Wang’s research concluded that scientists only undertook research 
that was economically profitable, which, interestingly was not detected at the 
beginning of the involvement of the inner circle.  
Technology in contrast did support the achievement and performance of a scientific 
study. While omics technology was not a driver for their motivation to study Chinese 
medicine, it was a tool to convey their ideas to the Western scientific community and 
to perform a scientific study on Chinese medicine. Systems biology with systems 
thinking, metabolomics and pattern recognition facilitated them to scientifically 
research Chinese medicine by interpreting patterns in personalised Chinese medicine 
diagnosis. This combination revolutionised the profiling of metabolites in zhengs. Due 
to the past studies of the inner circle in biochemistry, molecular plant biology and 
medical biology, they were familiar with the technology used in systems biology and 
they were convinced that it would facilitate them achieve their aims.  
The recognition of Chinese medicine in the Western scientific community was also 
apparent in the terminology the actors used. Terms like “holism”, “Daoism”, “rhythm”, 
“body and mind unity” or “complexity” appeared in many of my interviews with 
systems biologists. They used these terms to describe their personal involvement in 
Chinese medicine research. According to Asprem (2015, p. 549) these terms were 
frequently connected to pseudoscience or esotericism and were seen as a return to “a 
deeper, spiritual understanding of the cosmos”. The use of terms like “holism” by 
systems biologists indicated a wish for a more holistic research approach to understand 
the human body and nature. The actors also described Chinese medicine as an ancient 
medicine that preserved its practices and wisdom despite rapid political, economic, 
scientific and technological development during the last century. Their vision was to 
discover a holistic approach to health and diseases for developing new research and 
clinical methods based on the personalised diagnosis and treatments of Chinese 




Chinese herbal drugs and the establishment of a personalised medicine. For the actors 
or the inner circle, their involvement in Chinese medicine and systems biology 
changed their approach to medicine and their way of practising science in the long-
term to more holistic research.  
The next chapter will demonstrate the involvement of the actors and the 
development of their research on Chinese medicine and systems biology through 






6. LABORATORY PRACTICE AND INDUSTRIAL TIES  
 
In Chapter 5, we saw how the actors became involved in Chinese medicine and 
systems biology research. I described four involvement (Prof Frank, Kevin, Dr Huang 
and George) in Chinese medicine and systems biology research. They were the first 
actors who proposed the research of Chinese medicine with systems biology, and who 
laid the groundwork for this research which included the use of omics technologies, 
research proposals, and types of co-operation.  
This chapter will answer the research question of how the human and nonhuman actors 
participated in Chinese medicine and systems biology research and influenced the 
development of the relationship between Chinese medicine and systems biology. The 
data includes material from participant observations and interviews conducted in 
Dalian and Harbin in China and Tokyo, Japan during a four months period in 2016 
(see Table 1 for fieldwork schedule and Figures 2 and 3 for connections between the 
sites). This chapter focuses on the involvement of the actors and has been divided into 
three codes: (i) the co-operation projects between Dalian and Leiden, (ii) laboratory 
practice and technology in the Harbin site, and (iii) funding and industrial ties of both 
the Dalian and the Harbin groups.  
This chapter describes the involvement of Prof Yu, the Leiden collaborator in Dalian, 
his PhD student Lingma and a post-doctoral student Long (for more information on 
Prof Yu, Lingma and Long’s project on Lipidomics research, see Table 2). In 
Chapter 5, I presented the involvement of George, Prof Frank’s and Dr Huang’s PhD 
student, in Chinese medicine and systems biology. This chapter demonstrates 
George’s participation as a PhD student in the Chinese medicine diagnosis research 
project of the Leiden group. The actors from the Harbin site were Prof Xiong, the head 
of the department of the metabolomics centre, his assistant professors Ang and Xing, 
his PhD student Ruili and an undergraduate student Yuxi (see Table 2 for more 





Additionally, the two systems biology experts Prof Musashi and Prof Meng will 
provide insights into the technological limitations of conducting systems biology 
studies. Following the ethical regulation, all names of the actors are anonymised with 





6.1 CO-OPERATION PROJECTS 
 
This section demonstrates the involvement of the collaborators in a research co-
operation between the Netherlands and China. The Dalian institute is part of the 
Chinese Academy of Sciences (CAS) and due to its high reputation in new material 
research, it frequently conducts highly confidential military research. Its relationship 
with the military derives from its location in Dalian, a province in the Northeast of 
China. In the history of Chinese medicine, Dalian is known for its anti-plague efforts 
during the Manchurian plague epidemic of 1911/12 (see Rogaski, 2004; Lei, 2014). 
The institute in Dalian was a collaborative partner with the Leiden group in the 
Netherlands. The contact between the partners started in China, in 2003 when Prof 
Frank and Dr Huang introduced the research project. During their trip, Dr Huang and 
Prof Frank first contacted the vice president of the CAS who suggested Prof Yu and 
his metabolomics team in Dalian as a co-operation partner. Prof Yu was a molecular 
biologist who focused on metabolomics research in biomedicine. Dr Huang knew Prof 
Yu from their time at the university in Beijing and from his publications. Thus, she 
was convinced that Prof Yu would meet the research criteria for the investigation of 
diagnostic methods in Chinese medicine. Accordingly, Dr Huang functioned as a 
gatekeeper 2 in this network (see Table 3 for more information concerning her role) 
with ties to influential people in China through her upbringing in China, as she claims: 
“In fact, I have my colleagues, I have my classmates, who are in different 
functions in China and who are all in the field of biology and medicine. So, I 
kept in contact with them. They are in influential positions within China. That 
also helped to build up my own network in China. That was the reason why I 
also know the Minister of Health so well, and I also know the Minister of 
International Co-operation from the Chinese State Administration of TCM.” (Dr 
Huang, 2015, Leiden) 
In 2005, Prof Frank and Dr Huang set up the co-operation under the CAS-Royal 
Netherlands Academy of Arts and Sciences (KNAW) Joint PhD Training Programme. 
Dr Huang said that she built this co-operation on, I quote “The research quality and 
also the trust between each other on a human basis”. Her trust on a human basis was 
built on the fact that the partners in China were her acquaintances, see in the above-




they studied together period and her attention to his research publications. Interestingly, 
the term “trust” was in the title “Based on Science, Built on Trust” of the fifteenth 
anniversary report of the CAS-KNAW agreement (Ariën and van Genugten, 2012). 
The title suggest that trust was important ever since the first co-operation between the 
Netherlands and China occurred in the 1970s, at a time when China’s political and 
economic situation was unstable due to the Cultural Revolution and Mao’s death (see 
Chapter 2 and Scheid, 2002a). According to Ariën and van Genugten (2012), the CAS 
and KNAW funded several collaborations between China and the Netherlands, 
including the Leiden-Dalian research projects between 2007 and 2013 (see Table 2 for 
project details). Other sponsors were the Chinese and the Dutch governments, the 
Chinese and the Leiden University, a governmental organisation and Prof Frank’s and 
Dr Huang’s life sciences company. This indicates that trust was not a unique criterion 
for the Leiden-Dalian co-operation but for all KNAW and CAS funded projects.  
Notably, Prof Yu had no prior experience in Chinese medicine studies. According to 
Prof Yu’s PhD student Lingma26 and Prof Yu’s curriculum vitae, Chinese medicine 
research was an unfamiliar research topic for Prof Yu. Prof Yu’s expertise was in 
chromatography. In the 1990s, Prof Yu conducted his PhD project on chromatography 
at the Dalian institute. During the co-operation with Leiden, he obtained funding from 
the NSFC for six years of research (see Appendix A for details about the NSFC 
funding). With this funding, he invested in technology and its advancement. For 
example, Prof Yu’s labs were equipped with liquid chromatography machines, such as 
gas chromatography, Capillary Electrophoresis Systems, and diagnostic instruments 
for Cancer research. The lab purchased machines from global omics suppliers, for 
example, as the US companies Thermo Fisher Scientific, ABI Applied Biosystems Inc., 
Waters Corporation, Agilent, Leco, Micro-Tech Scientific, Beckham and the Japanese 
company Shimadzu. The amount of technology in the laboratory indicated a strong 
focus on the application of technology in his metabolomics research.  
                                               
 
26 Lingma was among the first PhD students in the joint research program between Leiden and Dalian 
from 2007 to 2013. She recommended further actors and fieldwork sites for this research (see Table 3 




George, the Leiden PhD student, was involved in this joint research program and made 
a similar observation about Prof Yu’s technological equipment and the funding:  
“They had the most advanced and brand-new machines in the lab. They had 
much better and more advanced equipment than we had in Leiden. The machines 
were good. I think they also had more experience in keeping the machines or 
let’s say running the machines so the technical aspect in getting the thing 
working. It is interesting because it seemed that the government wanted to spend 
a lot of money on research in China. And the professor that we had contact with 
he just got a really huge grant and they kept buying stuff. So, it is maybe easy to 
buy machines, but then experience and knowledge are hard to get. That takes 
time.” (George, 2015, Leiden) 
Lingma explained that Prof Yu’s lab with all its technological equipment was 
sponsored by the Chinese government’s “Hundred Talent Project”. The Hundred 
Talent Project was founded by the Chinese government with the purpose of recruiting 
distinguished Chinese scholars overseas and getting them to return to China and to 
develop China’s economic and scientific infrastructure (Yao, Li and Pei, 2013). 
According to Yao, Li and Pei (2013), 81% of the members of the CAS were funded 
by the Hundred Talent Project (ibid). They argue that since 1994, the Chinese 
government offered incentives that included laboratory space, start-up packages and 
positions as Principal Investigators for their return to China. In Prof Yu’s case, he 
obtained a fellowship from the Max Planck Society, which was one of the partners of 
the Hundred Talent Project. For that reason, he was identified as a distinguished 
researcher, which led in 1997 to his recruitment as a professor at the Dalian institute. 
With the Hundred Talent funding, Prof Yu established and equipped his lab with the 
technology needed to conduct the research with Leiden, as they had less money and 
equipment than the Dalian institute.  
 
6.1.1 EMPLOYING PHD STUDENTS IN SYSTEMS BIOLOGY AND CHINESE MEDICINE 
PROJECTS  
 
The Leiden and Dalian students were employed for the Chinese medicine diagnosis 
research project. The students presented in this chapter are George from Leiden and 
Long and Lingma from Dalian. They had an academic background in analytical 




agreement between Dalian and Leiden, the Leiden students had to provide training and 
workshops in analytical tools to the Dalian team. Thus, the Dalian team sent two of 
their PhD students and one post-doc for training to Leiden. All of the students had to 
learn systems and network data analysis and some Chinese medicine theories.  
The PhD student George was one of the first students who conducted Chinese 
medicine research within a biomedical department. As presented in Chapter 5, George 
became involved through a personal interest in Chinese medicine and discontentment 
with reductionism in medicine and science. He participated in the collaborative 
research project on Chinese medicine and systems biology through the offer of a PhD 
position by Prof Frank. Due to the unconventional topic for a biomedical institution at 
that time in Holland, which I discussed in Chapter 5, George experienced difficulties 
in being accepted by his colleagues at university. Thus, he had to debate with his 
biomedical colleagues, the benefits of Chinese medicine and his research. The 
situation changed after he finished his PhD, and new students who also carried out 
research on Chinese medicine, joined the program. They were “more accepted” as he 
says:  
“When I started there [in Leiden] as a PhD student this Chinese medicine 
thinking was kind of weird, so I was always, at least in the beginning, I was kind 
of a weird guy there who was studying Chinese medicine. So, it really took a 
long time to get kind of accepted in this way of looking at health, and why should 
we bother with Chinese medicine. So, we had a lot of discussions with the group, 
and now it is the next generation. They are three now, so it’s more accepted now.” 
(George, 2015, Leiden) 
At the beginning, George’s research project encountered a few issues. As George’s 
project was one of the first projects in the co-operation (another PhD student worked 
on diabetes) of a series of research projects on Chinese medicine and systems biology, 
the team in Leiden was confronted by many challenges. One such problem was, for 
example, the question of how to design the study to make Chinese medicine more 
accessible and acceptable to Western scientists and doctors. This problem reveals 
another tension between biomedicine and Chinese medicine with the bias of an 
unscientific but a very complex medicine. Thus, the team struggled with questions 
about large data sets and how to follow a pathway of drugs by revealing the 
relationships between various molecules, cells and different levels of organisms. Large 




hence, they decided that systems biology with multivariate data analysis and the 
chemical analysis of biofluids was a feasible method to establish a metabolite pattern 
and was acceptable for Western scientists.  
“We had a discussion on how we can do this, how can we make this more 
acceptable to Western doctors, and Western clinicians and that’s why we thought 
that systems biology might be a nice approach to bridge, let’s say, the Chinese 
view and something that is also explainable to Western doctors and clinicians. 
Then, we thought, we should start with the diagnosis because that is actually the 
foundation of Chinese medicine. Our thought was also to do another type of 
research from what all the other scientists did, no herbal medicine but diagnostics 
and starting from the base!” (George, 2015, Leiden) 
In contrast to George, the post-doc student Long refers to his study of Chinese 
medicine as “just a project” that did not reveal any profound change in his life. Long, 
who was Prof Yu’s post-doctoral student who studied first geography, biology and 
chemistry before he gained his PhD in biochemistry. Through the Leiden-Dalian 
collaboration, he received a post-doctoral position for the quality control of Chinese 
medicine. According to Long, Chinese medicine was not new to him and not difficult 
to research due to his Chinese background. He considered Chinese medicine as a 
familiar practice and theory. However, it was different with systems biology. His 
interest in systems biology came as a result of his interest in the use of omics 
technology.  
Lingma explained a similar involvement in Chinese medicine and systems biology 
studies to Long. She studied quantum chemistry and joined the Chinese medicine 
diagnosis project as a PhD student. To be more precise, Lingma’s involvement 
happened after her application for a PhD position in chemistry at the Dalian Institute. 
Her application focused on chemical analysis but did not mention that she would 
examine Chinese medicine with it. Once Prof Yu agreed to the co-operation with 
Leiden, he needed a researcher to investigate the effects of Western and Chinese 
medicine drugs on lipids. Consequently, he assigned Lingma to conduct a lipidomics 
analysis on the intervention of drugs on plasma lipid metabolisms. In particular, she 
generated lipidomics profiles to investigate whether biomedical drugs or Chinese 
medicine drugs affected different metabolic syndromes such as diabetes mellitus. For 
this, she used liquid chromatography combined with mass spectrometry and statistical 




for metabolic syndrome, and that systems biology can bridge Chinese and Western 
medicine. As part of the co-operation agreement, Lingma stayed for three years in 
Leiden and the post-doctoral student Long stayed for one year. Both, Lingma and Long 
were supervised by Prof Frank and Dr Huang during their research in Leiden. Prof Yu 
took over the supervision once they returned to Dalian. 
The three students’ involvement demonstrate that they did not have to create a new 
project or methods to study Chinese medicine and systems biology as their supervisors 
did. However, they were the ones who conducted the first research on Chinese 
medicine and systems biology and had to make sense of it. Only George had some 
experience in Chinese medicine and showed interest in gaining insights from Chinese 
medicine diagnosis, and not from its drugs to implement this knowledge in European 
healthcare systems. The other students were employed in the co-operation project with 
little or no experience in Chinese medicine or systems biology. Compared to George, 
Long and Lingma experienced a career-oriented involvement as they took on the 
project in order to enhance their academic career. They agreed with the technological 
aspect of systems biology without addressing the philosophical aspect of systems 
biology. Long and Lingma were employed for these projects in the joint research 
program with Leiden because they had experience with omics technology and 
chemistry. Overall, the participation of George, Long and Lingma in this co-operation 
showed that knowledge concerning the two disciplines of systems biology and Chinese 
medicine was already established.  
 
6.1.2 TENSIONS IN THE CO-OPERATION  
 
During the collaboration, those involved had to gather biofluid samples, i.e., blood and 
urine samples, from Chinese medicine hospitals with the aim of gaining insights into 
Chinese medicine. The Dalian and Leiden groups hoped to establish a personalised 
medicine based on the gained insights of the Chinese medicine diagnosis study. To 
this end, the Dalian group collected patients’ blood and urine samples and analysed 
them with quantitative methods. The task of the Leiden team was to undertake the 




and metabolomic profiles of different zhengs in Chinese medicine diagnosis. However, 
George stated that, I quote: “I think it was more about the data analysis and the 
processing part that kind of knowledge, which was less developed in Dalian than in 
Leiden”. The technological focus of the Dalian institute changed the dynamics of the 
agreed project on researching Chinese medicine with systems biology because the 
systems biologists from Leiden had to find new co-operation partners in China to aid 
them collect new samples. Hence, the co-operation suffered from three problems: (i) 
research protocols and the quality of samples, (ii) the reliability of the patients, and (iii) 
a breach in publication.  
The first problem emerged from the study design. The Leiden team designed the study 
with instructions for the students in Dalian to undertake the collection, preparation and 
measurements of the samples. However, as the Dalian students collected the samples 
and conducted the experiments before the co-operation with Leiden started, their 
protocols showed variations. When the Leiden group received the data, it was unclear 
when the students collected and handled the samples, i.e., storage, preparation and 
analysis. Finding the right student who was responsible for each step in the process 
was challenging for the students in Leiden. As a result, the team in Leiden was not 
sure where the data was collected and struggled to analyse it as Dr Huang recalls:  
“I think they conducted the clinical study partly in the university [and partly at 
the hospital] and they did not completely follow the instruction, the research plan. 
So, therefore, the result was scientifically not successful. We did a nice 
experiment design but in the actual experiment they didn’t follow the design.” 
(Dr Huang, 2015, Leiden) 
The second problem was the patients’ reliability. As patients voluntarily took part in 
the study, it was uncertain if they would come every day to deliver their blood and 
urine samples. In particular, if patients did not complete the full cycle of the study, 
their samples were useless to the researchers. The researchers needed samples from 
each patient every day throughout a period of fourteen days. The reliability of patients 
was beyond the control of the researchers and this was therefore another challenge that 
the study faced. However, the sample collection and handling were controlled by the 
students in Dalian, which was not satisfactory for the Leiden team. Dr Huang mentions 
a lack quality of the collected samples. Huang et al. (2011) state that the quality of 




temperature, which changes enzymes in the sample and causes inferior quality. As Dr 
Huang says:  
“So, we had a joint design for the experiment that said which time they have to 
take the samples and which kind of patient we needed. But patients were 
volunteers in this study, so, the patients didn’t show up or they gave us the first 
sample and they didn’t come for the second collection. We cannot blame the 
hospital for this. However, in the collected samples, I think we had some samples 
with good plasma quality, but the collection of the samples was not high end.” 
(Dr Huang, 2015, Leiden) 
Another key problem was the “trust” with which Dr Huang built this collaboration, as 
stated above. It was essential to her that the collaborative partners abided by the co-
operation agreement, but this was not always the case. Before George could publish 
the findings of his research, a member of the group in Dalian published some data in 
a Chinese journal without informing and acknowledging the Leiden group:  
“One thing, for instance, was that the data that we got from them, they also 
worked or downloaded the data and eventually we found out that they got some 
parts of it published in a kind of Chinese journal and we didn’t know about it. In 
the West, to publish the same result twice is a kind of no go. But for them, it was 
more common.” (George, 2015, Leiden) 
Overall, the co-operation started with the aim to gain insights into Chinese medicine 
diagnosis, but the collaborator’s intentions crystallised a division of the interests 
during the process. The Dalian team focused on technological advancements, rather 
than the conceptual interest of a holistic study on Chinese medicine. They followed 
the reductionistic paradigm within the framework of biomedicine, which was a 
significant setback for the Leiden team. Prof Frank believes that Prof Yu’s return to 
reductionism was for an economic reason. Prof Frank recalls the moment when he 
realised the research focus of his partners in Dalian had changed to technology and 
bioscientific methods:  
“…and that was a time when I learned a lot about China, sometimes being less 
holistic than I thought. Some Chinese people are more Western thinking than we 
are. What I thought was the treasure, is sometimes not so easy to find. People 
were more interested in extracting, extracting and extracting and then make a 
drug. Everybody was in the Western mode of wanting to earn a lot of money by 
making Western drugs and Chinese medicine. You cannot earn so much money 
with holistic Chinese medicine studies because there are patterns, they say this 
and this. So, it was very economic driven, and I thought that is not what I want.” 




In addition, George believes that the Dalian students showed a lack of enthusiasm for 
a novel research method for systems biology to investigate Chinese medicine. This 
highlights the fact that the Dalian students were employed for a job and not for the 
sake of Chinese medicine research: 
“It didn’t feel like a collaboration. For them also, it was more a kind of duty and 
do what the professor says, and you don’t feel really the enthusiasm for the study 
or something. We were all very enthusiastic in the Netherlands, but it almost felt 
like we are giving them more work to do for us to figure things out.” (George, 
2015, Leiden) 
The different interests emerged during the co-operation process and influenced the 
decision to end the co-operation once the Leiden institute had received the samples. 
Nevertheless, the experience with Dalian brought a better understanding of the 
scientific interest of the partners of the Leiden team, which was as modernised and 





6.2 LABORATORY PRACTICE AND TECHNOLOGY  
 
This section introduces the dual-trained Chinese medicine and systems biology 
researchers. The actors in this code are the Harbin team. Harbin is located in the 
province of Heilongjiang, China and in the team there was Prof Xiong, his two 
assistant professors Xing and Ang and 20 students. I will refer to the PhD student Ruili 
and the post-graduate student Yuxi in this chapter. All members of the team were 
trained in Chinese medicine pharmaceutical sciences, systems biology and the use of 
omics technologies. Prof Xiong founded the Chinese medicine pharmacology post-
graduate program in 2005 and since the 2010s, he has run a PhD program in Chinese 
medicine metabolomics in which Chinese medicine pharmaceutical students are 
trained in systems biology. Thus, they represent the group of dual-trained Chinese 
medicine and systems biology researchers in my study. In the following section, I will 
describe the involvement of Prof Xiong and his students in Harbin with extracts from 
field notes.  
The head of the department in Harbin, Prof Xiong, studied Chinese medicine serum 
pharmacochemistry, which focuses on the development of drugs, in Harbin. Following 
this, he gained his PhD in pharmacokinetics in Japan and worked for a pharmaceutical 
company in Germany. On Prof Xiong’s return to China, he received a position at a 
university in Harbin in the good agriculture research unit for investigating and setting 
standards for medicinal plant cultivation and harvest. According to the assistant 
professor Xing, shortly after his return, Prof Xiong received funding under the “973”27 
program for basic research in 2005 and established a post-graduate course in 
metabolomics. The Chinese government largely invested in various research and 
development programs and the 973 program was one of these investments was shown 
                                               
 
27 The “973” program was a MOST funding that aimed to develop collaborative basic and translational 
research, innovations and technologies aligned with the “national priorities in economic and social 
development”. Since 2006, it was extended to the “National Key Basic Research Programme” for 
specialised disciplines such as protein sciences, stem cell research, reproductive biology and 






by Zhou and Leydesdorff (2006) with the increase of the Chinese Gross Expenditure 
in Research and Development (GERD) ratio to 1.31% by 2003, which was almost one 
half of the 2010 agreed ratio aim of 3% by the European Commission (ibid). The next 
achievement of Prof Xiong was, in 2012, with the establishment of the centre for 
metabolomics studies of Chinese medicine as a combination of pharmacognosy28 and 
systems biology. 
My first meeting with Prof Xiong was at the International Conference on Health, 
Healthcare and Eco-civilisation at the London South Bank University on September 
5-6, 2015. The conference hosted scientists in Chinese medicine, biotechnology, life 
sciences, sinology and acupuncture from China and Europe to discuss the latest 
developments in Chinese medicine research. Prof Xiong presented his latest results of 
metabolomics studies on a Chinese medicine fufang which aimed to find the 
appropriate pattern or zheng for its use. After a conversation with him, he allowed me 
to conduct fieldwork in his department from April - June 2016 (see Table 1 for 
observation details from my fieldwork). I observed Prof Xiong’s students in wet 
laboratory experiments on human blood serum and urine samples. The observations 
took place in the metabolomics laboratory and the department of internal medicine in 
the affiliated Chinese medicine hospital of the university. 
In the department of metabolomics research, I followed Ruili who was conducting, as 
part of her PhD project, an in vivo study on metabolites of blood serum and urine 
samples on patients that suffered from jaundice, in particular the yang jaundice (yang 
huangdan zheng 阳黄疸证).29 Chinese medicine distinguishes two types of jaundice, 
a yin and a yang type. The Yang type presents a yellow pigmentation, and symptoms 
include damp heat such as fatigue, fever, a heaviness of head and body, no appetite, a 
thin tongue with a greasy coating and a floating, wiry or rapid pulse. The yin type (yin 
huangdan zheng 阴黄疸证) presents a poor appetite, bloating, aversion to cold, soft 
                                               
 
28  Pharmacognosy is a branch of pharmacology that deals with natural substances and especially 
medicinal substances obtained from plants, animal, fungi, molds and yeast (see Orhan, 2014). 
29 Jaundice is a liver dysfunction that hinders or completely disrupts the resorption of old blood cells, 
which causes aggregation of a chemical in haemoglobin namely the bilirubin in the body. This leads to 




stools, a swollen pale tongue with a greasy white coating and a deep, thin, or retarded 
pulse. This is the zheng of a damp cold in the body (Wang, Zhang and Sun, 2012). The 
Yinchenhao tang 茵陈蒿汤 (Virgate Wormwood Decoction) is a standard prescription 
in the Chinese medicine pharmacology to treat yang jaundice. Unschuld (2005, p. 446) 
states that in Chinese, the word tang 汤, as in Yinchenhao tang, means “hot liquid” or 
“decoction” and is a standard description for liquid Chinese medicine drugs.  
Three groups in the metabolomics department in Harbin studied the Yinchenhao tang. 
The first group examined the chemical compounds in the tang, which is the decocted 
formula. The second group tested the tang on animal models to determine biomarkers, 
efficacy, and safety. The third group assessed the decocted tang in clinical trials for 
the verification of the effect on human metabolism, proteins and genes. In the first 
group, students bought ingredients from an authorised Chinese medicine drug seller 
and prepared the complex prescription of various herbs, fufang, as a decoction, which 
is then called the tang. Prof Xiong was the only authorised person in the department 
to verify every single herb used in the studies. After the verification process, students 
decocted and examined the prepared tang in the laboratory. Then, they stored the 
packages in the fridge for the second project. In the following, I will focus on Ruili’s 
project with the third group.  
The third project was Ruili’s in vivo project. Ruili’s was introduced to the project by 
Prof Xiong. Prof Xiong arranged a co-operation with the leading doctor (laozhongyi 
老中医) of the department of internal medicine (neike 内科) in the affiliated TCM 
hospital. According to Farquhar (1994), laozhongyi was a term used to call Chinese 
medicine doctors in the 1950s. The laozhongyi allowed her to conduct her study in his 
department. In the next extract, I will describe a ward round in the hospital to identify 





On Monday mornings in the ward round, the laozhongyi selected the patients 
who were appropriate for Ruili’s study. Among two dozen doctors and other 
students, Ruili and I visited every patient room and listened to the doctors’ 
presentation of the patient’s records and the laozhongyi’s prescriptions. When the 
laozhongyi found a suitable patient for Ruili’s study, he introduced the study 
briefly to the patient and instructed Ruili to collect the consent and the data of 
the patient from the doctor in charge. Then, he continued with his ward round. 
After he finished the ward round, Ruili informed the doctor in charge of the 
selected patients about her study. The doctor told the patient about the procedure 
and that Ruili would collect two blood samples and urine samples for 14 days 
from the patient. Then, Ruili asked quickly for the patient’s medical history, 
demographic data including telephone number and his or her signature on the 
consent form. She had to add all the participants’ data into a national database 
for scientific studies. Then, Ruili’s study started with collecting the blood serum 
one day before the first administration of the tang and one day after a fourteen-
day period of taking the tang. The urine samples were collected throughout the 
fourteen-days period. As a part of the study design, the doctors had to prescribe 
all participants in the study the same formula without making any amendments 
to the recipe. This contrasted the usual practice Chinese medicine as usually 
doctors modify the prescription to the specific condition of the patient. (Fieldnote, 
2016, Harbin) 
Ruili had several mechanisms to collect information and prevent failures in the study. 
Compared to the above presented Leiden team, she knew the doctors in charge of her 
participants, and she had the telephone numbers to contact patients if they did not show 
up for the daily sample collection. Nevertheless, it often happened that patients signed 
up for the study and then they did not drop off their samples, or they forgot to hand in 
the blood or the urine sample as they were not inpatients. Although she had the patients’ 
numbers and called them, most of the patients had already eaten their breakfast, which 
made their sample useless for the experiment. In addition to this, sometimes it was 
difficult to get the samples from patients in an advanced state of the disease, as they 
needed the help of relatives to provide the sample.  
Due to the fact that not all the patients followed the instruction of not eating before the 
nurse took their blood or their urine sample, Ruili also faced the issue that many 
patients were transferred to biomedical hospitals because they felt that Chinese 
medicine was not helping them, or that their condition was becoming more severe. In 
more severe cases, Chinese medicine was sometimes difficult to consume as some of 
the patients could not intake any food or fluids; thus, it was not possible for them to 
drink the tang for 14 days. Others for example, developed liver cancer and needed 




advanced diseases were sent home because they wanted to die surrounded by their 
family. Practitioners often commented that I quote one practitioner “we do whatever 
is the best for the patient”.  
Back in the laboratory, Ruili prepared the samples for centrifugation. She separated 
the blood serum from the red blood cells and the pellet, i.e., dirt, from the clean blood 
serum with the centrifuge (lixinji 离心机). The serum is essential for the analysis of 
the proteins, as they carry the metabolised Chinese medicine.  
Ruili filled the urine from the 10-millilitre tubes with blue threaded fasteners in 
five two millilitre tubes with a click fastener. Then she put the test tubes in the 
centrifugal machine with 13000 round per minutes (rpm) for 10 minutes. When 
the program started, the tubes were cooled down to about eight degrees Celsius. 
In the next step, the machine sped up from 1 to 100 within a second, and after a 
few more seconds, it reached its full speed. The centrifuge worked like a washing 
machine, which was placed on a table. Once it had finished, she filled the 
numbered test tubes with urine. The test tubes were numbered with continuing 
numbers for each patient and the day of collection, such as 1-1 (first patient and 
first day after the first drug administration) and froze them in a fridge. She 
needed to freeze the samples at minus 80 degrees. A full analysis was done with 
a minimum batch of 10 patients (10 x 14 days=140 urine samples + 10 x 2 blood 
serum samples = 160 samples a batch). (Fieldnote, 2016, Harbin) 
Throughout the data collection and handling of the samples, the pattern zheng was only 
visible to Ruili in the form of urine or blood serum samples. Ruili and the other 
students did not know in advance how and in which metabolites, proteins or genes, the 
zheng would be manifested. Only in the analysis of the metabolites, by comparing all 
urine samples analysed in the fourteen day period the two blood serum samples, Ruili 
was able to see the zheng through a change in the metabolites as a reaction to the 
Yinchenhao tang. To analyse the samples and to identify metabolites, Ruili used mass 
spectrometry and the ultra-performance liquid chromatography (UPLC). The 
identification happened through a mass determination by consulting free accessible 
databases such as the Kyoto Encyclopaedia of Genes and Genomes (KEGG) or the 
METLIN Metabolomics Database. The databases were connected with software that 





In the metabolomics lab, Ruili analysed her samples with the UPCL. Every day 
she prepared a new batch of samples for which she took the urine for seven days 
and mixed it with a solvent. To mix the liquids, she put them in the mini 
centrifuge, which was a tiny version of a centrifuge in the size of a box for four 
eggs. Then she filled the liquids in small glasses, which she placed afterwards in 
the liquid chromatography-mass spectrometry (LC-MS) and the rest of the urine 
she froze. After ten minutes in the machine, the machine delivered her the first 
data set file. The analysis file showed a graph with hundreds of mini-peaks like 
a topographical map of the Alps. Every peak could be determined with special 
software with different functions like metabolite analysis that delivered her mass 
information. With the connection to databases such as Scripps, METLIN and 
KEGG, she found the name and the masses of chemical compounds. Ruili said 
that sometimes the metabolites are unknown. Hence, she needed to check in 
several other databases the number of the metabolites and their chemical 
compounds to find the mass information. (Field note, 2016, Harbin) 
Technology was vital when combining Chinese medicine and systems biology 
research for the evaluation of the metabolism of a fufang. Technology like mass 
spectrometry, gas chromatography, thin layer chromatography, high-speed counter-
current chromatography, and capillary electrophoresis was used for the Chinese 
medicine metabolomics studies, but not exclusively. Many scientists in Harbin did not 
relate themselves to systems biology research, but applied systems biology technology 
in their studies. The definition of “systems biology” according to the assistant 
professor Ang (later only Ang) shows that the Harbin team often defined systems 
biology on its four types of high-throughput measurements: genomics, proteomics, 
metabolomics, and transcriptomics. The method was a many-to-many approach (多对
多 duo dui duo) to investigate what Ang called the “different levels and properties”. 
This had the advantage of using technology as an analytical tool for large-scale and 
complex systems in a short period. The results disclosed, according to Ang, “the 
mystery of Chinese medicine” by screening its effect on genomes, proteomes, and 
metabolomes.  
Despite the optimism of Chinese metabolomics researchers, systems biology experts 
and promoters, for instance, Prof Musashi and Prof Meng (the observers of the 
research of Chinese medicine with systems biology as illustrated in Figure 3 the purple 
network) argue that omics technology is still too limited to conduct systems-level 
research in terms of systems biology. As a result of this, omics technology is also not 
advanced enough to grasp the complexity of Chinese medicine. Prof Musashi is a 




method which has two limitations for Chinese medicine research: technology and its 
theoretical aspect of systems research. 30  The various omics technologies systems 
biologists use are still inadequate to scan all the compounds in a complex Chinese 
medicine fufang. Through the identification of all the compounds, they are however 
able to determine the relationship and the change of behaviour of the whole fufang in 
metabolism. Prof Musashi, however, argues that omics technology is too limited to 
adequately study a whole system. This theoretical limitation also includes the fact that 
systems theory does not fully grasp the complexity of Chinese medicine. Thereby, he 
refers to qi and its all-encompassing status in an organism as not traceable in specific 
layers, but which moves freely between them. The complexity issue is described in 
Kevin’s involvement in Chapter 5. Nonetheless, Prof Musashi is convinced that 
systems biologists in the future will improve technology and their approach and will 
go from being able to identify only a small number of identified compounds to all 
compounds in a fufang and their interactions within a metabolism. Consequently, this 
also increases the amount of data beyond the present technological capacity used to 
study these changes.  
Prof Musashi believes AI will overcome the technological and theoretical limitations 
for big data problems. Big data is too complex, too fast-moving and the arrangement 
of the data is too unstructured, thus, traditional data processing software applications 
are unable to manage them. Hence, Prof Musashi believes that in the future AI systems 
and robotic systems will support the conduction of experiments, the analysis of 
systems biology and the diagnosis of traditional medicines. The benefits are as he says:  
“I think in particularly in the diagnosis with the AI system we can give a much 
more precise certification of the patient. We actually could have a robotic system 
to do the experiments. The AI system generates the diagnosis. So, we can classify 
the patient much more precise. We can diagnose specific subcategories we 
haven’t thought about yet. That could be possible so if we can find a biomarker 
and especially create an intervention that is a little bit fuzzy now… I think the 
goal is actually to build a system by 30 or 40 years from now, and I think that 
would completely revolutionise the way how we do things in biology.” (Prof 
Musashi, 2016, Tokyo)  
                                               
 
30 Prof Musashi’s systems biology project started in 2002 and was funded by the Japanese government. 




Prof Musashi assumes that AI will help overcome the big data of medical publications 
that include medical knowledge from all scientifically examined medicines. However, 
this would mean that only published studies will be integrated into an AI diagnostic 
calculation and evaluation. AI will use an algorithm to match the results of the 
biomedical tests doctors run on patients with the clinical data from databanks to find 
an appropriate treatment based on biomarkers and phenotypes 31  for individual 
diagnosis. The scientific evaluation of Chinese medicine and its integration into a big 
data medical database administrated by AI, indicates the inclusion of only selected 
knowledge, which relates to the standardisation process under Mao Zedong. Mao 
wished for a modern scientific medicine in the 1950s and 1960s and he only included 
standardised Chinese medicine theories and formulae into new Chinese medicine 
textbooks (see Chapter 2, see also Taylor, 2005). However, the difference is that Prof 
Musashi’s AI system aims to develop a worldwide medical system and a personalised 
treatment, which requires more information on existing drugs and their efficacy on the 
proposed disease.  
AI, according to Prof Musashi, will be soon essential in every leading institution of 
the world, in the same way omics technologies have become indispensable in 
laboratories over the past twenty years. Without AI, research would be old-fashioned, 
and doctors would not be able to cope with the increasing body of medical knowledge 
and have the ability to apply new findings to their daily practice. Prof Musashi 
estimates that by 2051 all acknowledged institutions will have a very well-built AI 
system for performing research. If they do not, the institutions will not be deemed 
internationally competitive.  
Similar to Prof Musashi, Prof Meng deems there are technological limitations when it 
comes to conducting systems biology and Chinese medicine research (see Table 2 for 
his diagnostic kit project data). Prof Meng is a geneticist and a systems biologist. He 
helped establish a systems biology research centre in 2000 and founded the first 
systems biology platform in China in 2006. Concerning systems biology and Chinese 
                                               
 
31 Phenotypes are representations of individual characteristics that result from the interaction between 
the genetic constitution of an individual organism (the genotype) and the environment (see John 




medicine research, he considers that systems biology research is not yet thoroughly 
performed, and that people underestimate the complexity of systems biology research, 
which aims to understand the whole system and not only its parts. This undertaking 
requires more advanced technology to gather larger data sets in less time to present the 
whole system. Therefore, the problem with systems biology is its technological 
limitations. Most systems biology institutes have limited capacity, as they are too small 
to conduct a systems level study in its full extent. He explains in detail the challenge 
of a “truly” systems biology study: 
“Systems biology basically understands systems at different levels like on the 
level of protein and dissects each component. Then you need to use the most 
advanced technology to understand each component. We call them the pathways. 
If you don’t have the technology, the pathway is not complete. Then you cannot 
do systems biology. I think in a way we still do systems biology not in a complete 
sense. We are doing these studies with the technology we can get, for example, 
with mass spectrometry. We can analyse a couple of thousands of proteins at one 
time but not the whole human protein. Because of all the limitations in 
technology systems biology has not lived up to its expectations yet.” (Prof Meng, 
2016, Hangzhou) 
Prof Meng believes that Chinese medicine studies with systems biology are an attempt 
to perform systems biology research without any outcome. He asserts that, “We are 
waiting for the results”. In contrast, the Harbin researchers are not concerned about the 
technology limitations, they are more interested in gaining results with the available 
technology for their Chinese medicine studies which evaluate drugs. They are not 
focused on performing a systems biology research in its complete theoretical 
understanding. The Harbin team’s approach is similar to the Dalian researchers. They 
both use the available technology to investigate their metabolomics studies and they 
were less interested in the theoretical components of systems biology. Systems biology 
was no more than a story writing tool or technology (see Section 4.3.2 on the definition 
of systems biology). However, both usages of systems biology differed from the 
Leiden team approach. The Leiden researchers were interested in systems and their 
whole function and relationships, thus, for them, the exploration of a technological 
application was only interesting when regarding the understanding of the system in 





6.3 FUNDING AND INDUSTRIAL TIES 
 
Similar to Dalian, Harbin used the technological equipment from the American 
company Waters Corporation. The purchase of the ultra-performance liquid 
chromatography (UPLC) machine from the American company in 2005 was a strategic 
plan to aid them publish more and to attract future sponsors. Prof Xiong gained the 
attention of the Waters Corp. by mentioning the UPLC machine in 200 publications. 
Due to the high publication rate, the company established a co-operation with the 
department. The team views this co-operation as a link to the industry and to a 
scientific co-operation between China and foreign companies and institutions.  
Industrial co-operation was necessary for the Harbin department as they gained 
research funding from national and international research institutions. For example, 
Prof Xiong’s paper on the application of Waters UPLC machine for Chinese medicine 
drug examinations in 2005 established a co-operation with the Hokkaido College of 
Pharmacy in Tokyo and initiated study exchanges for students and participation at 
conferences. Several students and associate professors from Harbin, such as Prof 
Xiong and assistant professor Xing, studied at Hokkaido University for at least half a 
year during their program. Every year Prof Xiong joins the conferences in Japan. In 
addition, technological connections between Chinese metabolomics and other 
universities were established. These included connections with Amur State University 
in Blagoveshchensk, which undertook several analyses of Russian folk remedies. 
Further study exchanges and technological co-operation were set up with Macao, Hong 
Kong, and Taiwan. 
Most of the funding for the Harbin studies came initially from the Chinese government, 
then the provincial government and from pharmaceutical companies. The funding 
from the pharmaceutical industry was only five per cent of the entire funding. For 
example, industrial funding was connected to patenting drugs, which stands for long-
term studies and thus was not very common. Moreover, the industrial funding 
depended on the region and revealed a North-South disparity, as Southern universities 
such as Jiangxi TCM University or Shanghai TCM University receive more industrial 




It is more complicated to gain funding for systems biology projects in China than to 
gain Chinese medicine funding. Prof Meng emphasises two issues in the struggle with 
funding in China. First, Chinese funding is disease focussed, funding is gained for the 
investigation into epidemic diseases, HIV, hepatitis-C virus diseases or other special 
problems. The second problem is the lengthy design and realisation process of systems 
biology studies, which is outside the normal funding timeframe of two years, and 
beyond the budgets of the funders. Prof Meng claims that China does not offer any 
“big systems type of funding”. Hence, systems biologists in China depend on funding 
from Chinese government funding bodies such as the National Science Foundation of 
China (NSFC, see Appendix A) and the Ministry of Science and Technology.  
“Two-thirds come from the public funding, and one third comes from the NSFC. 
The NSFC used to fund programmes on a much broader level of each project, 
but now it focusses on much smaller projects but many of them. Initially, the 
Ministry of Science and Technology used to fund big projects as well and they 
have called for a research proposal. You can have some money if the Central 
Government says this is what we ask everyone to go into, and then they ask 
professors in China to submit a proposal... And there is another funding from the 
Ministry of Health.” (Prof Meng, 2016, Hangzhou)  
Due to the change and the limited funding for long-term studies, which is needed for 
systems biology research, Prof Meng established his own company with start-up funds. 
However, those funds were not continuous either. Hence, to overcome the budget gap, 
his company focussed on the commercialisation of personalised medical ideas, for 
example, a liver diagnostic kit for blood serum diagnosis in the laboratory (see Table 
2 for project details).  
The change to short-term studies in China depended on the political agenda, which 
aimed after 2006 to increase innovations in China with the National Key Basic 
Research Programme funding (see, for example, Yao, Li and Pei, 2013). This program 
addressed protein research, which included any metabolomic drug study. As many of 
the projects in Harbin and Dalian were funded by this program, their study design 
prioritised the completion of a project within the time of a postgraduate or PhD 
research program of two to six years. This tendency restricted the conduction of long-
term projects and moved towards the evaluation of Chinese medicine fufang to 




With the aim of gaining funding, the Harbin and Dalian research centres offered 
services to other universities or companies. For example, the Harbin group began 
scanning products from other traditional medicines or the Dalian team analysed lipid 
in food products for local companies. It therefore appears that with the increased use 
of omics technology research in drug discovery and development, co-operation was 







This chapter demonstrated that PhD and post-doc students became involved in Chinese 
medicine and systems biology research projects in the course of their training and 
career. The outer circle did not intend to develop new methods to research Chinese 
medicine or learn from it; they developed their expertise in technology and analysis 
tools and were invited to take research positions. I identified the codes of: co-operation 
projects, technology and industry, for causes of their participation.  
The students in Dalian became involved through the research projects of their 
supervisors. They had to learn Chinese medicine from scratch or had limited 
knowledge due to their upbringing. They also had to learn systems biology, as their 
field of research was chemistry. As a result, the Dalian-Leiden co-operation showed 
that research in Chinese medicine and systems biology started with the idea of learning 
Chinese medicine from its very core complex of understanding the human body, 
diseases and life in harmony with nature. The research co-operation was built on trust 
and relationships between the supervisors and politicians. The intention of the Leiden 
team to conduct a study with a holistic approach on health and Chinese medicine with 
Chinese partners, remained partly unsuccessful due to their strong dependency on 
technology, as well as, the poor results of the samples combined with the breach of 
publication etiquette. These tensions caused the end of the co-operation between 
Dalian and Leiden.  
The involvement of the Harbin students was different from the involvement of the 
Dalian-Leiden students. The involvement differs in two aspects: first, the Harbin 
students were trained in systems biology and Chinese medicine and, secondly, they 
evaluated fufangs on specific zhengs rather than identifying biomarkers that determine 
a zheng. The first difference between the students in Harbin and Dalian was that the 
Harbin students were trained in Chinese medicine pharmacology and started with 
systems biology or omics techniques during their post-graduate studies. Thus, they 
combined their knowledge from previous studies on Chinese medicine and integrated 
systems biology to conduct basic research on Chinese medicine and examine drug 




systems biology before they were employed as doctoral and post-doctoral students, the 
Harbin researchers were trained in Chinese medicine and systems biology. The Harbin 
researchers tailored the study to identify the effects of a Chinese medicine fufang for 
a specific zheng on animal models or humans. The scientists in Harbin studied the drug 
first and then tested it on various zheng to determine on which zheng it was most 
efficacious. Thus, they verified the use of the drug and discovered active compounds 
for patents and new drug developments. This was a different approach to the Dalian 
case, as they studied the zheng first in order to develop a new drug.  
The Harbin team demonstrated that for Chinese medicine and omics studies, only one 
scientist, who integrated the knowledge of both, was needed. They highlighted that the 
development of a comprehensive study of understanding Chinese medicine as a 
foundation and the scientific methods of systems biology, were tools for discovering 
active compounds and developing new drugs. The zheng was a parameter to design 
studies and to assess the efficacy of Chinese medicine fufang. With this approach, the 
group created several links to the industry with drug patents to recap a small percentage 
of their funding. 
Similarities between the students from field sites, Harbin and Dalian, were that they 
referred to omics technology in their studies rather than systems biology and its 
complexity at systems-level understanding. They were interested in the application of 
technology for the evaluation of drugs or the identification of biomarkers in their 
studies. Another similarity was that they were challenged with the compliance of 
patients in clinical studies. This challenge caused incomplete samples collections of 
participants or an inferior quality of samples.  
The technological motivation affected the co-operation between Dalian and Leiden. 
Although at first both aimed to research Chinese medicine diagnosis with systems 
biology in order to understand Chinese medicine as a holistic system and practice the 
objective later changed to the technological development for metabolomics studies. 
The divergence of the initial aim, the incomplete and inferior quality of samples and 
the publication of results without agreement of the Leiden partner caused the end of 




It is possible to conclude this chapter by stating that the students in Harbin and Dalian 
were employed as researchers to conduct the studies designed by their supervisors, 
who were trained in Chinese medicine and metabolomics studies. Consequently, it can 
be said that the inner circle was involved because of their interest in Chinese medicine 
and systems biology. Whilst, the students in this chapter (the outer circle) were only 





7. NETWORKS AND POLITICAL TIES  
 
This chapter will answer the question of how did the human and nonhuman actors 
participate in Chinese medicine and systems biology research and influence the 
development of this “interface”? The theme “Networks and political ties” was 
identified through thematic coding of episodic interviews and a literature survey, 
which I discussed in Chapter 3. I conducted the interviews with pharmaceutical 
scientists, humanists, systems biologists, Chinese medicine practitioners. I collected 
data from organisations such as the WHO, a university network organisation, ERC and 
the European Pharmacopoeia Commission (EPC). The theme revealed three codes: (i) 
political networking, (ii) how they joined Chinese medicine studies and (iii) funding 
and regulations. These codes demonstrate that the actors formed and participated in 
networks and organisations or were invited by organisation to participate in Chinese 
medicine and systems biology research. This is different from the involvement in 
individual projects of the inner circle scientists (see Chapter 5) or co-operation projects 
(see Chapter 6).  
In this chapter, I will first present the data from a university network and how it is 
linked to politicians that generated an exchange platform for discussions on Chinese 
medicine between China and Austria. Then, I will demonstrate how the actors 
(including organisations and networks as nonhuman actors) were invited to participate 
as experts in a joint Chinese medicine research consortium. The last section of this 
chapter will elaborate on various research organisations and the specific funding that 





7.1 POLITICAL NETWORKING  
 
The political networking code arose from interview data with Prof Vera. Prof Vera is 
a humanist, the founder of a university network organisation and the head of the 
International Relations Department at an Austrian university. In her function, as a 
connector between China and Austria, she successfully established a network of 
politicians, scientists and Chinese medicine researchers in China which started in the 
1990s. This code demonstrates that in 2005, the research which explored Chinese 
medicine for prevention and research co-operation gained momentum and pushed the 
Austrian government to release funding for this research. This presents an intertwined 
relationship between academia and politics and Austrian political strategies which 
looked to increase co-operation with China. 
Prof Vera’s involvement in Chinese medicine started in the 1990s, with the university 
network organisation project. The university network had the main focus on student 
exchange programs between Austria and Asian countries. With this university network 
organisation, Prof Vera claims that she addressed the poorly developed relationships 
between her affiliated university and Asian universities. A statistic on the enrolment 
numbers disclosed that no Asian student was enrolled, for example, at the University 
of Salzburg in the academic year of 2000 and 2001 (see statistics in Appendix E). Thus, 
Prof Vera aimed to improve student exchange and research relationships with Asian 
countries. To this end, in 2000, she founded the university network organisation to 
shift the focus from the university relationships with the USA, Canada, Africa and 
Australia to Asian countries. With this organisation, Prof Vera developed a 
multidisciplinary student exchange program for a network of eligible scientists, 
researcher, students and politicians of Eurasian countries. 
Prof Vera recalls the initiation of Chinese medicine research in Austria as a link 
between political and academic interests. Since 2005, Prof Vera signed with Chinese 
universities and politicians various Memoranda of Understanding (MOUs) that agreed 
to promote and develop Chinese medicine through conferences and training programs. 
Thus, she organised the first experts’ workshops and conferences on quality standards 




West in 2006, and the prevention of age-related diseases such as dementia, 
neurodegenerative diseases, cardiovascular and metabolomic diseases in 2008. These 
conferences provided a discussion platform for Chinese medicine, which was the 
interest of the Austrian Ministry of Health. Compared to the Austrian interest in 
Chinese medicine, Prof Vera explains China’s research interest as a political strategy 
to improve Chinese medicine research:  
“There were ten researchers in a cluster in 2005, then our Ministry of Health 
showed an interest in traditional medicine so that the Austrian Ministry of Health 
signed an agreement with the Academy of Traditional Chinese Medicine and the 
Ministry of Science funded the research… On the other hand, the Chinese 
Ministry of Health and then also the Ministry of Science and Technology were 
charged with the task to advance the research on traditional Chinese medicine.” 
(Prof Vera, 2018, Vienna) 
Prof Vera’s university network organisation was funded by the Austrian Ministry of 
Education and the Ministry of Health. Her connections with Austrian politicians 
helped her to obtain funding from the Austrian government for her student exchange 
programs, which helped attract Asian students to study in Austria. Prof Vera argues 
that her relationships with politicians were crucial as in the early 2000s, the Federal 
Minister of Education, Science and Research, under minister Elisabeth Gehrer (2002-
2007), reduced the funding for students’ and researchers’ mobility programs. However, 
Prof Vera managed to maintain her funding by addressing the governments interest. 
The interest of minster Gehrer included increasing the competitiveness of Austria’s 
universities by connecting them on a “multidisciplinary” level with China. Prof Vera 
argued that, in the early 2000s, China was a top investing country in research and 
development, and the exchange programs with its top universities secured her funding. 
She believes that due to Austria’s small size of the country and the fact it has twenty-
two or twenty-three private and public universities, China was attracted to the country 
and eager to collaborate with them. Hence, she secured her student exchange program 
and extended her network to Chinese medicine practitioners, researchers and policy-
makers.  
Prof Vera reaffirmed the fact that in the late 2000s, China’s interest grew in both fields 
of science and technology (see Zhou and Leydesdorff, 2006). She observed that in the 
course of this interest, Chinese medicine became commercialised and globalised for 




Chinese propriety medicine that aimed to prove commercial fitness of Chinese 
medicine in biomedical fields and offered alternatives to biomedicine by adapting to 
biomedical drug production. The same applied to TCM hospitals in China. The 
government advanced TCM; thus, Prof Vera claims: “when you look at the hospital or 
medical universities in China, they all have TCM departments to promote and sell their 
TCM”. China increased their investment in Chinese medicine; however, the 
distribution depended on the interest of politicians that supported Chinese medicine 
funding and equal distribution among universities:  
“There is already a lot of interest in the marketing of Chinese medicine, which 
means the sale and the globalisation. Thus, the individual universities will 
receive less money, but the special universities will get enough money and 
promote the academy as a figurehead. And then they can dispose of their own 
resources. But it will always depend on who on a state’s level, in China and in 
Europe, is interested in it and after that, it will be supported or not.” (Prof Vera, 
2018, Vienna) 
Since the 2010s, the Austrian government’s funding for academia has been reduced, 
which has caused a decrease in investments for technological equipment and research 
development. Prof Vera’s interpretation of this development is that Austria needs 
visionaries to bring the issue of Chinese medicine forward and to generate new funding 
for this kind of research. While researchers in Austria struggle to gain funding, China 
increased their investment in research and with Prof Vera’s program, the interest of 
Austrian scientists to study in China became attractive due to the better technological 
equipment (see Zhou and Leydesdorff, 2006).  
The code political networking presented Prof Vera’s contribution to the establishment 
of political and scientific discussions and conferences on Chinese medicine research 
in Austria. Prof Vera’s participation in Chinese medicine research and conference 
correlated with the socio-political urgency and interest to research disease prevention 
and treatments of age-related diseases together with the interest of China to invest and 
promote in Chinese medicine research collaborations. Hence, she built scientific and 
medical exchange relationships between Austria and China, as well as Chinese 
medicine institutions. She encouraged through her conferences and workshops the 
government to release funding for Chinese medicine research in Austria. Therefore, 




vast network, her function to improve international relations, and the urgent need for 
treatments and the prevention of diseases.  
The next code will demonstrate how actors were invited to research projects and to a 





7.2 JOINING CHINESE MEDICINE STUDIES  
 
This code of joining Chinese medicine studies exemplifies two different reasons for 
the need of Chinese medicine research in Europe: the foundation of a TCM clinic in 
Germany and two renal failure cases caused through the use of a Chinese medicine 
slimming product in Belgium. These two causes evoked an interest in studying 
Chinese medicine during the 1990s. At that time, the first research on Chinese 
medicine was conducted by pharmaceutical scientists. Following this the first local 
and monograph studies developed during the 2000s to global projects that combined 
Chinese medicine fufang or practice examinations with systems biology methods. The 
code of joining Chinese medicine studies reveals an increasing interest in Chinese 
herbal product research in the late 1990s and early 2000s which developed an 
exchange between Chinese medicine and European pharmacologists, biomedical 
scientists and Chinese medicine researchers. The code consists of four participations 
in Chinese medicine research and the ERC TCM consortium (see Figure 3 which 
depicts their relationships). I will first present one participant in early Chinese 
medicine monograph studies, then, I will demonstrate how this research enlisted other 
scientists in ethnopharmacology research and to the ERC TCM consortium.  
Prof Carl’s participation in Chinese medicine research shows that Germany and 
China co-operated in the first Chinese herbal monographs carried out in Europe. In 
the early 2000s, funding emerged for Chinese medicine and CAM studies, the ERC 
TCM consortium and Cambrella projects. Prof Carl had studied Chinese medicine 
remedies for 30 years. During his PhD in the 1990s, he was asked to investigate 
the quality of Chinese medicinal herbs by studying a species of the Echinacea plant 
genus that was used in Chinese medicine. The plant was one of 250 herbs that the 
Chinese medicine collaborators in Beijing suggested for the use in a TCM clinic in 
Germany. Prof Carl and his fellow students ensured the quality and safety of all 
250 plants for the import to Germany and the use in the TCM clinic. 
The circumstance that led to Prof Carl’s PhD research project started in 1975 when the 
Prime Minister of the Free State of Bavaria, Franz Josef Strauß led a delegation to 




country was severely devastated and Mao Zedong was ill (Erling, 2015). One of Strauß’ 
delegates was the entrepreneur Anton Staudinger. He suffered a severe cardiac 
problem during the journey which required emergency treatment in a Chinese 
medicine hospital where practitioners treated him successfully. A Chinese medicine 
treatment in Chinese hospitals was not uncommon during the 1970s. This was because 
of the Chinese state policy that aimed to integrate Chinese medicine in Western 
medicine settings such as hospitals (see Karchmer, 2010; see also Taylor, 2005). 
According to Karchmer (2010), during the Cultural revolution only a small number of 
Western medicine doctors were available in hospitals who supervised a larger number 
of Chinese medicine practitioners in learning Western medicine and practicing herbal 
medicine, acupuncture and massages. The high number of Chinese medicine 
practitioners was the result of the previous political measurement to reduce costs in 
pharmaceutical and medical supply in rural areas by barefoot doctors during the 
revolution.32 These barefoot doctors were integrated in the hospital setting during the 
1970s. The number eclipsed the integration of Chinese medicine practitioners in 
Western medicine hospitals in the 1970s (Kiely, Goossaert and Lagerwey, 2015).  
After this experience and Staudinger’s return to Germany, Staudinger was convinced 
of the efficacy of Chinese medicine and wanted to set up a TCM clinic in order to 
provide all Germans with this medicine. However, the Bavarian Ministry of the 
Interior, under Strauß, imposed this from happening and would only allow it on the 
condition that the medicine practice and drugs would be scientifically evaluated under 
a scientific advisory board. This aimed to guarantee the safety of all applied Chinese 
medicine drugs for the patients. Staudinger met the condition by establishing a 
committee that included Prof Carl’s PhD supervisor, as well as other scientists and 
physicians from universities in Munich, Frankfurt and Witten-Herdecke.  
Prof Carl performed his first Chinese medicine research in the course of the newly 
established co-operation between his university and the new project of a TCM hospital 
in Bavaria. For the supply and evaluation of the herbs, the TCM hospital and the 
                                               
 
32 Barefoot doctors (chijiao yisheng 赤脚医生) were people trained in Chinese and Western medicine 
as mobile doctors with the aim to reduce pharmaceutical costs and bring them to the countryside (Kiely 




university co-operated with a TCM hospital in Beijing. The co-operator in Beijing 
delivered the clinic with selected and verified herbs and sent Chinese medicine 
practitioners for a specified period to Munich. Prof Carl and other PhD students 
evaluated the 250 selected herbs and compiled the results into single plant monographs. 
For this evaluation, they used thin layer chromatography and high-performance liquid 
chromatography, which were standard technologies for chemical analysis of the herbs. 
With these technologies, they critically evaluated and demonstrated through quality 
controls, the efficacy and safety of Chinese herbal drugs that set the first standards for 
legal requirements in this field. Those monographs were later employed in the Chinese 
medicine pharmacopoeia. Overall, Prof Carl and his supervisor worked for ten years 
on the evaluation of Chinese medicinal herbs. 
Prof Carl’s link to Chinese medicine research describes an early and political 
requirement for the scientific evaluation of Chinese medicinal herbs in order to set up 
of a TCM clinic in Germany. His supervisor, who was a co-operator of the TCM 
hospital, assigned Prof Carl to scientifically evaluate the Echinacea plant in 1991. His 
work in Chinese medicine research demonstrates the same employment type as the 
students in the research projects code in Chapter 6. This type reveals a participation 
through a supervisor who acquired a research project and recruited students in order 
to conduct experiments. Hence, Prof Carl decided to take on the job as a doctoral 
researcher in pharmaceutical science and examined a Chinese herbal plant according 
to the standards of European medicinal plant research. Through his PhD project, he 
established a vast network of Chinese medicine practitioners and researchers in China 
and Germany.  
Prof Jakob is another pharmacological scientist and ethnopharmacologist, who studies 
the use of medicinal substances using traditional knowledge and customs. Compared 
to Prof Carl, Prof Jakob does not present an early participation in Chinese medicine. 
According to his observation, the interest of Western scientists in Chinese medicine 
and other alternative medicine studies emerged in the mid-1990s. Prof Jakob claims 
that this was related to the foundation of the new journal Phytomedicine in 1994 by 
the scientific board member of the TCM clinic in Germany, which I elaborated on in 
Prof Carl’s participation above. This correlates with the commercialisation and 




Chapter 2. The journal Phytomedicine provided a platform for a scientific investigation 
of medicinal plants beyond the conventional biomedical paradigm (see, for example, 
Phytomedicine, 2015).  
Similar to Prof Carl, Prof Jakob argues that the two fatal renal failure cases in Belgium 
in the 1990s caused the demand of scientists to evaluate Chinese medicine. In Belgium, 
two young women died of kidney failure after the uncontrolled intake of a Chinese 
herbal slimming product. The slimming product included the toxic plant Aristolochia 
fangchi (fen fang ji 粉防己) as a replacement for the initially used and safe herb 
Stephania tetrandra (han fang ji 汉防己)33, which in most cases causes nephropathy. 
Nephropathy is a disease or dysfunction of the kidneys. Prof Carl argues that the fault 
for the nephrotoxic cases was the lack of regulation on Chinese medicine drugs in 
Belgium. Belgium regulated Chinese medicine drugs under the food supplements law 
which permitted the purchase of Chinese medicine slimming products over the counter 
without restrictions or instructions about their intake. Thus, the Belgium case, or also 
called the “Chinese Herb Nephrotoxy”, evoked public concerns about the safe use of 
Chinese medicinal products and the urgency to ensure the safe use of Chinese medicine 
remedies (see, for example, Heinrich et al., 1998; Dobos et al., 2005). In contrast, other 
countries such as Austria controlled all kinds of drugs under the Medicines Act.  
In the 1990s, another interest group emerged beside Chinese medicine, the CAM 
researchers. Prof Jakob argues that the Chinese medicine project Konstrukta started 
with clinical research in the TCM clinic in Germany and investigated both Chinese 
medicine, and other natural medicines. With the establishment of the TCM clinic, 
came the first evaluation of Chinese medicine. Thus, it was logical for the associated 
scientists to continue with this research by starting the journal Phytomedicine. Slowly 
after the journal was founded, funding structures for Chinese medicine research 
unfolded in Europe which also simulated projects in other CAM research fields. For 
example, Cambrella was the counterpart to the ERC TCM project and investigated 
                                               
 
33 The Aristolochia case in Belgium was discussed widely in the scientific field such as Heinrich et al. 
(1998) flagged the problem in the species Aristolochia and not especially the medicine which uses the 
plant. Dobos et al. (2005) discussed the control and regulation of Chinese medicine herbal drugs. Leung 
and Xue (2005) suggested to transform Chinese medicine into an evidence-based medicine because a 




CAM practices and legal regulations in the EU member states. In 2007, the ERC 
awarded Cambrella researchers a EUR 1 million grant from Framework Program 7 
(FP7). According to Prof Jakob, unfortunately, the Cambrella project did not continue 
after producing the final report for the ERC. As he says: “That [Cambrella] never really 
took off. Like many of these projects, the output was rather modest.” In contrast, the 
ERC TCM consortium continued with the Traditional Chinese medicine research 
association (TCM RA). 
According to both Prof Carl and Prof Jakob, the ERC TCM funding was the first 
European Union-wide funding for Chinese medicine in combination with cutting-edge 
technology (see Table 2 for a detailed account on ERC TCM projects). Prof Jakob 
remembers that the ERC TCM consortium funding was introduced at the conference 
of “TCM in Europe and International Cooperation TCM in Post-Genomic Era” in 2007. 
At the conference in Italy, European Ministers of Health and well-known scientists 
gathered to discuss Chinese medicine in Europe. The ERC initiated discussions about 
the best method to study Chinese medicine. Thus, the following ERC funding call in 
the FP7 program in 2007 aimed to coordinate interested researchers in Chinese 
medicine and systems biology in Europe and other countries.  
The ERC TCM consortium’s structure was divided into a core group of the 
management, the members of the consortium and the called-in experts. With the ERC 
FP7 funding, the consortium constructed a network of 200 scientists and gave them a 
three year timeframe. The consortium decided that omics technologies, as well as 
systems biology, were deemed the most appropriate methods to research Chinese 
medicine.  
Prof Carl functions as a gatekeeper (see Table 3 for more information on the 
gatekeepers) in this research due to his membership at the consortium, his relationship 
with other actors in the Chinese medicine and systems biology research field, and his 
PhD project. With the start of an ERC TCM research project, Prof Carl became a non-
beneficiary member. However, after the completion of the ERC TCM project he 
wanted to verify with omics and systems biology the effect of Chinese medicine; thus, 





Simultaneously, to the conference in Italy, Prof Vera arranged conferences and co-
operation between Austria and China to discuss quality standards in Chinese medicine 
and its use as preventive medicine in the Austrian healthcare system (see the code on 
political networking above). Prof Carl recognises her work and claims that co-
operation with China, such as the Academy of Chinese Medical Science were built due 
to Prof Vera’s contacts and conferences. Prof Vera’s efforts initiated Chinese medicine 
research in Austria. Consequently, in 2007, her university network contacts, such as 
Prof Carl, participated in the ERC TCM consortium.  
Prof Jakob became an expert in the ERC TCM due to his study on Aristolochia plants, 
which was a toxic plant in the Chinese slimming product, as above-mentioned. He was 
called-in as an expert and a non-beneficiary member for in general phytopharmacology 
to find active substances in plants, although he was not a specialist in Chinese Materia 
Medica. Prof Jakob investigated indigenous herbal treatments with the Aristolochia 
plant in Mexico. The results of his research showed that 99% of Aristolochia plants 
contained substances that cause nephropathy. The species of this genus were widely 
used in traditional medicines except in those countries where the plant is not 
indigenous, such as South Australia or South Africa. Through the case in Belgium, as 
above-mentioned, the plant became known as “Chinese herb nephrotoxin”. Hence, 
Prof Jakob argued that nephropathies were linked to certain substances in the genus of 
Aristolochia plants, which aroused among Chinese medicine expert’s criticism. They 
claimed that his argument was, I quote him: “nonsense”, “unfair”, or “it was an 
example of the inability of Europeans to use Chinese medicine drugs properly”. 
However, some recognised that the toxicity of the plant was a global problem that 
required more research. The reaction to Prof Jakob’s argument attracted the attention 
of the ERC TCM members who invited him into the consortium as a non-beneficiary 
member focussing on the safety, quality assurance and analytics of Chinese medicine 
research.  
Another called-in expert in the ERC TCM consortium was the systems biologists Prof 
Frank, whom I introduced in Chapter 5. Prof Frank attracted the attention of the 
consortium with his success in Chinese medicine diagnosis research, which started in 
2005. He supported the consortium with his expertise in systems biology and Chinese 




Netherlands at which some members, such as Prof Carl, transformed the ERC TCM 
into the TCM RA. Prof Frank distanced himself from both, as he did not want to, I 
quote him, “talk 90% of my time to people who are reductionist”. He considered that 
the consortium continued with a reductionist research paradigm, which would not 
address the complexity of Chinese medicine. Rather, the members of the ERC TCM 
would only aim to reconfigure Chinese medicine drugs to “manage” diseases. By 
doing so, the consortium would “isolate Chinese medicine again” by repeating 
reductionist studies the members have undertaken many times before in their 
pharmaceutical careers. The reductionist pattern did not meet Prof Frank’s definition 
of satisfactory development. Thus, he decided to only present his findings at the ERC 
TCM conferences. 
Dr Huang, a Chinese medicine scientist mentioned in Chapter 5, refused to take on 
“active” status as a member of the consortium because she committed her time to other 
projects. However, she was, in her words, “contracted” for the contribution of “some 
ideas”. In contrast to Prof Frank, Dr Huang joined the consortium without any 
concerns about the reductionist paradigm. She gave presentations and advice in the 
work groups of the consortium. In the subsequent TCM RA, which was founded in 
2012 as I mentioned above, Dr Huang took over the co-chair of the regulation of 
Chinese medicine interest group. She also participated in the European Pharmacopoeia 
research project with other members of the ERC TCM consortium and TCM RA which 
aimed to add Chinese medicinal drugs in the European Pharmacopoeia. Hence, her 
status as a called-in expert extended to related projects of the ERC TCM such as the 
European Pharmacopoeia and the TCM RA. This shows that Prof Frank and Dr Huang 
were linked to the ERC TCM (see Figure 3 for the link between the ERC TCM and 
the Chinese medicine diagnosis project). However, their participation was mainly 
representative as it did not affect their Chinese medicine diagnosis project.  
The aim of the ERC TCM consortium provoked discussions among participants. Prof 
Carl’s interest was to control the use of Chinese medicine through the Medicines Act 
that regulated the scientific evaluation and the distribution only through pharmacies, 
as pointed out above. The integration of Chinese medicine under the drug law would 
be necessary to avoid the marginalisation of Chinese medicine. Prof Carl argued that 




which are regulated and controlled in order to prevent them being sold without 
professional (i.e., medical doctor or pharmacist) advice. Additionally, the regulation 
of good practice in Chinese medicine research is necessary to avoid the unjustified 
prohibition of these drugs or plants. Prof Carl believes that Chinese medicine can help 
healthcare systems in treating many chronic diseases that lack appropriate treatment 
in biomedicine. Thus, Chinese medicine should experience a similar development as 
Traditional European medicine (TEM) 34 . Compared to Chinese medicine, many 
European nations recognise TEM products as drugs, as many biomedical drugs derive 
from TEM phytopharmaceuticals. Thus, the examination of TEM products is more 
advanced than Chinese medicine in Europe. Hence, Prof Carl stresses the need for 
more research on Chinese herbal medicine to accomplish the recognition of Chinese 
medicinal products as drugs. 
In contrast, Prof Jakob believed that Chinese stakeholders aimed to integrate Chinese 
herbal medicine in the European Pharmacopoeia. He said that Chinese scientists 
thought that the integration would achieve the approval for the import and 
marketisation of Chinese medicinal products, and the practice of Chinese medicine by 
EU member states rather than the control for its sale and protection of the consumer. 
However, the European Pharmacopoeia is unrelated to the import, the market laws and 
the acceptance of Chinese medicine practice in EU countries (EDQM, 2010). The 
consortium was in Prof Jakob’s perception, a project for the “modernisation and 
globalisation of Chinese medicine”. He compared this project with a “new silk road”35, 
which is a trading route for TCM into Europe. A group of engaged scientists supported 
this undertaking as they wanted to show their skills to integrate Chinese medicine into 
European healthcare services. Prof Jakob criticises the optimism of scientists from the 
outset of this consortium and agrees with Prof Meng’s opinion concerning the lack of 
results in Chinese medicine and systems biology research. According to Prof Jakob, 
                                               
 
34 TEM refers to the history of medical practice in Europe that experiences a renaissance since the early 
2000s (Uehleke, 2007). The practice with European plants is often referred to as Western herbal 
medicine (Waddell, 2016).  
35 The term “Silk Route” refers to a trading route from Europe to Northern China in the second century 




better coordination of the efforts of individual scientists would have increased the 
likelihood of the acceptance of Chinese medicine in Europe: 
“… the Chinese wanted to try somehow to show how great they are. That’s where 
modernisation and globalisation come in. One was more of a roadmap and the 
other was more of a New Silk Road to Europe… because that has such an amoeba 
structure, when such a group of single prima ballerina get together with TCM 
researchers, everyone wants to do something amazing. A lot happens but, in the 
end, nothing happens. And of course, there was a lot of efforts here, how can we 
drive this project, how can we ensure that traditional Chinese medicine is 
accepted in Europe?” (Prof Jakob, 2018, London) 
The consortium announced the successive project at the April 2011 conference in the 
Netherlands. At this conference, the management of the ERC TCM consortium 
declared the project complete. This TCM RA project was organised by some members 
and applicants who lost the funding for the ERC TCM consortium in 2009 (i.e., the 
Shanghai University). Consequently, they transformed the consortium into an 
industrial supported scientific TCM RA that linked Europe with China. The RA 
enlisted sponsors for meetings and devices for metabolomics studies, in return for 
selling the devices to the members of the consortium and RA. The development of the 
consortium into the RA continues with the attempt to push the integration of Chinese 
medicine as a drug, alternative or preventive medicine into healthcare systems in 
European countries.  
The code of joining Chinese medicine studies showed the development and 
participation of scientists in networks like the university network or a large-scale 
project on Chinese medicine research and systems biology. Interview data revealed 
that the interest in studying Chinese medicine appeared first in the 1990s with the 
establishment of the TCM clinic in Germany and the journal Phytomedicine. These 
establishments attracted the interested of many pharmacologists in traditional 





Specific plant studies engaged other scientists such as Prof Jakob with his study on 
widely traditional medicines used and the most toxic plant Aristolochia. For those 
scientists, the safety, quality and efficacy of Chinese medicinal drugs became crucial 
for the regulation, control and integration of Chinese medicine as a medicine in the 
European Pharmacopoeia or the Medicinal Act. Prof Jakob and Prof Vera claimed that 
the project was an attempt to modernise Chinese medicine and to enter the EU 
pharmaceutical market.  
This code demonstrated that a technological and ideological exchange connected 
Chinese medicine with European pharmacologists, biomedical scientists and Chinese 
medicine researchers in the late 2000s. This was financed by the ERC network funding 
which identified 200 scientists and decided that omics technology and systems biology 





7.3 FUNDING AND REGULATIONS  
 
The code “Funding and regulations” draws on data from the literature survey of 
scientific publications to complement the data in Chapters 6 and 7. The data is 
presented in three codes: (i) social demands for changes in the healthcare system, (ii) 
the European Research Council funding, and (iii) Chinese medicine in the European 
Pharmacopoeia. First, a series of social movements and political changes enforced 
European social and scientific interest in Chinese medicine. Secondly, the WHO and 
the EU requested research and policy strategies for Chinese medicine in Europe. In the 
last part of this chapter, I will elaborate on the function of the European Pharmacopoeia 
for Chinese medicine research and regulation.  
 
7.3.1 SOCIAL DEMANDS FOR CHANGES IN THE HEALTHCARE SYSTEM 
 
From the 1980s onwards, European healthcare systems were confronted with structural 
and monetary challenges (van der Greef et al., 2015). Social movements in the USA 
demanded the recognition of CAM as a profession, as well as a better quality in 
healthcare and less expensive caring costs (Hess et al., 2008). The WHO (2002) 
reported a tendency in developed and developing countries towards the use of 
traditional medicine. In their article, Baer, Singer and Susser (2003) argue that in 
developed countries, the shift to traditional medicines increased due to the lack of the 
right chemical drug treatments for chronic diseases, idiopathic and many autoimmune 
disorders in biomedicine. Hence, traditional medicines were for many patients a cheap 
alternative to biomedicine and offered for many chronic diseases, a more appropriate 
treatment that biomedicine could offer for their ailment. For instance, 70% of the 
people in Canada, 49% in France and 31% in Belgium used traditional medicine 
(WHO, 2002). The media in Austria reported in 2005 that pain management therapies 
with acupuncture were popular among the Austrians. Austrians either tried 
acupuncture for once out of curiosity or as a frequent alternative treatment to allopathic 
medicine and chemical drugs with side-effects (“Schmerz: Therapieaussicht kann 




formulated working strategies for its member states to integrate policies, safety and 
efficacy, access and rational use of traditional medicines. The WHO (2002) wanted to 
research the claim of less or no side-effects of traditional medicine drugs and to 
establish policies for traditional medicines to integrate them as moderate approaches 
to chronic or debilitating diseases.  
In developing countries, due to the lack of biomedical drugs available for AIDS, 
malaria or SARS and access problems, economic reasons and belief systems 
contributed to the growing usage of traditional medicine. The population in developing 
countries such as 80% of the African population and 40% of the Asian people relied 
on traditional medicines as a stable source of healthcare rather than biomedicine 
(WHO, 2002, p. 2). For example, a problem with biomedicine in developing countries 
was the non-existing or bad developed technological infrastructure on which 
biomedicine depended on to establish healthcare services and to deliver a diagnosis. 
Another problem was the high ratio between doctor and patients. The WHO (2002) 
reported that in Africa one medical doctor served 40,000 citizens, while the ratio 
between a traditional health practitioner and citizen was 1:500. Consequently, the 
geographical access problems and diagnostic challenges, traditional medicine, such as 
Chinese medicine was favoured over biomedicine. Reflecting on these circumstances 
in the early 2000s, it can be said that biomedicine arrived globally at a critical point 
that challenged to address health issues and lacked effective and cost-efficient 
therapeutic treatments. 
Though in many countries people opt for traditional medicines, only 25 WHO member 
states have implemented regulations for the application and the quality assessment of 
traditional medicines or included herbal products in their pharmacopoeia (WHO, 
2002). To increase the attention on traditional medicine, the WHO published a strategy 
for the implication of good practice in traditional Chinese medicine research in 2002 
(ibid). The Good Practice strategy stressed the need for policies and regulations on 
quality, safety, efficacy, access and rational use of traditional medicines and CAM. 
The WHO (2002) expected the member states to integrate traditional medicines as a 
healthcare package into their healthcare systems, which guaranteed the access to 
medicine independent from financial resources of people or cities where the medical 




Following the request for research and policies by the WHO, in 2002 the ERC funded 
a project on CAM practices, the Cambrella project. According to the Cambrella report 
by Wiesener and colleagues (2010), all twenty-seven member countries of the EU 
adjusted their national legislation to the EU regulations on CAM practice, but a unified 
regulation was missing. In the EU member states, the adaption of the law is a national 
decision. As a result, the degree of adjustment varied immensely between the member 
states and increased a disparity in research on effective therapies in CAM and 
individual practices and practitioners across EU countries. The challenge was to find 
a standard for studies on the safety and efficacy of CAM practices (ibid). For instance, 
Wiesner et al. (2010) reported that Austria legally recognises acupuncture as a 
scientific treatment for pain. However, according to Austria’s Law on Physicians of 
1984, only medical doctors are allowed to practice acupuncture. This law applies to 
any medical practice that requires medico-scientific knowledge or involves any 
therapeutic work on patients. The legislation includes any CAM specialisation, which 
is regulated by the Austrian Medical Chamber diploma (Ärztekammerdiplom). Hence, 
the diploma limits the practice of CAM treatments by medical doctors.  
The regulation of Chinese herbal drugs is a further problem between EU member states. 
The application of the Medicines Act (Arzneimittelgesetz) on Chinese herbal products 
requires the recognition of Chinese medicine as a drug extracted from a natural product 
(ibid). Comparable to medical practice, EU member states have individually strict 
Medicines Acts. For example, Belgium regulates Chinese herbal medicine under the 
food supplements law. Whereas, in Austria, Chinese herbal medicines are drugs, and 
they are only available on prescription in pharmacies (Wiesener et al., 2010). Thus, 
every country in Europe has its definition of whether Chinese medicinal products are 
food supplements or drugs. The demand for regulation and research on Chinese 
medicine by the WHO (2002) and the fragmented laws on CAM in the EU, were 
addressed in other EU funded projects on the control and regulation of Chinese 






7.3.2 THE EUROPEAN RESEARCH COUNCIL FUNDING  
 
The European Research Council (ERC) is a pan-European structure of scientific 
research programs. It founded the ERC TCM consortium. The funding was introduced 
at the first “Sino-European Conference on Traditional Chinese Medicine (TCM) - 
International Cooperation and Perspective in Science and Technology” (short Sino-
European Conference) in 2007. From 27 to 28 July 2007, European Ministers of 
Health and well-known scientists gathered in Rome to discuss Chinese medicine in 
Europe under the title “TCM in Europe & International Cooperation TCM in Post-
Genomic Era”. According to the conference program, Chinese medicine was at its 
core and seen as the political engagement of Chinese medicine between China, Italy 
and other EU states (Sino-European Conference, 2007). The China Academy of 
Chinese Medical Sciences (CACMS) and the Italian National Institute of Health 
(INIH) organised the conference (ibid). The focus of the conference was to bring 
members of the government and European organisations, universities, scientific 
institutes and enterprises together to discuss the policies and regulations for 
Chinese medicine development and products, collaborations for medical product 
development and clinical research for disease treatment with Chinese medicine.  
Interviewees found that the Sino-European Conference was the first attempt to push 
Chinese medicine research and drug marketisation in the EU on a political exchange 
platform (Prof Jakob, 2018, London). This statement can be supported by the list of 
chairs, sponsors and co-sponsors that indicates that the Chinese government and 
Chinese organisations used the conference to push Chinese medicine in the EU. The 
chair was the deputy director from the International Cooperation Department of the 
Ministry of Science and Technology from the People’s Republic of China (PRC) Ma 
Linying. The vice chairs were Zhang Qi from the State Administration of Traditional 
Chinese Medicine (SATCM) and Xu Youjun from the State Food and Drug 
Administration (SFDA) of the PRC. Maria Paola Di Martino from the Ministry of 
Health of the Republic of Italy was the only Italian co-chair in this conference. The 
main sponsor was the Directorate-General for Research in European Commission and 
the co-sponsors were predominantly from China and included the Ministry of Health 
(MOH), the SATCM, the SFDA and the State Intellectual Property Office. Participants 




the WHO and the United Kingdom Trade and Investment (Sino-European Conference, 
2007). Chinese organisations and political players took a central role in the conference, 
which strengthened the argument of China’s plan to marketize Chinese medicine drugs 
in the EU.  
The list of speakers at the conference in Bologna 2007, included members from 
European Commission, health ministers from the Italian, Austrian, German, Danish 
and Chinese governments. Important researchers for the creation of further research 
projects in systems biology and Chinese medicine research were the systems biologists 
Jan van der Greef and Jeremy Nicholson; the pharmaceutical scientist Rudolf Bauer; 
metabolomic researcher Xu Guowang; Chinese medicine researchers Guo Dean, Lu 
Aiping, Fan Taiping, Luo Guoan and the entrepreneur Anton Staudinger. They all gave 
talks about Chinese medicine policies and regulations, pharmaceutical products, 
treatments and cures. All these speakers were selected for this conference due to their 
expertise and participation in Chinese medicine practice and research. For example, 
Nicholson was one of the most cited systems biologists in Chinese research papers 
(see, for example, Zschocke et al., 2005; Luo et al., 2012a; van der Greef et al., 2013; 
Lu et al., 2012; Xu et al., 2013). Luo and his colleagues worked on their book their 
book System Biology for Traditional Chinese Medicine (2012) that discussed systems 
biology as a new way to study Chinese medicine, while also continuing the 
development of Chinese medicine as well as systems biology through experiments 
designs and strategies.  
The highlight of the conference was the introduction of a Chinese medicine research 
project funded by the ERC. On 27th June 2007, Andrzej Rys, the director for Public 
Health and Risk Assessment of the European Commission, introduced a new ERC 
funding for Chinese medicine and systems biology at the conference (Sino-European 
Conference, 2007). This funding supported for the first time in the EU a Chinese 
medicine research project from 2009 to 2011. The FP7-HEALTH-2007-2.1.2-7 - 
“Traditional Chinese Medicine in the post-genomic era” was one of the grants 
introduced for health-related research under the ERC FP7 (EC, 2006).36 This funding 
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was a “Coordination and Action plan” between EU and China and provided a fund to 
“promote and support networking and the coordination of research activities by 
applying functional genomics in the context of Traditional Chinese Medicine” in co-
operation with China (EC, 2007, p. 23).  
The FP7 aimed to promote the ERC as a research area and inaugurated a total budget 
of EUR 50.5 billion (GBP 44.55 billion).37 The ERC invested more than half of it in 
the co-operation and action program (EUR 32 million, GBP 29 million) and EUR 1.1 
million (GBP 968.194) in the ERC TCM consortium (EC, 2012). With a “Specific 
International Coordination Action” (SICA) program, the ERC aided the “International 
Cooperation Partner Country” (ICPC) between the EU and non-European countries 
such as China.38 The reason for China’s status as a special partner was that the EU 
signed an agreement with China as a scientific and technological co-operation partner 
(EC, 2006).39 With the funding decision in 2009, the ERC changed the name of the 
FP7 to the topic “Translational research” in human health by gathering large data 
including systems biology (ibid).  
The SICA funded applications that addressed the networking aspect between various 
institutions to research large datasets of Chinese medicine with systems biology. That 
followed the political aim of the EU to explore good practice with a systematic 
literature review for evidence on the safety and efficacy of Chinese medicine with 
omics technology. Consequently, the project aimed to fund multidisciplinary research 
                                               
 
37 The FP7 program started in 2007 and ended in 2013 (EC, 2007a). The first FP1 started in 1984, and 
FP6 terminated at the end of 2006. The current framework program is the Horizon 2020 began in 2014 
and will run until 2020, with a funding budget of nearly EUR 80 billion (ERC, n.d.).  
38 The and allocated the SICA as a third country co-operation program to contribute to turning the Union 
into “the” world’s leading research area. The EU FP7 has to ensure three points: coherence with EU 
policies, complementary programs and the achievement of the Millennium Development Goals (MDGs). 
Thus, the EU invested in world-class state-of-the art research with the principle of excellent research. 
The program included four categories: (i) Co-operation program for transnational and policy defined 
themes; (ii) Ideas program for the research community and investigator-driven research; (iii) People 
program to support individual researcher; and (iv) Capacities program to support research capacities 
(EC, 2006). The ERC TCM gained funding under the co-operation program. 
39 In 2007, the EU provided funding to the International Cooperation Partner Country (ICPC), in this 
case China, so that organisations from third industrialised countries can carry out research. Such 
programs aimed to support global health issues like malaria, tuberculosis, and other epidemics or mutual 
benefit of bi-regional co-operation, e.g., healthcare systems. The combination of EU and Chinese 
scientists fulfilled the SICA project requirements of two participants from two different Member States 




for developing new knowledge and methods that addressed European healthcare 
problems, as well as those in developing countries (EC, 2006). Concurrently, some 
members of the ERC TCM project examined Chinese medicine drugs for the 
integration in the European Pharmacopoeia as presented next.  
 
7.3.3 CHINESE MEDICINE IN THE EUROPEAN PHARMACOPOEIA 
 
The European Pharmacopoeia Commission (EPC) addressed the growing demand for 
Chinese medicine by organising a conference in 2010. In this conference, stakeholders 
like the Chinese Pharmacopoeia Commission, the SATCM of the People’s Republic 
of China and the National Key Laboratory of TCM Quality Control discussed safety 
issues of Chinese medicine. They signed a Memorandum of Understanding in 2011 
with the European Pharmacopoeia to reinforce their co-operation for the protection of 
public health (EDQM, 2010).  
Gerhard Franz, a member of the ERC TCM, formed and chaired the TCM working 
party of the European Pharmacopoeia research team, which was the Consortium for 
the Globalisation. The members aimed to reinforce monograph research on Chinese 
medicine for the integration of Chinese herbal drugs into the European Pharmacopoeia 
(EDQM, 2011, p. 38). However, the EPC, as part of the Council of Europe, regulates 
the development, production and marketing process of drugs. The EPC accepted 
several Chinese herbal products based on the standards of biomedical drugs, for 
example, the quality of medicinal drugs, the safe use for patients and the free 
movement of drugs in Europe (EDQM, 2011).  
Nevertheless, the approval of Chinese medicine practice is part of the general CAM 
legislation, which each EU member states individually regulate (see Section 7.3.1). 
According to the legislation and Prof Jakob’s assumption about the EPC regulations, 
the EPC does not regulate the implementation or the practice and use of Chinese 
medicine. Consequently, the integration of Chinese medicine drugs in the European 







This chapter showed from interview material and the results from a literature survey, 
three codes of political networking, joining Chinese medicine studies and funding and 
regulations. The scientists in this chapter participated in the ERC TCM consortium 
due to their experience in previous projects. They were members of the Dalian-Leiden 
collaboration, political networking with the university network organisation, specific 
plant research or the TCM clinic research on Chinese medicine in Germany. They all 
became part of the ERC TCM after they were invited to join the consortium as advisors. 
The expertise of the five scientists (Prof Vera, Prof Carl, Prof Jakob, Prof Frank 
and Dr Huang) was valuable to the ERC TCM to identify and enlist 200 scientists 
in the first ERC funded co-operation and networking project.  
This chapter presented the results to the question how the participation of human and 
nonhuman actors influences the development of this “interface”? The data showed that 
a series of action between organisations such as the WHO, and individuals such as 
scientists or researcher established research projects that developed to international 
consortium and co-operation in Chinese medicine and systems biology. This was 
shown with three main reasons why the ERC funded the ERC TCM project. First, the 
WHO addressed the problem of the increased use of traditional medicine by publishing 
a report with the research and policies in this field internationally. Second, the specific 
legislation across European countries showed a lack of consistent regulation and 
control of drugs. Thirdly, European scientists expected to decrease healthcare costs by 
discovering new single active compounds in Chinese herbal drugs for the development 
of new drugs. Some smaller projects continued with either the continuous intention of 
the twentieth century to globalise and modernise Chinese medicine or the efforts to 
integrate Chinese medicine drugs in the European Pharmacopoeia. 
In the codes of political networking, the process of generating networks and enlisting 
scientists and politicians in the research in first Chinese medicine then in Chinese 
medicine with systems biology. Thus, the code of political networking revealed how 




became an organisation platform for Chinese medicine conferences in Austria and the 
main political and academic contact source for the ERC TCM consortium.  
The joining Chinese medicine studies code revealed the scientific aspect of the 
participation in Chinese medicine studies in the 1990s. The interest in Chinese 
medicine research in Europe emerged from the co-operation between the TCM 
hospital and universities in Germany as well as the new journal of Phytomedicine. This 
stimulated a broader interest in Chinese medicinal products and other traditional 
medicines research. One of the presented actors was Prof Carl. His participation in 
Chinese medicine research stemmed from his PhD research which supported the 
establishment of a TCM clinic in Germany. The other actor was Prof Jakob who was 
invited to join the ERC TCM studies through his work on the plant Aristolochia. Prof 
Frank and Dr Huang were invited to the ERC TCM consortium as they conducted the 
first studies on Chinese medicine and systems biology. Additionally, Dr Huang 
contributed to the integration of Chinese medicine drugs in the European 
Pharmacopoeia, while Prof Frank not only contributed as a presenter, but also as an 
organiser of the final ERC TCM conference in Leiden in 2011. With the finalised 
projects, the actors published their findings in 2011 and 2012, which explains the high 
number of publications in these years (see Figure 1), as presented in Chapter 3.  
The focus of the ERC TCM was the assessment of research methods and standards for 
Chinese medicine drugs and their efficacious use. Simultaneously, the question of the 
best method for the evaluation of Chinese medicine drugs generated networks that 
connected universities, politicians and the industry to the ERC TCM consortium. Some 
of the identified scientists, such as Prof Carl and Dr Huang, continued in the successive 
association of the consortium, which intended to globalise Chinese medicine. 
The participation of the five actors was often regarded as a professional obligation and 
implied a degree of apprehension with regards to the aims of the ERC TCM 
management team. Prof Jakob and Prof Vera expressed their concerns about the 
aspirations to globalise and to marketize Chinese medicine. This aim was made evident 
by the successor of the consortium, the TCM RA that continued with the use of 
Chinese medicine as an export product to the European market. In their viewpoint, 
Chinese medicine developed in the direction of commercialisation of Chinese 




marginal interest in sciences into a European and Chinese co-operation project that 
established network, organisations and departments of Chinese medicine research. 
The results from this chapter and Chapters 4, 5, and 6 will be analysed together and 







In this chapter, I will analyse the life stories descripted by the codes presented in 
Chapters 4, 5, 6 and 7 in modes of a heterogeneous network, vision and vocation, to 
address the following research questions:  
 
1. Is there an “interface” and if so, can this latest contact between Chinese 
medicine and systems biology be referred to as an “interface” and what is its 
nature?  
2. How does this “interface” differ from previous encounters between Chinese 
medicine and modern science and Western medicine? 
3. How did the actors become involved in Chinese medicine and systems biology 
research?  
4. How did the participation of the human and nonhuman actors in Chinese 
medicine and systems biology research influence the development of the 
relationship between Chinese medicine and systems biology? 
 
Research Question 3 which examines how actors became involved in this “interface” 
is intertwined with the questions about the emergence and development of this 
“interface” (Questions 1 and 4) and the nature of it. I use Law’s (1994) “modes of 
ordering” approach to investigate the meanings (perceptions) and frames (codes) 
gained from thematic coding of ethnographic data (see Chapter 3). The modes of a 
heterogeneous network, vision and vocation explore how the ordering of the emergent 





TABLE 4: QUESTIONS AND MODE OF ORDERING ORIENTATION 
Table 4 presents the mode in which each research questions will be answered.  
 
Question 1: Mode of a heterogeneous network: description and nature of the “interface” 
Question 2: Mode of a heterogeneous network: nature of previous encounters compared to the current “interface” 
Question 3: Mode of vision: emergence and nature of Chinese medicine and systems biology research through personal involvement 
Question 4:  Mode of vocation: nature, emergence and development of Chinese medicine and systems biology research through co-operation  
 
“Modes of ordering” are strategies used to organise meanings and effects (i.e., agency, 
orders, networks, organisations) or collected “bits and pieces” that describe a process 
of how actors and networks emerged into the form they have taken and the place where 
they currently are (Law, 1994, p. 21). The ordering is a way to arrange empirical data 
into patterns, which emerge through various processes and transformations that are 
associated with and performed by “heterogeneous materials”. I will use Law’s (1994, 
p. 23) definition of “heterogeneous materials”, which are, for example, people, 
machines, architecture, texts, talks, decisions, computers or organisations. In the line 
of other ANT theorists (Callon, 1986; Latour, 1987, Law, 1994), Law (1994) argues 
that these materials perform as actors if they transform due to an interaction with other 
materials. For example, a computer is an actor as it consists of various elements and 
devices that process data through the interaction of these parts. Hence, in summing up 
Law’s (1994) definition, this means that various actors belong to different classes of 
things (humans or non-humans) that co-evolve to new things.  
In this chapter, I will first describe the concepts I use to carry out the analysis. I will 
then show how I apply these concepts to structure my analysis. Following this, I will 
present my modes of (i) a heterogeneous network, (ii) vision, and (iii) vocation. In the 
first mode of a heterogeneous network, I analyse the perceptions, descriptions and aims 
of the systems biologists and Chinese medicine researchers (the actors) and their 
relationship between Chinese medicine and systems biology. My argument is that 




which describes the nature of this “interface”. Secondly, the mode of vision reveals 
the involvement of the actors after a change from their comfort zone in their research 
area in science and biomedicine, to a traditional medicine or an enhancement of their 
academic career. Finally, in the last mode of vocation, I analyse how the participation 
of various actors and their co-operation with various field sites (see Table 2 for partner 
institutions and Figure 3 for linkages between sites) influenced the development of 
their relationship between Chinese medicine and systems biology.  
To understand “modes of ordering”, stories that describe and explain the relationships 
between Chinese medicine and systems biology and their context are needed in order 
to gain a “thick description”.40 Law (1994) argues that stories indicate patterns and 
relationships that order sociotechnical networks through relational materialism. With 
regards to relational materialism, Law (ibid) refers to Foucault’s discourse analysis, 
which in his opinion is concerned with the question of how materials perform 
themselves and generate effects, such as strategic arranging. Law (ibid. p. 95) uses 
relational materialism to perform a discourse analysis by taking “the notion of 
discourse and cut[ting] it down to size”. This means: “first, we should treat it [the story] 
as a set of patterns that might be imputed to the networks of the social; second, we 
should look for discourses in the plural, not discourse in the singular; third, we should 
treat discourses as ordering attempts, not orders; fourth we should explore how they 
are performed, embodied and told in different materials; and fifth, we should consider 
the ways in which they interact, change, or indeed face extinction”. This means that 
patterns are “imputed” to his stories as a way to identify and determine his mode. 
However, as my aim is to stay close to the material, I use the thematic codes described 
in Chapters 4, 5, 6 and 7 to generate patterns for modes, and develop from those, a 
detailed analysis of the involvement and process involved in developing a relationship 
between Chinese medicine and systems biology.  
 
                                               
 
40 Thick description describes and explains actions, such as, human behaviour and in which context 
these actions occur. Context information can be biographies, historical information on the cause of the 





Following Law’s (1994) stories approach, I employed multi-sited ethnography to 
detect multiple discourses that form “modes of ordering” and materials, which are 
performing relationships and associations. I collected stories including life stories and 
narratives about how research interests, projects and funding were generated and how 
relationships between the actors of Chinese medicine and systems biology, academia, 
industry and politics and nonhumans in the form of fluids, solvents, machines, 
organisations, governments and funding play into the creation of scientific and 
technological achievements in Chinese medicine and systems biology research. As a 
result, the “modes of ordering” present in-depth descriptions of the various processes 
of ordering of the relationship between Chinese medicine and systems biology. 
However, as ordering is a process; it has to be viewed as a verb that continually enacts, 
performs and generates (Law, 1994). This means that modes are never complete and 
can be interpreted in many other ways than, for instance, I present them in this thesis. 
The process of ordering generates a “centre of translations” (Law, 1994, p. 104). 
According to Law (1994), a “centre of translation” is a place where representations of 
actors and actions are generated and gathered. The “centre of translations” strains for 
reflexivity and self-reflexivity by monitoring the situation and happenings and makes 
calculations to act upon those observations. Thus, the “centre of translation” gathers, 
monitors, makes, simplifies, calculates and acts upon the flow of “immutable mobiles” 
(ibid) that are transported from and to the periphery. “Immutable mobiles” are 
materials that are easy to transport for dissemination and communication, and always 
maintain their shape (Law, 1994, p. 104; see also Latour, 2011). These can be seen in 
the forms of research papers, print material, money, a postal system, cartography, 
navigation, ocean-going vessels, cannons, gun powder or telephony (Law, 1994). In 
Law’s (1994) discourses, he differentiates materials between more and less durable 
materials and those various materials represent and control the actions within a mode. 
Accordingly, the periphery is the place where the actor is seen outside the network and 
is the place which is not involved in the reflexive activities.  
The two modes I adapt from Law (1994) in this thesis are: the “mode of ordering vision” 
and “the mode of ordering vocation”. First, the “mode of ordering vision” talks about 
a scientific vision of the future which concerns dreams, order and the practicability of 




genius, a workaholic, a charismatic leader or a decision maker, and who is attractive, 
inspirational, funny, single-minded, and committed to science. The actor has research 
organisations and the public behind his/her actions. Vision is elitist as only a few 
people perform scientific visions which distinguishes them from others. By using his 
“mode of ordering vision”, I analyse the involvement of systems biologists in Chinese 
medicine research as a change from their comfort zone in their discipline - science and 
biomedicine - to a traditional medicine. This mode reveals the scientific visions of 
actors that guided their involvement in Chinese medicine and systems biology studies 
and shows how they attracted with their vision, other scientists and funders. This mode 
demonstrates first how systems biologists decided to change from science to Chinese 
medicine, which is often referred to as a “non-scientific field” (Ward, 2011, p. 69), 
and then how they engaged with Chinese medicine practitioners, researchers, theories 
and materials.  
The “mode of ordering vocation” orders the stories of the scientists’ dedication to their 
job and the value they associate with it (Law, 1994). People in the vocation mode 
embody skills, expertise and importance, character and the required knowledge and 
training needed for a certain position. This mode portrays a person with the necessary 
qualifications or a person who has access to a research position and is able to creatively 
solve puzzles, is a self-starter and approaches ranking challenges such as publishing. I 
will use Law’s (1994) “mode of ordering vocation” to analyse the participation of 
actors in systems biology and Chinese medicine research projects or in the ERC TCM 
consortium. Visions, beliefs, and aspirations of the inner circle such as complexity or 
holistic research methods were not in the foreground of their participation in research 
projects. In contrast, what I call the actors in the mode of vocation, the outer circle, 
were either interested in a research position, or they were invited into Chinese 
medicine and systems biology projects due to their expertise in technology or 
biochemistry. Scientific activities and presentations of the inner circle’s work attracted 
the actors of the outer circle and recruited them in a variety of ways. Therefore, the 
mode of vocation analyses participations, job positions, funding and networks as a 
motivation to participate in the research projects between Chinese medicine and 
systems biology. Both modes of vision and vocation inform us about the involvement 
of the actors in Chinese medicine and systems biology. The difference between them 




creative ways to find solutions to their professional and private lives. Vision is more 
personal as it describes aims beyond the current or the next research project and it is 
about changing approaches in medical research and medicine in the long run.  
The mode of a “heterogeneous network” describes the perceptions and nature of the 
“interface” between Chinese medicine and systems biology through translations and 
“immutable mobiles” to establish co-operation (see Table 4 for modes of 
heterogeneous network). I use Law’s (1994, p. 23) definition of “heterogeneous” to 
mean different kinds of materials (omics technology, computers), organisations, and 
people for example agents, which are effects of a network of various materials (i.e., 
machines) or people. According to Law (1994), the word “network” describes 
associations between various human and nonhuman actors that create patterns. Hence, 
a heterogenous network denotes the kind of actors and their ways to generate and 
perform relationships. Consequently, a homogenous network consists of associations 
between either humans or nonhumans.  
The mode of a heterogeneous network is informed by the work of Moser (2005) who 
applied the “modes of ordering” to study disability with analytical tools outside the 
conventional approaches of disability studies and its focus on dualism of normal and 
not-normal. She collected life stories of disabled people in multiple sites in Norway 
and ordered them according to the perception of the actors and their interaction with 
technology that defined modes of normal, lack, fate and passion. I want to analyse 
various perceptions and descriptions of the relationships between Chinese medicine 
and systems biology in ethnographic data and life stories of various actors in multiple 
sites in Europe, China and Japan. Thus, this mode of a heterogeneous network aims to 
preserve the perceptions of the actors and the network character of a multi-sited 
research in Chinese medicine and systems biology, and also “cut down in size” the 
discourse of research projects and co-operation by showing “how ordering is done and 
how it enacts itself in different material forms” (Moser, 2005, p. 671).  
This chapter will first analyse the mode of a heterogeneous network. It will then 





8.1 THE MODE OF A HETEROGENEOUS NETWORK 
 
The mode of a heterogeneous network will be used to answer Question 1. It 
investigates which actors such as materials, machines or people are associated with 
this “interface” and how they generated and performed in relationships while 
researching Chinese medicine with systems biology. This mode orders the various 
perceptions and description of the actors I have interviewed in (i) co-operation, (ii) 
biochemistry and (iii) omics technology as a bridge of what the nature of this “interface” 
is and how it was built between Chinese medicine and systems biology. The projects, 
I refer to, are the Dalian-Leiden co-operation, the ERC TCM consortium, the Harbin 
research group, and the systems biology expert and AI scientists. I will first focus on 
the description of the co-operation or bridge. Biochemistry and technology will be 
discussed later in this section. 
 
8.1.1 CO-OPERATION AS NETWORKS OF EXCHANGE 
 
Most of the interviewed actors in Dalian and Leiden did not refer to the research 
relationship between Chinese medicine and systems biology as an “interface”, they 
referred to it as a “co-operation”. Co-operation was described as an exchange of 
materials. Some referred to technology and biochemistry to describe the connection 
and the translation between Chinese medicine and systems biology (George, Harbin 
team, Prof Carl). The materials in this mode of a heterogeneous network were: systems 
biologists, pharmaceutical scientists, biochemists, Chinese medicine researchers, 
politicians, molecules, omics technology, samples, zhengs, publications, reports, 
funding, organisations, patents, drugs and concepts. “Centres of translation” (Law, 
1994) were the Leiden team, omics technology, principal investigators and supervisors, 
AI, the ERC TCM management team and collaborators. “Immutable mobiles” 
connected materials between the different human and nonhuman actors and products 
of omics and biochemistry analysis, research papers, experiment protocols, biofluids, 




According to the description given by the actors, co-operation refers to two things: the 
exchange of materials and students. I argue that co-operation generated “centres of 
translation” (Law, 1994) that were constituted through the interaction between 
scientist and materials, which are listed below. First, the Dalian-Leiden groups 
consisted of systems biologists and molecular biologists who described their co-
operation as the exchange of materials and distribution of conceptual ideas for their 
studies on Chinese medicine and systems biology. Materials were omics technology, 
analysis results, experiment protocols, research papers, funding, concepts, samples and 
protocols. The Dalian team co-operated because they had a special interest in omics 
technology and the different ways it could be used to apply analytical tools in 
pharmaceutical research by trading materials for technological knowledge. Thus, it is 
evident that omics technology played a fundamental role in the establishment of this 
co-operation. The use of omics technology as the latest technology with its 
multivariate analysis attracted and convinced the Dalian group to agree to this co-
operation (as described in the mode of vocation). Omics technology represented for 
the Dalian group, a new way to interpret data for their metabolomics studies, which 
meant technological advancement and new funding resources from Chinese medicine 
sponsors.  
The second exchange was the exchange of students. According to Law (1994), bodies 
are “immutable mobiles”, which transport and disseminate information between the 
periphery and the centre. As above-mentioned, the Leiden group acted as a “centre of 
translation” in the exchange of students. This means, the students (Lingma and Long) 
performed a transmission of information by moving to and conducting their research 
in Leiden. They absorbed the concepts and analytical methods of systems biology to 
investigate Chinese medicine from professors and the research team in Leiden, which 
they then transmitted to the Dalian group. In return, the Dalian students shared their 
knowledge of the usage and maintenance of technology with the Leiden group. In 
contrast, the Leiden students (George and his fellow students) learned from materials, 
such as samples and wet experimental data. As a result of this co-operation, the Dalian 
students benefited in terms of learning support and by sending three students to Leiden 
for a period of one to three years. While the Leiden students acquired samples, 




In “modes of ordering” terms, the Leiden team represented the “centre of translation” 
due to their expertise in systems biology and analytical knowledge.  
Another type of “immutable mobiles” were experiment protocols that represented 
problems during the co-operation between Dalian and Leiden. Experiment protocols 
should have distributed experimental data. The research design depicted every step in 
the experiment so as to prevent mistakes. However, the students did not follow the 
design, thus, the experiment protocols lacked information on the exact experiment 
procedure including sample handling and preparation. Against the common 
assumption that communication suffered as a result of a language barrier between 
English or Dutch and Chinese, or the technical language of chemistry, there was the 
added issue of documentation and not following the research design. Consequently, 
the details were not transmitted to the Leiden group, which they needed to perform the 
analysis. Based on the results of the research and relationship performance, they 
calculated the value of this co-operation and ended it once the research had finished. 
The lack of data distribution was not a problem in any other co-operation; therefore, it 
was not calculated as a risk in the study design of the Leiden team. Hence, it was the 
issue of storing and sharing information between human actors that influenced the 
achievement of the Leiden and Dalian project and future co-operation.  
To sum up, Chinese medicine researchers and systems biologists co-operated through 
concepts and biofluids, which generated a platform for the exchange of expertise in 
analysis and technology. In addition, this co-operation aided the exchange of students, 
samples and data between the teams in Leiden and Dalian. This platform provided the 
students with workshops and training in Dalian and a distribution channel for data sets 
and batches of blood and urine samples from patients in Dalian to the laboratory in 
Leiden. Thus, the co-operation between Dalian and Leiden was an exchange of 
biochemical data and analytical and technical knowledge, and revealed ways on how 





8.1.2 BIOCHEMISTRY AS THE CENTRE OF INTERACTIONS  
 
Biochemistry appeared a couple of times at the heart of the relationship between 
Chinese medicine and systems biology. I argue that biochemistry is an “immutable 
mobile” as it is transportable in the form of samples or as the analysis of a paper, and 
it does not change its form. In terms of relational materialism, the results of a 
biochemical analysis are durable and transportable in written form on paper, and also 
in digital form as a set of chemical elements. The results of a biochemical analysis are 
not transformed when they are transferred between systems biology and Chinese 
medicine. 
Most of those interviewed argued that biochemistry connects the two fields as 
molecules at the lowest level in an organism, thus, molecules are the right place to start 
the investigation into the relationships between Chinese medicine with systems 
biology. This interpretation was informed by the knowledge that both sides understand 
biochemistry. It is obvious that systems biology, as a branch of biology and a 
multidisciplinary field of biologists, chemists, engineers and bioinformaticians 
comprehends biochemistry and molecules. The understanding of biochemistry in 
Chinese medicine is not so obvious. Hsu (1999) and Taylor (2005) argue that the 
integration of natural sciences in Chinese medicine curriculum and research happened 
in the 1960s. As a result, biochemistry represents data to connect Chinese medicine 
and systems biology through a common language. Put this way, biochemistry is an 
“immutable mobiles” because the data is critical for systems biologists and Chinese 
medicine researchers to prove their relatedness of a holistic and system-level 
understanding of the human body. Thus, biochemical analysis conveys vital 
information about both sides and both sides are able to interpret it with their own 
concepts. Following this, biochemistry performs a relating function between Chinese 
medicine and systems biology, as without biochemical analysis their communication 
and interaction is reduced or even inexistent. Therefore, biochemistry is the centre of 
actions. Based on biochemical information, the actors can calculate and adapt an 
analysis or the preparation of a sample. However, without a biochemical analysis, the 
study of any Chinese medicine drug or biofluid analysis would not be possible. 
Therefore, concerning research Question 1 which asks about the nature of this 




medicine with any field that understands biochemistry including systems biology or 
biomedicine.  
As a result, the “interface” is not only represented through human interactions but also 
as a relationship between humans (for example, systems biologists, pharmaceutical 
scientists, Chinese medicine researchers) and nonhumans (biochemistry and omics 
technology). Human and nonhuman actors interacted through biochemical analysis, 
sample preparation or publications, while the human actors used analysis data and 
samples for their co-operation. Besides extracting data, biochemistry generated 
reliable evidence for Chinese medicine through which the projects on Chinese 
medicine gained more attention from different stakeholders. However, to produce 
biochemical evidence, omics technology was required, which will be elaborated on in 
the section on mode of vocation (see Section 8.4).  
 
8.1.3 OMICS TECHNOLOGY AS THE CENTRE OF ORDERINGS  
 
Omics technology takes a central position in the relationship between Chinese 
medicine and systems biology. Omics technology functions as a “centre of translation” 
for biochemical analysis and as an actor. Firstly, it is the “centre of translation” as it 
controls the data of biochemistry as an “immutable mobiles” that moves between 
omics technology, systems biology and Chinese medicine. Most of the research in 
Chinese medicine is performed on active compounds research in fufangs of a 
maximum of twelve herbal ingredients, which consist of thousands of chemical 
components. In order to discover active compounds, omics technology is a crucial 
technology. In this case, omics technology performs a biochemical analysis. Due to 
this, omics technology is the “centre of translation” and biochemistry is an “immutable 
mobile”. 
Omics technology in its second function is an actor that represents a network of various 
materials, which are assembled by other machines, constructed by engineers and run 
by scientists. In the mode of a “heterogeneous network”, omics technology interplays 
with human actors and by doing so decentres them. Law (1994) argues that the agency 




networking associations that affects an agency. In the case of Chinese medicine and 
systems biology, omics technology orders the relationship between Chinese medicine 
and systems biology. This ordering happens through accumulating evidence for 
Chinese medicine efficacy and safety. It orders the biochemical analysis by 
determining the sequence of the analysis. As I argued above, biochemical analysis is 
the central means of communication and co-operation between the two fields. Thus, 
both fields are linked by omics technology. For systems biologists, omics technology 
embodies the method to accomplish holistic studies on all levels in a living organism. 
While for Chinese medicine researchers, it embodies the hope to prove the efficacy 
and in detail the effect and actions of Chinese medicine drugs and practices. Hence, to 
identify the molecules and their actions, scientists in this heterogeneous network 
needed omics technology. To put it in other words, omics technology is the effect of 
the efforts of systems biologists and Chinese medicine researcher to study the complex 
system of Chinese medicine in combination with various technologies (as seen in 
Chapter 5). Consequently, I argue that omics technology is an actor in this mode which 
orders the production of analysis data and facilitates communication between Chinese 
medicine and systems biology. It is clear therefore that omics technology and 
biochemistry are both at the centre of the attention and actions of Chinese medicine 
researchers and systems biologists.  
In conclusion, in the mode of a heterogeneous network I answered Question 1 by 
demonstrating that the term “interface”, as a description for the relationship and the 
research activities between Chinese medicine and systems biology, was not used by 
Chinese medicine researchers or systems biologists who had already conducted 
research in this area. Instead they referred to the nature of the relationship between 
Chinese medicine and systems biology as a co-operation or as it being a bridge 
between biochemistry or technology. Co-operation was described as the exchange of 
materials. I argue in the example of the Leiden group that they acted as a “centre of 
translation” in their co-operation with the Dalian group and that the “centre of 
translation” (the Leiden group) controlled and monitored the exchange and distribution 





Concerning the nature of the relationship between Chinese medicine and systems 
biology, the actors described an interaction based on the shared understanding of 
biochemistry. Biochemistry described the basic level of the human organism, thus, the 
actors anticipated that it would deliver information on the changes that occurred in a 
human organism through medical interventions. Thus, I analysed biochemistry as 
immutable mobile and omics technology as nonhuman actor as they were essential for 
the communication and establishment of the interaction between Chinese medicine 
researchers and systems biologists. Omics technology performed a role as the “centre 
of translation” between both sides, as well as an agent. This agency was an effect of 
establishing a research method for systems biology research on Chinese medicine. 
Omics technology represents a network of biochemical analysis and various machines 
as cutting-edge technology. Resulting from the various descriptions and performances 
in multiple locations, I argue that the nature of the relationship between Chinese 
medicine and systems biology is a heterogeneous network that is constituted by human 
and nonhuman actors such as biochemistry, omics technology, as well as human actors 





8.2 THE DIFFERENCES AND SIMILARITIES TO PREVIOUS ENCOUNTERS 
 
In order to answer the second research question of “How does this ‘interface’ differ 
from previous encounters between Chinese medicine and modern science and Western 
medicine?” I will compare historical accounts that focus on encounters between 
Chinese medicine and modern science and which are found in publications on the 
history of Chinese medicine with publication in Chinese medicine and systems 
biology after 2005. 
In the 2000s, the new effect on the interactions between Western medicine or modern 
science and Chinese medicine, was that scientists of different nationalities and 
disciplines interacted on a research platform to study Chinese medicine. This was an 
effect of the dialogue systems biologists had initiated with Chinese medicine 
researchers, practitioners and Chinese scientists. Systems biologists looked to the East 
for new ideas like, for example, what was witnessed in the 1970s when systems 
scientists such as Bateson and Grey studied Eastern philosophy and practices with their 
“Western science” approaches (see Section 4.4.3 and Pickering, 2010). Instead 
systems biologists approached Chinese medicine researchers and conducted Chinese 
medicine research with them to overcome the bottleneck of reductionism in Western 
science and medicine. They aimed to learn from Chinese medicine a holistic 
understanding of medicine and bianzheng lunzhi diagnosis for the establishment of 
personalised medicine and individualised treatments. The difference was that Western 
systems biologists approached and communicated with Chinese medicine researchers 
and scientists (see Chapter 2). Their communication was made possible as a result of 
the integration of modern science and systems theory in Chinese medicine which took 
place in the late twentieth century. 
The nature of the historical encounters was described by Rogaski (2004), as either 
being co-operative or coercive. Systems biologists and Chinese medicine researchers 
agreed on the definition of their research as co-operation. Even though this 
characterisation changed with the advancement of this relationship, it did never 
become coercive. As I showed with the analysis on co-operation (see Section 8.1.2) 




interactions by training students in Chinese medicine and systems biology. The 
interactions linked various actors and projects to become a heterogeneous network. I 
illustrated this effect with the example of the ERC TCM (see Section 7.2), which 
connected various actors and their networks to an international networking and 
coordination project. As a result, the nature of this “interface” was co-operative. It 
consisted of a globally distributed network that correlated various interests from 2009 
to 2011 in one representational project, the ERC TCM consortium. Hence, I suggest 
the term “heterogeneous network” for the description of the relationship between 
systems biology and Chinese medicine, instead of the term encounter or “interface”.  
A crucial difference from past encounters is that systems biologists engaged with both 
Chinese medicine practice and medicine researchers before they first conducted a 
study on Chinese medicine. This is evident in the Chinese medicine researchers’ 
interviews, rhetoric and visions (see Chapter 5), which stress the fact that systems 
thinking and holism are integral parts of Chinese medicine and systems biology. They 
perceived that both fields match on the common ground of systems thinking and 
holism, thus, systems biology was adequate to study Chinese medicine on its terms. 
This contrasts with the political oppression of the political agenda of implementing 
Western science, standardisation, curriculum and theories in Chinese medicine during 
the twentieth century. The engagement of systems biologists with Chinese medicine 
on shared concepts, makes a crucial difference to previous encounters. That is, that the 
actors established a co-operation and did not enforce the implementation of Western 
scientific concepts in Chinese medicine (see Section 4.4.4). 
Against the perception of those interviewed that believe that systems thinking and 
holism are integral parts of Chinese medicine, the analysis in Chapter 4 shows that 
these two concepts were integrated in Chinese medicine in the 1950s. This means that 
through the concepts of systems thinking and holism in systems biology provided a 
clear match for Chinese medicine. The historical sources showed that they were first 
integrated into Chinese medicine in the 1950 and 1980s, in alignment with the political 
agenda of Mao Zedong and the focus on Engels’ dialectic materialism. As an effect of 
these integrations, under the political agenda, holism was interpreted in the dualistic 
way of yin and yang. Chinese medicine practitioners such as Qin Bowei re-interpreted 




1980s, the political agenda for further standardisation and globalisation of Chinese 
medicine called for the implementation of systems science and cybernetics in Chinese 
medicine, which was supported by the Chinese medicine practitioner Lü Bingkui and 
Chinese cybernetician Qian Xuesen. Similarly, systems biology evolved from systems 
science and cybernetics, which made systems thinking into an integral part of systems 
biology. Thus, the perceived similarity between Chinese medicine and systems 
biology was the shared ideology of systems thinking and holism which derives from 
the same influence of cybernetics.  
The relationship between Chinese medicine and systems biology is only seen and 
understood as being coercive due to the continuous integration of modern science, 
theories and omics technology by Chinese medicine researchers in Chinese medicine. 
In the 2000s, Chinese medicine researchers applied omics technology and systems 
biology to examine Chinese medicine for basic research and evidence production. I 
refer here in particular to Chinese medicine researchers who chose the language of 
biochemistry and omics technology to describe the relationship between systems 
biology and Chinese medicine. I interpret the emphasis on biochemistry and 
technology as a process of self-colonialization. According to Noordenbos (2008), self-
colonization describes intellectuals who make themselves dependent on an alien 
culture to define the “Self”. In the process of self-colonization, Chinese medicine 
researchers assimilate the thinking and practice of biomedicine and then enact it in 
Chinese medicine. Karchmer (2010, p. 248) argues that the adaption of a postcolonial 
form of medicine is a “trend of Chinese medicine doctors to achieve ever-greater 
competency in Western medicine”. Karchmer’s (2010) case studies on clinical 
practices in China demonstrated how Chinese medicine practitioners diagnosed 
biomedical diseases by relating them to Chinese medicine bianzheng lunzhi. This 
means that these practitioners rely increasingly on biomedical diagnosis. Interestingly, 
Chinese medicine was affected by several cases of malpractice in China in 2006 when 
an online petition was started which aimed to remove Chinese medicine from the 
Chinese National Health Care System (ibid). This happened concurrently as the 
WHO’s 2002 report demanded good research practice and policies (as discussed in 
Section 7.3.1). Owing to the public discussions on Chinese medicine practice and 
research, I believe that the integration of systems biology and omics technology in 




attempt of Chinese medicine researchers to master Western scientific practice, as any 
other natural science.  
To conclude, the difference between past encounters and the relationship between 
Chinese medicine and systems biology in the 2000s was that in the twentieth century, 
the encounters were aligned to political agendas. These political agendas caused a self-
colonialization by aligning Chinese medicine increasingly to Western medicine to 
secure its survival as a medicine in China. This happened in particular in the 1920s 
and 1950s. Also, past encounters were confrontations between Chinese practitioners 
of Chinese medicine and doctors of Western medicine and politicians. In this 
relationship between Chinese medicine and systems biology, the aim to enhance 
scientific practice and to modernise Chinese medicine research continued. However, 
Western systems biologists changed the interactions mode as they approached Chinese 
medicine to learn from this medicine based on the shared theories of systems thinking 
and holism. Nevertheless, the actors did not reflect on the reshaping of Chinese 
medicine during the twentieth century. In fact, in their articles published after 2005, 
they did not reveal any awareness of the integration of systems thinking and holism in 
Chinese medicine. This unawareness, I believe, affected the view of the actors 
involved in Chinese medicine, as they saw it was a perfect “match”, mainly because 
they assumed that systems theory and holism have always been inherent in Chinese 
medicine and in the form they were presented to them, they perfectly fit with the 





8.3 THE MODE OF VISION  
 
The mode of vision will present the process of the involvement of the actors in Chinese 
medicine through their ambitions and interest in complexity and holistic approaches. 
This mode will answer the third research question of how the actors became involved 
in Chinese medicine and systems biology research. To build the order of involvement, 
I will elaborate on the involvement of Prof Frank, Dr Huang, Kevin and George. They 
represent what I call the inner circle of the heterogeneous network of Chinese medicine 
and systems biology research, as their involvement describes the emergence of the 
research relationship between Chinese medicine and systems biology mainly because 
they performed the first studies on systems biology and Chinese medicine. 
Their scientific visions included the want for personalised medicine, the aim to 
improve healthcare systems, acknowledgement and wanting to study its complexity 
and a desire to avoid the exploitation of Chinese medicine. The difference between 
these four actors and the rest of the actors I interviewed and observed, is that their 
involvement in Chinese medicine studies was guided by their aim to fulfil their visions. 
Visionaries were also mentioned by actors in the mode of vocation. Prof Vera and Prof 
Carl argued that the healthcare system in Austria does not change very often because 
of the lack of scientific vision or visionaries. Accordingly, the actors consider visions 
as crucial for change to take place in science and politics.  
The actors involved in the ordering of visions were ambitious, single-minded, highly 
skilled and thinkers. Their involvement in Chinese medicine research evolved over a 
long period, between ten and twenty years from their first time they were introduced 
to their first Chinese medicine study. Notable is that they all were determined and 
persistent to follow their aims and scientific visions, which was not only seen in the 
cases of actors with PhD degrees (Prof Frank, Dr Huang and George) who worked in 
academia, but also in Kevin’s case, as he completed a study in biochemistry and 
worked as a Chinese medicine practitioner. The pattern shows that the codes of 
involvement were built through technology and health, complexity, family and 
exploitation and discontentment with reductionism. This involvement was guided by 




Prof Frank’s vision of a “personalised medicine” aimed to attain a medicine that 
established an individual treatment for each patient and that was informed by the 
individual diagnosis and treatment prescriptions found in Chinese medicine. First, Prof 
Frank’s involvement in Chinese medicine started with his scientific achievement of 
studying biofluids with multiple variables, which paved the way for complex Chinese 
medicine drug studies. In the realisation of this aim, Prof Frank combined various 
machines and analysed his findings with a computer. He controlled the combination 
and the compatibility of the machine and eliminated electric interferences and other 
issues. Thus, he was a “centre of translation” between various machines and engineers, 
bioinformatics, chemists and technicians who supported him for this project. Based on 
the interferences or information given by his technicians and colleagues, he controlled 
the configurations, monitored the outputs and adapted his parameter and 
configurations until he and his team succeeded in combining the machines and run the 
first sample pattern recognition on biofluids with a computer. The combination of 
machines and skilled people started with an experiment on urine samples and 
developed into a method to study biofluids for metabolism studies using Chinese 
medicine drugs. Thus, the vision of Prof Frank’s personalised medicine started with 
an experiment to measure more variables and to gain more information.  
Prof Frank’s vision for a personalised medicine co-emerged with his second 
involvement in Chinese medicine after he experienced a successful treatment with 
Chinese medicine. This experience represented a change in his mindset, and he 
developed an interest in investigating Chinese medicine. I interpret his involvement as 
a re-ordering of his life which enacted a new ordering of his research interest. Prof 
Frank exhibited this by changing his mind set to positive thinking and to a holistic 
study biological phenomenon. The re-ordering of his professional life reflected the 
changes in his private life and these were first characterised by his technological 
achievements and his skills to apply technology to complex studies. Prof Frank 
mentions that his access to technology and his ability to use it, made it easy for him to 
engage first with systems biology and then with Chinese medicine. In addition, this 
shows that he positioned himself at the centre of a technological field, as he was able 
to tinker with technology and develop a new method. This development and his interest 
in systems thinking eased his move from his academic comfort zone in biomedical 




reductionistic research paradigm, to gaining a better understanding of the interactions 
between nature and humans and to acquiring an ecological worldview which he saw 
in Chinese medicine. The final step to the realisation of his vision of a personalised 
medicine happened when he worked with Dr Huang.  
Complexity and holism were crucial concepts in the involvement of George and Kevin 
in Chinese medicine research. Their scientific visions of the acknowledgement and the 
study of complexity in Western science and the improvement of healthcare systems 
and medical research by integrating holism, stress the problem of reductionism in 
science and medical care. George and Kevin’s discontentment with the dominant 
reductionist paradigm in science and medicine affected them both. Firstly, George’s 
changed from a job at the university to researching alternative medicines for a private 
organisation, and Kevin who had studied biochemistry started to study Chinese 
medicine. Kevin became involved in Chinese medicine and systems biology through 
his interest in complexity. Law and Mol (2002) describe complexity as a matter, 
multiple realities, an interest of researchers or a status. In this case, complexity was 
Kevin’s interest that triggered his involvement, in addition, it performed and controlled 
his involvement in Chinese medicine and systems biology. Kevin and George’s 
dedication to find alternative systems and their search for complexity and holism led 
to their involvement first into Chinese medicine practice and Taijiquan and then into 
Chinese medicine and systems biology research. Their return to Western science and 
academia happened because of the novel approach of dynamic self-organising systems 
which are used to study Chinese medicine. Interestingly, however, Prof Frank was 
attracted to Chinese medicine and systems biology, as both used a holistic approach to 
study life and health. Systems biology and Chinese medicine embodied the vision of 
complex and holistic research in Western science.  
The last ordering demonstrates an involvement in Chinese medicine research with a 
vision to avoid further exploitation of Chinese medicine with an adequate research 
method. Dr Huang hoped that a holistic study of Chinese medicine would stop the 
extensive research for active compounds in Chinese medicine. Additionally, she hoped 
that systems biology would allow her to evaluate Chinese medicine fufang to prove its 
efficacy and safety as a whole. Her ordering reveals that she was introduced to Chinese 




molecular biology. However, only with the emergence of systems biology and Prof 
Frank’s interest in Chinese medicine, did she then start to engage with Chinese 
medicine research. This late engagement shows that her research was centred around 
her career and an appropriate approach to study Chinese medicine, which would enable 
her to enhance her academic achievement. Dr Huang was the main collaborator and 
gatekeeper between China and the Netherlands (see Table 3 for her role as gatekeeper 
2). Amongst the four scientists, she had the second highest academic position in this 
mode and was the one who conveyed the idea about a Chinese medicine and systems 
biology study. Thus, she was a scientific visionary for this project, while the other 
actors presented scientific visions about other aspects of this study. It was important 
to her to investigate Chinese medicine drugs as a whole, which is similar to all of the 
other actors involved in this mode.  
Prof Frank, Kevin, Dr Huang and George’s order of vision presents an involvement in 
Chinese medicine research through their visions, which maintained their passion for 
Chinese medicine. Their visions were personalised medicine, improving healthcare 
systems, acknowledgement and study of complexity and a desire to avoid the 
exploitation of Chinese medicine. The actors had a personal interest in Chinese 
medicine, and they had had a long and sophisticated engagement with Chinese 
medicine up until the point they decided to conduct the study. This enactment was 
influenced by various factors such as disease, method development, family and a desire 
to study Chinese medicine. The actors were interested in the idea of the human body 
and nature as interrelated systems in Chinese medicine. It represented to them an 
alternative to the reductionist paradigm used by science and medicine, as Chinese 
medicine emphasises the complexity of life and nature, as well as considering the 
organism as a system. This group consisted of just a few people that represent the 
initiation of an international research interest in Chinese medicine and systems biology, 
which seems in comparison to the second mode, as a small number. However, Law 
(1994) explains that the proportion of scientific visionaries and the profane are 





8.4 THE MODE OF VOCATION 
 
In the mode of vocation, I address the fourth research question: how did human and 
nonhuman actors become involved in this emergent “interface” and how did the 
different modes change this emergent “interface” between Chinese medicine and 
systems biology? The mode of vocation demonstrates the participation of the actors in 
the outer circle and their involvement in Chinese medicine and systems biology 
research through invitation or employment (see Table 4 for research questions and 
modes). I analysed stories and publications of pharmaceutical scientists, systems 
biologists and Chinese medicine researchers invited or employed by research projects 
as experts, doctoral or post-doctoral students. The outer circle included actors from the 
networks of the Leiden-Dalian co-operation, the Harbin group, the ERC TCM, the 
network organisation and the systems biology experts. Their enrolments happened 
through research projects and omics technology. Some actors presented more than one 
ordering of enrolment. 
 
8.4.1 RESEARCH PROJECTS, PUBLICATIONS AND JOBS  
 
The mode of vocation introduces the actors and illustrates how they became employed 
or were asked to participate in a research project that dealt with Chinese medicine and 
systems biology. The aims and intentions of the enrolled actors, the outer circle, was 
to acquire a degree or a job (PhD, post-doctoral, research fellow) but, however, the 
study of Chinese medicine was not their principal interest. Their supervisors enrolled 
them for a specific research topic. In other words, the students did not actively decide 
to engage in a Chinese medicine research project. The project was monitored by the 
principal investigator or the individual team leaders (these were in most of the cases 
the supervisors) who received the funding. Thus, the principal investigators or 
supervisors represent a “centre of translation” with the task to reflect, self-reflect, 
monitor and control the collaborators and students who performed the study at the 




the representations of the performance of his or her students and collaborators. Based 
on the observations, he or she calculated the next steps in the project. 
Research projects were generated through the visions of the inner circle and their 
publication on Chinese medicine and systems biology research. Research papers as 
“immutable mobiles” informed, interested and enrolled actors into the research and 
funding of Chinese medicine and systems biology. As research papers conveyed the 
ideas of the inner circle, they co-generated the co-operation between the inner circle 
and the ERC TCM. Important actors, and interviewees, for example, Prof Vera 
coordinated the first interactions and co-operation between Austria and China. In her 
function, she co-ordinated and enacted several Memoranda of Understanding for 
Chinese medicine research and controlled and managed the exchange between both 
sides. Through this role, she established contacts with many politicians, scientists and 
practitioners in this research field. These contacts were essential for establishing 
research funding for Chinese medicine in Europe during the 2000s. Hence, Prof Vera’s 
network was important for the ERC TCM consortium which enrolled her as an advisor. 
In comparison, the ERC TCM was enacted by the WHO report and the EU plan to 
research Chinese medicine and enrolled scientists based on their publications which 
discussed Chinese medicine as a good practice research plan. The consortium was a 
“centre of translation” that aided the communication between the EU and China and 
the interest of the WHO and the EU to scientists and researchers, which is shown by 
the fact that there were a total of 200 members that participated in the consortium.  
The students in the outer circle were enrolled through their applications for a PhD or 
post-doctoral position in a research project. As the supervisors organised the projects, 
the students applied for a job in the research project because it used omics technology, 
and not because it was a Chinese medicine study. Hence, the students did not control 
their involvement in the Chinese medicine study. Their supervisors controlled, 
monitored and calculated the student’s projects. For example, Prof Carl described his 
enrolment in Chinese medicine analysis through his supervisor. A political 
arrangement between an entrepreneur, politicians and his supervisor demanded the 
evaluation of Chinese medicinal herbs for use in a TCM hospital. In his words, 
universities were supposed to know everything. Thus, his university had to prove that 




him to generate a plant monograph for a Chinese herb with the chemical analysis by 
using chromatography. The method was the same method his supervisor used for the 
examination of European plants, because chromatography was a commonly used 
method in his sector.  
In ordering terms, Prof Carl’s supervisor represented another “centre of translation” 
that acted between Prof Carl and chromatography. The liquid or thin layer 
chromatography (TLC), which Prof Carl used was cutting-edge technology at that time. 
TLC and advanced versions are still the most important machines in pharmaceutical 
studies (see Leung, Fong and Xue, 2006). Pharmaceutical scientists rarely applied 
systems biology, as they did not need the whole range of omics technology for their 
studies of plants (see Angelova et al., 2008). Prof Carl’s evaluation of a Chinese 
medicine plant depended on the TLC. For the successful examination of Chinese 
medicine plants, he needed TLC technology and the set of ordered relations between 
elements, such as co-operation with other universities, the hospital, the plant, the 
herbal supplier, the funder and the interaction between scientists, the sample 
preparation, the machines, the chemicals, the computer, the cables, the electricity 
network, the software program and the databases to establish a sophisticated analysis 
of the plant’s origin, functions, preparation and dangers. This technology enabled Prof 
Carl to investigate the properties of the Chinese medicine plant he was studying. By 
presenting the findings to his supervisor, Prof Carl reported his progression and further 
steps or adaptions to ensure he finished the project on time. By doing so, his supervisor 
monitored and controlled the project. The results were “immutable mobiles” that 
functioned as proof of his findings for the supervisor’s co-operator. Thus, the findings 
were an effect of the interaction between Prof Carl and technology, between him and 
his supervisor and between his supervisor and the co-operator.  
Prof Carl’s employment demonstrated a number of associations with people and 
machines. According to Law (1994), size is an effect, or a product generated by 
allocation and performances of a phenomenon. Prof Carl decided to participate in the 
already existing co-operation with the network of human and nonhuman actors and 
effectively established the research project and his PhD position. Prof Carl’s 
experience is different to those in the inner circle. Both Dr Huang and Prof Frank (from 




had the technology, a method and their unique expertise. They generated a network of 
funders, collaborators, students, peers and publishers whereas in Prof Carl’s case, the 
co-operation between the university, the TCM clinic and the university in Beijing was 
already established and his supervisor already had a lab, several students and 
technology. The size of Prof Carl’s supervisor’s network was the result of the TLC 
technique which was successfully used to study plants and enticed funders that 
supported previous research and Prof Carl’s project. The Bavarian government was 
the requestor of this research, as a condition for the establishment of the TCM clinic. 
Thus, Prof Carl’s participation was embedded in an established network of various 
actors with the task of examining Chinese medicine plants. Consequently, Prof Carl’s 
project represents a pre-established network of machines and humans that were 
associated with his supervisor’s previous projects and university, which proved to be 
strong and enduring for the Chinese medicine plant study. 
Similarly, the doctoral student Lingma and the post-doctoral student Long were 
enrolled on a PhD and a post-doctoral project. Before their employment in the Chinese 
medicine projects, they demonstrated neither personal nor professional interest in 
Chinese medicine research. Their research projects were effects of the relationship and 
interaction between their supervisor Prof Yu, Prof Frank and Dr Huang (from the inner 
circle), who established the research co-operation for the Chinese medicine diagnosis 
study. In the annual enrolment process at the Dalian university, Lingma and Long 
applied for PhD and post-doctoral research positions in Prof Yu’s lab and their 
engagement in the Chinese medicine project occurred after their acceptance. After the 
completion of their projects, and thus their co-operation, Prof Yu returned to 
biomedical research together with Long and Lingma. This demonstrates that their 
interest was attached to their vocations rather than to the study of Chinese medicine.  
A change in the research engagement changed the relationship between the Leiden-
Dalian co-operation partners. The principal investigators acted as a “centre of 
translations”, as they calculated the project beforehand and monitored its process and 
unfortunately, the interactions changed through inadequate performance and 
communication. For example, besides George’s involvement through his vision, he 
was also enlisted as a PhD student by Prof Frank. George’s story showed that once he 




journal without his or his supervisors’ consent. The publication affected a rewriting of 
his study and weakened his relationship with Dalian. A breach of the agreement was a 
risk that was not included in the calculations of the “centre of translation”. According 
to Law (1994), co-operation and interactions are contingent processes. This means that 
ordering processes are about local not exhaustive processes that are not determining 
how things turn out in general. Law (ibid) suggests committing to an ordering inquiry 
rather than uncovering other root orders. Thus, the co-operation problem could either 
be ordered as a different ordering or as one consequence of the ordering vocation. In 
following the latter, in a recursive procedure, the divergence of the co-operation 
agreement indicates that whatever the calculation of the “centre of translation” was at 
the beginning, the process of ordering was open, and included the risk that the co-
operation partner could counteract their agreement. In the action of the breach of the 
Dalian partner, the data represented an “immutable mobile” that moved in both ways 
between the Dalian and Leiden sites. Consequently, both sides could use the data either 
according to the agreement, and thus just for the co-operation purpose, or for their own 
publication purposes. As the Dalian team followed the latter, the data caused after the 
breach, a re-ordering of the research project by changing the focus of George’s project, 
and inevitably forced him to re-write his findings. However, the Dalian team published 
a paper with data on a novel analysis method.  
The presented mode of vocation talks about research projects and their association 
with technology, collaborators, politicians, funders and the industry. It focuses on an 
established organisation for projects that needs to be filled with researchers. The 
researchers in this mode were skilled, motivated and selected to participate in Chinese 
medicine projects that were controlled and monitored by their supervisors and 
principal investigators. The students described as actors in this research projects 
engaged with their individual projects, but not in the organisation of the co-operation, 
and they were not in control of the topic of their project. Of course, they could have 
rejected the project, however, they did not do so as they related to the projects with 




8.4.2 OMICS TECHNOLOGY, COMPLEXITY AND INDUSTRY 
 
What was demonstrated in most of the stories of enrolment in this “interface” was the 
interest in omics technology. Omics technology was intertwined with the research 
projects. Omics technology and systems biology enabled a new approach to medical 
studies and initiated most of the research projects between systems biology and 
Chinese medicine. As argued in the mode of a heterogeneous network, omics 
technology represents a “centre of translation” between Chinese medicine and systems 
biology. In detail, it facilitated a translation between molecules and zheng. First, omics 
technology enables the researcher to read biochemical data as scientific evidence for 
Chinese medicine, while Chinese medicine researchers translate this data back into 
zheng. Secondly, as a “centre of translation”, omics technology represents a new large-
scale method to study Chinese medicine and to grasp its complexity. Thus, in this 
section, I will start by demonstrating how omics technology was the “centre of 
translation” and how it generated a new way to investigate complex phenomena. This 
is evident in the demonstration of technology as a crucial link for the interaction 
between scientists and Chinese medicine researchers (I elaborated on this in the mode 
of a heterogeneous network – see Section 8.1.2). I will then show how omics 
technology persuaded pharmaceutical scientists and the industry to join the research 
field of Chinese medicine as the scientists were using omics technology as an 
analytical tool. This combination generated funding for research. Finally, I will show 
how omics technology restored the control of Chinese medicine researchers in their 
efforts to promote Chinese medicine studies.  
Omics technology instigated the co-operation between the Leiden-Dalian partners. 
Although the co-operation was initiated through the friendship between Prof Yu and 
Dr Huang, the main interest for the co-operation was technology. I strongly believe 
that the Dalian scientists enrolled in this project because of the technological approach. 
They wanted to learn about the latest omics technology and the use of metabolomics 
analysis. In contrast to the students George, Lingma, Long, Prof Carl, who were 
enrolled through projects, omics technology enlisted higher rank scientists in this 
“interface” such as supervisors, Prof Yu, Prof Jakob and Prof Carl’s supervisor. The 
Leiden scientists presented Prof Yu with their new approach to systems biology and 




one study, which immediately attracted Prof Yu. He participated in the hope to extend 
his technological spectrum from metabolomics to other omics technology and to 
advance his technology-focused research. In this co-operation, the Dalian scientists 
performed their first investigation in Chinese medicine and systems biology. 
Accordingly, omics technology was the “centre of translation” between the Dalian and 
the Leiden team.  
The relationship between Leiden and Dalian represents a hierarchical relationship 
based on analytical knowledge of systems biology research. This arrangement 
happened through the design of the research study by the Leiden team. The Leiden 
team also had the competency to apply systems biology and analytical tools. They 
were experts in biofluid analysis and understood the included devices and their 
technical arrangement. Due to this knowledge, they ranked higher than the Dalian team. 
The co-operation occurred through the interest of the Dalian group in the Leiden 
group’s know-how in the use of biofluid analysis with systems biology. They wanted 
to learn from the Leiden team. Although Prof Yu’s team was not familiar with systems 
biology and Chinese medicine, they started the co-operation. Following this, the 
Dalian team wanted to be trained in biofluid analysis through their co-operation with 
Leiden. Omics technology effectively evolved into a “centre of translation” between 
them and generated training opportunities and new machines for data collection and 
sample preparation of their study.  
The increased focus of the Dalian team on technology caused tensions and a deviation 
from their principal objective, which was studying Chinese medicine with systems 
biology analysis, to omics technology and its application. The deviation was evident 
when the Dalian group failed to fulfil their tasks – these included collecting and 
preparing blood and urine samples and handling them according to the study design of 
the Leiden group. Since the documentation of the investigation was not consistent and 
accurate, the report the scientists produced was incorrect. This caused problems for the 
principal investigators as they could not predict this disruption of the project 
beforehand, but they needed to make new arrangements to solve the issues. The 
solution was to mention in the research paper that the sample data was incomplete, 
thus, they needed to acquire replacement data from different collaborators. Therefore, 




one. As a reaction, George reduced his interaction with the Dalian team, and the 
exchange between the other Leiden students gradually decreased too until the 
completion of the project in 2013 (see Table 2 for the project timeframe).  
In contrast to the Dalian-Leiden co-operation, omics technology generated interactions 
between scientists and Chinese medicine researchers and practitioners, which had not 
happened on such a large and global scale before. By using omics technology, actors 
convinced politicians in the EU and China to establish an international co-operation in 
Chinese medicine research. The ERC demonstrated its interest in Chinese medicine in 
2007. At the centre of their program for Chinese medicine funding was what they 
called a “Translation research on human health” with systems biology in “Traditional 
Chinese Medicine in postgenomic era” (EC, 2007a). In this case, Chinese medicine 
research transformed from understanding Chinese medicine diagnosis with systems 
biology by the Leiden team, to translating Chinese medicine with systems biology. 
This was a result of the scientific reliability of systems biology. Systems biology 
incorporated both, big data and omics technology, and represented to stakeholders, 
funders and the scientific community an assurance as a scientific method to unravel 
the complexity of Chinese medicine. By generating visual models of molecular data 
and comparing them to Chinese medicine zheng patterns, the produced results of the 
first studies confirmed the competence of this method and caused the emergence of 
co-operation between systems biology and Chinese medicine on a molecular level. 
This process joins my argument that this relationship is an interaction between systems 
biology and Chinese medicine on a biochemical level and through omics technology. 
This was also confirmed in research papers as a bridge between metabolomics and 
Chinese medicine (see Wang et al., 2005). 
The Harbin research institution obtained public and industrial funding through the use 
of omics technology. In the late 2000s, the team received most of their funding from 
the Chinese government for their Chinese medicine metabolomics research projects. 
The government designed the funding for fundamental research in Chinese medicine 
with omics technology to conduct and to improve scientific understanding of Chinese 
medicine theories and drugs. This was also an important reason for Prof Yu from the 
Dalian group, to engage with Chinese medicine as it provided him access to a new 




technology as a “centre of translation” functioned as a connection between the interest 
of the Chinese government and scientists, as Chinese medicine research funding was 
tied to omics technology and the funding related to the industry supplied the 
institutions with omics technology. The connection to technology was seen in the 
application of several types of mass spectrometry and gas chromatography purchased 
and partly sponsored by the company Waters Corporation. Every field site in this 
heterogeneous network, which I visited, used Waters Corporation machines, which 
reveals the primacy of the company in this field. The Harbin’s purchase of this 
machine, as I suggest, was a strategic turn to attract the attention of the producer and 
the scientific community working with the same omics technology. The Harbin team 
first secured sponsorship from Water Corporation following numerous publications on 
Chinese medicine studies which mentioned the application of Waters’ machine in their 
methods section. As a result of this, the co-operation with Waters affected scientific 
partnerships, student exchange programs and conferences with researchers working on 
traditional medicines inside and outside of China. 
The second resource of funding in Chinese metabolomics research was the 
pharmaceutical industry in China. The use of omics technology on the analysis of 
Chinese medicine drugs generated a co-operation with producers of Chinese medicine 
pharmaceuticals. The particular interest was in patents. Scientists used omics 
technology to identify useful therapeutic fufangs for issuing patents. The acquired 
licenses generated a small percentage of their research budget, but more importantly, 
in the course of their co-operation, patents were a product of a long-term research and 
co-operation process. Thus, the Harbin group secured a long-term sponsorship from 
Chinese medicine pharmaceutical industry partners in China. What omics technology 
represented here was a link to the industry and economy through the commercialisation 
of Chinese medicine products.  
The increasing number of patents raised the awareness of the actors and the scientific 
community on the exploitation of Chinese medicine and other traditional medicines 
through commercialisation (see, for example, Helman, 2007; Efferth et al., 2018; 
Ansari, 2016, Hao and Xiao, 2014). Patenting traditional medicines entails the risk that 
foreign companies exploit indigenous and traditional knowledge by licensing them as 




revenues with the indigenous community, known as biopiracy (see Helman, 2007; 
Efferth et al., 2018). Against the common purpose of patents to protect innovation or 
an invention of one person or organisation, the patents on traditional medicines extract 
indigenous knowledge from folk remedies or customs, extinct plant species and 
destroy natural resources for the medical supply of the local people (see Efferth et al., 
2018). Patents for single Chinese herbs were first issued in 1924 for the herb Eumenol 
danggui (see Andrews, 2014). However, today, pharmaceutical scientists and 
pharmaceutical companies patent complex Chinese medicine formulae, fufangs (Wang 
and Chan, 2010). For this, only the chemical structures of its major active ingredients 
need to be identified (ibid). Once the active ingredients are found, pharmaceutical 
companies patent the fufang as a drug and by doing so they use the indigenous 
knowledge of people who have always used the drug and relied on its supply for their 
medical needs. Helman (2007) claims that the main issue is that pharmaceutical 
companies benefit financially from the patented drugs and do not share these benefits 
with the indigenous people. An increased production of the patented drug requires 
more resources; thus, it causes the over-harvesting of wild growing medicinal plants 
and therewith less supply for indigenous people, or even the extinction of those plants 
(see for example Leung, Fong and Xue, 2006; Efferth et al., 2018). Thus, Bodeker 
(2006, p. 35) believes that the “interface” (his own word) between Chinese medicine 
and biomedicine is shaped by the competition for shares from patents between non-
indigenous individuals and organisations or indigenous groups.  
The third point is the empowerment of Chinese medicine and researchers through 
omics technology, which translates zheng. The Harbin team demonstrated an 
empowering of Chinese medicine through the interpretation of zheng with omics 
technology. They studied zhengs in various models (i.e., in vitro and in vivo in animal 
and human models) and tried to translate the zheng into molecules, biomarkers, active 
compounds, genes, proteins or metabolites. To enact power omics technology would 
have required the performance of actions. However, omics technology did not act in 
this way as they collected and prepared the samples or operated by themselves. The 
operation and preparation happened with the help of Chinese medicine researchers and 
their knowledge. Thereby, the researchers obtained control of the machine by 
programming and monitoring the crucial functions. Through their interaction, they 




Chinese medicine zheng. In other words, the biofluid analysis presented a pattern in 
the form of graphs and numbers. It translated the zheng into another form or language. 
The researcher reconstructed the zheng by analysing the peaks in the charts and 
determining biomarkers or masses for vitamins, acids, or any other compounds that 
indicated and confirmed the characteristics of the zheng. Another method was 
metabolite profiling. This approach helped to recognise an inflammatory status, to 
count lymphocytes and to measure the differences between them. The application of 
these different methods performed the process of obtaining various representations of 
the pattern and enacted the empowerment of the Chinese medicine researcher. Hence, 
the biofluid analysis results became a representation of zheng, and the analysis of the 
researcher reconstructed the zheng in scientific terms. Accordingly, omics technology 
empowered the Chinese medicine researcher to study Chinese medicine, and through 
interaction with analytical tools and a scientific understanding, the zheng emerged.  
A biofluid analysis with an omics approach included multiple layers and 
“heterogeneous materials” (Law, 1994). Conversely, it excluded anything which 
omics technology cannot yet analyse in a blood or urine sample. Thus, the 
representation of omics techniques data excludes some aspects of Chinese medicine. 
Law (1994) argues that the mode of empowering affects the deletion of something, for 
example, of a low-status work. The exclusion of some aspects in Chinese medicine 
meant that researchers could not study all layers or perspectives of Chinese medicine 
at the same time, which caused the reduction of the complexity in Chinese medicine. 
For example, the Harbin team studied a fufang to find out on which zheng the fufang 
had the best therapeutic effect. With pharmacognosy methods, the Harbin group 
investigated the drug mechanism of a standardised drug that was commonly prescribed 
by Chinese medicine practitioners for more than one zheng. The researchers studied 
the interaction between the drug and the proteins, the genes and the metabolites in a 
human or animal model to detect how the fufang performed on each of these levels. 
The performance revealed on which zheng the medication was the best fit. Another 
option was that the researcher analysed the drug mechanism by identifying how and 
what the drug affected. The mechanism study represented a description of 
transcriptions, repairs, manipulations or influences, which induced the healing process. 
However, it did not represent the interaction between all levels as they were not 




As already indicated in the above-mentioned examples, omics technology had 
limitations in the study of complex issues and systems. Prof Musashi and Prof Meng 
were systems biology experts without having an involvement in the ERC TCM, but 
they became interested in Chinese medicine and Kampo studies. The crucial difference 
in their enrolment through omics technology was that they both independently 
demonstrated an enrolment with omics technology in Chinese medicine or Kampo 
medicine research. They both agreed that omics technology was too limited to 
undertake systems biology research on Chinese medicine. Thereby, this impasse 
represented a challenge for them, which they wanted to meet by assisting with their 
expertise. Both actors visualised systems biology and AI as an advancement in the 
study of Chinese medicine to generate and handle big data of any reported and 
evaluated medicine within less time and less errors. To put this into ordering terms, AI 
is in Prof Musashi’s perception, a “centre of translation” through its calculation speed. 
It controls and monitors any therapy given to the patient considering the symptoms. 
By evaluating those interventions, it immediately acts on them by prescribing different 
drugs or treatments. Therefore, AI represents an appropriate example for a “centre of 
translation” or a control unit that is unbiased in medical evaluation - as long as the AI 
designer is fair and integrates both medical and scientific knowledge. 
The mode of vocation demonstrates that omics technology was an attractor and caused 
the enrolment of various actors. Omics technology was central to the above-presented 
stories as it served as the “centre of translation” to attract funders, collaborators, 
industry and politicians and developed into a requirement for funding applications and 
the study of Chinese medicine in China and Europe. Consequently, omics technology 
made Chinese medicine studies credible, trustworthy and scientific to funders. While, 
this link between Chinese medicine and omics technology created a dependency on 
omics technology in Chinese medicine studies, it also implied that Chinese medicine 
was a weak entity without omics technology, and that the use of omics technology 
empowers Chinese medicine researchers to study their medicine on an equal footing 
as biomedicine, which consequently dismisses its association to quack medicine. The 
actors’ stories demonstrated that the “centre of translation” between omics technology 
and researchers and systems biologists was not limited to one location, one actor or 
one technique as control, calculation and monitoring emerged through various 




8.5 CHAPTER CONCLUSION  
 
In this chapter, I analysed the life stories descripted as codes in the Chapters 4, 5, 6 
and 7 as modes of a heterogeneous network, vision and vocation. These codes were 
used to address the research questions on the term and nature of the “interface” 
between Chinese medicine and systems biology and how it differs from past 
encounters between Chinese medicine and modern science and how the various 
involvements changed and influenced the development of the relationship between 
Chinese medicine and systems biology.  
In the first mode of a heterogeneous network, I demonstrated that various actors 
(practitioners, doctors, physicians, omics technology, concepts, ideas and methods) 
generated and participated in the research co-operation. These were the Leiden and 
Dalian co-operation, the Harbin research group, the university network organisation 
and the international ERC TCM consortium. There were numerous reasons as to why 
the actors became involved in the research of systems biology and Chinese medicine 
and these included: a scientific vision, the desire to take part in a research project and 
wanting to use omics technology. I analysed the involvement in mode of vision that 
presented the emergence of Chinese medicine and systems biology research through 
the scientific visions of the research co-operation of the Leiden group.  
The mode of vocation demonstrated the employment in the research field of Chinese 
medicine and systems biology. The projects described in the mode of vocation derived 
from the initial study of the inner circle and stimulated the participation of actors in 
the Harbin research group, the university network organisation and the international 
ERC TCM consortium. The participation of the actors developed through “immutable 
mobiles” such as research papers, analysis results, biochemistry, experiment protocols, 
biofluids, drugs and bodies and generated together with the co-operation of partners, 
principal investigators and supervisors, the consortium and omics technology a “centre 
of translation”, which globally distributed co-operation between Leiden and Dalian, 





The crucial finding of this research is that Western scientists initiated the research of 
Chinese medicine and systems biology and the different involvement of the actors 
(including omics technology) influenced its development from individual research co-
operation to a globally distributed heterogeneous research network on Chinese 







This thesis aimed to explore the emergent “interface” between Chinese medicine and 
systems biology. In this chapter, I am going to summarise the key findings of my 
research and address the primary research questions:  
1. Is there an “interface” and if so, can this latest contact between Chinese 
medicine and systems biology be referred to as an “interface” and what is its 
nature? 
2. How does this “interface” differ from previous encounters between Chinese 
medicine and modern science and Western medicine? 
3. How did the actors become involved in Chinese medicine and systems biology 
research?  
4. How did the participation of the human and nonhuman actors in Chinese 
medicine and systems biology research influence the development of the 
relationship between Chinese medicine and systems biology? 
Following this, I will show how my research contributes to the field of the history of 
Chinese medicine and STS studies. I will conclude the chapter by outlining the 
limitations of my research and highlighting some areas for future research. 
In Chapter 8, I defined an interface as a heterogeneous network that is composed of 
human and nonhuman actors. The actors in my research were systems biologists, 
Chinese medicine researchers, omics technology (including genomics, transcriptomics, 
proteomics and metabolomics) and biochemistry. All of which were involved in 
various globally distributed research projects on Chinese medicine and systems 
biology. I asked whether the various interactions between Chinese medicine and 
systems biology that have taken place since 2005 constructed an interface. Based on 
the analysis of my ethnography, I can now ascertain that an interface in the form of a 
heterogeneous network did indeed emerge after 2005 through personal and socio-
political interest in Chinese medicine research, and that the heterogeneous network 
does differ from pervious encounters due to the engagement of European systems 




The findings in Chapter 4 clearly show that in 2005, a relationship between Chinese 
medicine and systems biology emerged. Research articles written by various actors, 
political discussions and research projects on systems biology in Chinese medicine 
demonstrated an interest in examining Chinese medicine drugs and practices. An 
analysis with the concept “mode of ordering” a heterogeneous network showed that 
the “interface” was a heterogeneous network of human and nonhuman actors working 
in various research projects. The term “interface” however, was not used by the 
interviewees. They preferred the notion “co-operation”, as a description for the 
interaction between European and Chinese scientists working with systems biology on 
Chinese medicine. Co-operation as the nature of this heterogeneous network 
demonstrated multiple “centres of translations” (Law, 1994) that monitored and 
regulated the interactions between the co-operation partners: Leiden-Dalian group, the 
ERC TCM consortium and the university network organisation. Interactions happened 
through the exchange of students, concepts, omics technology and biochemistry. 
Omics technology and the common language of biochemistry enabled the co-operation 
between Chinese medicine and systems biology.  
The interactions between European systems biologists and Chinese medicine 
researchers, as presented in this heterogeneous network, make a significant difference 
to past encounters. This became apparent when European systems biologists tried to 
engage with Chinese medicine researchers and practitioners on their own terms and 
with Chinese medicine researchers and practitioners in a co-operative environment. In 
contrast, in the encounters of the twentieth century, Chinese medicine scholars either 
implemented Western medicine and science, or the relationship between Chinese 
medicine and Western medicine was coercive, not co-operative (as it later became). 
Subsequently, this heterogeneous network during the 2000s is different from past 
encounters between Chinese medicine and modern science in the twentieth century.  
The findings in Chapter 5 showed that scientific visions of a personalised medicine, 
an improvement of healthcare, the study of complex systems in Western science with 
Chinese medicine, and the avoidance of exploitation of Chinese medicine drugs were 
the main motivations for European systems biologists to engage with Chinese 
medicine. Four European systems biologists looked to the East, like systems scientists 




inspired by the holistic and systems thinking of Chinese medicine. In Chapter 5, I 
showed that systems biologists and Chinese medicine researchers perceive Chinese 
medicine and systems biology as the same, due to their shared ideology of holism and 
systems thinking. However, against the perception of actors, these concepts evolved 
through the process of continuous integration of Western theories in Chinese medicine 
during the twentieth century. While systems biology developed from cybernetics and 
systems science, which were grounded in holistic and systems thinking. As a result, 
the described match (see, for example, van der Greef et al., 2010; Wang et al., 2005; 
van Wietmarschen et al., 2011; Zhang et al., 2012; Hu, 2012) of systems biology 
and Chinese medicine was an effect of these developments.  
The perception that systems biology is a match for Chinese medicine through holistic 
and systems thinking, was one reason for the involvement of European systems 
biologists in Chinese medicine. I analysed the involvement of European systems 
biologists, the inner circle in the heterogeneous network, in Chinese medicine through 
the “mode of ordering vision” (Law, 1994). I demonstrated that systems biologists 
became involved in Chinese medicine research because of their scientific vision, which 
they hoped to fulfil by studying Chinese medicine zhengs and herbs. Their 
involvement illustrated a discontentment with the dominating reductionist paradigm 
in biomedicine and science during the 1990s, which stimulated an interest in Chinese 
medicine. This inner circle was introduced to Chinese medicine through health 
problems, Taijiquan practice, family members and neighbours. Through their 
engagement with Chinese medicine the inner circle gradually changed their mind set 
to holistic and complex thinking, and they changed their research interest from 
biomedicine to Chinese medicine. Thus, the scientific vision of changing the medical 
and scientific systems in Europe, stimulated the inner circle’s involvement in Chinese 
medicine research. 
The professional change of the inner circle to Chinese medicine research happened in 
the context of emerging discussions about the lack of evidence for Chinese medicine 
drugs and practices and their safety in China (see Karchmer, 2010) and Europe (WHO, 
2002). My data showed that socio-political discussions and actions on Chinese 
medicine started in the 1990s and included the Chinese herb Nephrotoxy in Belgium, 




networking funding. These discussions and actions provoked systems biologists and 
European pharmaceutical scientists to conduct studies on Chinese medicine with 
systems biology.  
The inner circle connected systems biologists and Chinese medicine researchers and 
persuaded politicians to invest in their research on Chinese medicine through the 
production of biochemical evidence for the evaluation of the safety, efficacy and 
quality of Chinese medicine drugs with systems biology. Systems biology and omics 
technology were viewed as a tool to realise their visions, and not as a determining 
factor for their involvement. The actors of the inner circle saw biochemistry as a bridge 
between Chinese medicine and biomedicine, and they also believed biochemistry was 
useful to demonstrate their approach to people from outside systems biology and 
Chinese medicine fields. The mode of vision of the inner circle presented an active 
and profound involvement of European systems biologists in Chinese medicine.  
The mode of vocation shown in Chapters 6 and 7 investigated how the relationship 
between Chinese medicine and systems biology developed. The mode demonstrated 
that the inner circle’s research papers on Chinese medicine and systems biology 
increased the interest of politicians in Europe and China and supported various 
research projects. The mode of vocation discovered that pharmaceutical scientists, 
Chinese medicine researchers and biochemists became employed in Chinese medicine 
and systems biology through their research area and ability to engage with omics 
technology. Research projects were mostly linked to co-operation and attracted various 
actors to participate in co-operative Chinese medicine and systems biology research 
that lasted two to six years. The involvement of these actors, however, was passive 
and with little knowledge of Chinese medicine before their participation. These actors 
did not connect Chinese medicine to their private life, as compared to the inner circle. 
Moreover, their commitment to Chinese medicine or systems biology was with their 
job and research skills, and this was evident when they returned to biomedical studies 
or they continued a reductionist paradigm after terminating their projects.  
Omics technology empowered Chinese medicine researchers to prove their theories on 
Chinese medicine (the research on zheng is a clear example). While for the funders, 
industry and politicians, omics technology represented scientific reliability of Chinese 




publication numbers). The co-operation between Chinese medicine and systems 
biology since Wang and her colleagues’ (2005) paper and the ERC TCM funding on 
Chinese medicine and systems biology in 2009, demonstrated that EU politicians, 
funders and scientists, accepted systems biology and omics technology together as a 
Western scientific approach to produce scientific evidence on Chinese medicine. 
Accordingly, the outer circle showed less interest in creating holistic methods and 
concepts to approach the complexity of Chinese medicine. Their research projects 
became a trust-worthy investment for stakeholders to fund Chinese medicine research, 
and by doing so, they boosted Chinese medicine studies on a global platform of 
political, economic and medical intertwining. 
The modes of vision and vocation showed diverse ways and degrees of involvements 
in international networks of systems biology and Chinese medicine research. They 
revealed that scientists engaged differently in the research projects, due to their 
expertise in systems biology or Chinese medicine. The diverse ways transformed the 
relationship between Chinese medicine and systems biology until the completion of 
the ERC TCM project in 2011. The focus of the ERC TCM consortium was on the use 
of “immutable mobiles” (Law, 1994) such as research papers which determined that 
omics technology was the best method to evaluate the quality, efficacy and safety of 
Chinese medicine. In the following project, the assessed methods changed from 
instruments of evidence and evaluation, to models for the modernisation and 
globalisation of Chinese medicine (see for example Li and Su, 2008). As a result, the 
research interest and participation changed increasingly due to these models.  
It can, therefore, be said that the heterogeneous network between Chinese medicine 
and systems biology research is a multi-disciplinary and global network that is 
composed by omics technology, biochemistry, systems biology, pharmacology 
scientists, researchers and politicians. Through the different modes of vison and 
vocation, the development of this heterogeneous network was revealed. For instance, 
the ideas of the inner circle were grounded on the firm beliefs that systems biology is 
a crucial concept when studying Chinese medicine, or that Chinese medicine is key to 
personalised medicine and the reform of healthcare systems. This means that the inner 
circle strived to find a new research model in science, while the outer circle continued 




biology ended. Moreover, rhetoric and achievements of the outer circle stressed the 
technological and scientific development in evidence production for the efficacy, 
safety and quality of Chinese medicine drugs. From my research findings, it was clear 
that the actors became involved in a variety of ways in this this heterogeneous network 
and they shaped its development through their engagement in this heterogeneous 
network. 
My work contributes to the history of Chinese medicine by showing that the scientific 
interaction between the actors from Western science and Chinese medicine changed. 
Compared to the historical encounters found in the twentieth century, European 
scientists engaged with Chinese medicine to gain insights to help establish a 
personalised medicine and to reform the European healthcare systems. Thus, the latest 
interactions aided the actors once they started to understand Chinese medicine and 
meant that they could then learn from it, rather than exploiting its herbal remedies for 
new biomedical drugs. This study answers the call of Chinese medicine researchers 
for a detailed ethnographic study on the emergent “interface” between Chinese 
medicine and systems biology in the past years (Scheid, 2014). The need for a better 
understanding on the ways of how Chinese medicine and technoscience interact, is 
supported by the widely acknowledged need to study medical anthropology at home 
to better understand the influence of biotechnology in science and medicine (Lei, 2014; 
Hadolt, Hörbst, and Müller-Rockstroh, 2012; Chen, 2003; Manderson, Harden and 
Cartwright, 2016; Helman, 2007).  
To answer the call for more detailed research on this “interface”, I employed a multi-
sited ethnography approach to study a globally distributed and heterogeneous 
network between Chinese medicine and systems biology in great depth. I explored 
the emergent heterogeneous network through the involvement of human and 
nonhuman actors, which has never been looked at before. Studies on traditional 
medicine have investigated remedies and their transformation into drugs that comply 
with biomedical and Western market standards (e.g., van der Valk, 2017) or the 
influence of science in traditional medicines (see, for example, Adams, Dhondup and 
Phuoc, 2010; Pordié and Gaudilliere, 2014; McKay, 2010). However, the increasing 
interest in traditional medicine studies and the phenomenon of pharmaceutical 




biomedicine, e.g., Ayurveda, Tibetan medicine, shows the significance of discovering 
the reasons for this change. The empirical findings in this study contribute to the body 
of knowledge on encounters between Chinese medicine and modern science. This new 
kind of interaction between Chinese medicine and systems biology reveals a new 
understanding of how and why systems biologists, pharmaceutical scientists, chemists, 
molecular biologist scientifically engage with Chinese medicine diagnosis and 
practices, Chinese medicine pharmacognosists, its practitioners, and industrials.  
With multi-sited ethnography, nine different field sites that worked with Chinese 
medicine and systems biology were observed (see Table 1 for the fieldwork schedule). 
Seven of them were involved in ERC TCM consortium for the evaluation of Chinese 
medicine with systems biology methods. In the other two sites were systems biology 
experts who used AI and computational modelling to address the challenge of a 
system-level understanding in Chinese medicine studies. I found that systems biology 
was either viewed as a discipline or a method. My fieldwork data reflected the 
incongruent description of systems biology in the literature as a discipline that is 
formed and influenced by the various backgrounds of its researchers (Nersessian, 2017; 
Alon, 2007). The actors described systems biology and their work as either a discipline 
to revolutionize the understanding of biological systems (Kitano, 2002; Bothwell, 
2006) or a discipline between reductionism and holism (Calvert and Fujimura, 2011). 
Accordingly, the actors identified themselves either as systems biologists or they 
applied systems biology methods into their studies.  
The other discoveries I made were that the combination of omics technology and 
biochemistry co-generated with scientific visions the engagement of European 
scientists in Chinese medicine studies, as well as Chinese medicine researchers in 
systems biology. This combination set the groundwork for the co-operation between 
those two fields. Secondly, the interaction between human actors and nonhuman actors 
(i.e., omics technology, biochemistry and biofluid samples) was performed during an 
experiment to acquire data. The relationship was also observed between various sites. 
These were demonstrated as co-operation to either exchange materials or students 
between various locations, such as China and the Netherlands, or actors were dual-
trained in Chinese medicine and systems biology such as in Harbin. Hence, the Harbin 




medicine or systems biology, they merely wanted to co-operate with the 
pharmaceutical industry in China. Finally, for the ERC TCM consortium members, the 
interaction was shown by discussions at conferences and literature reviews on systems 
biology as the best research approach for the evaluation of Chinese medicine.  
This is the first study that has investigated the various involvements of European 
scientists into Chinese medicine research with the lenses of “modes of ordering” (Law, 
1994). I applied Law’s (1994) theory of “modes of ordering” in the context of the 
exploration of this emerging scientific interaction between Chinese medicine and 
systems biology. The theory is based on ethnography (Law, 1994; Mol, 2002; Moser, 
2005) and is useful for organisational studies (Czarniawska-Joerges, 1996) and for 
ordering the life stories of people (Moser, 2005). I organised my material into three 
modes; a heterogeneous network, vision and vocation. By doing so, I discovered that 
what Scheid (2014) describes as an “interface” was a heterogeneous network that was 
co-generated and performed by human and nonhuman actors in various globally 
distributed research co-operation. This follows Law’s (1994) description of 
heterogenous networks as being composed of human and nonhuman actors with the 
inclusion of data from various sites, which are working on Chinese medicine and 
systems biology. Hence, my understanding of a heterogeneous network also relates to 
the function of the ERC TCM consortium as a networking project that identified 200 
scientists worldwide, working on Chinese medicine and systems biology. It 
established itself as an umbrella project above all other existing projects, which were 
created during the time of the consortium. The research into Chinese medicine and 
systems biology peaked with the ERC TCM consortium, which indicates its central 
position in Chinese medicine and systems biology research. The interest and the 
application of systems biology were diverse in this research area and range from a 
technological focus and advancement, to analysing pathways for new drug 
development, to diagnosis studies, to achieving holistic studies and understanding in 
medicine, to eventually publishing papers and obtaining funding. The projects focused 
on various aspects of a zheng and the applications of a fufang on different zhengs, 
which makes it heterogeneous in the participation of actors, as well as in the various 
aspects and distribution of research co-operation and projects. Due to the consortium 
and the various interests that exist in this research field, I interpret this relationship as 




The “modes of ordering vision” is defined by Law (1994) as a person who attracts and 
presents his position in a laboratory through grace, charisma and their scientific visions. 
In my application of modes of vision, I identified that the inner circle of this 
heterogeneous network produced the first studies on Chinese medicine and systems 
biology. They became involved in Chinese medicine research through their scientific 
visions. These European systems biologists wanted to study Chinese medicine 
research to reform European healthcare systems – this is important as understanding 
the interest of Western bioscientists in traditional medicines is rare and hardly 
investigated. They wished to improve the situation in science and healthcare by 
stopping the reductionistic approach in medicine and science, and the exploitative 
approach to Chinese medicine drugs studies. Subsequently, these actors aimed to fulfil 
their visions through a systems biology approach to complex issues, and Chinese 
medicine as a source for personalised diagnosis and a holistic and complex 
understanding. Therefore, visions were embodied in several systems biologists that 
joint their interests and generated the first projects on Chinese medicine and systems 
biology.  
In applying the “modes of ordering vocation” (Law, 1994), I demonstrated that the 
skills and expertise of the actors with omics technology and biochemistry, was crucial 
for their employment in Chinese medicine and systems biology research projects. 
Omics technology was not only the basic technology in systems biology, it also 
evolved together with biochemistry as a communication tool between Chinese 
medicine and systems biology, as well as a motivation tool for employing actors into 
this research field. Omics technology was used for the examination of any study of 
Chinese medicine drug or its practices. It analysed blood and urine samples and based 
on the biochemical analysis data, it generated a network analysis of genetic, protein 
and metabolic relationships that constituted zheng, a symptom pattern. Therefore, 
biochemistry and omics technology provided a crucial method, experiment protocols 
and analysis data that supported the systems biologists claim that they studied Chinese 
medicine because of their common understanding of systems thinking and holism and 





The “modes of vision and vocation” revealed different involvements and various 
motives for research co-operation. The mode of vision showed that active engagements 
with Chinese medicine were well-considered steps in the private and professional lives 
of the actors that involved them and maintained their interest in Chinese medicine and 
systems biology research. While omics technology and biochemistry, co-produced a 
method to evaluate Chinese medicine and attracted systems biologists and Chinese 
medicine researchers for their skills in this research relationship.  
To sum up, as an empirical contribution, I produced a detailed account on the 
involvement of the actors from different scientific backgrounds in various research 
projects on Chinese medicine and systems biology, the challenges they face by taking 
this step, by co-operating in multi-disciplinary research, and the practices they employ. 
In this account, the different involvements of the human and nonhuman actors showed 
that the application of omics technology and biochemistry in Chinese medicine was 
not challenging. However, the enrolment of humans, in particular, European 
pharmaceutical scientists and systems biologists in Chinese medicine research was 
different because humans have goals, intentions, and they evaluate and decide if they 
want to become involved and associated with Chinese medicine. Technology such as 
omics technology was employed in Chinese medicine to make it appear more scientific 
and helped to modernise this medicine. This integration was part of the continuous 
process that started in the twentieth century to modernise Chinese medicine by 
following Western scientific practice. Thus, the involvement of technology as a 
nonhuman actor was an organic development influenced by the political agenda and 
funding requirements which intended to modernise Chinese medicine. However, the 
involvement of systems biologists and Western scientists in Chinese medicine studies 
was until the 2000s uncommon. Thus, I argue that the investigation of involvement 
was essential to understand how this change of interest occurred.  
As presented above, this thesis contributes to the contemporary history of Chinese 
medicine. With the modes approach, I revealed a difference to previous encounters 
between Chinese medicine and modern science. Whereas previously, there was 
primarily only interaction between Chinese scientists and Chinese medicine 
researchers, in the 2000s, European systems biologists and pharmaceutical scientists 




it was clear that in the 2000s, the relationship between Chinese medicine researchers 
and systems biologists was established, on an equal understanding of systems theory 
and holism, and the actors found in systems biology, including omics technology and 
biochemistry, an approach that allowed Chinese medicine to maintain its concepts 
without translation it into the Western scientific context. By doing so, systems 
biologists identified a different way to perform their experiments – for example, they 
no longer extracted active compounds for potential drugs using Western reductionist 
methods. Systems biologists now investigated Chinese medicine with systems 
thinking, using a holistic approach. Hence, European systems biologists demonstrated 
that they were trying to understand Chinese medicine.  
In a historical analysis of the shared root of systems thinking and holism, I discovered 
that the ideas of cybernetics spread into Chinese medicine in the 1950s and lead to a 
co-operation between American and Chinese cyberneticians (see for example the work 
of Norbert Wiener and Li Yurong carried out in 1934 on the control and regulation of 
electronic systems). My study consequently offers insights into the contemporary 
history of Chinese medicine and systems biology, and the ordering of scientific 
engagements with Chinese medicine and systems biology by employing multi-sited 
ethnography. 
This study does not provide an exhaustive account of the entire structure of the 
heterogeneous network between Chinese medicine and systems biology and every 
actor involved in it. Rather, it demonstrates the specific modes that generated and 
represented this network in settings of globally, multidisciplinary and multi-sited 
research co-operation in the specific field of Chinese medicine and systems biology. 
Even though this project offers a great deal of complexity, and the represented modes 
and materials are used in many scientific projects, generalisations were limited due to 
the specific character every mode presented.  
In the future, it would be interesting to examine the involvement of Western scientists 
in studies on Chinese medicine practice such as acupuncture, Tuina and Qigong and 
other traditional medicines to establish whether these findings of scientific vision, 
personal connection to traditional medicines, and vocation are applicable to other 
settings and whether new findings emerge. Another possible area of future research 




influence of technological advancements in AI and what knowledge of these medicines 
will be included and excluded for establishing a new and faster AI diagnostic system.  
There were two main limitations in this study. First, I analysed Chinese medicine 
pharmaceutical studies in the absence of voices from acupuncture, Tuina and other 
Chinese medicine practices in this heterogeneous network. The reason for this 
limitation was the sparse involvement of those researchers in this heterogeneous 
network as it was dominated by drug researchers and these who were involved did not 
grant access to their research institutions. Thus, a greater focus on various Chinese 
medicine practices could produce findings that account for the value of Chinese 
medicine practices.  
The second shortcoming may be identified with regards to the selected methodological 
approaches. It may be argued that fourteen interviews are not enough to present the 
perceptions of the actors and demonstrate the historical process. A larger sample of 
interviews would undoubtedly increase the reliability of the findings. In addition to 
this, to generalise the involvement of European systems biologists in the research of 
Chinese medicine, the number of presented samples in this study might be questioned. 
However, the intention was to identify the key actors that initiated the study on Chinese 
medicine and systems biology actors and collect their stories. Indeed, for a 
generalisation of the involvement of European systems biologists, a larger sample 
would be needed.  
My study shows that various actors became differently involved in Chinese medicine 
and systems biology research, and their type of involvement shaped this research co-
operation. For the first research question, it is clear that an scientific relationship 
emerged, which was demonstrated in the interviews, research publications and co-
operation that took place between 2005 and 2015. However, this relationship was not 
an interface between human actors - it appeared as a globally distributed network of 
co-operation and interactions between human and nonhuman actors. For the second 
question, my results showed that the European systems biologists initiated the research 
on Chinese medicine with systems biology, because of a shared ideology of systems 
thinking and holism. These shared ideologies were crucial to establishing, based on 
this common ground, an interaction between systems biologists and Chinese medicine 




personally involved in Chinese medicine through visions of a personalised medicine, 
the desire to perform holistic research or the want to practice holistic medicine and 
science. With these intentions, the actors began working on their first Chinese 
medicine and systems biology project. The fourth question showed that the after the 
first project was established the number of projects increased, and the actors clearly 
became involved because of their expertise and skills in biochemistry and omics 
technology. It later became apparent that omics technology was the main reason why 
scientists decided to participate in Chinese medicine research with systems biology.  
To recap, the suspected “interface” between Chinese medicine and systems biology is 
a heterogenous network that consists of various actors and various research co-
operation between China and Europe. The heterogeneous network emerged from an 
interest in the personalised diagnosis of Chinese medicine, and developed into 
evaluations on the effect of Chinese medicine drugs on living organisms using 






APPENDIX A: DETAILS OF THE FUNDING GIVEN BY THE 
NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA 
(NSFC) 
 
Below you can find information about the research funding structure of the NSFC 
in China, and how it co-operated with the EU and European countries.  
 
The five Chinese research projects in Chinese medicine and/or systems biology 
selected for this dissertation (i.e., Lipidomics research, Chinese metabolomics, in vitro 
fertilisation and the fast examination kits) were all funded by the most significant 
funding agency in China, the NSFC. The NSFC is modelled on Western research 
funding agencies and directly financed by the State Council (highest governmental 
institution). In 2012, they announced that they would spend EUR 3,05 billion (GBP 
2,7 billion) to fund a number of natural science research projects. Of the proposals they 
received, 22.88% were for projects concerning Life Sciences and 18.79% for Health 
Sciences (ESC, 2014).  
According to the NSFC funding guideline (NSFC, 2016), funds were divided into three 
sectors: the research promotion, talent fostering and infrastructure construction for 
basic research. Of the five research programs under consideration for this thesis, 
promotion and talent fostering were the most relevant. They are divided into several 
themes and are described below: 
• Research promotion was divided into: 
o General Programs with a total funding of 50% of NSFC total funding. 
The funds were applied to unsolicited small basic research on bottom-
up based topics initiated by a principal investigator (PI) (i.e., senior 
researcher or PhD degree holder) in natural science projects. This 
covered projects on Chinese medicine research, Chinese materia 





o Key Programs supported medium-sized in-depth, systematic and 
innovative research that aimed for high good research practice and new 
disciplines, which were conducted in one research institution and 
within the priority area of the NSFC. 
o Major Program and Major Research Plan which included funding 
for large projects grounded in the economic and social development of 
national priority areas and included three programs: Fostering Program, 
Key Program and Integrated Program. 
Chinese medicine projects are regulated under the General Program under the 
Department of Health Sciences in Division X (NSFC, 2016). In 2016, The NSCF 
funded the following three research areas in Chinese medicine: (i) Traditional Chinese 
medicine and advancing of theories, clinical medicine, acupuncture and other 
ethnomedicine, (ii) Chinese Materia Medica, pharmacology and ethnopharmacology, 
and (iii) Integrated Chinese and Western Medicine (IM) with fundamental theories, 
clinical research and methodological and technical innovations in Chinese medicine 
(NSFC, 2016). In 2016, the NSFC required the integration of Chinese medicine theory 
in holistic studies with the use of cutting-edge technology (ibid). The Key Program 
includes two thematic areas concerning Chinese medicine: (i) biological study on 
correlations in classical formulas and TCM syndromes, (ii) toxicological analysis and 
clinical effectiveness in Chinese drugs.  
Furthermore, the NSFC funds international co-operation with researcher mobility and 
joint international research projects under the Major Program, as explained above. The 
five research projects under consideration of this study obtained funding from the 
following two talent fostering programs.  
• Talent fostering programs:  
o The Key International (Regional) Joint Research Programs are 
fostering programs that include major international joint research 
programs and joint research projects. These were established on 
Agreements/Memoranda of Understanding (MOUs) between the NSFC 
and the foreign partner. Applicants were expected to research in areas 
that were urgently needed to develop in China. The projects were 




researchers to conduct their research in overseas institutions. This Key 
International Cooperation Exchange Program supported student 
exchange of the Dalian-Leiden co-operation (see Chapter 6 for more 
details).  
o The International (Regional) Cooperation and Exchange Program 
under Agreements/MOUs supported international co-operation and 
exchange projects including going abroad to attend international 
academic workshops and a special fund for a short-term return of 
overseas Chinese scholars to work in China. This sponsored the 
exchange for the Dalian group with Leiden and the Harbin team with 
Japan (as described in Chapter 6).  
The Joint Research Programs run by the NSFC and ERC, offered financial support of 
between RMB 1 - 3 Million for five to twenty projects per year. The costs were shared 
between the NSFC and the ERC. The NSFC supported the travel aspect which included 
relocation costs, and the ERC covered the scientists’ local costs. In the example of the 
Dalian and Leiden co-operation (see Chapter 6), the agreement between the NSFC and 
the Netherlands Organization for Scientific Research (NWO) regulated the (i) 
exchange of short-term academic studies on a common interest, (ii) personal exchange 
of up to three months and (iii) bilateral workshops between scientists of the two 




APPENDIX B: TOPIC GUIDE FOR SEMI-STRUCTURED 
INTERVIEWS 
 
Below the topics, I used to guide my semi-structured interviews with the four 
gatekeepers.  
 
• Introduction and personal position in the field: 
o Can you tell me about yourself, your (academic) background and your 
expertise? 
o Can you tell me about your research? 
o Do you have any experience in Chinese medicine/systems biology? 
• Involvement in systems biology/Chinese medicine research: 
o Can you tell me about the Chinese medicine and systems biology 
research project you were involved? 
o How and when did you find out about the Chinese medicine/systems 
biology research project on which you are worked? 
o How and when did you become involved in systems biology/Chinese 
medicine project? 
o How did others become involved in the project? 
• Project or consortium structure and organisation: 
o How was the project team/consortium assembled? 
o Did you collaborate with other departments/laboratories/industry for 
this project? 
o How many students/researchers worked in your project? What was 
their background? 
o How did you select your partners to work on your project idea? 
o Were you approached by someone else to participate? 
o How did you locate the other researchers with whom you co-
operate/co-operated on the project? 
o Can you tell me about the management structure?  
o Who controlled and monitored the consortium/projects? 
o How was the work allocated between the partners? 




o Was there any problem with the co-operation partners? 
o What is your current project on? 
o Can you tell me more about the reason for this topic and the research 
design? 
• Funding:  
o How was the project funded?  
o Were there any alternative funders? 
o Who was involved in writing the proposal for your project/consortium? 
o Did you interact with funding bodies? Did you report to them? 
• Definitions and perceptions: 
o How do you define systems biology/Chinese medicine? 
o How do you think do Chinese medicine and systems biology relate to 
each other? 
o Why do you think is in particular systems biology the right approach 
for Chinese medicine research? 
• Experience and reflection on the Chinese medicine/systems biology project: 
o What was your experience with the project X? 
o What was your experience with the co-operation partners?  
o How would you describe the Chinese medicine and systems biology 
relationship? 
o How did the project develop? 
o When did this the first projects on Chinese medicine/systems biology 
start? 
o Who initiated the first project?  
• Future outlooks for Chinese medicine/systems biology research? 
o What do you expect from systems biology/Chinese medicine research? 
o What do you think about the acceptance of systems biology/Chinese 
medicine research by other natural science fields? 
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APPENDIX C: PARTICIPATION INFORMATION SHEET  
 
Elucidating the Relationship between Chinese Medicine and Systems Biology 
Researcher:   ____________________________  
Supervisors: ____________________________, ___________________________ 
You are invited to take part in a research study on systems biology (following just SB) 
and Chinese medicine (CM), which involves conducting participant observation in 
research laboratories, workplaces, conferences, workshops, meetings, or any other 
place and event and interviews. There is evidence form many studies on CM herbal 
remedies, acupuncture, and diagnosis with omics technology that CM and SB interact 
with each other. The aim of this research is to elucidate this “interface” between CM 
and SB, and also to demonstrate whether or not it differs from previous encounters 
between CM and biomedicine.  
 
This research is being undertaken as part of the researcher’s studies for a doctoral 
research programme at the university. 
The study will involve you: 
1) Participating in observations. The researcher will take part in the participant’s daily 
working live as a participant observer in order to understand how and where SB and 
CM are interfacing. The researcher may ask questions to the participant and other 
persons in the field. This will take around one or two months to complete. 
2) Participating in an interview with the researcher, about your professional position 
in this “interface” and your relationships with SB or CM. This will take about 1 hour 
and will be tape-recorded. The recording will be transcribed, and the audio recording 
retained by the researcher as part of this research without access of any third person. 
Please note: 
• Your participation in this research is entirely voluntary. 
• You have the right to withdraw at any time without giving a reason. 
• You have the right to ask for your data to be withdrawn as long as this is 
practical, and for personal information to be destroyed.  
• You do not have to answer particular questions in observations or in interviews 




• Your responses and your present research data will normally be made 
anonymous, unless indicated above to the contrary, and will be kept 
confidential unless you provide explicit consent to do otherwise, for example, 
the use of your image from photographs and/or video recordings. [NOTE: In 
case it may not be possible to maintain confidentiality in certain circumstances, 
you should seek clarification from the researcher and/or their supervisor if you 
are concerned about this]. 
• No individuals should be identifiable from any collated data, written report of 
the research, or any publications arising from it. 
• All computer data files will be encrypted, and password protected. The 
researcher will keep files in a secure place and will comply with the 
requirements of the Data Protection Act.   
• All hard copy documents, e.g. consent forms, completed questionnaires, etc. 
will be kept securely and in a locked cupboard, wherever possible on 
University premises. Documents may be scanned and stored electronically. 
This may be done to enable secure transmission of data to the university’s 
secure computer systems. 
• If you wish you, can receive information on the results of the research. Please 
indicate on the consent form if you would like to receive this information. 
• The researcher can be contacted during and after participation by email 
(s.glatz@westminster.ac.uk) or by telephone (0044 7479 208121). 
• If you have a complaint about this research project, you can contact the project 
supervisor, {Volker Scheid} by e-mail (v.g.scheid@westminster.ac.uk) or by 




APPENDIX D: CONSENT FORM  
 
Title of Study: Elucidating the Relationship between Chinese Medicine and Systems 
Biology  
 
Lead researcher: _____________________________________________________ 
 
I have been given the Participation Information Sheet and/or 
had its contents explained to me.  
 
Yes  r No  r 
I have had an opportunity to ask any questions and I am 
satisfied with the answers given. 
 
Yes  r No  r 
I understand I have a right to withdraw from the research at 
any time and I do not have to provide a reason. 
 
Yes  r No  r 
I understand that if I withdraw from the research any data 
included in the results will be removed if that is practicable   
(I understand that once anonymised data has been collated 
into other datasets it may not be possible to remove that data). 
 
Yes  r No  r 
I would like to receive information relating to the results from 
this study. 
 
Yes  r No  r 
I wish to receive a copy of this Consent form. 
 
Yes  r No  r 
I confirm I am willing to be a participant in the above research 
study. 
 
Yes  r No  r 
I note the data collected may be retained in an archive and I 
am happy for my data to be reused as part of future research 
activities.  I note my data will be fully anonymised (if 
applicable). 





Participant’s Name:  ____________________________ 
 
Signature: ____________________________ Date: _______________ 
 
This consent form will be stored separately from any data you provide so that your 
responses and data remain anonymous. 
____________________________________________________________________ 
I confirm I have provided a copy of the Participant Information Sheet approved by 
the Research Ethics Committee to the participant and fully explained its contents. I 
have given the participant an opportunity to ask questions, which have been 
answered.  
 
Researcher’s Name:  ____________________________  
 






APPENDIX E: STATISTICS ON ASIAN STUDENTS AT THE 
UNIVERSITY OF SALZBURG IN 2000/2001 
 


































































































































































































































































































































































































































































































































































































































































































































































































































































































bagang bianzheng 八纲辨证 
classification of syndromes according to the eight 
principles: yin and yang, exterior and interior, cold 
and hot, depletion and repletion (see Farquhar, 
1994). 
biantong 变通 the process of change and transformation (Scheid, 
2016) 
bianzheng lunzhi 辨证论治 pattern differentiation and treatment determination (Farquhar, 1994) 
changshan 常山 Dichroa febrifuga 
chijiao yisheng 赤脚医生 Barefoot doctors  
daojiao 道教 Daoism, Chinese philosophy, Taoist religion 
duili tongyi 对立统一 unity of opposites (Scheid, 2016) 
fangji 方剂 large repertoire of “formulae” or drug prescriptions or recipes (Farquhar, 1994) 
fen fang ji 粉防己 Aristolochia plant (Debelle, Vanherweghem and Nortier, 2008) 
fufang 复方 Chinese medicine multiple herb prescriptions or formula (Wang and Chan, 2010) 
guifanhua 规范化 standardisation   
guocui 国粹 national essence 
guoyi guan 国医官 Institute of National Medicine 
guoyi yundong 国医运动 National Medicine Movement  
han fang ji 汉防己 Stephania tetrandra plant (Debelle, Vanherweghem 
and Nortier, 2008) 
huanyuan lun 还原论 the theory of return to the original condition or 




jingluo 经络 meridian, main and collateral channels 
kejiao xingguo 科教兴国 Rejuvenation of the country through science and technology 
kexue 科学 science 
laozhongyi 老中医 senior doctors  
lixinji 离心机 centrifugal machine, centrifuge 
neike 内科 department of internal medicine  
qi 气 the concept of energy being active and a material (see Farquhar, 1994) 
qigong 气功 Chinese medicine practice, bodily cultivation (Xu, 1999) 
quanpan xihua 全盘西化 wholesale westernisation 
sai xiansheng 赛先生 Mr Science 
san tiao daolu 三条道路 three-pillar system  
shenjing bingli xue  
神经病理学 neuro-pathology theory  
sizhen 四诊 
four methods of examination: observation (wang 
望), auscultation and olfaction (wen 闻), 
interrogation (wen 问), touching pulse feeling and 
palpation (qie 切) (Farquhar, 1994) 
Taiji 太极 
the supreme ultimate, the great pole as the two 
extremes or contradictions of the absolute in ancient 
Chinese cosmology (see Schroën et al., 2014) 
Taijiquan 太极拳 Chinese medicine physical movement, martial art (shadowboxing) (Xu, 1999) 





interpenetration of opposites to grasp the dynamic 
of the relationships that constitute the world 
(Scheid, 2016). 
tuina 推拿 Chinese medical massage (Zhan, 2001) 
wuxing 五行 
five Elements, originally with emphasis on the five 
phases in the relationships between body and 
nature. Since the start of the publication of the 
Outline (1958), it has focused on five visceral 
functions and physiological transformations of 
substances (see Scheid, 2002a; Hsu, 1999) 
xitonghua 系统化 systematisation  
xuewei 穴位 acupuncture point 
yin/yang 阴阳 
the concept of polarities to describe extreme points 
such as hot and cold as a medical analysis technique 
(see Farquhar, 1994). 
Yinchenhao tang 茵陈蒿汤 Virgate Wormwood decoction to treat yang jaundice (Wang, Zhang and Sun, 2012) 
zheng 证 pattern or symptom (Farquhar, 1994) 
zhengti guannian 整体观念 
translation of holism in 1950s, zhengti stands for 
the “whole”, guannian is translated as the “direction 
of one’s attention” (Scheid, 2016) 
zhongxiyi hezuo 中西医合作 Co-operation between Chinese and Western Medicine  
zhongxiyi jiehe 中西医结合 integrating Chinese and Western Medicine 
zhongxiyi tuanjie 中西医团
结 
unifying Chinese and Western Medicine 
zhongyixue gailun 中医学概
论 
Outline of Traditional Chinese Medicine  





ANT Actor-network theory 
CAM Complementary and alternative medicine 
CCP Chinese Communist Party 
CM Chinese medicine 
CMP Chinese medicine pharmacotherapies   
EBM evidence-based medicine 
EPC European Pharmacopoeia Commission 
ERC European Research Council 
ERC TCM 
European Research Council Traditional Chinese 
medicine consortium 
EU European Union 
HGP Human Genome Project 
HLPC High-Liquid Performance Chromatography 
ISO International Organisation for Standardisation  
MAAH Medical anthropology at home 
MOH Chinese Ministry of Health 
MOST Chinese Ministry of Science and Technology 
MOU Memorandum of Understanding 
NSFC National Science Foundation of China 
PRC People’s Republic of China 





State Administration of Traditional Chinese 
Medicine 
SB systems biology 
SFDA State Food and Drug Administration 
STS Science and Technology Studies 
TCM Traditional Chinese medicine 
UPLC Ultra-High Performance Liquid Chromatography 
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